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Abstract 
 
This thesis examines the design, synthesis and biological applications of a series of 
inhibitors which incorporate an azobenzene photoswitch, a peptidyl backbone and a 
trifluoromethyl ketone warhead. The photoswitch can be isomerised by irradiation with 
UV or visible light and has been employed to modulate the reactivity of the enzyme. 
 
Chapter one gives a brief outline of some of the important areas related to this work. 
Examples of previously utilised photoswitches as well as some background on serine 
protease and the uses of fluorine in medicine have been covered. 
 
Chapter two outlines the synthesis of the key trifluoromethyl carbinol 2.6 by two different 
methods. The condensation of a fluorinated aldehyde with a nitroalkane affords an α-nitro 
trifluoromethyl carbinol which can be reduced to give the desired amine 2.6. Treatment of 
oxazolones with trifluoroacetic anhydride via a modified Dakin-West reaction gives 
trifluoromethyl ketones which can be reduced to give trifluoromethyl carbinols. 
 
Chapter three investigate the synthesis of substituted stilbenes and phenanthrenes as 
alternative molecular switches to azobenzenes. Molecular modelling of phenanthrenes 
suggests they may be suitable mimics of E-azobenzenes. 
 
Chapter four outlines the synthesis of a series of mono and disubstituted azobenzenes by 
direct sulfonation of azobenzene or by condensation of nitroso arenes with aryl amines. 
The switches incorporate one or two peptidyl residues designed to improve specificity 
towards the enzyme. 
 
Chapter five examines the photoisomerisation of eight potential inhibitors by irradiating 
with UV or visible light. Irradiation with UV light enriches the sample to give 78-93 % of 
the Z-isomer. Irradiation with visible light gave photostationary states with 14-21 % Z-
isomer. Ambient photostationary states are ca. 22 % Z-isomer.  
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Chapter six looks at the testing of five trifluoromethyl ketones as potential inhibitors of α-
chymotrypsin. The inhibitors vary in substituents, substitution patterns and chain length. 
The inhibitors were tested at both ambient and Z-enriched photostationary states and were 
found to exhibit slow binding kinetics. In all cases the Z-enriched inhibitor solution was at 
least 3-fold more potent than the ambient solution. 
 
Chapter seven is an experimental chapter and outlines the synthesis of the compounds 
prepared in this thesis. 
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Abbreviations 
 
δ  chemical shift 
∆  change or heat (depends on context) 
ε  molar absorptivity coefficient 
Ar  aryl 
Az  azobenzene 
Boc  tert-butoxycarbonyl 
BOP benzotriazol-1-yloxy-tris(dimethylamino)phosphonium 
hexafluorophosphate 
br  broad (in NMR) 
ca.  circa 
Cbz  benzyloxycarbonyl 
d  doublet (in NMR) 
dd  doublet of doublets (in NMR) 
DCC  dicyclohexylcarbodiimide 
DCM  dichloromethane 
DIPEA N,N-diisopropylethylamine (Hünigs base) 
DMA  N,N-dimethylacetamide 
DMF  N,N-dimethylformamide 
DMSO  dimethylsulphoxide 
EDCI  1-ethyl-3-(-3-dimethylaminopropyl)carbodiimide 
EI  electron impact ionisation 
eqm  equilibrium 
equiv  equivalent(s) 
Fmoc  9-fluorenylmethoxycarbonyl 
h  hour 
HATU O-(7-Azabenzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium 
hexafluorophosphate 
HEH  diethyl 1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate  
HEPES N-(2-hydroxyethyl)piperazine-N’-2-ethanesulfonic acid 
HMPA  hexamethylphosphoric triamide 
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HOBt  1-hydroxybenotriazole 
HRMS  high resolution mass spectrometry 
IR  infrared 
J  coupling constant (in NMR) 
Leu  leucine 
LRMS  low resolution mass spectrometry 
m  multiplet (in NMR) 
min  minute(s) 
mp  melting point 
NMR  nuclear magnetic resonance 
Ph  phenyl 
Phe  phenylalanine 
Phen  phenanthrene 
Phth  phthalimido 
ppm  parts per million 
PSS  photostationary state 
py  pyridine 
q  quartet (in NMR) 
rt  room temperature 
s  second or singlet (in NMR) 
t  triplet (in NMR) 
TBAF  tetrabutylammonium fluoride 
TBDMS tert-butyldimethylsilyl 
TEMPO 2,2,6,6-tetramethylpiperidin-1-oxyl 
TFMC  trifluoromethyl carbinol 
TFMK  trifluoromethyl ketone 
THF  tetrahydrofuran 
TRIS  tris(hydroxymethyl)aminoethane 
UV  ultraviolet 
Val  valine 
vis  visible 
v/v  volume per volume 
w/v  weight per volume 
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Introduction 
 
1.1 Overview 
 
The focus of this thesis is to prepare a series of inhibitors of α-chymotrypsin which 
incorporate a molecular switch that can be modulated by external stimuli to alter the 
reactivity of the target molecule. This modulation can be necessary if the molecule is too 
reactive, as this can result in undesirable side reactions which lead to depletion of the 
reactive species. On the other hand, if a molecule is too stable it may not perform its 
necessary function until some modulation of reactivity has occurred.  
 
An important area in this field is the modulation of enzyme activity by introduction of 
molecules that can interact with the enzyme. Usually this is in the form of an inhibitor 
which decelerates or inactivates the function of the enzyme. Inhibitors that are unreactive 
before reaching the active site of the enzyme but can be activated on demand would be a 
desirable trait.  
 
Efforts to this effect have been pursued by our group for a number of years to prepare 
compounds whose latent reactivity has been masked in some way. Under the right 
conditions the latent reactivity is unleashed within the molecule and the activated species 
can perform its designated function. One such example is the work on hydroxymethyl 
pyrole 1.1 which is transformed into the reactive azafulvene 1.2 in the active site of the 
enzyme. The azafulvene is attacked by a nucleophilic residue on the enzyme and forms a 
covalent linkage which deactivates the enzyme 1.3 (scheme 1.1).1 
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Scheme 1.1. Mechanism based inhibition by hydroxyalkyl pyrole 1.1. 
 
Further work by our group has investigated the modification of enzyme reactivity by 
synthesising inhibitors based around an azobenzene photoswitch.2 The conformation of the 
photoswitch can be altered by irradiation with UV or visible light to give a photostationary 
state comprised of a mixture of E- and Z-isomers (fig. 1.1).  
 
NN
R
R'
N N
R
R'
hv
hv'
 
Figure 1.1. E-Z isomerisation of azobenzenes. 
 
If one conformation of the azobenzene inhibitor is found to decreases the enzyme activity 
more than the other we can regulate the enzyme activity by altering the composition of the 
photostationary state. 
 
 
1.2 Light  
 
Diverse biological processes are triggered by light signals. Some of the more important 
processes include photosynthesis, vision, photomorphogenisis and conversion of light 
energy into chemical energy.3 Bioactive materials have many potential uses such as in 
optical signal recording, biosensors and biochemical probes and are of particular interest as 
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target-activated therapeutic substances. An important feature of all these processes is that 
they all contain a chromophore that upon absorption of light, activates a series of chemical 
transformations within the chromophore.4  
 
As well as biological processes, light plays an important role in organic photochemistry. It 
is used to effect pericyclic (electrocyclic) reactions5 and cis-trans isomerisations (fig. 1.2) 
in compounds that contain C=C, C=N and N=N moieties such as alkenes, imines, oximes 
and diazo compounds.6  
 
X Y R'R R
X Y
R'
hv
∆
X = C, N
Y = C, N
 
Figure 1.2. cis-trans Isomerisation of double bonds. 
 
By using these small organic molecules as simple models of more complex biological 
systems, scientists can examine the interaction of light with synthetic models and the 
interaction of these synthetic molecules with biomolecules in an attempt to improve our 
understanding of the truly complex and diverse nature of biological systems. 
 
 
1.3 Photochromism 
 
1.3.1 Bioswitches 
 
For a molecule to be termed photochromic, certain criteria need to be fulfilled: 
 
(i) The molecule requires a photoisomerisable chromophore 
(ii) The photoisomerisation must be reversible either by photonic excitation or 
thermal relaxation 
A Bhv
hv' or ∆
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(iii) The two states must have distinguishably different absorption spectra 
 
The method by which A is transformed into B (cis-trans isomerisation, ring 
opening/closing etc) is unimportant. Provided B reverts exclusively to A the criteria for 
photochromism is met.  
 
A photochromic molecule can exhibit properties analogous to a switch. Like a switch it has 
two states, ‘on’ and ‘off’. If this rationale is applied to a photobiological switch that acts 
on an enzyme the ‘on’ state allows the enzyme to function as normal, but when the 
photobiological switch is triggered to the ‘off’ position the enzyme is deactivated. 
 
Properties that would make the photochromic molecule useful as a biological photoswitch 
include: 
 
(i) The dipole moment and molecular structure exhibit significant difference 
between the ‘on’ and ‘off’ states 
(ii) The thermal back reaction is sufficiently slow that the molecule can have a 
lasting effect on the enzyme 
(iii) The reverse reaction can be induced photochemically 
(iv) The inactive form (‘off’) contains negligible amounts of the activating (‘on’) 
form 
(v) The synthesis of the photochromic molecule is relatively simple and can be 
obtained in a pure state 
 
1.3.2 Reversible photoisomerisable switches 
 
There are various classes of compounds that undergo reversible photoisomerisation. Many 
of these fit the criteria for photobiological switches and have been applied to biological 
systems. A few representative examples have been included below. 
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Photochemical (4n + 2)π electron ring opening and closing 
 
Diaryl arenes such as stilbene 1.4 undergo reversible cis-trans isomerisation about the 
double bond, however, cyclisation to the dihydrophenanthrene 1.5 can occur. The reverse 
reaction can occur thermally or photochemically to give a photostationary state comprising 
E- and Z- isomers. The major fatigue pathway for this process is the photooxidative 
reaction which leads to the irreversible formation of phenanthrene 1.6. The photochemistry 
of these compounds is discussed further in section 3.2. 
 
H Hhν
conrotation
O2
1.4 1.5 1.6
 
Figure 1.3. Cyclisation of cis-stilbene. 
 
Compounds such as 1.7 and 1.9 have been synthesised which undergo light induced ring 
opening and closing and show greater resistance to photofatigue than stilbenes. The 
diarylethene 1.7 is a P-type (photoisomerisation only) dye which has a coloured and non-
coloured form. The colour develops in the cyclised form due to increased conjugation in 
the ring. Spirooxazine 1.9 is a T-type (photo or thermal isomerisation) dye which becomes 
coloured upon ring opening (fig. 1.3).7 Compounds based on 1.7 have been used to form 
molecular ‘tweezers’ and molecular wires.8 
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Figure 1.3. Ring opening and closing of 1,2-dithienylperfluorocyclopentene 1.7 or spirooxazine 1.9. 
 
The thiophenefulgicide 1.11 and nitrospiropyran 1.13 (fig. 1.4) have been bound to lectin 
concanavalin A to alter the binding properties of two pyranose sugars α-D-mannopyranose 
and α-D-glucopyranose. 
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O O
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N
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Figure 1.4. Ring opening and closing of thiophenefulgicide 1.11 and nitrospiropyran 1.13. 
 
Thiophenefulgicide 1.11 electrocyclised after irradiation with UV light where as 
nitrospiropyran 1.13 ring-opened upon irradiation with UV light. Both processes were 
reversible upon irradiation with visible light and in both cases the cyclised form exhibited 
enhanced binding of the monosaccharides.3 
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Isomerisation about double bonds 
 
Azobenzenes and stilbenes undergo isomerisation about a double bond. The 
photochemistry is discussed for each in sections 5.2 and 3.2 respectively. Imines 1.15 and 
oximes 1.16 can undergo cis-trans isomerisation across the double bond but neither type of 
compound would be particularly useful as a biological photoswitch as imines are prone to 
hydrolysis and oximes can undergo a Beckman-type photorearrangement to give an amide 
(fig. 1.5).6 
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Figure 1.5. Isomerisation and degradation of imines and oximes. 
 
The indigos 1.17 can also isomerise about a carbon-carbon double bond but the overall 
structural change is minimal and therefore not suitable as a biological photoswitch. 
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O O
E-1.17 Z-1.17
 
Figure 1.6. Isomerisation of indigo. 
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1.4 Photoregulation of Enzyme Activity 
 
The aim of this project is to prepare molecules containing a photoswitch that undergoes 
light induced photoisomerism between different conformations (e.g. cis and trans isomers) 
to regulate the binding and release of the photoactive molecule to the target enzyme. The 
photoactive moiety can be incorporated into the system in several ways: 
 
(i) Attached to the enzyme through residues in the active site  
(ii) Attached to the protein backbone of the enzyme 
(iii) Covalently linked to the inhibitor that can bind to the enzyme 
 
Methods (i) and (ii) are ways of altering the shape of the enzyme by disrupting folding 
patterns and changing hydrophobic interactions.  
 
This project looks at option (iii) as it is a way of altering the shape of the inhibitor, 
hopefully allowing an active and non-active or on/off form of the inhibitor. Examples from 
the literature are discussed in section 5.2.2. The advantages of this approach are that the 
native structure of the enzyme is not disturbed. Attaching a photoswitch to the enzyme 
directly can cause perturbations to the native structure and therefore reduce the native 
activity of the enzyme irrespective of the conformation of the switch.9  
 
 
1.5 Serine Proteases 
 
Proteases are a class of enzymes of which serine proteases are the largest and most 
thoroughly understood. They have important roles in digestion, blood coagulation, 
compliment activation, fibrinolysis, reproduction, development and the release of 
physiologically active peptides. These processes are initiated by the protease catalysed 
cleavage of one or more peptide bonds in proteins or peptides and under physiological 
conditions the cleavage is irreversible. Not only are serine proteases a biological necessity 
but they are also a potential hazard as uncontrolled proteolysis leads to the destruction of 
the protein components of cells and tissues. Diseases that arise due to uncontrolled 
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cleavage include pulmonary emphysema, adult respiratory disease syndrome and 
pancreatitis. Serine proteases may also be involved in tumour invasion, viral 
transformations and inflammation.10  
 
The active site of a serine protease consists of two regions: 
 
(i) A catalytic site consisting of Ser-195, His-57 and Asp-102 also known as the 
catalytic triad which is responsible for proton transfer during the hydrolysis of 
the peptide bond (scheme.1.2) 
(ii) Sub site binding pocket(s) where the amino acid residues of the substrate 
interact with complementary sites on the enzyme to correctly orientate the 
substrate for catalysis (fig. 1.7) 
 
The mechanisms for peptide bond cleavage involves nucleophilic attack by the Ser-195 
hydroxyl (I-1) on the carbonyl of the scissile amide bond of the substrate to give a 
tetrahedral adduct (I-2). The unusual reactivity of the Ser-195 hydroxyl is due to increased 
nucleophilicity brought about through hydrogen bonding by the imidazole side chain of 
His-57, which in turn is involved with hydrogen bonding with Asp-102 (I-1). An oxyanion 
hole, formed by the NH groups of Ser-195 and Gly-193, increases the electrophilicity of 
the carbonyl oxygen before addition of Ser-195 and stabilises the oxyanion of the 
tetrahedral adduct. The tetrahedral adduct collapses to give an acyl enzyme intermediate 
and the free amine (I-3). Catalytic hydrolysis then affords the free carboxylic acid and 
regenerates the enzyme to repeat the cycle (I-4) (scheme 1.4). The overall sequence results 
in cleavage of the peptide bond. 
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Scheme 1.2. Schematic representation of peptide bond hydrolysis by serine proteases.11 Ser-195, His-57, 
Asp-102 and Gly-193 are all part of the serine protease. 
 
The substrate can increase affinity for the enzyme through binding to amino acid residues 
extending either side of the scissile bond (fig.1.7). Residues on the C-terminus of the 
scissile bond are labelled P1, P2…Pn and on the N-terminus P1’, P2’…Pn’ based on the 
notation of Schechter and Berger.12 The corresponding enzyme binding sub sites are 
designated S1, S1’…Sn’. The binding outside the catalytic site occurs through non-covalent 
interactions such as hydrogen bonding and hydrophobic forces. The most important being 
the interaction between the P1 residue and the S1 binding site and is the primary 
determinant of enzyme specificity. The nature of S1-n and S’1-n for a given protease, will 
determine which P1-n and P’1-n residues will bind and hence this defines the specificity of 
the different subclasses of serine proteases.  
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Figure 1.7. Extended binding site of serine proteases. 
 
There are three main types of serine proteases, trypsin-like, chymotrypsin-like and elastase 
like. The serine protease α-chymotrypsin has been chosen for initial work described in this 
proposal as its catalytic action is well studied. The S1 site for chymotrypsin is a narrow 
crevice that would best accommodate a planar aromatic residue such as phenylalanine, 
tyrosine or tryptophan. The choice of amino acids in the peptidyl chain is a means to 
improve the affinity for the S2 and S3 sites to increase specificity for the enzyme. Most 
serine proteases also have extended sub sites on the leaving group (P’) side of the scissile 
bond although these sites have not been studied in as much detail and are deemed less 
important for enzyme specificity.10  
 
 
1.6 Designing the inhibitors 
 
The main aim of this project is to develop a series of inhibitors of α-chymotrypsin that are 
more active in one conformation than the other and are stable in a physiological 
environment. The proposed inhibitors consist of three components (fig.1.8): 
 
(i) A switch that is photoisomerisable about a double bond 
(ii) A peptide chain to increase enzyme specificity (R1 and R2) 
(iii) A functional group that will act as an inhibitor of the enzyme 
 
There have been extensive studies done on inhibitors of serine proteases employing many 
types of functional groups11 including heterocycles, electrophilic carbonyl derivatives 
(diketones and aldehydes, halogenated ketones) and acylating and alkylating agents. 
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Figure 1.8. General structure of photoswitch based enzyme inhibitors. 
Z = C, N; Y = CO, CO-L-Leu; SO2, SO2-L-Leu; X = CF3, CO2Me; R = CH2Ph. 
 
Trifluoromethyl ketones (X = CF3) have been chosen as our initial target as they are a 
widely researched species and have been shown to be very potent reversible competitive 
inhibitors of serine proteases. Attack by a nucleophile forms a very stable tetrahedral 
adduct which mimics the transition state of enzymatic peptides (scheme 1.2 I-2) and 
therefore, if the nucleophile is the enzymatic Ser-195, trifluoromethyl ketones can act as 
inhibitors (fig.1.9). The reason for their potency is due to the strong electron withdrawing 
effects of the three fluorine atoms causing an electron deficiency on the adjacent carbonyl 
making it very susceptible to nucleophilic attack. The covalent adducts are not only 
stabilised by fluorine’s electronegativity but also by strong hydrogen bonding between 
fluorine and the acidic enzyme protons. 
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Figure 1.9. Reversible inhibition of α-chymotrypsin.  
 
Another advantage of using fluorinated inhibitors is that 19F NMR can be used. 19F NMR 
can be a powerful tool in synthetic and biological chemistry, with the main applications in 
this thesis being to use 19F NMR to determine E/Z ratios, diastereomeric ratios and 
monitor the progress of trifluoromethyl carbinol oxidations (fig. 1.10). Below is a 
summary of some of the applications of fluorine and 19F NMR in medicinal chemistry. 
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Fig. 1.10. Incomplete oxidation of a trifluoromethyl carbinol. Doublet (TFMC), singlet (ketone), singlet 
(hydrate). 
 
 
1.7 Fluorine 
 
1.7.1 Introduction 
 
Fluorine chemistry is a large and very important aspect of modern chemistry. Methods for 
preparing fluorinated compounds have increased immensely in range and effectiveness. As 
such it is now possible to prepare fluorinated analogues of most known molecules. The 
effect of inserting fluorine into a molecule can often have dramatic effects on its function. 
Fluorine has often been used as a replacement for hydrogen due to its small size. 
Incorporating fluorine can dramatically alter the properties of the molecule due to its 
increased electronegativity and additional lone pair electrons. Fluorinated analogues of 
biologically or agriculturally important molecules often have increased stability towards 
metabolism and binding to specific receptor sites. Examples of important fluorinated 
compounds include Diflucan 1.18 for treating thrush, Lefenuron 1.19, for controlling fleas 
on household pets and 5-fluorouracil 1.20, an anti-tumour drug (fig. 1.11).13  
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Figure 1.11. Some examples of fluorinated drugs. 
 
1.7.2 19F in NMR 
 
19F is the most stable isotope of fluorine having a natural abundance of 100 %. Like 1H it 
has a spin of ½ and is easily detected as its NMR sensitivity is 83 % of 1H. 19F NMR is 
sensitive to changes in Van der Waal interactions, electrostatic fields and long range 
effects, especially in macromolecules such as proteins. This is illustrated by the broad 
chemical shift range for organofluorines; δ = -267.9 (CH3F), 0 (CCl3F), +147.1 ppm 
(CF3OF). Some transition metal fluorides have chemical shifts upwards of + 5000 ppm.14 
 
1.7.3 19F NMR in biomedicine 
 
While 19F NMR spectroscopy has been used in classical areas of chemistry for some time, 
it has played a less important role than 1H and 13C NMR as so few naturally occurring 
fluorine compounds exist. It is however, becoming increasingly more important in 
biochemistry as unlike hydrogen, which is a major component of the body (mostly as 
water in tissue), physiological concentrations of fluorine are in the order of less than 10-6 
M and is mainly found immobilised in teeth and bone. This is an advantage as it allows 
monitoring of administered fluorinated molecules without interference from other fluorine 
sources. In vivo NMR using full body scanners is a non-invasive technique that can be 
applied to the detection of multiple nuclei. Biological applications which utilise fluorine as 
an NMR probe have included in vivo pharmacokinetics of the anti-tumour drug 5-
fluorouracil and its metabolites, in vivo studies of perfluorocarbons utilised in blood 
substitutes by 19F tomography,15 monitoring protein structure and function by introduction 
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of fluorinated amino acids or ligands,16 fluorinated drug partitioning in lip bilayers17 and 
studying the oxygenation of hypoxic tumours by 19F oximetry.18 An extensive NMR study 
on fluorinated carbohydrates has also been reported. A stereospecific synthesis of β2-
fluorinated amino acids (fig. 1.12) has been reported by our groupξ for use in the 
preparation of α-helices. 
 
H2N O
R F
H
O
R = PhCH2,CyCH2
 
Figure 1.12. An enantiomerically pure β2-fluorinated amino acid. 
 
1.7.4 Fluorine in enzyme inhibitors 
 
Due to its strong electron withdrawing ability, fluorine has gained interest from chemists 
designing peptidyl and non-peptidyl based inhibitors. These inhibitors possess a 
fluoromethyl ketone warhead comprising one, two or three fluorines covalently bound to 
the carbon. These fluoromethyl groups increase the electrophilicity of the adjacent 
carbonyl group thereby increasing the susceptibility of attack from the enzyme. The 
electrophilicity of the carbonyl group increases with increasing number of adjacent 
fluorine atoms. When assayed against α-chymotrypsin19 or acetylcholinesterase20 
increased fluorination resulted in a corresponding decrease in Ki (more potent inhibition). 
Though generally less potent, it can be advantageous to use mono and difluoromethanes to 
extend the molecule in two dimensions, whereas trifluoromethanes are limited to extension 
in one direction.21,22 
                                                 
ξ M. Edmonds; Unpublished work. 
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Figure 1.13. Extended binding of a difluoromethyl ketone. 
 
19F NMR has been used to study the degree of hydration mono-, di- and trifluoromethyl 
ketones undergo in aqueous solution by measuring the integrals of the appropriate 
spectrum. It was found that di- and trifluoromethyl ketones are essentially completely 
hydrated while monofluoromethyl ketones are only 50 % hydrated.19  
 
Studies of hemiketal formation from hydrated ketones19,21 have been used in an attempt to 
ascertain the mode of trifluoromethyl ketones binding with α-chymotrypsin. Addition of 
methanol to a solution of trifluoroacetone hydrate gave rise to a new peak downfield of the 
hydrate and upfield of the ketone. Analysis of enzyme solutions containing fluorinated 
inhibitor by 19F NMR show distinct resonances for the bound and unbound inhibitor, the 
resonance of the bound inhibitor shifts slightly downfield relative to the hydrate and 
exhibits typical line broadening associated with high molecular weight complexes. The 
chemical shift of the bound inhibitor was not inconsistent with the formation of a 
hemiketal with the serine hydroxyl; however, the chemical shifts of 19F signals are 
susceptible to solvent polarity and ionic strength and so on there own, are unsuitable for 
determining the mode of binding.  
 
A new type of phospholipase A2 (cPLA2), an enzyme responsible for hydrolysing 
phospholipids is readily inhibited by arachidonyl trifluoromethyl ketone and has been 
studied by 19F NMR to determine the stoichiometry of the inhibitor-enzyme complex and 
determine if its formation was reversible. Measurements with a 1:1 ratio of enzyme to 
inhibitor showed the disappearance of the free inhibitor with a corresponding increase in 
the formation of bound inhibitor. Once all free inhibitor had disappeared a second 
equivalent of inhibitor was added. A new peak appeared which was attributed to the 
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formation of a non-specific complex with the enzyme. The reversibility of the active 
inhibitor-enzyme complex was demonstrated by addition of a large excess of a competing 
difluoro analogue and monitoring by 19F NMR.23 
 
 
1.8 Work described in this thesis 
 
The work in this thesis continues with this concept of modulating enzyme activity via 
photoisomerisation of molecular switches. Work covered in this thesis will look at the 
design and synthesis of the key components of the enzyme inhibitors, namely the 
trifluoromethyl carbinol intermediate and the azobenzene switches. The synthesis of 
stilbene and phenanthrene derivatives as alternative types of molecular switches has been 
investigated. Incorporating additional functionality within the photoswitch is investigated 
as a means of improving the photoisomerisation and potency of the trifluoromethyl ketone 
inhibitors. Isomerisation and enzyme inhibition studies have been performed and certain 
trends were observed. 
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Synthesis of the Key Trifluoromethyl Carbinol Intermediate 
 
2.1 Introduction 
 
Trifluoromethyl ketones have gained in notoriety over the years due to their growing 
importance in biological systems and their potential as potent inhibitors of α-
chymotrypsin,1 renin,2,3 elastases4-8 and other proteolytic enzymes. A review on the 
preparation of trifluoromethyl ketones and related fluorinated ketones by Bégué and 
Bonnet-Delpon9 illustrates a wide range of methods by which trifluoromethyl ketones have 
been synthesised. A brief overview of some of the more pertinent methods has been 
outlined below. 
 
 
2.2 Preparation of fluorinated ketones and related compounds 
 
2.2.1 Preparation via organometallics 
 
Early methods of preparing fluoroalkyl ketones were based on two organometallic 
reactions; (i) reacting a non-fluorinated organometallic reagent with a fluorinated carbonyl 
compound, (ii) reacting a fluorinated organometallic reagent with a non-fluorinated 
carbonyl compound.  
 
Reactions between organometallic (RM = Grignard, organolithium, organozinc, organo-
cadmium and organomanganous) reagents and trifluoroacetic acid derivatives 1 (including 
alkyl trifluoroacetates, amides, trifluoroacetic anhydride and trifluoroacetonitrile) have 
been widely utilised in the synthesis of trifluoromethyl ketones 2 but suffer from the 
limitations in the variety of organometallic reagents available and the formation of 
secondary and tertiary alcohol by-products 3. It has been shown by Tamborski et al that 
the final product formed is very dependent on the stability of the initial tetrahedral 
intermediates (scheme 2.1).10  
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Scheme 2.1. Reaction of organometallics with fluorinated carbonyl compounds. 
 
The second method involves condensations of fluorinated organometallics with aldehydes 
and ketones to afford secondary and tertiary alcohols respectively. However, the 
introduction of perfluoroalkyl groups (especially CF3) to many carbonyl systems is 
hampered due to decreased nucleophilicity and instability of the fluorinated organometallic 
reagents used.  
 
Stereospecific synthesis of trifluoromethyl ketones 
 
A stereospecific synthesis of trifluoromethyl ketones employing fluorinated 
organometallics has been outlined by Edwards. Treatment of peptidyl aldehydes 4 with 
CF3ZnI11 yields secondary trifluoromethyl carbinols 5 which were subsequently oxidised 
to the corresponding trifluoromethyl ketones 6 (scheme 2.2).ξ
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Reagents and conditions: (a) LiAlH4; (b) RCO2H, i-BuOCOCl, NMM; (c) Swern oxidation; (d) CF3I, 
activated Zn, DMF; -20 °C; (e) Dess-Martin Periodinane. 
Scheme 2.2. Zn mediated preparation of trifluoromethyl carbinols. 
                                                 
ξ This was considered a limitation until the development of successful methods for oxidising secondary 
trifluoromethyl carbinols. 
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2.2.2 Silyl reagents 
 
New reagents based on trimethylsilanes, (CF3-TMS, Ruppert’s reagent) have been reported 
as efficient fluoroalkylating agents in many systems4,12-17 and facilitates the direct 
conversion of esters 8 into trifluoromethyl ketones 9 (scheme 2.3).14,16  
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R" = PhCH2O
X = OSiMe3
X = OH
8 9
 
Reagents and conditions: (a) CF3-TMS, TBAF or CsF; (b) 2 M HCl; (c) TBAF; (d) Amberlite® IR-120, 
MeCN. 
Scheme 2.3. Reactions of carbonyl compounds with CF3-TMS. 
 
2.2.3 Ethyl trifluoroacetoacetate 
 
Commercially available ethyl trifluoroacetoacetate has been shown to be a feasible 
building block for the synthesis of new trifluoromethyl ketones. Mono or dialkylation of 
the corresponding enol occurs in moderate to good yields provided reactive alkyl halidesξ 
are employed.18 
 
                                                 
ξ O-alkylation is favoured when non-activated alkyl halides are used. 
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Further work has been undertaken by Bégué et al to improve the alkylation of ethyl 
trifluoracetoacetate when non-activated halides were used. This involved firstly protecting 
the trifluoromethyl carbonyl moiety as either the dioxolane 10 or N, N-dimethyl hydrazone 
11, thus eliminating the possibility of O-alkylation, alkylating the base induced enol and 
deprotecting the carbonyl to give C-alkylated ethyl trifluoroacetoacetate 12. Treatment of 
12 with base and a second equivalent of alkyl halide affords the dialkylated ethyl 
trifluoroacetoacetate 13 (scheme 2.4).9 
 
EtO CF3
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EtO CF3
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EtO CF3
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a,b c,d
EtO CF3
N-N(Me)2O
EtO CF3
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R
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Reagents and conditions: (a) KH; (b) RX, KI cat., acetone, reflux 24-72 h; (c) KH; (d) R’X, THF-HMPA; (e) 
NH2N(Me)2; (f) LDA, RX, THF-HMPA; (g) R”X, EtOH, reflux; (h) NaH; (i) ClCH2CH2OH; (j) LDA, RX, 
THF-HMPA; (k) BBr3, Hexane. 
Scheme 2.4. Alkylation of ethyl trifluoroacetoacetate. 
 
Work by Patel et al have shown that reduction of ethyl trifluoroacetoacetate with sodium 
borohydride, followed by treatment with TBDMS-OTf gave the silyl protected 
trifluoromethyl carbinol 14. Hydrolysis of the ester allows the molecule to undergo a 
Curtius rearrangement, in the presence of benzyl alcohol to give the Cbz protected 
trifluoromethyl carbinol 15 in 75 % overall yield (scheme 2.5).2 This work could have 
been extended to include alkylation of the induced enol with an alkyl halide (benzyl 
bromide) prior to reduction of the trifluoromethyl ketone. 
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Reagents and conditions; (a) NaBH4; (b) 1 M NaOH; (c) Et3N, TBDMS-OTf; (d) K2CO3; (e) Et3N, DPPA, 
PhCH2OH, hexane, reflux 3 h. 
Scheme 2.5. α-Amino trifluoromethyl carbinols via a Curtius rearrangement. 
 
2.2.4 Oxidation of secondary trifluoromethyl carbinols 
 
As previously discussed, trifluoromethyl carbinols can be prepared by treatment of an 
aldehyde with trifluoromethylating agents. Another approach is to condense stabilised 
carbanions with fluorinated aldehydes to afford trifluoromethyl carbinols.2-4,19 One 
downside to this method however, is the lack of stereochemical control. Three different 
groups have reported two important strategies in this area. 
 
Condensation of carbanions with trifluoroacetaldehyde 
 
The synthesis of renin inhibitors by Patel et al had two key steps. The first step employed 
the condensation of a carboxylate dianion with trifluoroacetaldehyde followed by 
treatment with TBDMSCl to afford the silyl protected β-hydroxy acid 16. The second key 
step involved a Curtius rearrangement of the carboxyl moiety by treatment with 
diphenylphosphoryl azide (DPPA) and benzyl alcohol affording a Cbz protected α-amino 
trifluoromethyl carbinol 17. Double deprotection of the silyl ether (TBAF) and the 
carbamate (p-toluenesulfonic acid/MeOH) afforded the α-amino trifluoromethyl carbinol 
as the p-tosyl salt 18 (scheme 2.6).2,3 
Chapter Two: Synthesis of the Key Trifluoromethyl Carbinol Intermediate 36
HO2C HO2C
CF3
OTBDMS
CbzHN CF3
OTBDMS
a,b,c,d e
TsOH.H2N
CF3
OH
f,g,h
16 17
18
 
Reagents and conditions: (a) LDA, THF, -20 °C; (b) [CF3CHO], (c) Et3N, TBDMS-OTf; (d) K2CO3; MeOH; 
(e) Et3N, DPPA, PhCH2OH, hexane, reflux 14 h.; (f) H2, Pd(OH)2/C, EtOAc; (g) TBAF; (h) TsOH, MeOH. 
Scheme 2.6. Synthesis of an α-amino trifluoromethyl carbinol via a Curtius rearrangement. 
 
The work of Abeles et al and Skiles et al both utilised the base catalysed condensation of a 
nitroalkane 19 with trifluoroacetaldehyde (Henry reaction) to give the corresponding α-
nitro trifluoromethyl carbinol 20. Reduction of the nitro group with Raney nickel/H2 or 
LiAlH4 gave the α-amino trifluoromethyl carbinol 21 (scheme 2.7).4,19  
 
O2N
R H CF3
OHHO O2N
CF3
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Reagents; (a) K2CO3, 50 °C, 6 h., (b) Raney Ni/H2, EtOH  or LiAlH4, THF. 
Scheme 2.7. Synthesis of α-nitro trifluoromethyl carbinols via a Henry reaction. 
 
Trifluoroacetylation of oxazolones 
 
The second strategy is that of Kolb et al and involves trifluoroacetylating 5(4H)-
oxazolones with trifluoroacetic anhydride via a modified Dakin-West reaction. The 5(4H)-
oxazolones 23 were prepared directly by acetic anhydride induced cyclisation of various 
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N-benzoyl protected amino acids 22. The oxazolones were subjected to 
trifluoroacetylation, decarboxylation and ring opening in a one-pot synthesis that afforded 
N-benzoyl protected trifluoromethyl ketones 24 in moderate to good yields. Reduction of 
the ketone and deprotection of the amine afforded the trifluoromethyl carbinol 26 (scheme 
2.8).7,20,21 
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Reagents and conditions; (a) Ac2O; (b) (CF3CO)2O; (c) oxalic acid; (d) NaBH4, EtOH, 0 °C; (e) HCl, EtOH, 
H2O, reflux 12 h. 
Scheme 2.8. Synthesis of trifluoromethyl carbinols via a modified Dakin-West reaction. 
 
Oxidation of trifluoromethyl carbinols 
 
Once the trifluoromethyl carbinol has been synthesised it can be readily coupled with other 
compounds to produce extended trifluoromethyl carbinols. Oxidation to the corresponding 
trifluoromethyl ketone has been achieved by a variety of reagents. These include oxalyl 
chloride/DMSO/Et3N (Swern),7,17,22 carbodiimide/dichloroacetic acid/DMSO (Moffatt-
Pfitzner),5,6,11 1,1,1-triacetoxy-1,1-dihydro-1,2-benziodoxol-3(1H)-one (Dess-Martin 
periodinane),2-4,11,23 TEMPO/NaOCl/KBr and Ru(II)(biox)2Cl2/NaIO4.24 
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2.2.5 Solid phase synthesis of polypeptidyl trifluoromethyl ketones 
 
Poupart et al have successfully applied this methodology to the synthesis of a series of 
pentapeptidyl trifluoromethyl ketones using solid phase techniques. The key aspects of 
their system is the utilisation of a semicarbazone linker bound to a resin which serves as a 
protecting group for the trifluoromethyl carbonyl moiety and eliminates the need for a final 
oxidation step at the end of the synthesis (scheme 2.9).22 
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Scheme 2.9. Solid phase synthesis of peptidyl trifluoromethyl ketones. 
 
 
2.3 Designing the key trifluoromethyl carbinol intermediate 2.6 
 
The focus of this thesis is the design and synthesis of potential photoswitchable inhibitors 
of α-chymotrypsin. After reviewing the literature it was decided that the easiest way to 
synthesise inhibitors based on trifluoromethyl ketones would be to oxidise the 
corresponding trifluoromethyl carbinol. Retrosynthetic analysis of attractive target 
molecules indicated the need to synthesise trifluoromethyl carbinols that mimic amino 
acids (scheme 2.10), therefore, the method chosen needed to be amenable to the synthesis 
of α-amino trifluoromethyl carbinols based on L-phenylalanine or L-tyrosine due to their 
preference for binding in the S1 pocket.1,25  
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Scheme 2.10. Retrosynthetic analysis of a target molecule. 
 
There are a variety of methods outlined for preparing trifluoromethyl carbinols, including 
the aforementioned reaction of an organometallic reagent with trifluoroacetaldehyde or 
reaction of an aldehyde with CF3I/activated zinc.11 or CF3-TMS4,17 The method involving 
CF3I was discounted immediately due to the difficulties involved with trying to import 
banned CFC’s into the country. The option of using CF3-TMS was not immediately used 
as the author wished to avoid preparing amino aldehydes. 
 
Modifications to the methods of both Abeles et al and Kolb et al have been used 
extensively in the work described in this thesis. This work, and other methods attempted 
will be discussed in sections 2.4. 
 
 
2.4 Synthesis of 3-amino-1,1,1-trifluoro-4-phenylbutan-2-ol hydro-
chloride 2.6  
 
2.4.1 Route 1: Synthesis of 2.6 via trifluoroacetaldehyde 
 
The initial work undertaken in this thesis (scheme 2.12) was based on the synthetic route 
of Abeles and Imperiali19 which employs the condensation of floral with a nitroalkane. 
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The Henry reaction 
 
The Henry reaction, also know as the nitroaldol reaction is an important C-C bond forming 
reaction utilised in the synthesis of many key targets. The resulting β-nitroalkanol is very 
versatile as it can undergo many different transformations, including reduction of the nitro 
group, oxidation of the alcohol and elimination of water to afford nitroalkenes.26 
Unfortunately yields are often poor due to the susceptibility for side reactions (Aldol 
condensation, Cannizzaro reaction) to occur in the presence of base.  
 
Treatment of nitroalkanes with a catalytic amount of base produces a resonance stabilised 
anion which then attacks the electrophilic centre of the aldehyde to afford the β-
nitroalkoxide. The resulting alkoxide acts as a base, which in turn deprotonates another 
molecule of nitroalkane to give the desired β-nitroalkanol and another molecule of 
resonance stabilised anion (scheme 2.11). 
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Scheme 2.11. Mechanism of the Henry reaction. 
 
Synthetic scheme 
 
In order to prevent complications it was decided that all inhibitors synthesised would be 
based on the phenylalanine rather than tyrosine core to minimise any potential problems 
the phenolic hydroxide might cause further down the synthetic pathway. 
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Reagents and conditions; (a) CH3NO2, NaOH, MeOH, -10 °C; (b) 4 M HCl; (c) HEH, silica gel, toluene, 65 
°C, 50 h; (d) [CF3CHO], K2CO3, 50 °C; (e) Raney Nickel, H2, EtOH; (f) TBDMSCl, imidazole, DMF, 35 °C; 
(g) LiAlH4, ether, reflux. 
Scheme 2.12. Synthetic scheme for Route 1.  
 
Preparation of nitroalkane 2.3 
 
For α-nitro trifluoromethyl carbinols based upon phenylalanine, the required nitroalkane is 
1-nitro-2-phenylethane 2.3 which can be prepared by reduction of the corresponding 
alkene β- nitrostyrene 2.1. Although 2.1 is commercially available, it is readily prepared in 
the lab in less than a day from simple starting materials.27 A mixture of benzaldehyde and 
nitromethane in MeOH was treated with an aqueous solution of sodium hydroxide 
followed by 4 M aqueous HCl to eliminate water from the molecule and afford crude 
nitrostyrene 2.1. Recrystallistion from hot EtOH gave the pure product in 22 % yield.  
 
Reduction of nitrostyrene 2.1 
 
Nitroalkanes are often obtained by reduction of α,β-unsaturated nitro compounds. 
Reduction can be achieved by various methods, but these methods are often harsh, result in 
product dimers and suffer poor chemoselectivity (especially when hydride reagents are 
employed). An attractive method is the use of NAD(P)H models such as Hantzsch ester 
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2.2 with an activator to effect reduction under mild conditions with very high 
chemoselectivity.28,29  
 
Hantzsch ester 2.2 was easily prepared by condensation of ethyl acetoacetate and 
formaldehyde with ammonia by the method of Singer et al.30 Recrystallisation from EtOH 
gave the pure product in 62 % yield (scheme 2.13). 
 
EtO
O
O
O
OEt
O
H H
O
NH3
N
H
OEtEtO
O O
a
+
2.2
 
Reagents and conditions: (a) Diethyl amine, EtOH, 4 °C. 
Scheme 2.13. Synthesis of Hantzsch ester 2.2. 
 
Nitrostyrene 2.1 in toluene was reduced with 2.2 in the presence of silica gel28 over a 
period of 50 h. in a darkened fumehood. The resulting oil was distilled under reduced 
pressure and chromatographed to afford the pure nitroalkane 2.3 in 88 % yield (scheme 
2.12). It has been shown that reduction also proceeds smoothly when catalytic amounts of 
acetic acid is used in place of silica gel.29 
 
α-Nitro trifluoromethyl carbinol 2.4 
 
The condensation of nitroalkane 2.3 with trifluoroacetaldehyde methyl hemiacetal was 
catalysed under mild conditions with anhydrous K2CO3 in the absence of solvent (scheme 
2.12). The outcome of this reaction was often variable and dependant on the amount of 
base added, temperature of the oil bath and purity of the hemiacetal. Usually a brown oil 
was obtained which was distilled under reduced pressure to afford 2.4 as a pale yellow oil 
comprising a variable mixture of diastereomers (1:1-2:1) in ca. 40-60% yield (fig. 2.1). In 
all cases where an excess of one diastereomer existed, the major diastereomer was always 
same. Freeze drying a sample of the oil resulted in crystallisation of the major 
diastereomer (fig. 2.2) which has been tentatively assigned as the (2R,3S + 2S,3R) isomers 
based on the coupling constants of the β-H, the stereochemistry of the major isomer of the 
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nitro reduction and a reported observation that the anti isomer crystallised from the oil of a 
similar compound.4 Sometimes the mixture would turn orange and solidify to give an 
unidentified gum. The problem was rectified when a new sample of hemiacetal was used. 
 
 
Figure 2.1. 1H NMR spectrum of the 2:1 diastereomeric mixture of 2.4. Key chemical shifts; α-H, major + 
minor, 4.96; β-H, minor, 4.65; β-H, major, 4.24 ppm. 
 
 
Figure 2.2.1H NMR spectrum of (2R,3S + 2S,3R) 2.4. Key chemical shifts; α-H 4.95, β-H 4.21 ppm. 
 
α-Amino trifluoromethyl carbinol 2.6 
 
The final step in the synthesis of the key trifluoromethyl carbinol was the reduction of the 
α-nitro trifluoromethyl carbinol to an α-amino trifluoromethyl carbinol. Raney nickel has 
been successfully utilised to reduce nitrocarbinols to aminocarbinols19 so Raney nickel W-
2 was prepared from Ni-Al alloy according to the method outlined in Vogel’s textbook of 
practical organic chemistry.31 A mixture of Raney nickel catalyst and nitrocarbinol 2.4 in 
EtOH was agitated under an atmosphere of hydrogen in a Parr shaker overnight. The 
resulting amine was converted to the hydrochloride and recrystallised from hot ethyl 
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acetate/petroleum ether to afford 2.6 as a single diastereomer in 34 % yield (scheme 2.12). 
Washing the filtrate with aqueous saturated NaHCO3 afforded the free amine which 
consisted of > 90 % of the minor isomer. By comparing the 1H and 19F NMR of both 
diastereomers to experimental data obtained by Andrés et al,17 the major isomer was 
tentatively assigned as (2R,3S + 2S,3R)-3-amino-1,1,1-trifluoro-4-phenylbutan-2-ol (anti-
2.6) and the minor isomer as (2S,3S + 2R,3R)-3-amino-1,1,1-trifluoro-4-phenylbutan-2-ol 
(syn-2.6) based on the chemical shifts and coupling constants of the β-H (fig. 2.3). 
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Figure 2.3. The four stereoisomers of 2.6. 
 
Due to the low yields, fickleness and pyrophoric nature of the Raney nickel reduction, 
other methods of reduction were investigated to see if the final step could be improved. 
The most promising of those investigated was reduction via LiAlH4. Reports that LiAlH4 
reduction of unprotected α-nitrocarbinols may undergo bond cleavage to yield the starting 
aldehyde and nitroalkane prompted the protection of the alcohol as a silyl ether before 
reduction.32 
 
The α-nitrocarbinol 2.4 was protected as the tert-butyldimethysilyl ether33 by treating 2.4 
with TBDMSCl and imidazole in DMF to afford a 3:2 mixture of 2.5 in 93 % yield. 
Reduction of 2.5 in a suspension of ethereal LiAlH4 at reflux, followed by a saturated 
aqueous Na2SO4 work-up gave the free amine. Treatment with HCl and recrystallisation 
from ethyl acetate/petroleum ether gave (2R,3S + 2S,3R) 2.6 in 24 % yield. Evaporation of 
the filtrate yielded a 1:2 mixture (by 19F NMR) of the (2R,3S + 2S,3R) and (2S,3S + 2R,3R) 
isomers in 33 % yield. 
 
This method, while successful, was not ideal as it required an additional synthetic step and 
purification, made use of the also potentially hazardous LiAlH4 and the yield of isolated 
product was not great. This may have been due to difficulties in extracting the product 
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from the resulting white gelatinous mass that formed upon addition of aqueous Na2SO4 to 
the ethereal solution. 
 
Other methods of reduction that were attempted included NiB2/NaBH4 34, NiB2/hydrazine35 
and Pd/C/hydrazine but met with failure and often decomposed the starting material and 
were therefore discontinued. 
 
2.4.2 Route 2: Synthesis of 2.6 via trifluoroacetylation of oxazolones 
 
Oxazolone formation 
 
Due to the unreliability of the Abeles method, and the generally mediocre yielding steps, 
an alternative method was required. The procedure by Kolb7 (scheme 2.8) had been 
previously investigated, but not pursued, as early attempts at preparing oxazolones with 
acetic anhydride were low yielding and difficult to purify. Further research into oxazolone 
formation showed that acyl amino acid cyclisation occurs readily during peptide synthesis 
and is responsible for the racemisation of the chiral centre (scheme 2.14).36 Oxazolone 
formation is promoted by activation of the carboxylic acid to give a good leaving group, 
therefore carbodiimide mediated cyclisation was a viable method to try. 
 
O
N
Ph
R
O
HN O
XPh
R
O
N O
XPh
R
OH O
N
Ph
O
O
N
Ph
R
O
R
O
N
Ph
O
R
-H+
+H+
+H+-H+X = good leaving group
 
Scheme 2.14. Oxazolone formation and racemisation. 
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The synthesis of trifluoromethyl carbinol 2.6 from benzoyl phenylalanine was undertaken 
following the method of Kolb et al (scheme 2.15) 
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Reagents and conditions; (a) EDCI, DCM; (b) (CF3CO)2O; (c) oxalic acid; (d) NaBH4, EtOH, 0 °C; (e) HCl, 
EtOH, H2O, reflux 12 h. 
Scheme 2.15. Synthesis of 2.6 via a modified Dakin-West reaction. 
 
Synthesis of oxazolone 2.8 
 
N-Benzoyl-L-phenylalanine 2.7 was prepared by treating L-phenylalanine with benzoyl 
chloride in basic solution followed by acidification to precipitate out the N- protected acid 
2.7. The resulting white precipitate was recrystallised from hot water to afford the pure 
product. Treatment of a suspension of N-benzoyl-L-phenylalanine in dry dichloromethane 
with EDCI afforded oxazolone 2.8 in high yields (> 95 %) and purity (scheme 2.15).37 
Preparation was successful on a 50 mmol scale, but due to the relatively high cost and 
demand in the lab for EDCI, cheaper methods were investigated. The reaction was 
repeated using DCC in a THF/dichloromethane solvent system on a 65 mmol scale giving 
the identical product in 69 % yield. Acetyl chloride (1 equiv) and DMAP in 
dichloromethane also gave the pure oxazolone 2.8 in 49 % yield.  
 
From these results it can be seen that EDCI gave the highest yields, but is also the most 
expensive of the reagents used to cyclise N-benzoyl-L-phenylalanine. Both DCC and 
Chapter Two: Synthesis of the Key Trifluoromethyl Carbinol Intermediate 47
acetyl chloride have shown promise, however the conditions used were not optimised, 
therefore yields may be improved upon if the conditions were altered somewhat. 
 
Introduction of the trifluoromethyl group 
 
Recrystallised oxazolone 2.8 was stirred for 3 days in trifluoroacetic anhydride. After 
removal of residual anhydride and trifluoroacetic acid, the trifluoroacetylated oxazolone 
was treated with anhydrous oxalic acid at 120 °C to promote decarboxylation and 
subjected to a hydrolytic work-up to afford a 2:3 mixture of trifluoromethyl ketone 2.9 and 
the corresponding hydrate in 77% yield (scheme 2.15). The ketone and hydrate could be 
separated by column chromatography but was tedious due to the polar nature of the 
molecules, especially the hydrate. Chromatography was unnecessary however as the usual 
yellow impurity was easily removed with an ether wash and both ketone and hydrate were 
smoothly reduced to the corresponding trifluoromethyl carbinol 2.10.  
 
Reduction of the trifluoromethyl ketone 
 
Reduction of the ketone/hydrate mixture was achieved using NaBH4 in EtOH (scheme 
2.15). After 12 h the reaction was quenched with 6 M aqueous HCl and worked up. The 
benzoyl protected trifluoromethyl carbinol 2.10 was isolated in > 95 % yield as a 2:3 
mixture of diastereomers (fig. 2.4). No purification was required. 
 
 
 
Figure 2.4. 1H NMR spectrum of the 2:3 diastereomeric mixture of 2.10. Key chemical shifts; OH, minor, 
6.48; OH, major, 6.00; α-H, major + minor, 4.73; β-H, major, 4.52; β-H, minor, 4.32 ppm. 
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Trifluoromethyl carbinol deprotection 
 
Removal of the benzoyl group was achieved by hydrolysis in concentrated 
HCl/EtOH/water at reflux (scheme 2.15). Removal of the liberated benzoic acid by 
extraction, followed by removal of the solvent afforded the crude α-amino trifluoromethyl 
carbinol as a 3:2 mixture of diastereomers. The crude hydrochloride salts were dissolved in 
hot ethyl acetate to give a green solution. Addition of cold petroleum ether induced 
precipitation of a white fluffy solid consisting of mainly the major diastereomer (9:1) in 65 
% yield. A second recrystallisation afforded a single diastereomer identical to 2.6, and 
therefore assigned as the (2R,3S + 2S,3R) isomers.  
 
2.4.3 Attempted synthesis of 2.6 utilising CF3-TMS 
 
Synthesis of 2.6 via routes 1 and 2 gives rise to mixtures of all 4 possible isomers. 
Oxidation of the N-protected trifluoromethyl carbinol afforded the racemic trifluoromethyl 
ketone. Synthesis of stereospecific trifluoromethyl ketones would be desirable as that 
should lead to more potent inhibitors. Several authors4,11,17 report methods of synthesising 
trifluoromethyl ketones stereospecifically by preparing trifluoromethyl carbinols 28 from 
amino aldehydes 27 with predefined stereochemistry and oxidising the epimeric center to 
give enantiomerically pure trifluoromethyl ketones 29 (scheme 2.16). 
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Reagents and conditions: (a) CF3-TMS, TBAF, THF, 0 °C; (b) aq. NH4Cl; (c) (COCl)2, DMSO, Et3N, DCM, 
-78 °C; (d) NaBH4, MeOH, THF, -18 °C. 
Scheme 2.16. Diastereoselective synthesis of trifluoromethyl carbinols. 
 
Andés et al go even further and have devised a diastereoselective synthesis of α-amino 
trifluoromethyl carbinols from homochiral α-dibenzyl aldehydes 27 utilising CF3-TMS. 
Swern oxidation of the resulting mixtures of syn (minor) and anti (major) diastereomers 28 
afforded enantiomerically pure trifluoromethyl ketones 29. Reduction of the ketones with 
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excess NaBH4 in THF/MeOH afforded the syn isomer 30 with high diastereomeric excess 
(scheme 2.16). 
 
For my work, a series of N-protected aminoaldehydes were prepared from N-protected L-
phenylalanine. The aldehydes were synthesised either by LiAlH4 reduction of Weinreb 
amides in THF at 0 °C or DIBAL reductions of methyl esters in toluene at -78 °C (scheme 
2.17). The reductions usually went smoothly and in high yield, however reductions 
utilising DIBAL gave products of higher purity. The compounds are summarised in figure 
2.5. 
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RHN CF3
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Reagents and conditions: (a) X = OMe, DIBAL, toluene, -78 °C; (b) X = N(OCH3)CH3, LiAlH4, THF, 0 °C; 
(c) CF3-TMS, CsF or TBAF; (d) 4 M aq. HCl. 
Scheme 2.17. Attempted trifluoromethylation of aldehydes with CF3-TMS. 
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Figure 2.5. Derivatives of L-phenylalanine. 
 
Initially, a solution of aldehyde 35 in dimethoxyethane was treated with a catalytic amount 
of CsF followed by a solution of CF3-TMS in THF (0.5 M, Aldrich®) (scheme 2.17).16 
After stirring at rt overnight the solution was analysed by 1H NMR but only starting 
materials were detected. Crushed molecular sieves and a second equivalent of CF3-TMS 
were added to the reaction mixture and stirred for a further 16 h. 19F NMR of the crude 
solution showed the presence of a doublet and a multiplet, the doublet being consistent 
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with fluorine atoms adjacent to a proton. 1H NMR indicated the loss of the aldehyde 
proton at 9.55 ppm and the presence of a TMS peak at 0.05 ppm. The solution was filtered 
to remove the sieves then treated with 4 M aqueous HCl to hydrolyse the silyl ether. 1H 
NMR of the hydrolysed product showed a more complex spectrum that did not match the 
starting aldehyde or expected product. No peaks were observed in the 19F NMR spectrum 
which indicated no trifluoromethylated product was isolated. 
 
The reaction was repeated in THF with 2 equivalents of CF3-TMS and initiated with 
TBAF12 but again no fluorinated product was obtained. Reaction of Cbz-L-phenylalanal 
(32) with CF3-TMS/TBAF (scheme 2.17) gave similar, disappointing results. Direct 
conversion of methyl ester 32 to the corresponding trifluoromethyl ketone (scheme 
2.18)14,16 was unsuccessful and only ester 32 was recovered.  
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Reagents and conditions: (a) CF3-TMS, TBAF, THF. 
Scheme 2.18. Attempted direct conversion of an ester into a trifluoromethyl ketone. 
 
It was concluded that the CF3-TMS reagent purchased from Aldrich® may have hydrolysed 
over time to give an inactive mixture of CF3H and TMS-OH. A fresh supply of neat CF3-
TMS was ordered but due to time constraints this area has not been continued. 
 
 
2.5 Summary 
 
Although two different routes were taken to synthesise the key trifluoromethyl carbinol 
2.6, both methods ultimately gave the same product as varying mixtures of (2R,3S), 
(2S,3R), (2S,3S) and (2R,3R) isomers. Overall the route based on the oxazolone chemistry 
was preferred as the starting materials were generally cheaper, the reactions higher 
yielding, the products easier to purify and consistently more successful. Recrystallisation 
from ethyl acetate/petroleum ether afforded the major anti-diastereomer. This 
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recrystallisation could be seen as wasteful because ultimately, further down the synthetic 
route the 2-hydroxyl group was oxidised, removing one of the stereogenic centres and 
therefore reducing the number of possible isomers. The decision to remove the minor 
isomers from trifluoromethyl carbinol 2.6 was made to make isolation and purification of 
compounds discussed in chapters 3 and 4 more straight forward and to simplify the already 
complex NMR spectra of many azobenzene-trifluoromethyl carbinol based compounds 
described in this thesis. 
 
 
2.6 Future work 
ontinuation in this area should focus on two main aspects. Firstly, optimising the 
oth of these areas can be expanded to include the synthesis of trifluoromethyl ketones 
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syntheses of the key intermediate 2.6, in particular, improving the formation of oxazolone 
2.8 by cyclisation with cheap activating reagents such as DCC or acetyl chloride should be 
investigated. Secondly, the preparation of enantiomerically pure trifluoromethyl ketones 
should be revisited using a fresh supply of Ruppert’s reagent. 
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which can inhibit other classes of enzyme. This could be achieved by altering the nature of 
the residue at the P1 position, i.e. change the initial amino acid used from phenylalanine to 
something more specific to the enzymes’ active site. 
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Synthesis of Stilbene and Phenanthrene Derivatives 
 
3.1 Introduction 
 
Previous work by our group1 has demonstrated the applicability of incorporating an 
azobenzene photoswitch into inhibitors of α-chymotrypsin. Introduction of such a 
photoswitch allows the potential to modify the potency of the inhibitor by inducing 
conformational change upon irradiation of UV and visible light (section 5.2.2). It was 
found that azobenzene based inhibitors enriched with the cis (Z) conformation were 2-3 
fold more potent in their inhibition of α-chymotrypsin than the corresponding trans (E) 
isomers. Photoisomerisation of azobenzenes in solution are both photochemically and 
thermally reversible and will revert to a photostationary state comprising a mixture of cis 
and trans isomers upon standing, even in the dark.2 As a consequence, it can be difficult to 
study the thermodynamically less stable cis isomer in a pure state. 
 
It was envisaged that replacing the azo group with ethylene would afford the 
corresponding stilbene which are also known to undergo light induced E-Z isomerisation. 
Unlike azobenzenes however, it is possible to ‘trap’ cis-stilbenes by oxidative 
photocoupling to a rigid phenanthrene derivative (scheme 3.1).3 It was hoped that these 
phenanthrenes could be used as potential cis mimics of azobenzenes. 
 
H Hhν
conrotation
O2,I2
hν hν',∆
E-1
Z-1 2 3
 
Scheme 3.1. Photoisomerisation, cyclisation and oxidative coupling of stilbene. 
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3.2 Photochemistry of stilbenes 3,4 
 
Photo-induced cis-trans isomerisation is a well studied phenomenon that appears to be 
general for any double bond capable of geometrical isomerisation. Thermal or ground state 
isomerisation reactions are considered to proceed via a non-planar transition state common 
to both cis and trans isomers. The transition state collapses to give the thermodynamically 
more stable product (usually trans).  
 
Photo-induced isomerisations involve population of excited singlet (paired electron spin) 
states (S1) and triplet (parallel electron spin) states (T1) followed by a vibrational cascade 
(collisional transfer) associated with twisting of the C-C σ-bond. The minimum energy 
state (p-state) occurs when adjacent p-orbitals are at 90° to one another. Internal 
conversion from the S1 state or intersystem crossing from the T1 state (fig. 3.1) affords a 
high energy ground state for the alkene which collapses to give a mixture of cis and trans 
isomers which comprise the photostationary state.  
 
 
Figure 3.1. Jablonski diagram showing excitation and deactivation routes. 
A = absorption; F = fluorescence; P = phosphorescence; V = vibrational cascade; IC = internal conversion; 
ISC = intersystem crossing 
 
Irradiation of cis (Z-1) or trans (E-1) stilbene gives rise to an excited state Z-1* or E-1* 
which can undergo radiationless decay by way of a common twisted species 1#* to give 
either E-1 or Z-1. Generally mixtures of the two are formed, the exact composition of the 
V
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photostationary state being determined by the wavelength of irradiation. For a more 
detailed discussion of photostationary states see section 5.2. 
 
Excitation of Z-1 to give the high energy species Z-1* can also undergo cyclisation to the 
excited dihydrophenanthrene 2*. If an oxidant is present 2 can be trapped as the 
phenanthrene 3, in the absence of an oxidant 2 thermally or photochemically reverts to Z-1 
(fig. 3.2).4 
 
Z-1*
2*
E-1*
1#*
hv
hv 
hv  2
1#
or ∆ O2 or I2
Z-1
3 
E-1 
 
Figure 3.2. Energy level diagram for the photochemical processes of stilbene. Taken from Mallory and 
Mallory4 
 
Absorption characteristics for cis-trans isomers are rarely the same; therefore effective 
filtering of light to give a single wavelength allows preferential absorption by one isomer 
resulting in complete conversion to the other and is known as optical pumping. Highly 
conjugated systems, in particular, stabilised alkenes such as stilbene undergo 
photoisomerisation more readily than non-conjugated alkenes. As a result, diaryl ethenes 
(stilbenes) have been widely studied. Steric hindrance between the ortho-hydrogens of cis-
stilbene causes one phenyl ring to rotate out of the plane with respect to the rest of the 
molecule. This result is less effective overlap of the π system which alters the absorption 
characteristics of the molecule i.e. the cis and trans stilbenes exhibit different maxima 
(λmax) and molar absorptivity coefficients (ε) therefore UV/Visible spectroscopy has been 
widely utilised to monitor the isomerisation of stilbenes.5 This was especially important 
before the widespread use of NMR for interpreting results. 
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3.3 Synthesis of substituted stilbenes 
 
In order for stilbene to be used as a switch for α-chymotrypsin inhibitors, some sort of 
linker to allow attachment to the peptidyl portion of the inhibitor needs to be incorporated 
into the molecule. Amide or sulfonamide linkages have previously been successfully 
incorporated into azobenzene moieties and allowed coupling of peptides and 
peptidomimetics in high yield (fig 3.3).  
 
X NHR
X = CO, SO2
 
Figure 3.3. Stilbene coupled to an amine by an amide or sulfonamide linker 
 
There are several methods for preparing diarylethenes. Traditional methods include 
condensation of aryl acetic acids with substituted benzaldehydes6 (Perkins reaction), aryl 
diazonium salts with cinnamic acid derivatives6,7 (Meerwein reaction), phosphonium 
ylides with aldehydes/ketones (Wittig reaction) or phosphonates and aldehydes/ketones 
(Wittig-Horner).8 Recently, a series of trans-tetrastilbenemethanes were synthesised via a 
Wittig-Horner reaction.5 More recent methods include use of palladium catalysed C-C 
coupling of aryl halides and arylethylenes9 (Heck reaction) or arylethenyl halides with aryl 
boric acids10 (Suzuki reaction).  
 
3.3.1 The Wittig reaction 
 
The Wittig reaction is an important C-C bond forming reaction discovered by Georg 
Wittig in 1953. It involves replacement of the carbonyl oxygen of aldehydes or ketones 
with an alkene. The reactive carbonyl is attacked by the nucleophilic phosphorous ylide to 
give an oxaphosphetane which undergoes rearrangement to displace triphenylphosphine 
and liberate the alkene (scheme 3.2).8 
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Scheme 3.2. Mechanism of the Wittig reaction. 
 
The driving force behind this reaction is the formation of a phosphorous-oxygen double 
bond which is stronger than the carbon-oxygen double bond and thus thermodynamically 
more favourable. The Wittig reaction is generally mild, tolerates a wide range of 
substituents and leaves no doubt as to the position of the double bond. Non-stabilised 
ylides (R1, R2 = H, alkyl) are more reactive than stabilised ylides (R1, R2 = COR, CN, 
CO2R) and are therefore prone to hydrolysis under aqueous conditions. Use of bi-phasic 
mixtures can be employed to minimise potential loss of product.11 
 
3.3.2 Synthesis of 4-cyanostilbene and 4-stilbenecarboxylic acid 
 
Synthesis of 4-cyanostilbene and 4-stilbenecarboxylic acid (scheme 3.3) was achieved via 
the Wittig reaction by modification of an old undergraduate lab synthesis of 4-
vinylbenzoic acid.11  
 
4-Stilbenecarboxylic acid via 4-cyanostilbene 
 
4-Cyanostilbene 7 was prepared by treating commercially available α-bromo methyl 
benzonitrile 4 with triphenylphosphine in acetone to give the phosphonium bromide 5 in 
79 % yield. A bi-phasic mixture of 5 in water and benzaldehyde in dichloromethane were 
stirred vigorously and ylide 6 generated in situ by slowly treating with concentrated 
aqueous NaOH. The reaction was stirred for 1 h, the organic layer separated, washed with 
water then brine, dried over MgSO4 and concentrated in vacuo. The resulting oil was 
titurated with hot petroleum ether and 4-cyanostilbene 7 filtered off. 4-Cyanostilbene 7 
was purified by flash chromatography affording a low melting solid in 24 % yield. Basic 
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hydrolysis of the nitrile with 10 % KOH in ethylene glycol6 followed by acidification gave 
the carboxylic acid 8 in 15 % yield (scheme 3.3). 
 
OH
O
CN
Br
CN
BrPh3P
CN
Ph3P
CN
a b
c
d,e
5 6
78
4
 
Reagents and conditions: (a) PPh3, acetone, reflux; (b) 50 % aqueous NaOH; (c) benzaldehyde, 
dichloromethane; (d) KOH, ethylene glycol, 165 °C; (e) conc. HCl. 
Scheme 3.3. Synthesis of 4-stilbenecarboxylic acid via 4-cyanostilbene. 
 
Direct synthesis of 4-stilbenecarboxylic acid 
 
Due to the low yields of the Wittig reaction and subsequent hydrolysis it was thought that 
4-stilbenecarboxylic acid could be made from toluic acid and benzaldehyde. This would 
reduce the number of synthetic steps by eliminating the hydrolysis of the nitrile and 
purification could be achieved via an aqueous work-up. 
 
α-Bromo-toluic acid 10 was prepared by radical initiated bromination of toluic acid 9 with 
NBS in 86 % yield.12 The phosphonium bromide 11 was prepared by treating 10 with 
triphenylphosphine in acetone. The phosphonium salt 11 precipitated from solution in 63 
% yield. A bi-phasic mixture of benzaldehyde and 11 were treated with concentrated 
aqueous NaOH to generate ylide 12. The suspension was filtered through celite, the 
aqueous layer extracted with dichloromethane to remove residual triphenylphosphine 
oxide and benzaldehyde then acidified to precipitate the 4-stilbenecarboxylic acid 8 in 31 
% yield (scheme 3.4). 
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Reagents and conditions: (a) NBS, benzoyl peroxide, chlorobenzene, reflux; (b) PPh3, acetone, reflux; (c) 50 
% aqueous NaOH; (d) benzaldehyde, dichloromethane; (e) conc. HCl.  
Scheme 3.4. Synthesis of 4-stilbenecarboxylic acid via the Wittig reaction. 
 
3.3.3 Attempted synthesis of E-[N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)-4-styryl 
benzamide] 16 
 
4-Stilbenecarboxylic acid 8 was coupled to trifluoromethyl carbinol 2.6 utilising EDCI 
methodology to afford the crude stilbene protected trifluoromethyl carbinol 13 (scheme 
3.5). Purification by radial chromatography gave the desired product in 50 % yield. A 
second product was obtained and from the 1H NMR spectrum it was noted that the olefinic 
protons at 6.65 ppm normally found in stilbene derivatives had disappeared. A repeat of 
the reaction utilising the same starting material resulted in ca. 1:3 mixture of stilbene 13 
and presumably cyclised product (14 or 15). This was based on comparing the ratio of 
integrals of the olefinic protons with the NH, β, α and PhCH2 proton signals in the 1H 
NMR spectrum (1:2:2:2:4). 
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Reagents and conditions; (a) 2.6, EDCI, HOBt, DIPEA, DCM, DMF. 
Scheme 3.5 EDCI coupling of stilbene 8 with trifluoromethyl carbinol 2.6. 
 
Oxidation of trifluoromethyl carbinol 13 with Dess-Martin periodinane was unsuccessful, 
possibly due to poor solubility of the trifluoromethyl carbinol in dichloromethane. TEMPO 
oxidation in ethyl acetate/dichloromethane afforded a ketone and hydrate (scheme 3.6) 
which was confirmed by two singlets in the 19F NMR spectrum. However it was also noted 
that the olefinic protons at 6.65 ppm had completely disappeared indicating that the 
desired product 16 was not present but instead presumably underwent cyclisation and 
oxidation to the corresponding phenanthrene 17 (scheme 3.6).  
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Reagents and conditions: (a) TEMPO, NaOCl, KBr, ethyl acetate/dichloromethane, 0 °C. 
Scheme 3.6. TEMPO oxidation of E-stilbene 13. 
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It has been reported that stilbenes incorporating fluoro, chloro, bromo, methoxy, methyl, 
trifluoromethyl, phenyl and carboxyl substituents undergo cyclisation and oxidation to the 
phenanthrene in the presence of an oxidant13 which gives some credence to the assumption 
that product 17 is the phenanthrene. 
 
 
3.4 Alternate synthetic route for 4-substituted stilbenes 
 
To minimise loss of product due to cyclisation, it was decided that a new approach was 
needed where the double bond is introduced further down the synthetic pathway. The new 
route was also designed to incorporate a sulfonyl rather than carbonyl linker to increase the 
similarity between the stilbene and azobenzene inhibitors synthesised in this thesis.ξ  
 
The proposed scheme involved coupling toluenesulfonyl chloride with trifluoromethyl 
carbinol 2.6 then brominating with NBS. At this point the trifluoromethyl carbinol 19 
would be oxidised and the resulting trifluoromethyl ketone protected as the dioxolane 21 
or dithiolane due their stability to a wide range of reaction conditions. The protected 
ketone could then follow a similar procedure already outlined to synthesis stilbene 23. The 
final step would involve deprotection of the ketone to afford the desired product 16 
(scheme 3.7). 
                                                 
ξ Attempts at direct sulfonation of stilbene with chlorosulfonic acid had previously failed. 
Chapter Three: Synthesis of Stilbene and Phenanthrene Derivatives 64
SO2Cl HCl.H2N
CF3
OH
Ph
O2S N
H
CF3
Ph
OH
+
O2S N
H
CF3
Ph
OHBr
O2S N
H
CF3
Ph
Br O O
O2S N
H
CF3
Ph
BrPh3P
O O
O2S N
H
CF3
Ph
O O
O2S N
H
CF3
Ph
O
O2S N
H
CF3
Ph
OBr
16
182.6
1920
21 22
23
 
Scheme 3.7. Proposed synthetic route for stilbene 16. 
 
3.4.1 Bromination of toluenesulfonamides 
 
A model system using N-tosyl-L-phenylalanine methyl ester was set up to determine 
whether toluenesulfonamides could undergo successful bromination. Toluenesulfonyl 
chloride and L-PheOMe.HCl were coupled in the presence of Hünigs base to give 24 in 94 
% yield. Radical initiated bromination of 24 with NBS afforded a mixture of 24, mono-
brominated 25 and dibrominated 26 products (scheme 3.8). The ratios were difficult to 
determine from the 1H NMR spectrum but it appears that 24 was the major component 
followed by 26 and the desired product 25 being the minor component. Chromatography 
of the mixture removed some of the unreacted starting material but could not separate the 
two brominated products, attempts at separation by recrystallisation also failed. 
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Reagents and conditions: (a) DIPEA, DCM, reflux; (b) NBS, benzoyl peroxide, chlorobenzene, reflux. 
Scheme 3.8. Bromination of toluenesulfonamide 24. 
 
At this point the synthetic route was abandoned in favour of synthesising 
phenanthrenesulfonyl chlorides directly. This would eliminate the problems of complex 
mixtures of cyclised and non-cyclised products and allow us to synthesise pure 
phenanthrene compounds for comparison with analogous cis-azobenzenes. 
 
 
3.5 Synthesis of phenanthrene based inhibitors 
 
3.5.1 Fuctionalisation of phenanthrene 
 
Due to the failure of preparing substituted stilbenes suitable for photoisomerisation studies 
it was decided to prepare pure phenanthrene sulfonamides due to their increased stability. 
The sulfonyl group was chosen as the linker to match the analogous azobenzene 
derivatives. The sulfonyl chloride is more stable than an acid chloride and does not need 
activating when reacting with amines. Arylsulfonyl chlorides are readily prepared from 
aryl sulfonates.14  
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2- and 3- Potassium phenanthrene sulfonates 
 
Potassium 2- and 3-phenanthrene sulfonates were synthesised and isolated by the method 
outlined by Fieser.15  
 
Recrystallised phenanthrene was heated until molten and treated with concentrated sulfuric 
acid to afford a mixture of mono and disulfonic acids. Addition of aqueous NaOH 
precipitated out the 2- and 3-isomers while the highly soluble disulfonates remained in 
solution. The two isomers were separated by exploiting their differences in solubility 
(scheme 3.9).  
 
SO3H
SO3K
SO3K
a,b c,d 3.1
3.2
 
Reagents and conditions: (a) H2SO4; (b) NaOH; (c) BaCl2.2H2O; (d) KOH. 
Scheme 3.9. Synthesis of 2- and 3-phenanthrene sulfonates. 
 
The sodium salts were redissolved in acidified water and concentrated. The less soluble 2-
isomer crystallised out upon cooling. The mother liquor containing mostly 3-sulfonate 
with some 2-sulfonate was retained. The precipitated sodium 2-sulfonate was redissolved 
in a large volume of boiling water, treated with BaCl2 and precipitated out as the highly 
insoluble barium salt. Several digestions of the barium sulfonate mixture followed by 
filtration removed the remaining traces of the sparingly soluble barium 3-sulfonate which 
crystallised out of solution upon cooling. The now pure barium 2-sulfonate in boiling 
water was treated with sulfuric acid and filtered to remove the barium as insoluble BaSO4, 
neutralised with KOH, concentrated and salted out with KCl. The precipitated 2-sulfonate 
was dissolved in the minimum amount of hot water and allowed to crystallise to give pure 
potassium 2-phenanthrene sulfonate in 9 % yield. The 3-sulfonate was obtained by 
Chapter Three: Synthesis of Stilbene and Phenanthrene Derivatives 67
concentrating the original mother liquor and salting out with KCl. The precipitated 
potassium salts were dissolved in the minimum amount of hot water and cooled to 
crystallise out pure potassium 3-phenanthrene sulfonate in 10 % yield. 
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Reagents and conditions; (a) POCl3/sulfolane, MeCN, DMA, 70 °C; (b) 2.6, DIPEA, DCM, reflux; (c) Dess-
Martin periodinane, DCM; (d) L-ValOMe.HCl or L-LeuOMe.HCl, DIPEA, DCM, reflux; (e) K2CO3, 
MeOH/H2O, reflux; (f) EDCI, HOBt, DIPEA, DCM; (g) Dess-Martin periodinane, DCM. 
Scheme 3.10. Synthesis of phenanthrenesulfonamides. 
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Substitution 
position 
R 
3.1 2 OK 
3.2 3 OK 
3.3 2 Cl 
3.4 2 TFMC 
3.5 2 TFMK 
3.12 3 Cl 
3.13 3 TFMC 
3.14 3 TFMK 
SO2R
 
 
Y R X 
3.6 2-SO2 CH(CH3)2 OMe 
3.7 2-SO2 CH(CH3)2 OH 
3.8 2-SO2 CH(CH3)2 TFMC 
3.9 2-SO2 CH2CH(CH3)2 OMe 
3.10 2-SO2 CH2CH(CH3)2 OH 
3.11 2-SO2 CH2CH(CH3)2 TFMC 
3.15 3-SO2 CH(CH3)2 OMe 
3.16 3-SO2 CH(CH3)2 OH 
3.17 3-SO2 CH(CH3)2 TFMC 
3.18 3-SO2 CH2CH(CH3)2 OMe 
3.19 3-SO2 CH2CH(CH3)2 OH 
3.20 3-SO2 CH2CH(CH3)2 TFMC 
Y
H
N X
O
R
 
Figure 3.5. Compound numbers for 2- and 3-peptidyl phenanthrenesulfonamides from scheme 3.10. 
 
Although the overall yields were low, the chemistry was undertaken on a large scale and 
resulted in ca. 4 g of each phenanthrene sulfonate being obtained. Both were subsequently 
utilised in the synthesis of a series of phenanthrene based inhibitors (scheme 3.10). 
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2- and 3-Phenanthrenesulfonyl chloride 
he isolated sulfonates were readily converted into the corresponding sulfonyl chlorides 
MR characteristics of 2- and 3-phenanthrenes 
he phenanthrene isomers were readily identified by 1H NMR. The 1H NMR spectra of the 
 
igure 3.6a. A representative H NMR spectrum for 2-phenanthrene protons. The doublets corresponding to 
9 (7.86 ppm) and H10 (7.80 ppm) are separated by 31 Hz. 
 
T
by treating a suspension of 3.1 or 3.2 in a mixture of sulfolane and acetonitrile with 
POCl3.14 Addition of a few drops of dimethylacetamide catalysed the reaction and afforded 
the 2- and 3-sulfonyl chlorides 3.3 and 3.12 in 95 and 98 % yield respectively (scheme 
3.10). 
 
N
 
T
2-isomers have characteristic doublet, doublet, (doublet) singlet patterns (fig. 3.6a) while 
the 1H NMR spectra of the 3-isomers shows distinct singlet, doublet (doublet), patterns 
(fig. 3.6b).  
 
F 1
H
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Figure 3.6b. A representative 1H NMR spectrum for 3-phenanthrene protons. The doublets corresponding to 
H9 (7.85 ppm) and H10 (7.22 ppm) are separated by 64 Hz. 
 
In all cases, the singlet peak of 3-phenanthrenesulfonyl compounds, corresponding to the 
4-position of the phenanthrene ring is furthest downfield. In some cases the singlet appears 
as a minor doublet (J = 2 Hz) due to long range coupling with the other proton adjacent to 
the sulfur, resulting in the appearance of a corresponding doublet of doublets (J = 2, 9 Hz). 
Another common feature is the large separation of the signals corresponding to the 
doublets associated with H9 and H10. The separation between the two doublets is 
typically around 30 Hz for the 2-isomer (fig. 3.6a) and 60-80 Hz for the 3-isomer (fig. 
3.6b). 
 
3.5.2 Synthesis of 2- and 3-phenanthrene trifluoromethyl carbinols 
 
A series of peptides and peptidyl analogues were smoothly coupled to the 2- and 3-
phenanthrenesulfonyl chlorides 3.3 and 3.12 (scheme 3.10) using the Hünigs base method 
(General method C) in high yields. Initially the standard pyridine coupling method was 
used (General method A)16 but this often resulted in oily solids which required further 
work-up and purification. The ease of coupling, high yield, and crystalline nature of most 
of the solids demonstrates a great potential as a means of crystallising and identifying 
unknown amino acids and amines. The chemical shifts of the phenanthrene protons are 
generally downfield of most normal aromatic protons and when performed in deuterated 
acetone give well resolved, separated peaks which make coupling constant analysis much 
more simple. 
 
 
Chapter Three: Synthesis of Stilbene and Phenanthrene Derivatives 71
Oxidation of phenanthrene trifluoromethyl carbinols 
 
Phenanthrenesulfonyl chlorides 3.3 and 3.12 were coupled to trifluoromethyl carbinol 2.6 
in quantitative yields. Oxidation of 3.4 and 3.13 to the trifluoromethyl ketones 3.5 and 
3.14 was achieved by Dess-Martin periodinane17 in 56 and 48 % yields respectively 
(scheme 3.10). The low solubility of 3.4 and 3.13 and periodinane in dichloromethane may 
have contributed to the moderate yields. A mixture of ketone and hydrate was observed 
when the NMR was run in CDCl3; however running the NMR in a hydroscopic solvent 
such as DMSO or deuterated acetone greatly diminished the amount of ketone 3.5 or 3.14 
present. Addition of a drop of D2O to the sample gave exclusively hydrate, simplifying the 
spectrum and confirming the rapid formation of the hydrate in aqueous media. 
 
3.5.3 Synthesis of 2- and 3-phenanthrene dipeptidyl analogues 
 
In order to increase the specificity of the inhibitor for α-chymotrypsin it is desirable to 
increase the number of residues that interact with the binding pockets of the enzyme.  
 
It has been reported that the addition of a single amino acid to the peptidyl core of the 
inhibitor increased the potency of 27 some 30 fold.18 For α-chymotrypsin a hydrophobic 
non-aromatic residue such as L-valine or L-leucine in the P2 site is recommended to 
complement the S2 subsite (fig. 3.7).19 Syntheses that incorporate both of these residues 
were undertaken. 
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Figure 3.7. A reported inhibitor of α-chymotrypsin. 
 
 
Chapter Three: Synthesis of Stilbene and Phenanthrene Derivatives 72
Ester hydrolysis 
 
Phenanthrenes 3.3 and 3.12 were each coupled to L-valine or L-leucine methyl ester 
hydrochloride in the presence of Hünigs base to afford the N-protected amino acids 3.6, 
3.9, 3.15 and 3.18 in excellent yields (scheme 3.10). All four compounds were 
recrystallised to afford very pure crystalline products. Hydrolysis of the ester was first 
attempted with 0.25 M LiOH in MeOH/H2O at rt. Little or no hydrolysis was observed 
after 18 h. Hydrolysis was eventually achieved with KOH in EtOH/H2O at reflux but the 
hydrolysed product contained an unknown yellow impurity that was usually removed with 
repeated recrystallisation. Repeating the hydrolysis under milder conditions using K2CO3 
in MeOH/H2O at reflux afforded the free acids 3.7, 3.10, 3.16 and 3.19 in very high yield 
(scheme 3.10). The free acids contained none of the impurities present using KOH, 
although longer reaction times were required to effect hydrolysis, especially for valine 
methyl esters.  
 
Coupling and attempted oxidation of dipeptidyl trifluoromethyl carbinols 
 
Trifluoromethyl carbinol 2.6 was coupled to each of the four free acids 3.7, 3.10, 3.16 and 
3.19 utilising EDCI methodology to give ca. 1:1 mixtures of diastereomers 3.8, 3.11, 3.17 
and 3.20 in good yields (scheme 3.10). Attempted oxidations of the dipeptidyl 
trifluoromethyl carbinols 3.8, 3.11, 3.17 and 3.20 with Dess-Martin periodinane failed; 
again the near insolubility of the dipeptides in dichloromethane was probably a 
contributing factor. It was also suspected that due to the continued failure of the Dess-
Martin periodinane to oxidise trifluoromethyl carbinols, even on compounds previously 
oxidised with Dess-Martin periodinane that this particular batch had deteriorated to give 
hydrolysed and/or polymeric material. A new batch of Dess-Martin periodinane was 
synthesised20 but the oxidations were not repeated as it was believed that the poor 
solubility of the dipeptidyl mimics would limit their effectiveness as inhibitors in aqueous 
media. 
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3.6 Molecular modelling 
 
When comparing the structures of cis-azobenzene and phenanthrene derivatives drawn in 
the same orientation, side by side, cis-3-azobenzene and 2-phenanthrene derivatives appear 
to adopt similar conformations as do cis-4-azobenzene and 3-phenanthrene derivatives 
(fig. 3.8).  
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Figure 3.8. Comparisons of phenanthrene and azobenzene conformations. 
 
However, it is know from the crystal structure21 that cis-azobenzenes adopt a non-planar 
conformation (fig. 3.9) whereas trans-azobenzenes and phenanthrenes are planar and as 
such will occupy different spatial environments. 
 
Molecular modelling was undertaken by B. Stuart on the hydrate forms of trifluoromethyl 
ketones E-4.68, Z-4.68, E-4.12, Z-4.12, 3.5 and 3.14. The hydrate structure has been 
modelled as it is the predominant species found in solution.18,22 Superimposition of all four 
models of the azobenzene isomers along the trifluoromethyl ketone backbone of both 
phenanthrene isomers enabled comparison of the terminal ring systems.  
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Figure 3.9. Overlapped 3-D models of E- and Z-4.12 
 
3.6.1 Minimum energy conformation 
 
The six structures were constructed in silico using the Maestro build function of the 
Schrodinger molecular modelling suite. A conformational search of each structure was 
carried out with MacroModel using the OPLS2001 forcefield with the CHCl3 solvent 
model. Constraints were used for cis-azobenzenzes Z-4.88 and Z-4.12 where the C-N-N-C 
dihedral angle was constrained to 8° with a force constant of 100 kJ/mol.23 The criteria for 
convergence of each conformational search was the generation of 3000 starting 
conformations and a maximum of 5000 iterations in the energy minimisation routine for 
each conformer, collecting the ensemble of conformers within 12 kJ of the global mimima. 
The lowest energy conformer of each structure was then used for superimposition. Non-
polar hydrogens have been removed and the azobenzene carbon skeleton coloured orange 
for clarity. 
 
3.6.2 General characteristics of the models 
 
There are several features common to each of the energy minimised structures. The 
aromatic ring of the phenylalanine mimic is arranged so that complementary π-π stacking, 
as can be seen in figure 3.9, occurs between the phenyl ring and the first ring of the switch 
or pseudo switch. The peptidyl backbone has also rearranged to take advantage of 
intramolecular attractions between the sulfonamide and the diol (2.293 Å), the 
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trifluoromethyl moiety and diol (2.375 Å) and a true hydrogen bond between the sulfonyl 
oxygens and the diol (1.682 Å). 
 
Comparisons of 2-phenanthrene with E/Z 3- and 4-azobenzenes 
y comparing the overlap of the 2-phenanthrene isomer 3.5 with azobenzenes 4.12 and 
 
igure 3.10. Comparison of 3- and 4-azobenzenes with 2-phenanthrenes. 
 
B
4.68 (fig 3.10) it is obvious that E-4.12 is most similar. The phenanthrene ring is 
somewhat shorter the azobenzene moiety but the overall dimensions and spatial 
arrangements are comparable. Z-4.12 is comparable in length but the twisting of terminal 
phenyl ring from planarity significantly alters the spatial arrangement of the azobenzene. 
In contrast to the structural diagrams, both E-4.68 and Z-4.68 compare poorly as mimics of 
the 2-phenanthrene derivatives. 
F
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3.6.4 Comparisons of 3-phenanthrene with E/Z-3- and 4-azobenzenes 
By comparing the overlap of phenanthrene 3.14 with azobenzenes 4.12 and 4.68 (fig. 3.11) 
owed that E-4.68 occupies a similar spatial environment. Again the phenanthrene moiety 
 
Fig
 
sh
is shorter than the azobenzene but the rigid planar structure compliments the trans 
configuration of the azo group nicely. Geometrically, the Z-4-12 compares favourably as 
the twisted azo group mimics the shape of 3.14 quite well. However, the protrusion of the 
phenyl ring out of the plane does alter its spatial arrangement. E-4.12 does not fare as well 
as the planar azobenzene is nearly perpendicular to the phenanthrene ring and Z-3.68 
exhibits very poor overlap of the terminal ring systems with the phenyl ring pointing up 
and away from the phenanthrene ring system. 
 
ure 3.11. Comparison of 3- and 4-azobenzenes with 3-phenanthrenes 
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3.7 Summary 
 
Substituted stilbene 13 incorporating the key trifluoromethyl carbinol 2.6 was successfully 
ed utilising standard Wittig chemistry to prepare the stilbene 8 followed by routine 
readily prepared from the corresponding 
 phenanthrene sulfonates in high yield and purity. Their effectiveness at coupling 
the hypothesis that phenanthrenes could be 
cis mimics of azobenzenes. The models showed that 2-phenanthrenes mimic E-4-
prepar
peptide coupling. Major loss of product was often observed due to probable isomerisation 
and cyclisation of the stilbene. Oxidation of the trifluoromethyl carbinol to the 
corresponding trifluoromethyl ketone was achieved with TEMPO/NaOCl but complete 
oxidative photocoupling of the stilbene occurred as an undesired side reaction. Attempts at 
introducing the double bond further down the synthetic pathway were abandoned in favour 
of synthesising phenanthrenesulfonamides. 
 
2- and 3-phenanthrenesulfonyl chloride was 
potassium
to primary amines has been demonstrated; although no attempts at regenerating the free 
amine has been undertaken. The resulting sulfonamides were readily purified by 
chromatography or recrystallisation. Phenanthrenes incorporating only the trifluoromethyl 
carbinol 2.6 were successfully oxidised to the trifluoromethyl ketone, but incorporation of 
another amino acid to increase specificity had a significant impact on their solubilities and 
thus their ability to be oxidised. Their poor solubility in aqueous media was expected to be 
detrimental to their use as inhibitors.  
 
Molecular modelling was undertaking to test 
used as 
azobenzenes well, mimic Z-4-azobenzenes to a lesser extent and would be poor mimics of 
3-azobenzenes, contrary to the two dimensional projections. 3-Phenanthrenes were found 
to be reasonable mimics of E-3-azobenzenes and to a lesser extent, Z-4-azobenzenes but 
poor mimics of Z-3 and E-4-azobenzenes. 
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3.8 Future work 
 
From the molecular modelling studies it is apparent that neither 2- or 3-phenanthrene 
derivatives would be good mimics for Z-azobenzenes, they do however show some 
promise as fused analogues of E-3- and 4-substituted azobenzenes. It is unlikely that any 
planar, fused ring system would make a suitable mimic of Z-azobenzenes due to the non-
planar nature of the Z-azobenzene moiety. However, a better fused mimic of E-
azobenzenes might be the benzo[c]cinnolines (fig. 3.12) which incorporate the azo group 
fused within the ring. Molecular modelling of the structure should be undertaken to assess 
the potential of benzo[c]cinnoline as mimics of E- and Z-azobenzene and if the results look 
promising synthetic methods for the preparation of benzo[c]cinnoline based inhibitors 
should be investigated.  
 
NN
 
Figure 3.12. Benzo[c]cinnoline. 
 
So far several potential inhibitors of α-chymotrypsin incorporating phenanthrene have 
been limited by their poor solubility in aqueous media. Future work in this field could 
investigate the incorporation of additional functionality (amines, sulfonic acids, carboxylic 
acids, glycol units) in the phenanthrene ring system in order to increase water solubility. 
 
Further investigation into the preparation of mono- and disubstituted stilbenes via metal 
catalysed cross coupling or Wittig-Horner reactions may yield better results and open up 
new areas of research. 
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Synthesis of E-Azobenzene Derivatives 
 
4.1  Introduction 
 
In 1993 Westmark et al1 reported the synthesis of protease inhibitors which incorporated a 
photoswitchable azobenzene group which utilised a sulfonamide linkage to couple the 
switch to either an aldehyde or boronic acid inhibitory group (fig. 4.1). 
 
N
H
NN
5.8
O
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O2S N
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NN
B(OH)2
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Figure 4.1. Inhibitors incorporation an azobenzene photoswitch. 
 
Later work by our group2 utilised an azobenzene switch incorporating an amide linkage 
and the addition of peptidyl moieties to increase enzyme specificity and thus increase the 
potency of potential inhibitors (fig. 4.2). 
 
N
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O
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4.5
 
Figure 4.2. An amide linked azobenzene with peptidyl features. 
 
The main focus of this thesis is to design and synthesise a series of α-chymotrypsin 
inhibitors which incorporate aspects from both types of inhibitors. The photoswitch is 
based around an azobenzene moiety containing the sulfonyl group and the inhibitory group 
is a peptidyl trifluoromethyl ketone peptidomimetic of phenylalanine due to α-
chymotrypsin’s well known preference for binding substrates with an aromatic residue in 
the P1 position. The molecular switch is important as it constitutes a method by which the 
reactivity of the molecule can be changed. Irradiation of the photoswitch with UV or 
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visible light induces a conformational change which enriches the photostationary state with 
either the Z- or E-conformation. 
 
This thesis also investigates how increasing the peptide chain by one amino acid, varying 
the position of substitution of the linking moiety and adding substituents into the terminal 
ring of the azobenzene switch affects the potency of the enzyme inhibitor and composition 
of the photostationary state. Described below are the synthetic routes taken to synthesise a 
range of compounds based on the azobenzene core. 
 
 
4.2 Synthetic methods for preparing azobenzenes 
 
Symmetrical azobenzenes 
 
Symmetrical azobenzenes are readily prepared by either reducing substituted nitroarenes 
or oxidising substituted aryl amines (scheme 4.1) and are often produced as unwanted by-
products of oxidation or reduction reactions. 
 
R
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H2N
R
N N
R
R
R
NO2
O2N
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Scheme 4.1. Formation of symmetrical azobenzenes. 
 
Diazonium chemistry 
 
Unsymmetrical polysubstituted azobenzenes can be synthesised via diazonium chemistry. 
This involves diazotisation of an aryl amine with nitrous acidψ at 0-5 °C to afford a 
diazonium salt. Diazonium salts undergo typical electrophilic substitution with activated 
                                                 
ψ Prepared in situ by treating NaNO2 with mineral acids HCl or H2SO4. 
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arenes such as aniline or phenol derivatives which results in the rapid formation of 
aromatic azo compounds. The reaction will generally only proceed when an electron 
donating group (Y = NR2, OR) is present within the aromatic ring (scheme 4.2).  
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Scheme 4.2. Synthesis of azobenzenes via diazonium chemistry. 
 
The directing effects of -NR2 and -OR are activating ortho-para directors, para 
substitution invariably occurs unless the position is already blocked, in which case ortho 
substitution occurs. A vast number of azo dyes have been prepared in this manner.3 
 
Diazonium chemistry has been utilised to prepare triazenes by reacting sulfonated 
benzenediazonium salts with cyclic and heterocyclic amines.4 Several compounds of this 
type have been synthesised by our group as potential inhibitors of the cysteine protease 
calpain (scheme 4.3).ξ
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Scheme 4.3. Synthesis of triazene based inhibitors of calpain. 
 
                                                 
ξ M. Jones; Unpublished work. 
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The reaction of nitroso arenes with anilines to form azobenzenes has been known since the 
late 1800’s.5 The reaction is acid catalysed and is generally performed in acetic acid or an 
acetic acid/solvent mixture6 as strong inorganic acids lead to the formation of a tarry 
material.7 The postulated mechanism involves protonation of the nitroso arene 1 to give an 
activated N-hydroxylamine 3. The rate determining step is the attack on the electrophilic 
nitrogen of 3 by the nucleophilic aryl amine 2 to give an intermediate 4 which undergoes 
dehydration to give the azobenzene 5 (scheme 4.4).7  
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Scheme 4.4. Postulated mechanism for the condensation of nitroso arenes with aryl amines. 
 
The effect of substituents on the rate of formation of the azobenzene can be summarised as 
follows: If R1 is an electron acceptor (e.g. p-NO2) or R2 is an electron donor (e.g. p-
methyl) the rate is increased whereas if the substituents are switched around the rate 
decreases. The kinetic results also indicate that undissociated acetic acid is important in the 
mechanism (fig. 4.3) which explains the unsatisfactory results obtained with strong acids. 
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Figure 4.3. Postulated coordination of acetic acid during the reaction. 
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This is seen as a convenient way of preparing unsymmetrical, unique, unambiguous 
azobenzenes. The improvements in methods for preparing substituted nitrosobenzenes6,8 
and aryl amines has opened up a wide range of possibilities for the synthesis of more 
complex, functionalised azobenzenes. It is this chemistry that has been utilised to prepare a 
series of 3-azobenzenes and 4’,3- and 4’,4-disubstituted azobenzenes described in this 
thesis. 
 
 
4.3 Synthesis of 3- and 4-substituted azobenzenes 
 
4.3.1 3-Azobenzene amides 
 
Based on the work of Harvey,2 3-phenylazobenzoic acid derivatives incorporating an α-
keto ester moiety are potent inhibitors of α-chymotrypsin. Photoswitch 4.3 was 
synthesised so that compound 4.7, a trifluoromethyl ketone analogue of Harvey’s most 
potent compound 4.5 could be prepared for comparison (scheme 4.5).  
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Reagents and conditions; (a) HCl(g), EtOH, reflux; (b) AcOH, 100 °C, 4 h; (c) KOH, 4:1 EtOH/H2O, reflux; 
(d) 3S-amino-2R-hydroxy-4-phenylbutyric acid methyl ester, BOP, DIPEA, DCM; (e) 2.6, BOP, DIPEA, 
DCM; (f) TEMPO, KBr, NaOCl, DCM, 0 °C. Scheme 4.5. Synthesis of 3-azobenzene based inhibitors of α-
chymotrypsin. 
 
Synthesis of 3-phenylazobenzoic acid 4.3 
 
Following Harvey’s procedure 3-aminobenzoic acid was esterified in acidified EtOH to 
afford the ester 4.1 in 83 % yield. Condensation of 4.1 with nitrosobenzene in glacial 
acetic acid at 100 °C gave a black tar. Chromatography on alumina then silica gave the 
azobenzene 4.2 as an orange red oil in 74 % yield. Hydrolysis of the ester 4.2 with KOH in 
EtOH afforded 3-phenylazobenzoic acid 4.3 in 83 % yield (scheme 4.5). 
 
The sequence to prepare 4.3 could possibly be simplified by following an analogous route 
used to prepare 4-phenylazobenzoic acid by shaking a solution of 4-aminobenzoic acid 
dissolved in acetic acid with nitrosobenzene for 12 h at room temperature. The resulting 
product crystallised out of solution eliminating the need for chromatography.9 
 
Synthesis of 3-azobenzene amide derivatives 
 
The photoswitch 4.3 was coupled to trifluoromethyl carbinol 2.6 or 3S-amino-2R-hydroxy-
4-phenylbutyric acid methyl ester utilising BOP coupling methodology. The resulting 
solids were recrystallised from aqueous acetone to afford the amides 4.4 and 4.6 in 66 and 
98 % yield respectively (scheme 4.5). 
 
Oxidation of secondary alcohols 
 
Oxidation of secondary alcohols to ketones can be achieved by a variety of reagents10 
(section 2.2.4) with Dess-Martin periodinane being particularly effective on a wide range 
of substrates. Most alcohols, even sterically hindered secondary alcohols can undergo 
smooth oxidation in high yield with the periodinane and generally do not suffer from over 
oxidation, epimerisation or bond isomerisation. Dess-Martin periodinane has shown to be a 
very effective oxidising agent of electron deficient, weakly nucleophilic alcohols such as 
α-hydroxy esters, α-hydroxy amides and α-trifluoromethyl alcohols (scheme 4.6).11 
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Scheme 4.6. Dess-Martine periodinane oxidation of alcohols. 
 
A second reagent that has proved very effective for the oxidation of both α-hydroxy esters 
and α-trifluoromethyl alcohols is the nitroxide TEMPO 1. When utilised in a catalytic 
system with KBr as co-catalyst and buffered NaOCl as a co-oxidant secondary alcohols are 
smoothly and cleanly oxidised to ketones (scheme 4.7).12 This method is particularly 
useful for small scale oxidations. 
 
N
O
N
O
N
O O R'
H R
NaOCl NaOBr
Br
Br
N
OH
R R'
O
+
NaOBr
1
 
Scheme 4.7. Proposed mechanism for the catalytic TEMPO oxidation of alcohols  
 
α-Hydroxy ester 4.4 and trifluoromethyl carbinol 4.6 were oxidised at 0 °C by 
TEMPO/KBr/NaOCl to give ketones 4.5 and 4.7 (scheme 4.5). α-Keto ester 4.5 was 
recrystallised from aqueous acetone to give orange needles as ca. 1:1 mixture of ketone 
and hydrate in 56 % yield. Recrystallisation of trifluoromethyl ketone 4.7 from aqueous 
MeOH gave an orange solid which was predominantly hydrated in 87 % yield. Similar 
results were obtained when 4.6 was oxidised with Dess-Martin periodinane. 
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4.3.2 4-Azobenzenesulfonamides 
 
The sulfonyl linkage was chosen based on its increased stability towards hydrolysis in 
chemical and biological systems. The photoswitch can be prepared as the sulfonyl chloride 
which is significantly more stable towards air and moisture compared to the analogous 
acid chloride.13 Another advantage is it does not require coupling reagents to activate the 
electrophilic centre during amine coupling unlike the corresponding carboxylic acid due to 
the high reactivity of sulfonyl chlorides with amines. Scheme 4.8 outlines the synthesis of 
the photoswitch 4.8 and a series of 4-azobenzenesulfonamides (fig. 4.4) prepared by 
reactions with various amines. 
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Reagents and conditions; (a) HOSO2Cl, 100 °C; (b) 2.6, Py or DIPEA, DCM, reflux; (c) amino acid methyl 
ester.HCl, Py or DIPEA, DCM; (d) K2CO3, MeOH/H2O, reflux; (e) 2.6, BOP, DIPEA, DCM; (f) Dess-
Martin periodinane, DCM; (g) TEMPO, NaOCl, KBr, DCM, 0 °C or Dess-Martin periodinane, DCM. 
Scheme 4.8. Synthesis of 4-azobenzenesulfonamides. 
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Figure 4.4. Amino acid based 4-azobenzenesulfonamides. 
 
Synthesis of 4-azobenzenesulfonyl chloride 4.8 
 
The series of compounds based on the 4-azobenzenesulfonyl core were the easiest to 
prepare because the switch is readily prepared by direct sulfonation of azobenzene.14 
Recrystallised azobenzene was treated with freshly distilled chlorosulfonic acid to afford 
the crude product. Repeated extract with hot petroleum ether followed by flash 
chromatography of the orange product gave the pure 4-azobenzenesulfonyl chloride 4.8 in 
41 % yield. The phenylazo group is ortho-para directing and as a result only the mono 
para derivative is isolated provided the reaction temperature is kept below 130 °C. At 
higher temperatures the trisulfonated product is obtained (fig.4.5).14 
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Figure 4.5. Trisulfonated azobenzene. 
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Sulfonamide coupling 
 
The switch 4.8 has been utilised by Desai14 for the preparation of sulfanilamide derivatives 
and Woolfok15 in the separation, purification and identification of a wide range of amines 
including primary and secondary aliphatic and aromatic amines, secondary mixed amines 
and heterocyclic amines.  
 
Sulfonyl chloride 4.8 was readily coupled to L-phenylalanine, L-leucine and L-valine 
methyl esters and trifluoromethyl carbinol 2.6 affording sulfonamides 4.9, 4.13, 4.17 and 
4.11 (scheme 4.8) utilising either pyridine (yield > 84 %) or Hünigs base (yield > 97 %). 
Recrystallisation from aqueous MeOH resulted in crystalline products of high purity.  
 
Hydrolysis of methyl esters 
 
The methyl esters of sulfonamides 4.9, 4.13, 4.17 were hydrolysed under mild conditions 
using K2CO3 in aqueous MeOH (scheme 4.8). The reaction proceeded smoothly over a 
period of 10 h for the phenylalanine derivative but took nearly 24 h for the leucine methyl 
ester and 48 h for the valine methyl ester. The free acids 4.10, 4.14 and 4.18 were 
precipitated from solution by addition of aqueous acid to give orange solids in yields > 
97%. Free acids 4.14 and 4.18 were used to prepare dipeptides 4.16 and 4.19 while the 
phenylalanine derivatives 4.9 and 4.10 were used to prepare amino aldehydes (section 
2.4.3). 
 
Synthesis of dipeptidyl sulfonamides 
 
Increases in inhibitor potency have been reported by incorporation of additional amino 
acids to improve enzyme specificity. Studies have shown that the S2 binding pocket of α-
chymotrypsin favours hydrophobic residues such as L-leucine and L-valine. Two 
dipeptides have been synthesised which incorporate one of these residues in addition to the 
phenylalanine residue required for binding in the S1 pocket of the enzyme active site. The 
dipeptides have been introduced in two ways; firstly the peptides were introduced 
sequentially by using protection-deprotection methodology. 
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The O-protected amino acid L-leucine or L-valine methyl ester was N-protected as the 4-
azobenzenesulfonamide 4.13 and 4.17. The sulfonamide was O-deprotected by basic 
hydrolysis to the N-protected free acids 4.14 and 4.18. Trifluoromethyl carbinol 2.6 was 
coupled to the free acid via BOP methodology to give the dipeptides 4.15 and 4.19 in 59 
and 70 % yield respectively (scheme 4.8). Due to the mixed stereochemistry of 
trifluoromethyl carbinol 2.6 introduction of another stereogenic centre gives rise to a 
mixture of diastereomers. The ratio of diastereomers can easily determined by 1H and 19F 
NMR and the agreement between the two methods is generally very good. For 4.15 the 
ratio of diastereomers was 1:2 while for 4.19 the ratio was 2:3. The diastereomer ratio 
should be the same for each dipeptide provided the same sample of 2.6 was used in each 
synthesis. Possible explanations for the difference include racemisation of the α-carbon 
during chromatography on silica, or more likely, due to the prolonged period of reflux 
required for the hydrolysis of valine methyl ester 4.17 some base induced racemisation at 
the α-carbon centre may have occurred. 
 
The second method involved preparing the dipeptides (6a and 6b) separately then coupling 
the N-deprotected dipeptide with 4-azobenzenesulfonyl chloride 4.8 directly (scheme 4.9). 
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Reagents and conditions; (a) BOP, DIPEA, DCM; (b) Pd/C, H2, DCM or 33 % HBr in AcOH; (c) 4.8, 
DIPEA, DCM, reflux; (d) Dess Martin periodinane, DCM. 
Scheme 4.9. Alternate route for synthesising dipeptidyl 4-azobenzenes. 
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N-Cbz protected L-leucine or L-valine was coupled to trifluoromethyl carbinol 2.6 using 
the BOP coupling methodology to give the N-Cbz protected dipeptides 6a and 6b in 
quantitative yields. Deprotection via hydrogenation (> 90 %) or acidolysis (65 %) gave the 
free amino dipeptides 7a and 7b. The dipeptides were coupled to 4.8 in the presence of 
Hünigs base to give dipeptidyl sulfonamides 4.15 and 4.19 in 61 and 79 % yield 
respectively. 
 
Deprotection of the Cbz group via hydrogenation over palladium on carbon gave a cleaner 
product in higher yield than treatment with HBr in acetic acid. This second route would be 
faster and prevent potential base induced racemisation as the hydrolysis step is no longer 
required, it does however introduce valuable trifluoromethyl carbinol 2.6 a step earlier in 
the synthesis so each step would need to be as efficient as possible to minimise potential 
loss of product.  
 
 
4.4 Synthesis of 4’,3- and 4’,4-disubstituted azobenzenes 
 
Retrosynthetically, it can be seen that the disubstituted azobenzenes can be synthesised 
from nitrosobenzenes and metanilamides or sulfanilamides. Nitrosobenzenes can be 
prepared from the corresponding aryl amine or nitro arene while the metanilamides and 
sulfanilamides can be prepared from the corresponding 3- or 4-nitrobenzenesulfonyl 
chloride respectively (scheme 4.10). It was therefore imperative that facile means of 
synthesising these types of compounds be found. 
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Scheme 4.10. Retrosynthetic analysis of substituted azobenzenesulfonamides. 
 
4.4.1 Synthesis of 4-substituted nitrosobenzenes 
 
The nitrosobenzene used to synthesise 4.2 was prepared by the reduction of nitrobenzene 
with Zn dust and NH4Cl to give the hydroxyl amine followed by oxidation with acidified 
dichromate to afford the crude nitrosobenzene (scheme 4.11) which required purification 
by steam distillation.16  
 
a b
NO2 N NOOH
H
 
Reagents and conditions; (a) Zn, aq. NH4Cl, 55 °C; (b) H2SO4, Na2Cr2O7, 0 °C. 
Scheme 4.11. Synthesis of nitrosobenzene. 
 
This method seemed rather cumbersome so an investigation of the literature revealed that 
nitrosobenzenes could be obtained by the catalytic oxidation of aryl amines with tungsten 
or molybdenum species in the presence of hydrogen peroxide (scheme 4.12).8,17 
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Scheme 4.12. Catalytic oxidation of aryl amines with MoVI and hydrogen peroxide. 
 
4-Halogenated nitrosobenzenes 
 
4-Bromonitrosobenzene 4.25 and 4-iodonitrosobenzene 4.26 were prepared from 
commercially available 4-bromoaniline and 4-iodoaniline by oxidation with MoVI-
hydrogen peroxide over 16-18 h in 51 and 19 % yields respectively. The formation of 4.26 
was particularly low due to the formation of multiple by-products. At least six different 
bands were observed on the column. It has been reported that side reactions can be 
minimised by employing the bi-phasic system developed by Priewisch et al.6 The 
advantages of this method are that no catalyst is required, oxidation is achieved with 
cheap, commercially available Oxone in a mixture of water/dichloromethane, requires 
much shorter reaction times (3.5 h for the Br derivative) and can be performed on larger 
scales than previous methods.6 
 
4-Nitrosobenzoic acid ethyl ester 4.27 
 
4-Nitrosobenzoic acid ethyl ester 4.27 was prepared from 4-aminobenzoic acid which was 
esterified in acidified EtOH in an analogous manner to 4.1 then oxidised with MoVI-
hydrogen peroxide over ca. 50 h to give 4.27 in 64 % yield. 
 
Fmoc protected 4-aminomethylnitrosobenzene 4.24 
 
The N-protected 4-aminomethylaniline 4.23 was prepared from commercially available 4-
nitrobenzyl chloride (scheme 4.13). The amino group was introduced by nucleophilic 
displacement by the phthalimide anion to give phthalimide 4.20 in 89 % yield after 
recrystallisation. The phthalimido protecting group was removed by treating with 
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hydrazine hydrate at reflux and acidifying the filtrate to afford the hydrochloride 4.21 in 82 
% yield. The amino group was protected with Fmoc to give 4.22 in 71 % yield. The choice 
to remove the phthalimido group and reprotect as the Fmoc derivative was made because 
the harsh conditions utilised in removing phthalimides are often incompatible with more 
sensitive functional groups that may be present within the molecule. Fmoc was chosen due 
to its stability under acidic and hydrogenation conditions and ease of removal with TBAF 
or piperidine. The nitrobenzene 4.22 was reduced under a hydrogen atmosphere utilising 
Adams’ catalyst18 to afford the aniline 4.23 in quantitative yield. The final step in the 
synthesis was the molybdenum catalysed oxidation over 14 h which was remarkably 
efficient compared to the other nitroso compounds formed and gave 4.24 in 98 % yield 
(scheme 4.13). 
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Reagents and conditions; (a) potassium phthalimide, DMF, 50 °C, (b) hydrazine, EtOH, reflux; (c) AcOH; 
(d) FmocCl, DIPEA, DCM; (e) PtO2.H2O, H2, EtOAc; (f) MoVI, H2O2, DCM, 14 h. 
Scheme 4.13. Synthesis of 4.24 from 4-nitrobenzylchloride. 
 
All nitroso compounds synthesised were readily recrystallised from aqueous EtOH. The 
colour in solution was green but in solid form the colours varied from green to yellow to 
brown indicating the formation of dimers in solution. The compounds were stored at -18 
°C to prevent oxidation and decomposition of the nitrosobenzenes. 
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4.4.2 Synthesis of metanilamides and sulfanilamides 
 
Monopeptidyl metanilamides and sulfanilamides 
 
Amino acids L-leucine and L-phenylalanine and trifluoromethyl carbinol 2.6 were coupled 
to 3- and 4-nitrobenzenesulfonyl chloride in the presence of Hünigs base to give 
sulfonamides 4.28, 4.30, 4.32, 4.35, 4.37 and 4.39 in excellent yields. The phenylalanine 
derivatives 4.28, 4.35 and trifluoromethyl carbinols 4.30, 4.37 were reduced under a 
hydrogen atmosphere with Adams’ catalyst to afford metanilamides 4.29, 4.31 and 
sulfanilamides 4.36, 4.38 in isolated yields > 95 % (scheme 4.14). 
 
SO2Cl
O2N
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N
H
CF3
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O2S
O2N
N
H
X
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Reagents and conditions; (a) L-LeuOMe.HCl, DIPEA, DCM, reflux; (b) K2CO3, MeOH/H2O, reflux; (c) 2.6, 
BOP, DIPEA, DCM; (d) PtO2.H2O, H2, EtOAc; (e) 2.6, DIPEA, DCM, reflux. 
Scheme 4.14. Synthesis of metanilamides and sulfanilamides. 
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Y R X 
4.28 3-NO2 CH2Ph OMe 
4.29 3-NH2 CH2Ph OMe 
4.32 3-NO2 CH2CH(CH3)2 OMe 
4.33 3-NO2 CH2CH(CH3)2 OH 
4.34 3-NO2 CH2CH(CH3)2 TFMC 
4.35 4-NO2 CH2Ph OMe 
4.36 4-NH2 CH2Ph OMe 
4.39 4-NO2 CH2CH(CH3)2 OMe 
4.40 4-NO2 CH2CH(CH3)2 OH 
4.41 4-NO2 CH2CH(CH3)2 TFMC 
4.42 4-NH2 CH2CH(CH3)2 TFMC 
O2S
Y
N
H
X
O
R
 
 
Y 
4.30 3-NO2
4.31 3-NH2
4.37 4-NO2
4.38 4-NH2
O2S
Y
N
H
CF3
OH
Ph
 
Figure 4.6. Compounds prepared during the synthesis of metanilamides and sulfanilamides. 
 
Dipeptidyl metanilamides and sulfanilamides 
 
The leucine methyl esters 4.32 and 4.39 were hydrolysed under basic conditions with 
K2CO3 in aqueous MeOH to give the free acids 4.33 and 4.40 in isolated yields of 90 and 
72 % respectively (scheme 4.14). 
 
The free acids 4.33 and 4.40 were coupled to trifluoromethyl carbinol 2.6 using the BOP 
coupling methodology to give the dipeptidyl sulfonamides 4.34 and 4.41 (scheme 4.14) in 
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isolated yields of 85 and 77 % respectively as 1:1 and 2:3 mixtures of diastereomers. 
Dipeptide 4.41 was reduced under an atmosphere of hydrogen with Adams’ catalyst to 
give sulfanilamide 4.42 in 83 % yield as a 2:3 mixture of diastereomers. Due to time 
constraints the metanilamide of 4.34 was not prepared. 
 
The use of hydrogen and Adams’ catalyst proved to be a mild and efficient method for the 
synthesis of aryl amines from nitroarenes and avoided the use of more harsh reductive 
methods such as metal/acid systems. Little or no by-products were observed, the only 
major exception was the formation of symmetrical azobenzene 8 (fig. 4.7) when 4.35 was 
left under hydrogen for 4 days.  
 
O2S N
H
OMe
O
Ph
NN
S
O2
H
NMeO
Ph
O
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Figure 4.7. Symmetrical azobenzene formed during catalytic hydrogenation of 4.35. 
 
 
4.4.3 Disubstituted azobenzene formation  
 
4’,3-Azobenzenesulfonamides 
 
Metanilamide 4.31 was condensed with nitrosobenzenes 4.25 and 4.26 in acetic acid at 75 
°C (scheme 4.15). After chromatography the 4’,3-disubstituted azobenzenes 4.43 and 4.45 
were isolated in 76 and 77 % yields respectively.  
 
4’,4-Azobenzenesulfonamides 
 
Sulfanilamides 4.36, 4.38 and 4.42 were condensed with various nitrosobenzenes 4.24, 
4.25, 4.26 and 4.27 in acetic acid at 75 °C (scheme 4.15). After chromatography various 
4’,4-disubstituted azobenzenes were obtained (fig. 4.8) in yields ranging from 9-69 %.  
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NO
SO2NHR
H2N
N N
SO2NHRAcOH
75 oC
+
X
 
Scheme 4.
 
onopeptidyl azobenzenes with halogen or ethyl carboxy groups gave acceptable yields 
zobenzene 4.53 was significantly lower at 29 
. The yields of dipeptides 4.60 and 4.61 were especially poor at 9 and 23 % respectively; 
 position 
R 
15. Synthesis of disubstituted azobenzenes. 
M
between 64-69 % while the Fmoc protected a
%
however significant amounts of starting material were recovered suggesting that the low 
yields were a result of slower rates of reaction/higher activation energies and not due to 
decomposition of the starting materials. Longer reaction times and/or higher temperatures 
may result in improved yields. 
 
X 
Substitution 
X
N N
SO2R
X
4.43 Br 3 TFMC 
4.45 I 3 TFMC 
4.47 Br 4 L-PheOMe 
4.48 Br 4 TFMC 
4.50 I 4 L-PheOMe 
4.51 I 4 TFMC 
4.53 FmocNHCH2 4 TFMC 
4.55 EtO2C 4 TFMC 
4.60 Br MC 4 L-LeuTF
4.61 I 4 L-LeuTFMC 
 
Figure 4.8. S ised disubstitute benzenes by co sation of nitroso l amines. 
 
ynthes d azo nden benzenes with ary
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The aryl peaks in the 1H NMR spectrum for each of the 4’-3-disubstituted azobenzenes 
were easily assigned based on the integral ratios and multiplicity of the peaks (fig. 4.9).  
 
 
Figure 4.9. 1H NMR of 4.43. The key feature is the ability to unequivocally assign the two doublets of the 
brominated ring. H2’ (8.05 ppm); H3’ (7.95 ppm). 
 
The information gleaned from these spectra simplified the interpretation of the analogous 
4’,4-disubstituted azobenzenes as the proton chemical shifts of the azobenzene rings had 
very little variation between derivatives containing the same X substituent (fig. 4.10). 
 
X 
2 3 2’ 3’ 
Br 7.9 7.7 8.05 7.95 
I 7.9 7.7 7.9 8.1 
FmocNHCH2 7.9 7.7 8.1 7.7 
EtO2C 7.95 7.75 8.2 8.4 
N N
X
3'
2'
2
3 SO2R
 
Figure 4.10. Approximate chemical shifts of the protons of the 4’,4-disubstituted azobenzene. 
 
4.4.4 Miscellaneous couplings of functionalised azobenzenes 
 
The potential for extending the azobenzene switch in the terminal direction was 
investigated. The feasibility of incorporating additional aryl rings by metal catalysed cross 
couplings were tested by employing the Suzuki coupling of some available boronic acids 
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with aryl halides. The bromide 4.47 was coupled to 4-methoxyboronic acid and 2-
fluoropyridine-5-boronic acid utilising Pd0(PPh3)4 and KOH under phase transfer 
conditions. The reactions gave the desired biaryl compounds 4.63 and 4.64 in 23 and 27 % 
isolated yield. The low yields were due to hydrolysis of the methyl esters resulting in free 
acids which bound to the silica column. Attempted coupling of bromide 4.48 to the 
boronic acids under the same conditions failed. The coupling was repeated with 4-
methoxyboronic acid via modified procedure19 which utilised the more reactive aryl iodide 
4.51, a milder base (Na2CO3), deoxygenated solvents and bi-phasic conditions. The 
reaction proceeded smoothly to afford the biaryl 4.65 (fig. 4.11) in 67 % yield. 
 
N N
O2S N
H
Ph
CF3
OH
4.65
MeO
 
Figure 4.11. Biaryl 4.65 prepared by Suzuki coupling. 
 
Ethyl ester 4.55 was hydrolysed by LiOH in aqueous MeOH to give the water soluble 
lithium carboxylate. Acidification and recrystallisation afforded the free acid 4.58 in an 
isolated yield of 98 %. The carboxylic acid moiety can now potentially be used to couple 
other molecules onto the azobenzene unit. The most obvious choice is to form an amide 
bond under peptide coupling conditions. To test this out and to make an interesting 
molecule, half an equivalent of ethylenediamine dihydrochloride was coupled with 4.58 
under HATU conditions to give the bridged dimer 4.59 (fig. 4.12) in 96 % yield.  
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Figure 4.12. Bridged dimer of 4.58. 
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The Fmoc protected azobenzene 4.53 was deprotected with TBAF to give the free amine. 
Due to time restraints no reactions have been performed on the deprotected molecule yet, 
however similar azo compounds prepared by our group have been successfully coupled to 
carboxylic acids and amino acids in reasonable yields.ξ
 
4.4.5 Trifluoromethyl carbinol oxidation 
 
Oxidation of all 4’,3- and 4’,4-disubstituted azobenzene trifluoromethyl carbinols were 
achieved using Dess-Martin periodinane or TEMPO/NaOCl (fig. 4.13). 
 
 
X 
Substitution 
position 
R 
4.44 Br 3 TFMK 
4.46 I 3 TFMK 
4.49 Br 4 TFMK 
4.52 I 4 TFMK 
4.54 FmocNHCH2 4 TFMK 
4.57 EtO2C 4 TFMK 
4.62 I 4 L-LeuTFMK 
N N
SO2R
X
 
Figure 4.13. Synthesised disubstituted azobenzene trifluoromethyl ketones. 
 
Generally, if one method proved unsuccessful, oxidation could be achieved with the other. 
In cases where solubility was an issue, oxidations were achieved with TEMPO in a 2:1 
dichloromethane/ethyl acetate solvent system. The yields were generally 60-85 % with the 
Fmoc protected 4.53 again proving to be the exception with a yield of 39 %. The 
trifluoromethyl ketones were found to exist predominantly in a hydrated state (by 1H and 
19F NMR) and can be completely hydrated upon addition of water to the sample. This is in 
agreement of studies performed by Abeles et al which showed that the ketone/hydrate ratio 
is 1:500 in aqueous media.20 
                                                 
ξ D. Pearson. Ph.D student. 
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4.5 Summary and future work 
 
A series of trifluoromethyl ketones have been synthesised as potential inhibitors of α-
chymotrypsin. These inhibitors incorporate a photoswitchable mono or disubstituted 
azobenzene which has been synthesised by the acid catalysed condensation of nitrosoarene 
and aryl amine derivatives or by direct coupling to a preformed switch. The position of the 
sulfonamide has been varied between the 3- and 4- positions of the azobenzene ring while 
additional substituents (Br, I, EtO2C, NHRCH2) have been incorporated into the 4’- 
position of the terminal ring. These groups were chosen as they have the potential to allow 
further modification of the azobenzene switch. Some potential modifications which should 
impart beneficial properties to the inhibitor include; addition of functionalities which 
improve water solubility (e.g. sugars, polyethylene glycols, tetraalkylamines) and increase 
steric bulk to increase conformational differences between the E- and Z-isomers and 
incorporate linkers to allow attachment to solid supports for investigation into 
photoregulated purification of enzymes. A general method for preparing polysubstituted 
azobenzenes could be useful for the synthesis of important dye molecules used in digital 
recording and liquid crystal displays. 
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Isomerisation Studies 
 
5.1 Introduction 
 
A series of α-chymotrypsin inhibitors have be designed and synthesised which incorporate 
an azobenzene moiety coupled to a peptidyl core. The azobenzene group is an important 
feature in the design as it can undergo conformation change between a planar E-(trans) 
and a twisted Z-(cis) conformation of the molecule. The rationale behind the design was to 
synthesise a series of enzyme inhibitors which can switched between bioactive and less 
bioactive forms under the influence of external stimuli. In this case the trigger is irradiation 
of the azobenzene switch with UV or visible light to induce preferential conversion to one 
conformation or the other.  
 
5.1.1 Structural properties of azobenzene 1 
 
The azo group is characterised by two nitrogen atoms linked by a double bond with each 
nitrogen atom having a pair of non-bonding electrons. The photochemical and chemical 
stability of the azo compound is greatly dependent on the substituents incorporated into the 
molecule. This stability increases with increasing resonance and inductive effects.2 The 
N=N bond distance varies little between aromatic and aliphatic azo compounds with 
azobenzene having a bond length of 1.23 Å. The C-N bond length is slightly shorter in E-
azobenzene than Z-azobenzene (1.41 and 1.46 Å respectively) with C-N-N bond angles 
close to 120 °giving rise to geometrical isomers.  
 
E-Azobenzenes adopt a planar conformation through the N=N backbone while one of the 
phenyl rings of the Z-azobenzene is twisted out of the plane of the azo group by ca. 56 ° 
(section 3.6) due to steric hindrance between the ortho protons. This difference in spatial 
arrangement alters the dipole moments of the two isomers; values of 0 and 3 D have been 
determined for E- and Z-azobenzene respectively.  
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5.1.2 Spectroscopic properties of azobenzenes2 
 
Molecular systems possess the ability to absorb or emit radiation. In this process only 
discrete quanta (hv) of characteristic energy are involved. This leads to a change in energy 
states where the spin state (S0 ? S1) must remain the same i.e. any change in multiplicity 
(So ? T1) is forbidden (fig. 1.1a). These states can be classed as rotational, vibrational and 
electronic motion. In solution rotational sates are rarely observed and therefore discounted. 
An interaction between two states leads to the formation of a new high and low energy 
state (fig. 1.1b). The energy difference (∆E) depends on the extent of coupling between 
states. 
 
 
Figure 5.1. (a) Spin allowed and spin forbidden processes; (b) Coupled states. 
 
(n ? π*) transitions 
 
Azo compounds are characterised spectroscopically by a low energy 1(n,π*) state which 
gives rise to an absorption band at ca. 440 nm. This is the result of a weak (n ? π*) 
transition. Comparison of a range of aromatic azo compounds indicates that the position of 
the (n ? π*) transition is relatively unaffected by substitution of the aryl rings while the 
intensity of the transition is only slightly affected by the nature of the substituents and 
unaffected by position within the aromatic ring i.e. (n ? π*) transitions are determined by 
local symmetry not molecular geometry. This intensity is greater for Z-azobenzenes (λ449 = 
1250 M-1.cm-1 for Z-azobenzene)3 as the transition to the lowest 1(n ? π*) state is 
symmetry allowed and approaches oscillator strengths comparable to (π ? π*) transitions. 
∆E
v4
v3
v2v1
hvthvs
0 
E 
T1
S0
S1
(a) (b) 
v 
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The same transition for the E-isomer is forbidden by selection rules but does occur, albeit 
at lower intensity, as there is sufficient vibrational coupling with the 1(π ? π*) transition to 
permit the transition (λ449 = 405 M-1.cm-1 for E-azobenzene).3 
 
(π ? π*) transitions 
 
A second characteristic peak in the spectra of azobenzenes is an intense band at ca. 340 nm 
arising from the (π ? π*) transition, which, unlike the (n ? π*) transition is dependent on 
the substituents on the phenyl rings of the azo compounds. The highest occupied π orbital 
is sensitive to substituents, therefore upon substitution the (π ? π*) band is displaced 
whereas the (n ? π*) is not. In the case of E-azobenzene (π ? π*) vibrational bands are 
structured and separated at intervals of 220 cm-1 and 1300-1400 cm-1 whereas Z-
azobenzenes show no structure even at low temperature. A study of solvent effects on the 
(π ? π*) transition of substituted azobenzenes show that the absorption band red shifts with 
increasing solvent polarity, the effect being more pronounced with aprotic solvents.4 
 
 
5.2 E-Z Isomerisation of azobenzenes 
 
Irradiation of azo compounds with UV or visible light results in the formation of a 
photoisomeric equilibrium of the E- and Z-conformations (fig. 5.2).  
 
NN
R
R'
N N
R
R'
hv
hv'
 
Figure 5.2. E-Z isomerisation of aromatic azo compounds. 
 
These photostationary states arise because there are absorbance overlaps for the E- and Z-
isomers at all wavelengths. These conformations exhibit considerable differences in the 
size, shape and polarity of the two isomers. These differences can be exploited which 
make azobenzenes ideal candidates for photoregulation. The E-isomer is 
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thermodynamically more stable by 50 kJ.mol-1 and while Z-azobenzene can thermally 
revert to the E-isomer in the absence of light the activation barrier for this process is 96 
kJ.mol-1 in solution or 130 kJ.mol-1 in the solid state.2 The corresponding half life of the Z-
isomer is in the order of 1 day at room temperature.  
 
The composition of the photostationary is dependant on the ratio of the molar absorptivity 
coefficients at the wavelength of irradiation. Under these conditions the equilibrium 
favours the isomer with the lowest ε.5  
 
Consider the case where a compound can exist as either isomer A or B. Irradiation of the 
mixture with a specific wavelength of light which favours isomer A will lead to a high 
energy state A* which decays to give an excited transition state P*. Subsequent decay leads 
to transition state P which then has the choice of relaxing to either ground state A or B by 
internal conversion followed by loss of excess vibrational energy. If α is the probability of 
forming A then the probability that B is formed must be (1-α). Due to some overlap of the 
absorbance of B at the wavelength of irradiation, B is also excited to give B* which decays 
to the common transition state P which also relaxes to give either A or B (fig. 5.3). 
 
A* B*
P*
hv hv 
P 1-αα
A B
 
Figure 5.3. Photochemical processes for the photoisomerisation between states A and B. 
 
The photostationary composition of isomers A and B is determined by the steady state 
equilibrium expressed in equation 5.1. 
 
[A]
[B] = ⎝⎜
⎛
⎠⎟
⎞εB
εA  ⎝⎜
⎛
⎠⎟
⎞α
1 - α         Equation 5.1 
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To put this into practice; if we want to enrich the photostationary state of azobenzene with 
the Z-isomer, the sample is irradiated with UV light (λ < 350 nm) as εZ is lower for all 
wavelengths between 375 and 275 nm. The opposite is true if E-enrichment is required, at 
all wavelengths > 375 nm, εE is lower so irradiation with visible light (λ > 400 nm) will 
afford predominantly E-azobenzene (fig. 5.4).  
 
 
Figure 5.4. A plot of log(ε) vs. λ for E- and Z-azobenzene. Taken from Zimmerman et al (1957).6 
 
If B has a higher ground state energy than A, the activation energy for the thermal back 
reaction is lower than for the forward reaction and therefore favoured in many cases. Since 
the thermal Z ? E isomerisation was first reported in 19377 many studies have been 
undertaken to determine the isomerisation mechanism and factors which influence the rate. 
Activation energies for the thermal isomerisation typically range from 88-100 kJ.mol-1and 
are very dependant on substitution, solvent polarity and proton concentration. The thermal 
isomerisation rate of disubstituted azobenzenes incorporating an electron donating 
substituent (NR2, OR) and an electron withdrawing group (NO2, CO2R) is significantly 
increased in polar aprotic solvents due to stabilisation of the dipolar transition state.4 At 
low pH the rate of isomerisation is greatly accelerated while at high pH the rate is 
inhibited.8  
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5.2.1 Mechanism of isomerisation 
 
The proportion of Z-isomer formed in solution is dependant on the wavelength of light 
used and the solvent the photostationary state is obtained in. The final photostationary state 
is independent of the initial composition, sample concentration and the intensity of light. 
Only the time taken to reach the photostationary state is dependent on sample 
concentration and intensity of irradiation which can take from minutes to hours.5 
 
The mechanism by which azobenzenes undergo isomerisation has been debated by various 
groups (Asano,9 Bellobono,10 and Nishimura11). The two favoured mechanisms are 
inversion of a nitrogen atom which involves the (n ? π*) state and rotation about the N-N 
σ-bond which involves the (π ? π*) state.  
 
The most popular mechanism for isomerisation, ‘inversion’ proceeds through a transition 
state where one of the nitrogen atoms has been sp-hybridised. Evidence for this was 
obtained from the facile isomerisation of an azobenzene unit (5.1) incorporated within a 
ring system (fig. 5.5).  
 
N
N S
S
N
N
5.1
 
Figure 5.5. E-2,19-dithia[3,3](4,4’)-diphenyldiazeno-(4)-phane. 
 
Under these circumstances, a rotational mechanism would have been improbable because 
of the difficulties associated with rotating the phenyl ring around the N-N bond due to 
steric effects. A study of the mechanism of isomerisation for simple disubstituted 
azobenzenes lead to some conflicting conclusions. Both Nishimura and Bellobono were in 
favour of a single path (inversion) mechanism while Asano favoured a mixed inversion-
rotation pathway (fig. 5.6).9 
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Figure 5.6. Mixed pathway for the isomerisation of 4-(dialkylamino)-4’-nitroazobenzene. 
 
Asano et al found that 4-amino-4’-nitroazobenzenes underwent thermal isomerisation by 
both inversion and rotational routes. This conclusion was based on the effects of solvent, 
temperature and pressure on the isomerisation kinetics which could not be explained by an 
inversion only mechanism. It was concluded that the mechanism of isomerisation was 
dependent on the solvent and nature of the substituents. Rotation around the N-N σ-bond 
favours polar solvents as the zwitterionic intermediate (1) is stabilised by polar solvents 
while inversion occurs predominantly in non-polar solvents where the intermediate (2) has 
no charge and therefore stabilisation of charge is not required. 
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5.2.2 Practical applications 
 
Azo dyes 
 
Many of the examples of azo compounds in the literature are based on simple mono- and 
disubstituted azobenzenes which have been synthesised for kinetic and mechanistic studies 
or as models for more complex dyes. Another niche are the so called azo dyes which range 
from simple substituted azobenzenes (5.2) through to complex macromolecules (5.4) 
which incorporate multiple azo units, aryl rings and substituents and tend to be highly 
conjugated (fig. 5.7).  
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Figure 5.7. Azo dyes Methyl orange 5.2, Direct yellow 12 5.3 and Direct red 80 5.4. 
 
Azo dyes generally exist in a full E-configuration but can undergo E-Z isomerisation 
which often results in colour change or changes in colour intensity. Potentially, due to 
multiple double bonds within the structure, the photochemistry can be quite complex and 
result in mixtures of E- and Z-substituted double bonds within the molecule. An interesting 
observation noted that fibre affinity can be affected by isomerisation. Applications of 
Direct yellow 12 include dying of cellulose fibres. Upon irradiation of an aqueous solution 
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of the dye the hue visibly intensified and the affinity for the cellulose decreased. This was 
presumably because the non-linear geometry of Z-5.3 no longer complimented the rigid 
cellulose structure.12 
 
Host-Guest chemistry 
 
Azobenzene units have been utilised to enforce reversible changes in larger molecules 
such as crown ethers, cryptands, cyclodextrins and polymers and have proved useful as 
agents for reversibly binding host ions and molecules during extraction.13 For example, 
cryptand E-5.4 was found to bind heavy metal ions such as Cu2+, Ni2+, Co2+ and Hg2+ from 
aqueous media and extract them into organic solutions. Conversely, Z-5.5 was unable to 
bind the metal ions due to expansion of the cavity. Photoswitching of the cryptand allowed 
the metals to be released from the complex upon isomerisation to the Z-isomer (fig. 5.8). 
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Figure 5.8. Specific binding of heavy metals by an azo bridged cryptand. 
 
Photoregulation of enzyme activity 
 
The work in this field has focused on two main areas; modification of the enzyme or 
enzyme analogue by covalently linking the photoactive molecule through a side chain 
residue14 or polymer matrix;15 or by synthesis of specific molecules incorporating the 
photoactive moiety which can interact with the enzyme or macromolecule.16-22  
 
Photoregulation of enzyme inhibition with small molecules is the basis for this thesis. A 
series of inhibitors have been designed which incorporate three key features; molecular 
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switching, enzyme specificity and an inhibitory warhead. The design of these inhibitors 
has been discussed in greater detail in section 4.1. 
 
Previous work in this area began in the late sixties when Kaufman et al23 and later Bieth et 
al16 modified known acetylcholinesterase inhibitors by incorporating azobenzene into the 
structure. In this way the activity of N-diphenylcarbamyl halides 5.6 were compared with 
the activity of N-4-phenylazophenyl-N-phenylcarbamyl halides 5.7.  
 
N X
O
N X
ONN
X = Cl, F
5.6 5.7
 
Figure 5.9. Acetylchloinesterase inhibitors. 
 
Compounds 5.7 exhibited significant photoswitching and upon irradiation with UV light 
gave enriched mixtures consisting of 85-90 % Z-isomer. Kinetic studies showed the Z-
isomers to be 3-6 fold more active than the corresponding E-isomers and in all cases the 
introduction of an azobenzene moiety improved the potency of the inhibitor compared 
with the parent carbamate. 
 
Westmark et al designed transition state analogue inhibitors of cysteine and serine 
proteases which incorporated an azobenzene photoswitch and either an aldehyde 5.8 or 
boronic acid 5.9 warhead.17 Boronic acid warheads have also been incorporated into some 
inhibitors synthesised in our laboratories. 
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Figure 5.10. Cysteine 5.8 and serine 5.9 protease inhibitors. 
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Irradiation of 5.8 and 5.9 with UV light (330 < λ < 370 nm) gave 83 and 80 % Z-
enrichment respectively while irradiation of 5.8 with visible light (λ > 400 nm) gave 
complete restoration of the E-isomer. Unlike the acetylcholinesterase inhibitors it was 
found that both E-isomers were more active against their respective enzymes than the Z-
isomers (fig. 5.11). 
 
 Ki (µM) 
compound E-enriched Z-enriched 
5.8 2.1 8.8 
5.9 11 41 
 
Figure 5.11. Apparent Ki for the E- and Z-enriched conformations of 5.8 and 5.9. 
 
Work by Amato et al showed that alfalfa leaf protease was inhibited by interlinked 
positively charged amino groups. By separating the charges with an azobenzene linker 
(fig. 5.12) they demonstrated biological activity of the enzyme depended on the 
conformation of the azobenzene.  
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Figure 5.12. An alfalfa leaf protease inhibitor. 
 
The symmetrical disubstituted azobenzene 5.10 was synthesised and when irradiated at 
340 nm gave 60 % Z-isomer while irradiation at 417 nm reduced the proportion of Z-
isomer to 5 %. It was found that E-5.10 was a competitive inhibitor of the enzyme (Ki = 
5.7 x 10-4 M) while Z-5.10 was completely inactive under the experimental conditions. 
The difference in biological activity was attributed to the change in distance between the 
two amino groups as a result of the different conformations.18 
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Tyrosinase is an enzyme with a binuclear copper active site responsible for converting L-
tyrosine into melanin and may also be useful for detoxifying phenolic compounds. It is 
inhibited by benzoic acid derivatives and as such deemed a potential target for 
photoregulation. Komori et al prepared 4-azobenzene carboxylic acid 5.11 and 4,4’-
azobenzene dicarboxylic acid 5.12 as photoswitchable analogues of benzoic acid.22  
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Figure 5.13 Tyrosinase inhibitors. 
 
Irradiation of 5.11 and 5.12 with UV light (λ < 370 nm) gave 65 and 68 % Z-isomer 
respectively. Irradiation of Z-5.11 with visible light (λ > 400 nm) gave 67 % E-5.11. 
Interestingly, Z-5.11 was more potent than the E-isomer while Z-5.12 was less inhibitory 
than the E-isomer. Under their experimental conditions the changes in enzyme activity 
were 2-fold or less. The changes in the active conformation were attributed to different 
electron densities of the carboxylic acid groups which coordinate to the copper in the 
active site and differences in steric hindrance; 5.12 was expected to be more sterically 
hindered due to the extra carboxylic acid.  
 
The work of Harvey examined the effects of substitution patterns of the azobenzene 
moiety as well as connectivity order within the molecule for a series of α-keto esters based 
on L-phenylalanine. It was found that the most active order of connectivity is based on 
switch-peptide-α-keto ester and that for substitution the order of potency was m- > p- > o-
substituted azobenzenes.20 The most active compound synthesised was the 3-substituted 
azobenzene 5.13 (fig. 14). 
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Figure 5.14. An azobenzene based α-keto ester. 
 
The ambient photostationary state for 5.13 was 28 % Z-isomer while irradiation with UV 
light (330 > λ > 370 nm) increased the proportion to 54 %. Assays against α-chymotrypsin 
showed that Z-5.13 (Ki = 40 nM) was 2-fold more active than E-5.13 (Ki = 80 nM) which 
was consistent with the 2-fold increase in the proportion of Z-isomer upon irradiation with 
UV light.20 It was trying to improve this work which much of my thesis was based on. 
 
From work described in the literature it is clear that biological activity can be influenced 
by the conformation of the photoactive inhibitor and as such photoregulation is possible. 
The active conformation varies, for some the Z-isomers are more bioactive while for others 
it is the E-isomer. Obviously the active conformation of the inhibitor must be dependent on 
interactions and steric requirements within the enzymes active site. Currently the 
differences in activity are of the order of 2-6 fold but as mechanistic understanding 
improves these differences may be increased.  
 
 
5.3 Experimental setup 
 
Eight potential inhibitors were chosen for the isomerisation studies. The samples were 
prepared as ca. 10 mM solutions in deuterated acetonitrile or DMSO and analysed by 1H 
NMR in a 5 mm quartz NMR tube. Samples were irradiated with a 500 W high pressure 
mercury arc lamp filtered to allow either UV or visible light transmission. A Schott UG11 
filter (230 < λ < 410 nm) or a Corning 7-37 filter (310 < λ < 390 nm) afforded Z-isomer 
enrichment while a Corning 0-51 filter (λ > 380 nm) afforded enrichment of the E-isomer. 
The filter was mounted at the end of a plastic tube 30 cm in length which contained a 17 
cm water cell with quartz glass windows to allow passage of UV and visible light but 
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reduce sample heating from infrared radiation. Samples were placed an additional 5 cm 
from the filter. 
 
 
5.4 Isomerisation of the target molecules 
 
A typical experiment involved recording an NMR spectrum of the freshly prepared sample 
to ensure 100 % E-enrichment. If significant amounts of ketone were present, 10 µL of 
H2O was added to give hydrate exclusively. The use of H2O rather than D2O was 
important to prevent deuterium exchange of the NH and OH peaks which were necessary 
for integration. The sample was then irradiated with filtered UV light for 75-90 min in a 
darkened fume hood to enrich the sample with the Z-isomer. The sample was encased with 
foil to protect from ambient light and analysed by 1H NMR immediately after irradiation. 
E/Z ratios were determined by measurement of the average E/Z integrals of appropriate 
non-overlapping proton resonances, typically the hydrate OH, α-H and NH signals were 
used depending on the degree of overlap. The sample was then irradiated with visible light 
for 75-90 min and analysed in an analogous manner. The photostationary state was 
determined by leaving the sample sitting on a window sill for one or two days then 
measuring the E/Z ratio by 1H NMR. All experiments were repeated on the same samples 
and agree within ± 2 %. The average value has been reported, rounded to the nearest 1 %. 
 
5.4.1 Schott UG11 UV filter 
 
Initially, the UG11 filter was used for the UV irradiations, however it was found the Z-
enrichment reached a maximum of ca. 50 ± 5 % for the mono substituted azobenzenes and 
the alkyl substituted azobenzene 4.54, for the halogenated derivatives Z-enrichment was 
very poor at only ca. 30 % (fig. 5.15).  
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X Y R 
PSS 
ambient 
(% Z) 
PSS 
uv 
(% Z ) 
4.4 H 3-CO CO2Me 26 56 
4.7 H 3-CO CF3 21 47 
4.12 H 4-SO2 CF3 21 50 
4.49 Br 4-SO2 CF3 17 32 
4.52 I 4-SO2 CF3 17 31 
4.54 FmocNHCH2 4-SO2 CF3 15 49 
N N
X
Y
H
N R
O
Ph
 
Figure 5.15. Z-Enrichment of substituted azobenzenes with a UG filter. 
 
Comparison of other E/Z photostationary states after Z-enrichment with the reported 
literature (section 5.2.2) suggested these values were lower than should be expected. 
Analysis of the UV spectrum of the UG11 filter showed a broad, intense UV profile 
between 230 and 410 nm. This band was found to overlap with the band of Z-azobenzenes 
corresponding to the (n ? π*) transition and resulted in conversion of Z ? E giving lower 
than expected Z-enrichment. A new Corning 7-37 filter was purchased and was found to 
have a narrower, less intense UV profile with minimal overlap (fig. 5.16). 
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Figure 5.16. UV profiles for the Schott and Corning filters overlaid against the UV profile of an inhibitor at 
an ambient photostationary state. The inhibitor profile is not to scale. 
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5.4.2 Corning 7-37 UV filter 
 
The isomerisation experiments were repeated using the Corning 7-37 filter on eight 
samples deemed most suitable as inhibitors of α-chymotrypsin. Z-Enrichment was 
improved to the point where most samples exhibited 80-90 % enrichment. The biggest 
improvements were for the halogenated azobenzenes 4.49 and 4.52, increasing from ca. 30 
to ca. 90 %. The results were not so impressive for 4.7; Z-enrichment only went from 47 to 
66 % (fig. 5.17). A representative 1H NMR spectrum of 4.52 after irradiation for 90 min 
with UV light is shown in figure 5.18. 
 
 
X Y 
PSS 
ambient 
(% Z) 
PSS 
uv 
(% Z) 
PSS 
vis 
(% Z) 
4.12 H 4-SO2 22 78 18 
4.12# H 4-SO2 23 80 19 
4.16 H 4-SO2-Leu 23 66 20 
4.44 Br 3-SO2 23 91 18 
4.46 I 3-SO2 22 92 18 
4.49 Br 4-SO2 19 87 17 
4.52 I 4-SO2 17 87 14 
4.62 I 4-SO2-Leu 16 83 14 
4.7 H 3-CO 27 66 21 
N N
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Y
H
N CF3
O
Ph
 
Figure 5.17. E-Z Isomerisations of substituted azobenzenes with Corning filters. # Sample dissolved in 
DMSO-d6
 
5.4.3 Corning 0-51 visible filter 
 
Irradiations of a sample with the Corning 0-51 filter typically gave a photostationary state 
within 5 % of the ambient photostationary state (fig. 5.17). As a result it was decided that 
the ambient photostationary state could be used as a good approximation for the visible 
photostationary state during the enzyme assays. A representative 1H NMR spectrum of 
4.52 after irradiation for 90 min with visible light is shown in figure 5.19.  
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Figure 5.18. 1H NMR spectrum of 4.52 after irradiation for 90 min with UV light. The composition was 
determined by measuring the integrals of the OH protons at 5.37 (E) and 5.27 (Z) ppm. 
 
 
Figure 5.18. 1H NMR spectrum of 4.52 after irradiation for 90 min with visible light. The composition was 
determined by measuring the integrals of the OH protons at 5.37 (E) and 5.27 (Z) ppm. 
 
A second experiment was performed to illustrate the dependence of wavelength and 
independence of composition on the degree of isomerisation. A solution of 4.12 in 
deuterated acetonitrile was allowed to reach its ambient photostationary state comprising 
23 % Z-isomer. The sample was first irradiated with visible light for 90 min to reduce the 
Z-isomer to 18 % then with UV light for 90 min to enrich the Z-isomer to 78 %. Irradiation 
with visible light once again gave 18 % Z-isomer and after 1 day sitting under fluorescent 
lights the photostationary state reverted to 22 % Z-isomer. From these results it can be 
concluded the E- and Z-isomer compositions for the three photostationary states are fixed 
for specific wavelengths and are independent of the initial composition of E- and Z-
isomers. 
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5.4.4 Isomerisation in deuterated DMSO 
 
Originally, the inhibitors used in the enzyme assays were dissolved in acetonitrile and 
added to the assay media such that the final concentration of acetonitrile in the assay was 5 
% v/v. Due to solubility issues of the inhibitors in the aqueous environment of the assay 
medium; it became necessary to change the organic solvent from acetonitrile to DMSO in 
an attempt to enhance solubility. As most of the isomerisation studies had already been 
performed in deuterated acetonitrile, it became prudent to investigate whether a model 
inhibitor underwent the same degree of isomerisation in DMSO as for acetonitrile.  
 
It has been reported that the photostationary state of a sample is dependent on the polarity 
of the solvent. Polar solvents stabilise the Z-isomer and therefore it is expected that the 
percentage of Z-isomer will increase with increasing polarity.24 The dielectric constant25 
and dipole moment25 for acetonitrile is 37.5 and 3.92 respectively and a relative polarity26 
of 0.460 compared to water. For DMSO the values are 47, 3.96 and 0.444 respectively. 
These values compare favourably and as such it was expected that the results obtained in 
either solvent would be similar. 
 
A sample of 4.12 was dissolved in deuterated DMSO from a freshly opened ampoule in an 
attempt to minimise the amount of water in the solvent. The 1H NMR spectrum showed 
resonances for the NH and OH peaks had shifted significantly downfield from 6.35 and 
5.40 ppm to 8.10 and 7.20 ppm respectively. This was seen as a problem due to the 
potential for overlap with the aromatic protons. Fortunately, at least for 4.12, the E- and Z-
NH resonances were situated between aromatic peaks and as such could be integrated with 
only minor overlap. The hydrate OH peaks could not be integrated due to significant 
overlap of the aromatic protons. The α-H was free from overlap from other protons 
however minor overlap occurred between the resonances for the E- and Z-isomers. As 
such, the estimates for the ratios of E/Z incur an error of ± 5 %. UV irradiation with the 
Corning 7-37 filter gave Z-enrichment of 80 % (78).ξ The enriched sample was encased in 
foil and placed in a dark cupboard over the weekend. After two days in the dark the sample 
had only reverted to 39 % Z. Irradiation with UV light gave 81 % Z. Subsequent irradiation 
                                                 
ξ Percentage of Z-isomer in CD3CN is included in brackets for comparison. 
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with visible light gave 19 % (18) Z and after exposure to sunlight for a day reached a 
photostationary state comprising 23 % (22) Z-isomer.  
 
From these model results the assumption that the photostationary state of the inhibitors in 
DMSO should approximate those seen in acetonitrile is a fair one. The results also show 
that even in the absence of light, Z ? E isomerisation occurs. From the literature it has 
been shown that isomerisation in the absence of light occurs via a thermal route (section 
5.2).  
 
Selected 1H NMR data for the isomerisation studies can be found in section 7.5.3. 
 
 
5.5 Summary 
 
All the inhibitors synthesised exhibit excellent photoswitching which can be cycled by 
irradiation with UV or visible light. The ambient photostationary state for each inhibitor 
was found to be within 5 % of the visible photostationary state and as such made a good 
approximation. Compound 4.12 exhibited very similar photochemistry in both DMSO and 
acetonitrile, and again the approximation that the isomerisation in either solvent is the 
same appears valid. Incorporation of a halogen into the azobenzene ring system increased 
the percentage of Z-isomer after UV irradiation for 4.49 and 4.52 by 9 % compared with 
the analogous non-halogenated azobenzene 4.12. In the case of the dipeptide 4.62 the 
increase was 17 % compared to 4.16. Interestingly, the percentage of Z-isomer for the 
ambient and visible photostationary states decreased compared with the non-halogenated 
molecule. The higher percentages of halogenated Z-isomers could be rationalised as being 
stabilised to a greater degree by the polar solvent due to the increased dipole moments 
caused by the electronegative effects of the halogens. 
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Enzyme Inhibition Studies 
 
6.1 Introduction 
 
A selection of trifluoromethyl ketones were assayed against α-chymotrypsin in order to 
ascertain their potential as protease inhibitors. Each inhibitor was assayed at its ambient 
and UV photostationary state and the level of inhibition determined for each 
photostationary state. The aim of this study was to confirm the mode of inhibition and 
observe how Ki is affected by E/Z-conformations, substitution patterns and peptide chain 
length.  
 
Enzyme catalysed reactions are very important in nature due to their remarkable specificity 
towards a substrate, exceptional levels of catalytic turnover and efficiency. In order to 
study enzyme kinetics methods need to be devised in which either the disappearance of 
substrate or formation of product is monitored. Importantly, the use of UV/Vis 
spectroscopy allows one to continuously measure the change in absorbance of the analyte 
of interest. A common method for studying enzyme kinetics involves hydrolysis of a 
peptidyl substrate which incorporates a chromophore that upon cleavage from the substrate 
liberates a compound with a high molar absorptivity coefficient (ε > 104 M-1.cm-1) at a 
wavelength not strongly absorbed by the enzyme or substrate. Some chromophore 
examples include 4-nitroaniline, 7-amino-4-methylcoumarin, 2-naphthylamine and 
substituted phenols (fig. 6.1).3 
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Figure 6.1. Enzymatic hydrolysis of peptidyl substrates. 
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6.2 Michaelis-Menten kinetics1,2 
 
If we look at a simple model where the enzyme acts on a single substrate to give a single 
product we can write an expression as follows: 
 
 
E + S ES EP E + P
k1
k-1
k2
k-2
k3
k-3
However, this equation can be simplified if we only consider the enzyme kinetics at the 
onset of the reaction i.e. measure initial velocities (Vo) when [S] ≈ 100 % and [P] ≈ 0 %. 
While [P] remains low the back reaction is negligible and the above expression may be 
simplified to: 
 
E + S ES E + P
k1
k-1
k2
 
In this model, substrate (S) binds reversibly with the enzyme (E) to form an enzyme-
substrate complex (ES) which undergoes conversion to give product (P) and free enzyme. 
From this expression two equations can be derived depending on the assumption made. If 
one assumes that the equilibrium of E + S        ES is only slightly perturbed by the 
conversion of ES → P (k-1 » k2) then equation 6.1 takes the form: 
 
Vo = 
Vmax [S]
K + [S]    where  
K = 
k-1
k1   and  Vmax = [E]Tk2  Equation 6.1 
 
The value Vmax refers to the maximal velocity or limiting rate and K a true dissociation 
constant. This dissociation constant is a true measure of binding affinity, the smaller the 
value of K, the stronger the binding of substrate to enzyme.  
 
Unfortunately, the assumption that enzymes achieve rapid equilibrium is invalid in most 
cases so a second model involving a steady state assumption for the ES complex was 
postulated by Briggs and Haldane. 
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In this model [S] and [P] are changing but [ES] remains relatively static after an initial 
burst phase (pre-steady state) provided [S] » [E] i.e. 
d[ES]
dt  ≈ 0 
By a similar derivation equation 6.2 is obtained. 
 
Vo = 
Vmax [S]
⎝⎜
⎛
⎠⎟
⎞k-1 + k2
k1  
+ [S]
         Equation 6.2 
 
This is more often expressed in the form: 
 
Vo = 
Vmax [S]
Km + [S]  where  
Km = ⎝⎜
⎛
⎠⎟
⎞k-1 + k2
k1   and  Vmax = [E]Tk2 Equation 6.3 
 
This equation is commonly referred to as the Michaelis-Menten equation even though they 
actually developed equation 6.1. However, irrespective of whichever assumption is made, 
the fundamental equation is the same. The rapid equilibrium assumption can be seen as a 
limiting case of the steady state assumption when k-1 » k2. The Michaelis constant Km is 
not an equilibrium constant as it is obtained under steady-state rather than equilibrium 
conditions but is often mistakenly used to describe enzyme affinity. Km = K is only true 
when k2 is very small relative to k-1.  
 
6.2.1 Linearisation of the Michaelis-Menten equation 
 
If a graph of Vo is plotted against [S] a non-linear curve is obtained (fig. 6.2). At high [S] 
saturation of the enzyme occurs (i.e. all the active sites of the enzyme are bound to 
substrate) and Vo approaches Vmax. A graph of this type is not useful as Vmax can never be 
achieved in practice; [S] would theoretically need to reach infinity before Vmax is reached. 
As a consequence, Km, which is defined as the substrate concentration at half the maximal 
velocity, can not be measured accurately from the graph. To overcome these difficulties, 
equation 6.3 can be reformulated in several ways to give a liner fit of the Michaelis-
Menten equation. The four most popular forms are described below: 
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Figure 6.2. Dependence of initial rates on increasing substrate concentration. 
 
Double reciprocal plot 
 
Taking the reciprocal of both sides of equation 6.3 gives:  
 
1
Vo 
= 
Km
Vmax 
1
[S] + 
1
Vmax         Equation 6.4 
 
A plot of 1Vo vs. 
1
[S] gives a straight line with a slope of 
Km
Vmax and intercepts on the x and y-
axes of - 1Km and 
1
Vmax respectively (fig. 6.3). This double reciprocal plot is referred to as the 
Lineweaver-Burk plot and is often preferred due to its ease of interpretation. 
Experimentally however it is flawed as the data tends to get more crowded as [S] increases 
while at low [S] and Vo values errors are often exaggerated. Of the three methods for 
obtaining a straight line the double reciprocal plot is the least accurate for obtaining kinetic 
parameters. 
 
Modified double reciprocal plot 
 
The Eadie-Hofstee equation is obtained if both sides of equation 6.4 are multiplied by 
Vo.Vmax then rearranged in terms of 
Vo
[S] and Vo.  
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Vo
[S] = 
Vmax
Km   
-  
1
Km 
Vo         Equation 6.5 
 
A plot of Vo[S] vs. Vo gives a straight line with a slope of - 
1
Km and an x-axis intercept of Vmax 
(fig. 6.3). An advantage of this graph is the ability to detect deviations from normal 
Michaelis-Menten behaviour. The errors associated with the Lineweaver-Burk plot are 
lessened by eliminating one reciprocal variable but now any errors in Vo are expressed 
along both axes. 
 
The Hanes-Woolf plot 
 
Multiplying both sides of the double reciprocal equation 6.4 by [S] gives: 
 
[S]
Vo  
= 
1
Vmax 
[S] + 
Km
Vmax        Equation 6.6 
 
A plot of [S]Vo  vs. [S] affords a straight line with a slope of 
1
Vmax and an x-intercept of -Km 
(fig. 6.3). This is the preferred of the three linear plots with errors being more evenly 
distributed across a range of substrate concentrations. 
 
Modified direct linear plots 
 
The Hanes-Woolf equation 6.6 can be rearranged to show the dependence of 1Vmax on 
Km
Vmax. 
 
1
Vmax 
= 
1
Vo  
-  
1
[S] 
Km
Vmax        Equation 6.7 
 
1
Vmax and 
Km
Vmax are treated as variables while 
1
Vo and 
[S]
Vo  are treated as constants. For any set of 
1
Voand 
[S]
Vo  there are an infinite set of values for 
1
Vmax and 
Km
Vmax. If a second line is drawn with a 
different set of 1Vo and 
[S]
Vo  values the point at which the two lines intersect must be a unique 
value of 1Vmax and 
Km
Vmax which satisfies both sets of data.  
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A plot of 1Vmax vs. 
Km
Vmax for n values of 
1
Vo and 
[S]
Vo  (fig. 6.3) will afford 
n(n-1)
2  estimates for 
1
Vmax 
and KmVmax. It is common practice that the median value is taken as it has the statistical 
advantage of being unaffected by outlying values.  
 
 
Figure 6.3. Graphical representations of the Michaelis-Menten equation; (a) Lineweaver-Burk; (b) Eadie-
Hofstee; (c) Hanes-Woolf; (d) Modified direct linear plot. 
 
Non-Linear regression 
 
While graphical representations of data fitted to the Michaelis-Menten equation are useful, 
especially in the laboratory they have been superseded by computational methods which 
utilise non-linear regression. Using computer software such as Enzfitter the data can be 
fitted to the Michaelis-Menten equation 6.3 directly affording the desired kinetic 
parameters. 
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6.2.2 Types of inhibition 
 
In the presence of a reversible inhibitor the observed effects on the initial rate will fall 
within one of four categories; competitive, mixed, non-competitive (a special case of 
mixed inhibition) and uncompetitive inhibition. The type of inhibition can be categorised 
by the effect the inhibitor has on the apparent Vmax and 
Vmax
Km  (V
*
max and 
V
*
max
K
*
m
 respectively) but 
does not necessarily imply a particular mechanism (fig. 6.4).  
 
Inhibition type V*max 
V*max
K*m
 
Competitive unaffected decreased 
Mixed decreased decreased 
Non-competitive decreased decreased 
Uncompetitive decreased unaffected 
 
Figure 6.4. Effects of inhibition type on V*max and 
V
*
max
K*m
 
 
Simple mechanisms have been postulated for each type of inhibition which is consistent 
with the observed kinetics but only the mechanism and corresponding plots for reversible 
competitive inhibitors is outlined as previous studies have determined that trifluoromethyl 
ketones are reversible competitive inhibitors of α-chymotrypsin.4 
 
Reversible competitive inhibition 
 
A simple model for an enzyme catalysed reaction in the presence of an inhibitor can be 
expressed as follows: 
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E ES
EI ESI
E + P
Ki
k1
k-1
k2
KESI
For a competitive inhibitor we can assume KESI = ∞ (therefore ES complex cannot 
combine with I nor EI with S) which simplifies to: 
 
 
E  +  S
+
I
ES
EI
E + P
Ki
k1
k-1
k2
A rate equation can be written in the form of the Michaelis-Menten equation: 
 
Vo = 
Vmax [S]
⎝⎜
⎛
⎠⎟
⎞1 + [I]Ki  Km + [S]
         Equation 6.8 
 
This is more commonly expressed as: 
 
Vo = 
Vmax [S]
αKm + [S]  where  α = ⎝⎜
⎛
⎠⎟
⎞1 + [I]Ki       Equation 6.9 
 
The characteristic feature of competitive inhibition is an apparent increase in Km but no 
apparent change in Vmax with increasing [I], however based on the recommendations of the 
International Union of Biochemistry and Molecular Biology5 the inhibition type should be 
classified by the effects of the inhibitor on VmaxKm  and Vmax. A competitive inhibitor decreases 
the apparent affinity of the substrate for the enzyme thus increasing Km, but does not alter 
the reactivity of the enzyme hence Vmax remains unchanged. If Vmax is unchanged and Km 
increases by a factor of ⎝⎛ ⎠⎞1 + 
[I]
Ki  then 
Vmax
Km  should decrease with increasing [I].  
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V*max = Vmax  and K
*
m = ⎝⎜
⎛
⎠⎟
⎞1 + [I]Ki Km     Equation 6.10 
 
One mechanism devised to explain these observations is that the inhibitor competes with 
the substrate to bind to the active site of the enzyme. This process is reversible as 
increasing [S] or decreasing [I] (dilution or dialysis) acts to ‘wash out’ the inhibitor from 
the active site.  
 
The kinetic parameters Km, Vmax and Ki can be determined graphically by applying the 
same methodologies previously outlined for the Michaelis-Menten equation 6.3. Taking 
the inverse of both sides of equation 6.8 gives: 
 
1
Vo 
= ⎝⎜
⎛
⎠⎟
⎞1 + [I]Ki  
Km
Vmax 
1
[S] + 
1
Vmax       Equation 6.11 
 
A plot of 1Vo vs. 
1
[S] for n different [I] gives a series of n straight lines with a slope of 
αKm
Vmax 
and intercepts on the x and y-axes of - 1αKm and 
1
Vmax respectively (fig. 6.5). A replot of the 
slope (αKmVmax) vs. [I] should afford a straight line with the x and y-intercepts giving the values 
of -Ki and 
Km
Vmax respectively (fig. 6.6). It should be noted that the same inaccuracies 
outlined for the double reciprocal plots hold for kinetic parameters derived from this type 
of analysis. 
 
The same modification used in equation 6.6 can be employed here to reduce inaccuracy. 
Multiplying the double reciprocal equation by [S] gives: 
 
[S]
Vo  
= 
1
Vmax 
[S] + ⎝⎜
⎛
⎠⎟
⎞1 + [I]Ki  
Km
Vmax      Equation 6.12 
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Figure 6.5. (a) A double reciprocal plot of a competitive inhibitor; (b) A replot of 
αKm
Vmax vs. [I] to determine 
the kinetic parameters Ki and 
Km
Vmax. 
 
A plot of 1Vo vs. [I] (Dixon Plot) or 
[S]
Vo  vs. [I] (Modified Dixon plot) avoids some of the 
inaccuracy incurred by the double reciprocal plot and affords the kinetic parameters and 
inhibition type from the same graph. Lines from a Dixon plot intersect in the second 
quadrant giving an estimate for -Ki and 
1
Vmax on the x and y-axes respectively while the 
Modified Dixon plot afford a series of parallel lines for competitive inhibition (fig.6.6). 
 
 
Figure 6.6. (a) Dixon plot of a competitive inhibitor; (b) Modified Dixon plot of a competitive inhibitor. 
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6.3 Experimental setup 
 
6.3.1 Designing the assay 
 
N N
H
H
N
Ph
NO2
NH
H
N
O
O
O
HO
O
O
O
N N
H
OH
Ph
NH
H
N
O
O
O
HO
O
O
O
H2N
NO2
+
yellow
colourless
α-chymotrypsin
H2O, 25 
oC, pH 7.8
 
Scheme 6.1. Cleavage of N-Suc-Ala-Ala-Pro-Phe-4-NA by α-chymotrypsin. 
 
The activity of α-chymotrypsin was measured by monitoring the formation of 4-
nitroaniline (4-NA) by the enzymatic hydrolysis of N-Suc-Ala-Ala-Pro-Phe-4-NA at 25 °C 
and pH 7.8. The absorbance of 4-nitroaniline was measured at 405 nm as a function of 
time for a period of 5 or 10 min. 4-Nitroaniline was chosen as the chromophore as it is 
well studied, strongly coloured and the inhibitors (λmax ≈ 330, 445 nm, fig. 5.16) do not 
absorb strongly at 405 nm. Assays were initiated by addition of enzyme rather than by 
addition of substrate in order to get a true measure of the competition between the binding 
of substrate and inhibitor to the active site of the enzyme. 
 
Rates of reaction (V or v) were obtained from the linear portions of the absorbance vs. time 
profiles and converted to the appropriate units. Results were analysed by a combination of 
graphical methods and non-linear regression to obtain the kinetic parameters Km, Vmax and 
Ki. Errors from the graphs were determined at the 95 % confidence level (2 standard 
deviations from the mean) using the Microsoft Excel LINEST function. 
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6.3.2 Equipment used in the enzyme assays 
 
Absorbance measurements were made on a GBC 918 UV/Vis spectrophotometer running 
the default GBC Scientific v2.01 software package. Plastic cuvettes (1.8 mL) were held in 
a water block regulated at 25 ± 0.2 °C by circulating water. The buffer and substrate 
solutions were stored in a water bath heated to 25 ± 0.2 °C with a Tempette TE-8A water 
bath thermostat. Small volume transfers were made with Eppendorf micropipettes (100, 
200, 1000 µL). Substrate and inhibitor solutions were made up in acetonitrile or DMSO 
(analytical grade or better). 
 
6.3.3 Buffer solutions 
 
Phosphate buffer; Phosphate, 0.078 M; K+, 0.18 M; Triton X-100, 0.05 %; pH 7.8. 
 
K2HPO4 (13.6 g), KCl (2.2 g) and Triton X-100 (0.5 g) were dissolved in double distilled 
water (750 mL), acidified with aqueous HCl (1 M) until the pH reached 7.8 and made up 
to 1 L. The solution was stored at 4 °C when not in use. 
 
TRIS buffer; TRIS (0.1 M); Ca2+, 0.02 M; Triton X-100, 0.05 %; pH 7.8. 
 
TRIS.HCl (12.2 g), CaCl2 (2.2 g) and Triton X-100 (0.5 g) were dissolved in Milli Q water 
(800 mL). The solution was adjusted to pH 7.8 by addition of aqueous HCl (0.1 M) then 
made up to 1 L with Milli Q water. The buffer was stored at 4 °C when not in use. 
 
6.3.4 Substrate solutions 
 
Substrate solution 1; N-Suc-Ala-Ala-Pro-Phe-4-NA (ca. 3.4 mM); TRIS, 100 mM; pH 7.0. 
 
A neutral TRIS buffer was prepared by dissolving a commercially available sachet in Milli 
Q water (1 L) 
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N-Suc-Ala-Ala-Pro-Phe-4-NA (Sigma®, 21 mg, 34 µmol) was suspended in TRIS buffer 
(10 mL) and sonicated at ca. 5 °C for 10 min to complete dissolution. The solution was 
stored below 0 °C for up to a week. The concentration of the substrate was determined 
each day by measuring the absorbance at 315 nm of a 1 % substrate solution in buffer (ε315 
= 14000 M-1.cm-1). 
 
Substrate solution 2; N-Suc-Ala-Ala-Pro-Phe-4-NA (ca. 20 mM).  
 
N-Suc-Ala-Ala-Pro-Phe-4-NA (25 mg, 40 mmol) was dissolved in DMSO (2 mL) and 
stored below 0 °C when not in use. The concentration of the substrate solution was 
determined by diluting a 25 µL aliquot of substrate with DMSO (25 µL) and phosphate 
buffer (950 µL). The solution was mixed by inversion and a 50 µL aliquot of the solution 
further diluted with phosphate buffer (950 µL). The absorbance was measured at 315 nm 
and the concentration determined (ε315 = 14000 M-1.cm-1). 
 
Substrate solution 3; N-Suc-Phe-4-NA (40 mM). 
 
N-Suc-Phe-4-NA (Sigma®, 7.7 mg, 20 µmol) was dissolved in DMSO (500 µL). The 
solution was prepared fresh each day. 
 
6.3.5 Enzyme solutions 
 
Enzyme solution 1; α-Chymotrypsin, 6.8 µg.mL-1 (272 nM); HCl, 2.5 mM; Triton X-100, 
0.05 % (w/v). 
 
A stock enzyme solution was prepared by dissolving α-chymotrypsin (3.4 mg, 136 nmol, 
Sigma®, Type II: from bovine pancreas 3 x crystallised from 4 x crystallised 
chymotrypsinogen) in Milli Q water (1 mL). The stock solution (100 µL, 13.6 nmol) was 
further diluted in a 50 mL volumetric flask with Milli Q water (30 mL) to which was 
added HCl (analytical reagent grade, 10 µL, 1.2 mM) and Triton X-100 (25 mg, 0.05 % 
w/v). The contents were thoroughly mixed by inversion then made up to 50 mL with Milli 
Q water. The enzyme solution was made fresh each day. 
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Enzyme solution 2; α-Chymotrypsin, 4.0 mg.mL-1, (160 µM); HCl, 2.5 mM, Triton X-100, 
0.05 % (w/v). 
 
A stock acid solution was prepared by diluting concentrated HCl (216 µL, 2.5 mmol) to 
750 mL with double distilled water, adding Triton X-100 (0.5 g, 0.05 % w/v) and mixing 
thoroughly by inversion. The solution was made up to 1 L and stored at 4 °C when not in 
use. 
 
A stock enzyme solution was prepared by dissolving α-chymotrypsin (3.0 mg, 120 nmol, 
Sigma®, Type II: from bovine pancreas 3 x crystallised from 4 x crystallised 
chymotrypsinogen) in the above acid solution (750 µL). The enzyme solution was 
prepared fresh each day. 
 
 
6.4 Determination of the Michaelis constant (Km) and limiting rate 
(Vmax) 
 
The assay procedure was adapted from the methods outlined by Geiger3 and Harvey.6 
TRIS buffer was used in accordance with Geiger as HEPES (Harvey) was found to 
hydrolyse the substrate before addition of the enzyme. 
 
To a plastic cuvette (1.8 mL) was added TRIS buffer ((1020 –x-y) µL), substrate solution 1 
(x µL, x = 30-160 µL) and acetonitrile (y µL, y = 0, 50 µL). The assay solution was mixed 
by inversion and incubated at 25 °C for 5 min. The assay was initiated by the addition of 
the enzyme (30 µL) and the progress monitored by measuring the absorbance of 4-
nitroaniline at 405 nm over a period of 5 min (ε405 = 10200 M-1.cm-1). A plot of absorbance 
vs. time gave a linear slope over the entire course of the reaction in most cases, the 
exception being at low substrate concentrations, for which the initial rate was determined 
from the linear portion of the graph. Each measurement was performed in duplicate and 
the raw data for the measurements can be found in figure 6.7.  
 
 0 % MeCN  4.76 % MeCN 
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[S] (µM) Vo (µmol.s-1.mg-1) [S] (µM) Vo (µmol.s-1.mg-1) 
87 0.765 0.822 84 0.893 0.913 
173 0.905 0.907 168 1.066 1.047 
260 0.945 0.970 252 1.167 1.195 
346 1.003 1.052 336 1.135 1.192 
433 0.996 1.039 420 1.185 1.217 
 
Figure 6.7. Kinetic data for Km and Vmax determination utilising N-Suc-Ala-Ala-Pro-Phe-4-NA as the 
substrate. 
 
The initial rate Vo was determined from the slope of the absorbance vs. time profiles at five 
different substrate concentrations by using equation 6.13. 
 
V o = ⎝⎜
⎛
⎠⎟
⎞V T
m enz ε
 
405 l 
  slope       Equation 6.13 
 
Vo = initial rate (µmol.s-1.mg-1) 
slope is the linear portion of the profile (s-1) 
VT = total volume of solution in the assay run (µL) 
menz = mass of enzyme present in assay run (mg) 
ε405 = Molar absorptivity coefficient of 4-nitroaniline at 405 nm (M-1.cm-1) 
l = path length of the cell (cm) 
 
The initial rates were processed by four graphical methods to give the kinetic parameters 
Km and Vmax (fig. 6.8).  
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Km (µM) Vmax (µmol.s-1.mg-1) 
 
Run 1 Run 2 Run 1 Run 2 
0 % MeCN 35.2 31.4 1.079 1.107 
Lineweaver-Burk 
4.76 % MeCN 38.0 39.8 1.300 1.337 
0 % MeCN 34.1 36.1 1.074 1.118 
Hanes-Woolf 
4.76 % MeCN 35.9 39.8 1.290 1.338 
0 % MeCN 34.9 32.0 1.078 1.111 
Eadie-Hofstee 
4.76 % MeCN 37.7 39.9 1.300 1.338 
0 % MeCN 34.6 44.0 1.078 1.019 Modified direct 
linear 4.76 % MeCN 40.8 45.7 1.318 1.430 
 
Figure 6.8. Kinetic parameters determined by four graphical methods. 
 
By averaging the results the kinetic parameters for α-chymotrypsin were estimated in the 
presence and absence of acetonitrile. When a solution of buffer only was used, Km and 
Vmax were determined to be approximately 35 ± 8 µM and 1080 ± 60 nmol.s-1.mg-1 
respectively. When acetonitrile (50 µL) was added to the assay media, the values of Km 
and Vmax increased to approximately 39 ± 6 µM and 1330 ± 90 nmol.s-1.mg-1 respectively. 
A Hanes-Woolf plot of the experimental data gives a common intersection on the x-axis 
but different y-intercepts (fig. 6.9).  
Hanes-Woolf plot
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Figure 6.9. Modified double reciprocal plots of N-Suc-Ala-Ala-Pro-Phe-4-NA hydrolysis in the presence and 
absence of acetonitrile. 
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A common x-intercept implies that Km is unchanged by the addition of acetonitrile while 
the differing slopes imply the rate is affected by acetonitrile. Within experimental error the 
value of Km is unaffected acetonitrile (Km ≈ 37 ± 8 µM) whereas Vmax and 
V
*
max
K*m
 increase in 
the presence of acetonitrile. Comparing these observations to those in figure 6.4 indicates 
the opposite effect of uncompetitive inhibition i.e. acetonitrile activates α-chymotrypsin 
rather than inhibiting the enzyme. The results with the addition of acetonitrile offer a better 
estimation of the kinetic parameters as the conditions more accurately mimic the 
conditions used when an inhibitor is added to the assay.  
 
6.4.1 Comparison with a reported inhibitor 
 
The assays testing enzyme inhibition were first run using a reported inhibitor 4.5 at an 
ambient photostationary state following the procedure of Harvey, with the exceptions that 
TRIS rather than HEPES buffer was used and the concentration of acetonitrile was kept 
constant. 
 
N
H
N
O
N
Ph
O
OMe
O
4.5
 
A stock solution of inhibitor (ca. 0.1 mg.mL-1) was prepared by dissolving 4.5 (5.0 mg, 
12.0 µmol) in acetonitrile (50 mL). A solution suitable for assay was prepared by diluting 
stock solution (1 mL) to 10 mL with acetonitrile to give a final concentration of 10.0 
µg.mL-1 (24.0 µM).  
 
Initially, 0, 10, 20, 30, 40 and 50 µL aliquots of the diluted solution were added to the 
assay media and the acetonitrile concentration maintained at 4.76 % by making the total 
volume of acetonitrile 50 µL. The results obtained for these assays were variable and it 
was believed the problem was due to low accuracy of the micropipettes when dispensing 
volumes less than 20 µL. To overcome these problems five inhibitor solutions of different 
concentrations (1.5-18 µM) were prepared by further dilution of the stock inhibitor 
solution with acetonitrile. 
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The assay was run at five different substrate concentrations and six different inhibitor 
concentrations to give a large data set suitable for analysis. Into a plastic cuvette was 
added TRIS buffer ((970-x) µL), substrate solution 1 (x µL, x = 40-140 µL) and inhibitor 
solution (50 µL). The assay solution was mixed by inversion and incubated at 25 °C. After 
5 min the reaction was initiated by addition of enzyme solution 1 (30 µL) and absorbance 
of 4-nitroaniline measured over 5 min. The slopes of the graphs were used to determine the 
initial rates of reaction and the averaged raw data is given in figure 6.10. 
 
 4.5 [I] (µM) 
[S] (µM) 0 0.072 0.143 0.287 0.573 0.860  
113.9 1.143 0.840 0.745 0.552 0.320 0.218 
185.1 1.269 0.966 0.922 0.726 0.458 0.324 
256.3 1.320 1.181 1.042 0.846 0.563 0.431 
327.5 1.370 1.238 1.130 0.947 0.663 0.513 
398.7 1.408 1.314 1.181 1.048 0.739 0.609 
V
o  (µm
ol.s -1.m
g
-1) 
 
Figure 6.10. Inhibition of α-chymotrypsin by the ambient photostationary state of 4.5. 
 
The kinetic parameters K*m and V
*
max were determined by double reciprocal (fig. 6.11) and 
modified double reciprocal plots (fig. 6.12).  
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Figure 6.11 Double reciprocal plots for the ambient photostationary state of 4.5. 
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Figure 6.12. Modified double reciprocal plot for the ambient photostationary state of 4.5. 
 
Replotting the slopes of the double reciprocal graphs (fig 6.11) against [I] gave an 
estimated value for Ki (fig. 6.13). 
Figure 6.13. Estimation of Ki for the ambient photostationary state of 4.5. 
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Analysis of the results clearly indicates that 4.5 acts as a competitive inhibitor of α-
chymotrypsin because K*m increases with increasing [I], 
V*max
K*m
 decreases with increasing [I] 
while V*max remains constant (fig. 6.14).  
 
Harvey Alexander 
[I] 
(µM) 
K*m 
(µM) 
V*max 
V
*
max
K
*
m
 
Ki 
(µM) 
[I] 
(µM) 
K*m 
(µM) 
V*max 
V
*
max
K
*
m
 
Ki 
(µM) 
0.11 130 1.10 8.46 0.063 0.072 118 1.68 14.24 0.041 
0.22 220 1.10 5.00 0.069 0.143 123 1.54 12.52 0.067 
0.34 250 1.10 4.40 0.089 0.287 210 1.56 7.43 0.066 
0.44 410 1.30 3.17 0.089 0.573 431 1.53 3.55 0.056 
0.55 390 1.10 2.82 0.096 0.860 926 1.98 2.14 0.049 
 
Figure 6.14. Comparison of kinetic data for the ambient photostationary state for 4.5.  
Units for V*max (µmol.s
-1.mg-1), units for 
V*max
K
*
m
 (mL.s-1.mg-1). 
 
The estimated value for Ki (ca. 0.05 µM) is comparable to that obtained by Harvey (0.08 
µM).6 The activation of α-chymotrypsin observed by Harvey when acetonitrile was used in 
conjunction with the enzyme assays was confirmed and accounted for by using a constant 
concentration of the organic solvent. 
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6.5 Inhibition studies of trifluoromethyl ketone based inhibitors 
 
Inhibitor 4.49 was initially chosen as a test compound due to its high purity (> 99 %) and 
availability. 
 
N N
Br
O2S N
H
Ph
CF3
O
4.49
 
6.5.1 Assays in TRIS buffer 
 
A solution of 4.49 in acetonitrile (0.12 mg.mL-1, 0.22 mM) was prepared in an analogous 
manner to that of 4.49 and allowed to reach an ambient photostationary state. No inhibition 
of the enzyme was observed at [I] = 10.5 µM so a new, more concentrated solution was 
prepared. 4.49 (4.2 mg, 7.8 mmol) was dissolved in acetonitrile (2 mL) to give a stock 
inhibitor solution (2.1 mg.mL-1, 3.9 mM) and allowed to equilibrate for 24 h. Diluted 
solutions were prepared in the range 263-2100 µM to give final assay concentrations of 
12.5-100 µM. At [I] < 50 µM, precipitation occurred resulting in lower than expected 
concentrations of inhibitor in solution and generally poor absorbance measurements 
obtained due to the turbidity of the solution. As a consequence only solutions where [I] ≤ 
50 µM were used. 
 
The assays were performed as per normal; however, a plot of absorbance vs. time for 
assays containing inhibitor did not give the expected linear graphs at any substrate 
concentration. The assays were repeated several times but the results were not particularly 
reproducible. Under these conditions the results were unsatisfactory; precipitation, poor 
reproducibility and non-linearity of the curves prompted the investigation of a new assay 
system. 
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6.5.2 Assays in Phosphate buffer 
 
A new assay protocol was set up which incorporated aspects of the procedure outlined by 
Abeles et al for the assay of trifluoromethyl ketones and the procedure of Harvey.  
 
The buffer was changed in accordance with reported studies of trifluoromethyl ketones 
which use phosphate buffer predominantly. The substrate was kept the same due to its high 
specificity for α-chymotrypsin but the organic solution was changed to DMSO in an 
attempt to increase solubility of the inhibitors in aqueous media. As per the previous 
assays the concentration of organic solvent was kept constant.  
 
Aliquots of substrate solution 2 were diluted with DMSO to give substrate solutions 
ranging from ca. 2-16 mM. The inhibitor 4.49 (4.4 mg, 8.1 mmol) was dissolved in DMSO 
(2 mL) to give a solution of 4.1 mM which was allowed to reach an ambient 
photostationary state. Aliquots of stock inhibitor solution were diluted to give 1, 2 and 3 
mM solutions. 
 
To a plastic cuvette was added phosphate buffer (925 µL), substrate (25 µL) and inhibitor 
or DMSO (25 µL). The total volume of DMSO in the aqueous media was 50 µL (5 % v/v). 
After incubating 5 min at 25 °C the hydrolysis was initiated by addition of enzyme solution 
1 (25 µL) and the progress monitored over 5 min at 405 nm. The lines were non-linear for 
runs containing inhibitor at all substrate concentrations assayed against. All curves were 
characteristic in that there was little change in slope for the first minute followed by 
deviations from linearity (fig. 6.15). 
 
Kinetic parameters were determined by using the slope of the linear portion of the last 100 
seconds of each run and using that data as an estimation of Vo. The assays were run in 
duplicate and the raw data is presented in figure 6.16. 
 
The stock inhibitor solution (4 mM, 1 mL) was irradiated in a quartz cell with UV light for 
1 h then aliquots were diluted to give 1 and 2 mM solutions which were protected from 
light as much as possible. The assays were run as for the ambient inhibitor photostationary 
state, in duplicate and the raw data presented in figure 6.16. 
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Figure 6.15. Absorbance vs. time plots for the ambient photostationary state of 4.49. [S] = 475 µM. 
 
 4.49 [I] (µM) 
0 25.4 50.9 101.8 [S] 
(µM) - eqm 
Z-
enriched 
eqm 
Z-
enriched  
eqm 
Z-
enriched 
 
95 0.95 0.77 - 0.62 - 0.41 - 
190 1.20 1.06 0.91 0.94 0.70 0.76 0.40 
285 1.26 - 1.06 1.06 0.87 0.89 0.62 
380 1.34 1.25 1.13 1.15 0.97 1.01 0.73 
475 1.39 1.30 1.18 1.19 1.04 1.06 0.81 
V
o  (µm
ol.s -1.m
g
-1) 
 
Figure 6.16. Inhibition of α-chymotrypsin by 4.49. 
 
The data was analysed by graphical methods (Lineweaver-Burke and Hanes-Woolf plots) 
and non-linear regression (Enzfitter) to determine the kinetic parameters K*m, V
*
max and Ki 
for the ambient and Z-enriched photostationary states of 4.49 (fig. 6.17).  
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PSSambient PSSUV
 Km
(µM) 
V*max  
Ki
(µM) 
Km
(µM) 
V*max  
Ki 
(µM) 
LW-B 61 ± 18 1.55 ± 0.4 52 ± 14 53 ± 23 1.52 ± 0.7 15 ± 4 
H-W 62 ± 8 1.53 ± 0.2 50 ± 6 62 ± 38 1.51 ± 0.9 16 ± 6 
Enzfitter 61 ± 12 1.56 ± 0.1 40 ± 9 52 ± 24 1.54 ± 0.1 15 ± 6 
 
Figure 6.17. Kinetic parameters for 4.49. 
 
The kinetic parameters determined graphically are comparable to those determined by the 
enzfitter program which should be considered the more accurate method as it does not 
propagate errors associated with reformulating the Michaelis-Menten equation to produce 
linear graphs (section 6.2.1).  
 
Further research into kinetic studies of trifluoromethyl ketones indicated that 
monopeptidyl trifluoromethyl ketones often adhered to Michaelis-Menten type kinetics 
whereas dipeptidyl and higher trifluoromethyl ketones exhibit slow binding kinetics which 
are characterised by an initial uninhibited rate of hydrolysis followed by a gradual decrease 
in the rate of reaction. This strongly resembled the curves obtained for the assays of 
ambient and Z-enriched 4.49. Kinetics of this type are routinely analysed by the method of 
Cha7 and relates both the initial (vo) and steady state (vs) velocities as a function of time (t).  
 
6.5.3 Slow binding kinetics 
 
In cases where association and/or dissociation of the enzyme-inhibitor complex are slow in 
comparison to ordinary enzyme-substrate processes, it becomes obvious that standard 
steady-state rate equations (i.e. the Michaelis-Menten equation) are inadequate for 
determining kinetic parameters. 
 
A model describing the kinetics of an enzyme and substrate in the presence of an inhibitor 
can be constructed in an analogous manner to that of the Michaelis-Menten model; 
however, for slow binding inhibitors the association and dissociation rate constants kon and 
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koff (using the notation of Abeles and Imperiali)4 are significantly slower than k1 and k2 so 
a near steady-state is achieved for E and ES much faster than E and EI.7  
 
 
E  +  S
+
I
ES
EI
E + P
kon
k1
k-1
k2
koff
k-2
Slow binding inhibitors exhibit the defining characteristics that upon initiation of the 
reaction by addition of enzyme the rate proceeds at an initial uninhibited rate followed by a 
gradual decrease in reaction rate until a steady-state velocity is reached (i.e. equilibrium 
occurs slowly). This can be expressed by the equation: 
 
v = vs + (vo – vs)e-k’t        Equation 6.14 
 
Integration of equation 6.14 gives equation 6.15 in terms of absorbance and time: 
 
A = vst - 
(vs - vo)[1 - e-k't]
k'  + Ao       Equation 6.15 
 
From the standard UV profile of A vs. t, vo and vs can be determined from the initial and 
final slopes of the curve respectively (fig. 6.18).  
 
 
Figure 6.18. Plot of absorbance vs. time 
t (s) 
vs
vo
A 
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The values of absorbance and time can be fitted to equation 6.15 using non-linear 
regression to obtain estimates of k’ at different [I]. A plot of k’ vs. [I] should afford a 
straight line where kon and koff can be evaluated from the slope and y-intercept respectively 
(equation 6.16). 
 
k' = koff + 
kon [I]
⎝⎛ ⎠⎞1 + 
[S]
Km 
        Equation 6.16 
 
The inhibition constant Ki for a competitive inhibitor can be determined from single values 
using equation 6.17 
 
Ki = 
vs [I]
(vo - vs) ⎝⎛ ⎠⎞1 + 
[S]
Km 
        Equation 6.17 
 
However to get a better estimation of Ki, equation 6.17 can be rearranged in terms of 
known variables. A plot of (vo - vs)vs  vs. [I] should afford a straight line with the slope being 
inversely proportional to Ki. 
 
(vo - vs)
vs  
= 
[I]
Ki ⎝⎛ ⎠⎞1 + 
[S]
Km 
        Equation 6.18 
 
6.5.4 Hydration of trifluoromethyl ketones 
 
It is well established that trifluoromethyl ketones are equilibrium with their hydrates in 
aqueous media. The formation of hydrate is fast (k-1 = 0.25 s-1) and the equilibrium heavily 
favours the hydrate (500:1). The dissociation of water from the hydrate is several orders of 
magnitude slower (k1 = 5 x 10-4 s-1) resulting in Khyd ⎝⎛ ⎠⎞= 
k-1
k1[H2O] .= 9 M
-1.8  
 
IK + E EI E + P
k1
k-1[H2O]
IH
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The predominance of hydrate in aqueous acetone ( > 95 % by 1H and 19F NMR) was 
observed in all cases for trifluoromethyl ketones synthesised in this thesis. Trifluoromethyl 
ketones that possess additional electron withdrawing groups such as amides and 
sulfonamides are shown to decrease the amount of ketone present by about a factor of 
nine, therefore the ratio of hydrate to ketone is potentially 4500:1. Studies have shown that 
the ketone, not hydrate is the reactive species that undergoes nucleophilic attack by the 
Ser-195 hydroxyl group to give an ionised hemiketal (scheme 6.2); therefore dehydration 
of the inhibitor must occur before formation of the ES complex is permitted. At high [E], 
ketone may be consumed faster than it is formed from the hydrate, thus the dehydration of 
the hydrate (k1) can be rate limiting. 
 
R CF3
HO OH
R CF3
O
R CF3
O OCH2Enz
HOCH2Enz-H2O
 
Scheme 6.2. Inhibition of α-chymotrypsin by trifluoromethyl ketones. 
 
In some cases authors have applied correction factors to their values of Ki and kon to 
account for the true concentration of reactive species in solution giving Ki values in the 
nanomolar rather than micromolar range.  
 
6.5.5 Assay of the target compounds 
 
Representative targets (fig. 6.19) were chosen based on the degree of E/Z isomerisation, 
purity and structural type. Initial work was performed on the simplest target 4.12 which 
exhibited a high degree of Z-enrichment (78 %). Other inhibitors were tested to examine 
the effects of increasing peptide chain length, increased substitution of the azobenzene 
switch and different substitution patterns and were compared to 4.12.  
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X Y 
4.12 H 4-SO2
4.16 H 4-SO2-L-Leu 
4.46 I 3-SO2
4.52 I 4-SO2
4.62 I 4-SO2-L-Leu 
N N
X
Y
H
N CF3
Ph
O
 
Figure 6.19. Inhibitors chosen for enzyme inhibition studies. 
 
Initially substrate solution 2 was to be used as it is very a sensitive substrate for α-
chymotrypsin; however it was found that its purity was questionable. The solid N-Suc-Ala-
Ala-Pro-Phe-4-NA was distinctly yellow (it should be white) and when dissolved in 
aqueous media or DMSO gave a deep yellow solution. Determining the concentration of 
the solution by UV/Vis spectroscopy gave confusing results as the values obtained 
changed non-systematically. A new supply of substrate was ordered from the more 
reputable Sigma-Aldrich chemical company but due to time constraints could not wait for 
it to arrive. As a result, the less sensitive N-Suc-Phe-4-NA was used instead. A typical 
experiment is outlined below. 
 
The kinetic parameters Km and Vmax were determined for the N-Suc-Phe-4-NA/α-
chymotrypsin system in the presence of 5 % DMSO in a manner analogous to determining 
kinetic parameters for N-Suc-Ala-Ala-Pro-Phe-4-NA (section 6.4). The DMSO 
concentration was held constant to account for any activation/deactivation effects. The 
concentration of substrate was varied from 0.5 to 5 mM while [E] was held constant at 4 
µM. Analysis of the raw data by a Hanes-Woolf plot gave Km = 1.65 ± 0.20 mM and Vmax 
= (7.5 ± 0.1) x 10-4 nmol.s-1.mg-1. From these results it can be seen that the specificity and 
catalytic activity (kcat = Vmax[E]T) is greatly decreased compared to the N-Suc-Ala-Ala-Pro-
Phe-4-NA/α-chymotrypsin system (fig. 6.20) and as such required a greater concentration 
of enzyme to affect hydrolysis. 
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Km
(µM) 
Vmax
(µmol.s-1.mg-1) 
kcat
(s-1) 
N-Suc-Ala-Ala-Pro-
Phe-4-NA 
35 1.08 27 
N-Suc-Phe-4-NA 1650 7.46 x 10-4 0.0187 
 
Figure 6.20. Comparison of kinetic data for two different substrates. 
 
To a plastic cuvette was added substrate solution 3 (25 µL), phosphate buffer (925 µL) and 
inhibitor solution or DMSO (25 µL). The contents were mixed by inversion and incubated 
at 25 °C for 5 min. The reaction was initiated by addition of enzyme solution 2 (25 µL) and 
the progress of the reaction monitored at 405 nm for 10 min. Each measurement was 
performed in duplicate. 
 
Stock inhibitor solutions were irradiated with UV radiation for 1 h. Aliquots were diluted 
with DMSO to give concentrations of 0.4 - 2 mM and the solutions protected from light as 
much as possible. 
 
Initial velocities (vo) were determined from 15-20 data points at the beginning of the 
reaction curve while steady state velocities (vs) were determined from the linear portion of 
the curve between 400-600 s. The pseudo first-order rate constant k’ was determined by 
non-linear regression for five different inhibitor concentrations and a plot of k’ vs. [I] was 
obtained (equation 6.16). In most cases the graph was scattered but with linear trends 
which could be used to give an estimation of kon and koff. Unfortunately due to a 
miscalculation during the assay design, [E]T is at least 10-fold more concentrated than 
desired and as a consequence [E] ≈ [I] at low [I] rather than [E] ≤ 10 [I] as is required for 
pseudo first order conditions. The inhibition constant Ki was determined by plotting 
(vo - vs)
vs  
vs. [I] (equation 6.18).  
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6.5.6 A representative data set: Full kinetic data for 4.62 
 
Outlined below is the full kinetic data for the dipeptide 4.62.  
 
N N
I
O2S N
H
H
N
O
CF3
Ph
O
4.62
 
The raw data for vs and vo and k’ is tabulated in figure 6.21. 
 
A plot of (vo - vs)vs  vs. [I] for the ambient (fig. 6.22) and Z-enriched (fig. 6.23) photo-
stationary states afforded straight lines from which Ki could be determined. Estimates for 
the association and dissociation rate constants for the ambient (fig. 6.24) and Z-enriched 
(fig. 6.25) photostationary state of 4.62 were achieved by plotting k’ vs. [I]. The second 
order rate constant kon was obtained from the slope while koff was determined from the y-
intercept. 
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PSSambient PSSZ-Enriched
[I] 
(µM) 
vs
(x 10-5 s-1) 
vo
(x 10-5 s-1) 
k’ 
(x 10-3 M-1.s-1) 
[I] 
(µM) 
vs
(x 10-5 s-1) 
vo
(x 10-5 s-1) 
k’ 
 (x 10-3 M-
1.s-1) 
26.2 25.4 27.7 28.0 
0 
27.5 28.6 
- 0 
27.7 28.0 
- 
25.0 28.0 24.2 31.8 3.70 
10 
22.6 26.3 
2.86 5 
18.3 26.7 4.18 
22.8 31.3 16.4 26.7 3.01 
20 
18.4 24.4 
3.97 10 
15.0 26.4 3.43 
18.7 25.9 13.9 28.1 5.13 
30 
20.4 25.9 
4.93 15 
12.1 24.3 4.25 
18.2 27.4 11.1 26.4 4.23 
40 
18.7 29.4 
4.97 20 
9.1 24.6 3.90 
18.5 27.4 9.0 24.1 4.53 
50 
20.1 29.4 
7.77 25 
8.4 20.9 4.35 
 
Figure 6.21. Raw data for vs, vo and k’ for 4.62. 
 
Ki determination for inhibitor 4.62 (ambient PSS) 
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Figure 6.22. Determination of Ki for the ambient photostationary state of 4.62. Ki = 50 ± 12 µM. 
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Ki determination for Z-enriched inhibitor 4.62
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Figure 6.23. Determination of Ki for Z-enriched 4.62. Ki = 9 ± 1 µM. 
 
Determination of k on and k off
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Figure 6.24. Determination of kon and koff for ambient 4.62. kon = 170 ± 70 M-1.s-1; koff = (1.7 ± 1.7) x 10-3 s-1.  
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Figure 6.25. Determination of kon and koff for Z-enriched 4.62. kon = 130 ± 40 M-1.s-1; koff = (2.4 ± 0.5) x 10-3 
s-1. 
 
By analysing the data obtained from figures 6.19-6.23 three important parameters could be 
obtained for each of the photostationary states. The inhibition constant Ki was determined 
to be 50 ± 12 µM for the ambient photostationary state and 9 ± 1 µM for the UV 
photostationary state. From this it is apparent that the Z-isomer is the more active form of 
the inhibitor and represents a 5-fold increase in potency. The dissociation constant koff was 
determined from the y-intercept to be (1.7 ± 1.7) x 10-3 s-1 for the ambient photostationary 
state and (2.4 ± 0.5) x 10-3 s-1 for the UV photostationary state, therefore, within 
experimental error, the value of koff is constant. This implies that the rate of dissociation is 
independent of conformation. The association rate constant kon was determined from the 
slope to be 170 ± 70 M-1.s-1 for the ambient photostationary state and 130 ± 40 M-1.s-1 for 
the UV photostationary state. Though the errors overlap and one could state that kon is 
independent of conformation, comparison with the other four inhibitors indicates that kon is 
larger for the UV photostationary state. This would not be unexpected as the Z-isomer has 
shown to be the more potent inhibitor therefore it seems plausible that it might bind faster 
than the less potent conformation. 
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Based on the obtained data it can be concluded that the dipeptidyl inhibitor 4.62 is a 
competitive reversible slow binding inhibitor of α-chymotrypsin. The kinetic data for the 
other inhibitors has been summarised in figure 6.26. 
 
6.5.7 Problems with the assays 
 
It has been pointed out by Cha that the significance of k’ (equation 6.16) only holds true 
when depletion of the free inhibitor by binding (i.e. formation of EI) is negligible. For this 
to be valid the total enzyme concentration must be at least an order of magnitude less than 
the total inhibitor concentration ([E]T ≤ 10 [I]T) and the inhibitor concentration must also 
be kept sufficiently low compared to Ki to ensure the enzyme is not completely inhibited.7 
 
In such cases better estimates for the association and dissociation can be determined by 
pre-incubation of enzyme with inhibitor4,9 and assaying for remaining activity (kon) and by 
completely binding the enzyme with excess inhibitor, separating the EI complex from 
residual inhibitor by gel filtration and measuring the recovery of enzyme activity (koff).10,11 
 
At high [E] there is significant depletion of the ketone species which results in decreased 
kon. Studies performed on Ac-Phe-CF3 show that as [E] increases, kon decreases.10 
Equations which take in to account the depletion of inhibitor and slow rates of association 
have been derived by Cha which resemble equation 6.15 but include extra terms 
comprising Ki, [E]T and [I]T (equation 6.19).12 
 
P = vst + 
(1 - γ)(vo - vs)
kγ  ln⎝⎜
⎛
⎠⎟
⎞1 - γe-kt
1 - γ  where k = 
kon{(Ki + [E]T + [I]T)2 - 4[E]T[I]T}½
⎝⎜
⎛
⎠⎟
⎞1 + [S]Km
  and 
γ =  
Ki + [E]T + [I]T - {(Ki + [E]T + [I]T)2 - 4[E]T[I]T}½
Ki + [E]T + [I]T + {(Ki + [E]T + [I]T)2 - 4[E]T[I]T}½   Equation 6.19 
 
Analyses of this type would be very complex and thus deemed beyond the scope of this 
thesis. 
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Assay results 
 
The constants Ki, kon and koff for the five inhibitors have been summarised in figure 6.26. 
 
PSSambient PSSUV 
X Y Ki
(µM) 
kon
(M-1.s-1) 
koff 
x 10-3
Ki
(µM) 
kon
(M-1.s-1) 
koff
x 10-3  
4.12 H 4-SO2 11 ± 2 
190 ± 
60 
2.7 ± 
1.2 
2* ± 0.4 
740 ± 
180 
3.3 ± 
1.4 
4.46 I 3-SO2 19 ± 3 
100 ± 
50 
3.1 ± 
0.7 
1* ± 0.3 
290 ± 
60 
3.0 ± 
0.7 
4.52 I 4-SO2 47 ± 11 # # 6* ± 1 
270 ± 
200 
4.2 ± 
2.2 
4.16 H 4-SO2 18 ± 2 60 ± 40 
3.5 ± 
0.6 
6 ± 1 170 ±50 
3.2 ± 
0.6 
4.62 I 4-SO2 50 ± 12 
170 ± 
70 
1.7 ± 
1.5 
9 ± 1 
130 ± 
40 
2.4 ± 
0.5 
N N
X
Y
H
N CF3
Ph
O
 
Figure 6.26. Kinetic parameters Ki, kon and koff estimated for the ambient and Z-enriched photostationary 
state of α-chymotrypsin inhibitors. * Ki has been estimated from the slope of a best fit line through a curve. # 
Data was too scattered to obtain a straight line. 
 
Plots of (vo - vs)vs  vs. [I] (equation 6.18) were linear for all inhibitors measured at an ambient 
photostationary state and for Z-enriched dipeptides 4.16 and 4.62. The plots for Z-enriched 
monopeptides 4.12, 4.46 and 4.52 were distinctly parabolic and a replot of (vo - vs)vs  vs. [I]
2 
gave a linear slope. Potentially this could occur because a ternary complex is formed (i.e. 
two molecules of inhibitor bind to the enzyme giving mixed inhibition), more work would 
be needed to determine this, or because of experimental error due to the high [E] used in 
conjunction with inhibitors possessing a relatively low Ki. 
 
Kinetic results obtained for slow binding inhibitors in this thesis should be viewed with 
some caution. Data was obtained under less the optimal conditions and the resulting 
analyses are comparable to each other but not necessarily comparable to other published 
results in this field.4,8-11 
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While the validity of some of the results maybe questionable, certain trends between the 
different inhibitors have been noted. All inhibitors (mono and dipeptidyl) at both ambient 
and Z-enriched photostationary state exhibited slow-binding kinetics; this is in contrast to 
the results of Abeles et al who report that Ac-Phe-CF3 shows fast reversible competitive 
inhibition whereas Ac-Leu-Phe-CF3 exhibit slow-binding kinetics. This phenomenon had 
been attributed to slow but catalytically relevant van der Waals interactions between His-
57 and Isl-99 of the enzyme and the leucine residue of the inhibitor. A study of various 
dipeptide ester and amide substrates showed that increasing the bulk of the substituents at 
the P2 subsite resulted in tighter binding and slower association rates.9,10 Because of the 
slow-binding kinetics observed for all azobenzene based mono- and dipeptidyl inhibitors it 
was postulated that the azobenzene moiety arranges itself to take advantage of 
complementary columbic and electrostatic interactions within the enzyme. 
 
For the five inhibitors tested it was found that the Z-enriched inhibitors had lower values of 
Ki and were therefore more potent than the corresponding inhibitor at an ambient 
photostationary state. This follows the same trend observed by Harvey when investigating 
α-keto ester based inhibitors of α-chymotrypsin.13 The increases in potency were 3-6 fold 
which is consistent with the degree of isomerisation i.e. a 3-fold increase in ratio of the 
percentage of Z-isomer resulted in ca. 3-fold decrease in the ratio of Ki values (fig. 6.27).  
 
compound Ki (Z-enriched)Ki (ambient)  
% Z (Z-enriched)
% Z (ambient)  
4.16 3.0 ± 0.8 2.9 
4.12 5.5 ± 2.1 3.5 
4.46 19.0 ± 8 4.2 
4.52 7.8 ± 3.1 5.1 
4.62 5.6 ± 2.0 5.2 
 
Figure 6.27. Comparison of Ki and % Z ratios for the ambient and Z-enriched photostationary state. 
 
The result for 4.46 appears to be an anomaly and is due to the difficulty in determining the 
Ki from poor data. It is probable that the true ratio of Ki values is closer to 4-5 than 19-fold 
difference in potency.  
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The association rates (kon) for the ambient photostationary state of the inhibitors was found 
to be lower than that of the corresponding Z-enriched inhibitors and both dipeptidyl 
inhibitors appear to have lower association rates than the three monopeptidyl inhibitors. It 
is presumed that like Ac-Leu-Phe-CF3, dipeptidyl inhibitors 4.16 and 4.62 require a delay 
period to setup secondary interactions of the leucine with the enzyme in addition to any 
interactions which may occur between the switch and the enzyme. The dissociation rate 
(koff) remained relatively constant (3 x10-3 s-1) for all inhibitors at both photostationary 
states. 
 
The effects of incorporating an iodine atom into the azobenzene switch are somewhat 
variable. Comparison of Ki values for 4.16 (18 and 6 µM) and 4.62  (50 and 9 µM) 
indicated that while the Ki for the Z-enriched inhibitors are similar, there were noticeable 
differences between the Ki of the ambient photostationary states which can be attributed to 
the differences in the degree of photoisomerisation (fig. 6.27). The effect is less 
pronounced when comparing 4.12 and 4.52 although similar trends are observed. Due to 
the anomalous result obtained for 4.46 it is difficult to draw any sound conclusions other 
than it a potent inhibitor. This was not unexpected as Harvey found that 3-substituted 
azobenzene peptidyl α-keto esters were more potent than the equivalent 4-substituted 
azobenzene inhibitors.6 Based on the observation that bulkier substituents at the P2 subsite 
decreases kon it was not surprising that kon was lower for disubstituted azobenzenes Z-4.16 
(170 ± 50 M-1.s-1) and Z-4.62 (130 ± 40 M-1.s-1) compared to 4.12 (740 ± 180 M-1.s-1), 
especially for the Z-enriched inhibitors as the twisted conformation of the iodine 
substituted phenyl ring may be in closer proximity to the P2 subsite than the corresponding 
planar E-conformation. 
 
 
6.6 Summary 
 
Five inhibitors were assayed against α-chymotrypsin at both ambient and Z-enriched 
photostationary states. In all cases slow binding kinetics were observed and the Z-enriched 
inhibitors were at least 3-fold more potent than the same inhibitor at an ambient 
photostationary state. These increases compared well to the degree of Z-enrichment 
exhibited by each inhibitor. Increasing the peptide chain length to improve specificity and 
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thus improve binding did not lower the Ki as expected, however incorporation of leucine 
into the peptide chain did decrease the association rate and increase the potency of the Z-
enriched inhibitors 4.16 and 4.62 3- and 5-fold respectively. Incorporation of iodine into 
the molecule had little effect on the value of Ki but did increase the ratio of Ki for ambient 
and Z-enriched inhibitors 4.46, 4.52 and 4.62 and decreased the association rate. The effect 
of altering the position of substitution from 4- to 3- is inconclusive but general 
observations suggest that 3-substituted azobenzenes would be as good, if not better 
inhibitors of α-chymotrypsin. 
 
 
6.7 Future work 
 
Azobenzene based peptidyl trifluoromethyl ketones have shown great promise as potent 
inhibitors of α-chymotrypsin. Effective switching between active and less active forms of 
the inhibitors has been achieved. Addition of bulky substituents to the unsubstituted 
phenyl ring stabilises the Z-conformation of the azobenzene switch and increases the 
proportion of Z-isomer present after irradiation. The assays performed in this thesis need to 
be repeated with a better substrate than N-Suc-Phe-4-NA in order to reduce the 
concentration of enzyme used and get more definitive values for Ki, kon and koff.  
 
Testing of some of the other inhibitors which incorporate different moieties such as 
bromine, carboxyl, amino and additional carbocycles needs to be done. Potentially some of 
the inhibitors already synthesised could be modified to incorporate functional groups 
designed to improve the solubility of azobenzene based inhibitors in aqueous media. 
Currently we are limited to an upper limit of ca. 50-60 µM therefore improved solubility 
would be advantageous and allow comprehensive testing over a wider range of inhibitor 
concentrations.  
 
Comparison of a wider selection of mono- and disubstituted azobenzenes with varying 
substitution patterns would better illustrate various trends and perhaps help elucidate 
potential mechanisms of inhibition. Testing of the phenanthrene derivatives could also be 
of use to see how well they compare to similar azobenzene derivatives and whether they 
could potentially mimic either E- or Z-azobenzenes. 
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Further investigation needs to be undertaken to confirm whether the mechanism is purely 
competitive or whether other mechanisms such as mixed inhibition is occurring in some 
instances. 
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Experimental 
 
7.1 General Methods and Procedures 
 
7.1.1 General practice 
 
Compound numbering 
 
Compounds described in this thesis were numbered for NMR characterisation in the 
following manner and do not necessarily follow IUPAC standards. 
 
         Azobenzene     Phenanthrene        Fmoc 
N N 1 32
4
3'
4'
2' 1'
1
2
3
4
5
6
7
8
9
10
O X
O
a
b
c d
e
f
SO2RR
X
 
When reporting NMR data α refers to the carbon (or hydrogen) adjacent to the nitrogen 
functionality, β refers to the second carbon (or hydrogen) from the nitrogen and so on. 
This is irrespective of priority rules and applies to NMR assignments only. 
 
H2N
CF3
OH
Ph
α β H2N O
R
OH
O
α
β
γ
α-amino-TFMC α-hydroxyester
Me
 
NMR reporting 
 
Invariably, synthesis of azobenzene compounds result in minor amounts of the Z-isomer 
being present. Recrystallisation of the purified material usually gave the E-isomer 
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exclusively. Unless otherwise stated, all reported data is for the E-isomer only. A solution 
of an azobenzene derivative reached an ambient photo-stationary state (a mixture of E- and 
Z-isomers) after exposure to light for ca. one day. 
 
For compounds containing two diastereomers, NMR data associated with the minor isomer 
in the mixture has been labelled with an asterisk (*). For spectra that contain both ketone 
and hydrate peaks, the hydrate data has been labelled with an asterisk (*). 
 
Concentrating in vacuo 
 
Concentrating in vacuo refers to the bulk removal of solvent and volatiles under reduced 
pressure using a Büchii rotary evaporator (low vacuum pump). More rigorous drying was 
achieved under high vacuum (oil pump) for at least 30 min. 
 
Elemental Analysis 
 
Elemental analyses were performed for carbon, hydrogen, nitrogen and occasionally 
sulphur at the University of Otago Microanalytical laboratory and agree within ± 0.4 % of 
the calculated value. 
 
Flash Chromatography 
 
Flash chromatography (positive pressure) and column chromatography (atmospheric 
pressure) were performed on 230-400 mesh Merck silica 60 based on the guidelines of 
Still et al.1 The eluting solvents, petroleum ether 50/70,ξ dichloromethane, and ethyl 
acetate were distilled in bulk from calcium hydride chips and stored in brown bottles away 
from light. 
 
                                                 
ξ A mixture of hexanes with a boiling point range between 50-70 °C. 
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Melting points 
 
All melting points were obtained on an Electrothermal apparatus and are uncorrected. 
Melting points are not reported for diastereomeric or ketone/hydrate mixtures. 
 
Mass Spectrometry 
 
Electron impact ionisation (EI) mass spectroscopy was performed on a Kratos MS80 Mass 
Spectrometer operating at 4 kV (accelerating potential) and 70 eV (ionising potential). 
Electrospray ionisation (EI) mass spectroscopy was performed on a Micromass LCT TOF 
Mass Spectrometer operating with a probe voltage of 3.2 kV at 150 °C and a source 
temperature of 80 °C. 
 
Nuclear Magnetic Resonance 
 
1H NMR spectra were obtained on either a Varian Unity 300 or Inova 500 spectrometer 
operating at 300 and 500 MHz respectively .19F NMR were obtained on the Varian Unity 
300 spectrometer operating at 282 MHz. 13C NMR were obtained on the Varian Unity 300 
spectrometer operating at 75 MHz. All spectra were obtained at 23 °C with a delay (D1) of 
at least 1 s. 1H and 19F NMR experiments had an acquisition time (At) of 2 s, 13C NMR 
experiments had an acquisition time of 1-2 s. All two-dimensional NMR experiments, 
which include; COSY, HSQC and CIGAR were run on the Inova 500 spectrometer with a 
delay of 1 s.  
 
Chemical shifts are reported in parts per million (ppm) on the δ scale and were referenced 
to the appropriate residual solvent peaks: CDCl3 referenced to (CH3)4Si at δH 0.00 ppm 
(1H) and (CDCl3) at δC 77.01 ppm (13C); D2O referenced to 1,4-dioxane as an internal 
standard at δH 3.70 ppm (1H) and δC 67.4 ppm (13C); methanol-d4 referenced to CHD2OD 
at δH 3.30 ppm (1H) and CD3OD at δC 49.3 ppm (13C); acetone-d6 referenced to 
(CHD2)(CD3)CO at δH 2.17 ppm (1H) and (CD3)2CO at δC 29.2 ppm (13C); acetonitrile-d3 
referenced to CHD2CN at δH 2.00 ppm (1H) and CD3CN at δC 1.30 ppm; DMSO-d6 
Chapter Seven: Experimental 172
referenced to (CHD2)(CD3)SO at δH 2.60 ppm (1H) and (CD3)2SO at δC 39.6 ppm (13C). 
All 19F NMR spectra were referenced against an internal standard (fluorobenzene C6H5F) 
at δF –113.15 ppm (19F). 
 
Optical Rotary Dispersion 
 
Optical rotation measurements were performed on a Perkin Elmer polarimeter Model 341 
with a 1.00 dm pathlength. Measurements were taken at 20 ºC in HPLC grade MeOH (λ = 
589 nm). [α]D values are given in º.mL.g-1.dm-1 and the sample concentration given in 
units of 101 mg.mL-1. 
 
Ultraviolet Spectroscopy 
 
UV/Visible spectroscopy was performed on a GBC UV/Vis 918 spectrometer running the 
default GBC Scientific v 2.01 software package. 
 
Thin Layer Chromatography 
 
Analytical TLC was performed on plastic-backed Merck-Kieselgel KG60F254 or Polygram 
Sil G/UV254 plates. Traces were visualised with UV light and a suitable dip, typically, 
basic potassium permanganate (general use), ninhydrin (amines), Mary’s Dipξ 
(oxazolones, free acids) and ammonium molybdate-cericIV sulphate dip (azobenzenes). 
 
Reagents and solvents 
 
Reagents purchased from Aldrich or Sigma were used as supplied, with the exceptions of 
3- and 4-nitrobenzene sulfonyl chloride, which required further purification.ψ All other 
reagents and solvents were purified according to well established procedures.2 
                                                 
ξ 4, 4’-Bis(dimethylamino)benzhydrol in acetone. 
ψ Recrystallisation from petroleum ether or petroleum ether/dichloromethane. 
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Triethylamine, dichloromethane, pyridine, benzene and toluene were distilled from 
calcium hydride powder immediately prior to use. Diethyl ether and THF were distilled 
from sodium benzophenone ketyl immediately prior to use. Super dry ethanol and 
methanol were distilled from magnesium ethoxide or magnesium methoxide respectively 
and stored under argon over 4 Å molecular sieves.  
 
7.1.2 General methods 
 
General Method A: Phenanthrenesulfonyl chlorides from phenanthrene sulfonates 3 
 
SO2X
X = OK
X = Cl
 
The phenanthrene sulfonate (1.0 equiv) was suspended in a mixture of acetonitrile and 
sulfolane (2:1, 1.5 mL/mmol). Freshly distilled POCl3 (0.38 mL/mmol) and dimethyl 
acetamide (1-3 drops) were added and the reaction mixture stirred for 75-90 min at 70 °C. 
Cooling of the reaction mixture to ca. 5 °C, followed by addition of cold water induced 
precipitation of the sulfonyl chloride. The precipitate was filtered, washed with distilled 
water and dried under vacuum. The crude sulfonyl chloride was purified by flash 
chromatography where required. 
 
General Method B: Sulfonamide coupling (pyridine) 4 
 
SO2X
X = Cl
X = NHRR
 
The sulfonyl chloride (1.0 equiv) and the amine hydrochloride (1.1 equiv) were dissolved 
in dry pyridine (11 mL/mmol) and heated at reflux for 2-4 h under an inert atmosphere. 
After cooling, the mixture was poured into a cold, saturated solution of aqueous NaHCO3 
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and the resulting precipitate collected by vacuum filtration, washed twice with 10 % 
aqueous HCl and distilled water then air-dried. Further purification of the crude 
sulfonamide was achieved by flash chromatography or recrystallisation. 
 
General Method C: Sulfonamide coupling (Hünigs base) 
 
SO2X
X = Cl
X = NHRR
 
To a stirred suspension of sulfonyl chloride (1.0 equiv) and the amine hydrochloride (1.1 
equiv) in dry dichloromethane (5-10 mL/mmol) was added Hünigs base (2.2 equiv) to 
complete dissolution. The resulting solution was heated at reflux under an inert atmosphere 
for 2-4 h, cooled, and the solvent removed in vacuo. The residue was redissolved in ethyl 
acetate, successively extracted with 10 % aqueous HCl, saturated aqueous NaHCO3 and 
brine, dried over MgSO4, filtered and concentrated in vacuo. Further purification of the 
crude sulfonamide was achieved by recrystallisation or flash chromatography where 
required. 
 
General Method D: EDCI coupling of free amines and N-protected amino acids 5,6 
 
RHN X
O
R' X = OH
X = NHR"
 
A suspension of the N-protected amino acid (1.0 equiv), amine hydrochloride (1.1 equiv), 
EDCI (1.3 equiv), and HOBt (1.5 equiv) in dry dichloromethane (25 mL/mmol) was 
stirred at rt under an inert atmosphere. After 5 min Hünigs base (2.2 equiv) was added 
dropwise to complete dissolution. The resulting solution was stirred for a further 16 h then 
diluted with a 4 x volume of ethyl acetate. The organics were successively extracted with 
10 % aqueous HCl, saturated aqueous NaHCO3 and brine, dried over MgSO4, filtered and 
concentrated in vacuo. Further purification of the crude product was achieved by 
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recrystallisation or flash chromatography. 
 
General Method E: BOP coupling of free amines and N-protected amino acids 5 
 
RHN X
O
R' X = OH
X = NHR"
 
A suspension of the N-protected amino acid (1.0 equiv), amine hydrochloride (1.1 equiv), 
and BOP (1.1 equiv) in dry dichloromethane (5-20 mL/mmol) was stirred at rt under an 
inert atmosphere. After 5 min Hünigs base (2.2 equiv) was added dropwise to complete 
dissolution. The resulting solution was stirred for a further 16 h then diluted with a 4 x 
volume of ethyl acetate. The organics were successively extracted with 10 % aqueous HCl, 
saturated aqueous NaHCO3 and brine, dried over MgSO4, filtered and concentrated in 
vacuo. Further purification of the crude product was achieved by recrystallisation or flash 
chromatography. 
 
General Method F: Trifluoromethyl carbinol oxidation via Dess-Martin Periodinane7 
 
RHN CF3
OH
Ph
RHN CF3
O
Ph
 
Trifluoromethyl carbinol (1.0 equiv) and Dess-Martin periodinane (3.7 equiv) were 
suspended in dry dichloromethane (0.5-1 mL/µmol) and stirred at rt under an inert 
atmosphere for 3-16 h The reaction mixture was diluted with 3-5 x volume of diethyl ether 
or ethyl acetate followed by addition of an equal volume of a solution containing 10 % w/v 
Na2S2O3 in saturated aqueous NaHCO3. The bi-phasic mixture was stirred for a further 20 
min then separated. The aqueous layer was back extracted with dichloromethane and the 
combined organics washed with brine, dried over MgSO4, filtered and concentrated in 
vacuo. Further purification of the crude product was achieved by recrystallisation or 
column chromatography where necessary. 
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General Method G: Trifluoromethyl carbinol oxidation via TEMPO-NaOCl 8 
 
RHN CF3
OH
Ph
RHN CF3
O
Ph
 
A buffered solution of sodium hypochlorite (5.25 %, 9.7 mL commercial bleach, 15.3 mL 
distilled water) was prepared by addition of solid NaHCO3 (ca. 300 mg) until the pH lay 
within the range 8.6-9.5.ψ  
 
A solution of trifluoromethyl carbinol (1.0 equiv), KBr (0.2 equiv) and TEMPO (0.1 
equiv) in dichloromethane (35 mL/mmol) was cooled to 0 °C.ξ Buffered NaOCl (0.5 
mL/mL dichloromethane) was added drop-wise and the reaction mixture stirred rapidly for 
30-120 min. The bi-phasic mixture was diluted with ethyl acetate, separated, washed with 
brine, dried over MgSO4, filtered and concentrated in vacuo. Further purification of the 
crude product was achieved by recrystallisation or column chromatography.  
 
Modified General Method G 
 
To a cooled solution of trifluoromethyl carbinol (1.0 equiv) in dichloromethane (12.5 
mL/mmol) was added 1.25 equiv of buffered aqueous NaOCl solution (2.6 %, 0.35 M, pH 
8.6), 0.1 equiv of aqueous KBr solution (50 mM) and 0.01 equiv of a solution of TEMPO 
dissolved in dichloromethane (400 µM). The bi-phasic mixture was rapid stirred at ca. 0 
°C for 2 h, diluted with a 4 x volume ethyl acetate, washed with water then brine, dried 
over MgSO4, filtered and concentrated in vacuo. Further purification of the crude product 
was achieved by recrystallisation or column chromatography.  
 
                                                 
ψ The required pH range for HOCl distribution between both phases.8
ξThe temperature of the solution must be maintained at around 0 °C to minimise decomposition of the 
TEMPO catalyst.8  
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General Method H: K2CO3 mediated hydrolysis of methyl esters  
 
RHN X
O
R' X = OMe
X = OH
 
A suspension of the methyl ester (1.0 equiv) and K2CO3 (1.5 equiv) in a mixture of 
methanol/water (9:1, 10 mL/mmol) was heated at reflux until hydrolysis complete by TLC 
(9-72 h). The reaction mixture was cooled, acidified with 10 % aqueous HCl and the 
resulting precipitate taken up in ethyl acetate. The separated aqueous layer was back 
extracted with dichloromethane and the combined organics washed with brine, dried over 
MgSO4, filtered and concentrated in vacuo. Further purification of the free acid was 
achieved by recrystallisation when necessary. 
 
General Method I: Reduction of substituted nitrobenzenes 9 
 
Y
R
Y = NO2
Y = NH2
 
In a two necked flask fitted with a hydrogen balloon was placed the substituted 
nitrobenzene. Ethyl acetate (half volume of flask) was added followed by Adams’ catalyst 
(PtO2.H2O, catalytic amount). The suspension was rapidly stirred under vacuum for 3-5 
min then stirred under a hydrogen atmosphere for a further 16 h. The suspension was 
filtered through a mixture of celite and MgSO4 and concentrated in vacuo. Further 
purification of the crude product was achieved by flash chromatography where necessary. 
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General Method J: Molybdenum catalysed oxidation of substituted anilines to 
nitrosobenzenes 10 
 
Y Y = NH2
Y = NOX
 
To a solution (or suspension) of 4-substituted aniline (1.0 equiv) in dichloromethane (5 
mL/mmol) was added 30 % aqueous H2O2 (5.0 equiv) followed by the catalyst 
([MoVI(O)O2(H2O)(HMPA)],11 0.1 equiv in 1 mL dichloromethane). After a few minutes 
the solution became tinged with green indicating the formation of the desired nitroso 
compound. The reaction mixture was stirred under an inert atmosphere for 12-48 h until no 
nitrobenzene remained by TLC.ξ The aqueous solvent was removed by addition of solid 
Na2SO4, filtered, and concentrated in vacuo. The crude nitrosobenzene was purified by 
flash chromatography. 
 
General Method K: Synthesis of (4-substituted phenylazo)benzenesulfonamidyl 
derivatives 12 
 
NO
X H2N
+ N N
X
SO2NHR
SO2NHR
 
A suspension of 4-substituted nitrosobenzene (1.0 equiv) and sulfanilamide OR 
metanilamide (1.0 equiv) in glacial acetic acid (4 mL/mmol) was stirred at 70-100 °C for 4 
h. The reaction mixture was cooled to rt then diluted with water/dichloromethane (1:1, 50 
mL). Solid Na2CO3 was added cautiously until effervescence ceased and the aqueous layer 
basic to litmus. The aqueous layer was back extracted with dichloromethane and the 
combined organics washed successively with 10 % aqueous HCl, saturated aqueous 
NaHCO3 and brine, dried over MgSO4, filtered and concentrated in vacuo. Further 
                                                 
ξ The reaction was very time dependent. Prolonged stirring lead to the formation of undesirable azobenzenes.  
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purification of the crude azobenzene was achieved by column chromatography. 
 
General Method L: Suzuki coupling of aryl boronic acids 13 
 
B OH
OH
R
X
R
R' R'
+
 
A suspension of aryl boronic acid (1.0 equiv), aryl bromide (1.2 equiv), 
tetrakis(triphenylphosphine)palladium(0) (0.05 equiv), tetrabutylammonium bromide (1.0 
equiv) and KOH (3.0 equiv) in dry THF (30 mL/mmol) were heated at reflux under an 
inert atmosphere for 16 h. The cooled reaction mixture was diluted with ethyl acetate, 
washed with distilled water and brine, dried over MgSO4, filtered and concentrated in 
vacuo. The crude product was purified by column chromatography. 
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7.2 Experimental work outlined in chapter two  
 
Synthesis of the key intermediate (2R*,3S*)-3-amino-1,1,1-trifluoro-4-
phenylbutan-2-ol hydrochloride  
 
7.2.1 Route 1: Condensation of 1-nitro-2-phenylethane with trifluoroacetaldehyde 14 
 
β-trans-Nitrostyrene (2.1)15,16 
 
NO2
2.1
 
β-Nitrostyrene was prepared by the condensation of nitromethane (30.5 g, 0.5 mol) and 
freshly distilled benzaldehyde (53.6 g, 0.5 mol) according to literature methods.15,16 
Recrystallisation of the crude product from hot EtOH afforded pale yellow needles (16.3 g, 
22 %). Severe irritant! 
1H NMR (CDCl3, 500 MHz); δ 7.98 (d, 1H, J = 13.7 Hz, PhCH), 7.58 (d, 1H, J = 13.7 Hz, 
CHNO2), 7.53 (d, 2H, J = 7.3 Hz, o-Ph), 7.48 (d, 1H, J = 7.1 Hz, p-Ph), 7.44 (t, 2H, J = 7.4 
Hz, m-Ph). 
13C NMR (CDCl3, 75 MHz); δ 139.0, 137.1, 132.1, 130.0, 129.4, 129.1. 
 
Chapter Seven: Experimental 181
Diethyl 1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate (2.2, Hantzsch ester)17,18  
 
N
H
OEtEtO
O O
2.2
 
Hantzsch ester was prepared by condensation of freshly distilled ethyl acetoacetate (75.0 g, 
0.58 mol) and 37 % aqueous formaldehyde (24.3 g, 0.30 mol), and subsequent 
condensation with gaseous ammonia following literature methods.17,18 Recrystallisation of 
the crude product from the minimum amount of hot EtOH afforded 2.2 as fluffy yellow 
crystals (45.0 g, 62 %). 
mp 181-185 °C, (Lit. 181-183 ºC) 
1H NMR (DMSO-d6, 300 MHz); δ 8.38 (s, 1H, NH), 4.15 (q, 4H, J = 7.2 Hz, CH3CH2), 
3.20 (s, 2H, CH2), 2.20 (s, 6H, CH3), 1.28 (t, 6H, J = 7.1 Hz, CH3CH2). 
13C NMR (DMSO-d6, 75 MHz); δ 167.2 (CO), 146.6 (C2), 97.2 (C3), 59.1 (CH3CH2), 24.9 
(C4), 18.1 (CH3), 14.6 (CH3CH2). 
 
1-Nitro-2-phenylethane (2.3)19  
 
NO2
2.3
 
Nitrostyrene 2.1 (14.9 g, 100 mmol), Hantzsch ester 2.2 (28.0 g, 110 mmol) and silica 
(16.0 g) were suspended in dry toluene (300 mL). The reaction mixture was stirred under 
an inert atmosphere at 65 °C in a darkened fumehood. The progress of the reaction was 
monitored by TLC and after 50 h the reaction mixture was cooled to rt, filtered and 
concentrated in vacuo to ca. 150 mL. The organics were continually extracted with 40 % 
aqueous HCl until the aqueous layer no longer appeared green. The organics were washed 
with saturated aqueous NaHCO3 and brine, dried over MgSO4 and concentrated in vacuo 
to give a yellowish oil. The residue was rigorously dried on the high vacuum to remove 
toluene then distilled under reduced pressure to give 2.3 as a pale green oil (13.3 g, 88 %). 
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1H NMR (CDCl3, 500 MHz); δ 7.33-7.18 (m, 5H, o/m/p-Ph), 4.58 (t, 2H, J = 7.3 Hz, 
CH2NO2), 3.29 (t, 2H, J = 7.3 Hz, PhCH2). 
13C NMR (CDCl3, 75 MHz); δ 135.6 (i-Ph), 128.7 (m-Ph), 128.4 (o-Ph), 127.2 (p-Ph), 
76.0 (CH2NO2), 33.1 (PhCH2). 
 
(2R*,3S*)-1,1,1-Trifluoro-3-nitro-4-phenylbutan-2-ol (2.4)14,20 
 
O2N
CF3
OH
Ph
2.4
 
2-Nitro-1-phenylethane 2.3 (9.63 g, 63.7 mmol), trifluoroacetaldehyde methyl hemiacetalξ 
(9.60 g, 70.1 mmol) and K2CO3 (0.35 g, 2.5 mmol) were stirred under an inert atmosphere 
for 12 h at 50 °C and 8 h at rt. The resulting brown oil was diluted with ethyl acetate (50 
mL) and washed with 10 % aqueous HCl (3 x 50 mL) and brine (50 mL), dried over 
MgSO4, filtered and concentrated in vacuo. The residue was purified by distillation under 
reduced pressure, followed by flash chromatography (dichloromethane) to give 2.4 as a 
pale yellow oil (9.50 g, 60 %) as a mixture of diastereomers (2:1 by 1H and 19F NMR). 
Freeze drying of a small amount of the oil under vacuum initiated crystallisation of one 
diastereomer as fine white crystals. It was tentatively assigned the stereochemistry 
(2R*,3S*) based on comparisons of coupling constants, the resulting stereochemistry of the 
reduction product and the crystallisation from oil reported on a similar compound.20 
Recrystallisation from hot petroleum ether removed traces of the minor diastereomer. 
mp 59-60 °C 
1H NMR (CDCl3, 500 MHz); Mixture (2:1) δ 7.38-7.29 (m, 6H, m/p-Ph, major + minor), 
7.22 (d, 2H, J = 6.5 Hz, o-Ph), 7.19* (d, 2H, J = 6.8 Hz, o-Ph), 4.96 (m, 2H, α-H, major + 
minor), 4.65* (m, 1H, β-H), 4.24 (m, 1H, β-H), 3.82 (br s, 1H, OH), 3.51* (br s, 1H, OH), 
3.39* (d, 2H, J = 7.3 Hz, PhCH2), 3.36 (d, 2H, J = 7.8 Hz, PhCH2). 
                                                 
ξ Lancaster, 80% technical grade, distilled through a 15-cm vigereux column prior to use. 
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1H NMR (CDCl3, 500 MHz); Major (isolated) δ 7.37-7.30 (m, 3H, m/p-Ph), 7.21 (d, 2H, J 
= 7.8 Hz, o-Ph), 4.95 (m, 1H, α-H), 4.21 (m, 1H, β-H), 3.72 (d, 1H, J = 8.8 Hz, OH), 3.36 
(d, 2H, J = 7.8 Hz, PhCH2).  
13C NMR (CDCl3, 75 MHz); Major (isolated) δ 133.2 (i-Ph), 129.2, 128.9, 128.2 (p-Ph), 
123.3 (q, J = 283.2 Hz, CF3), 86.6 (α-C), 70.1 (q, J = 30.5 Hz, β-C), 36.5 (PhCH2); Minor 
(from mixture) δ 134.4 (i-Ph), 129.0, 128.1, 127.7 (p-Ph), 87.6 (α-C), 70.6 (q, J = 28.0 Hz, 
β-C), 34.4 (PhCH2). The CF3 quartet could not be detected over the baseline noise. 
19F NMR (CDCl3, 282 MHz); Mixture (2:1) δ –76.4 (d, J = 6.6 Hz), –76.9* (d, J = 6.4 Hz).  
 
tert-Butyldimethyl-(2-nitro-3-phenyl-1-trifluoromethylpropoxy)silane (2.5)21 
 
O2N
CF3
OTBDMS
Ph
2.5
 
The nitrocarbinol 2.4 (5.80 g, 23.3 mmol, 3:2 mixture of diastereomers), TBDMSCl (4.39 
g, 96 %, 28.0 mmol) and imidazole (3.97 g, 58.3 mmol) were dissolved in dry DMF (10 
mL) and stirred at 35 °C under an inert atmosphere for 18 h. The reaction mixture was 
diluted with ethyl acetate (50 mL) and successively washed with water (5 x 30 mL), 
saturated aqueous NaHCO3 (2 x 30 mL) and brine (30 mL), dried over MgSO4, filtered and 
concentrated in vacuo. The residue was purified by flash chromatography 
(dichloromethane) to give 2.5 as a bright yellow oil (7.87 g, 93 %) comprising a mixture of 
diastereomers (3:2 by 1H NMR). 
1H NMR (CDCl3, 300 MHz); Mixture (3:2) δ 7.46-7.24 (m, 10H, o/m/p-Ph, major + 
minor), 5.07-5.00 (m, 2H, α-H, major + minor), 4.82* (m, 1H, β-H), 4.63 (m, 1H, β-H), 
3.55-3.32 (m, 4H, PhCH2, major + minor), 1.08* (s, 9H, (C(CH3)3), 0.99 (s, 9H, 
(C(CH3)3), 0.29* (s, 6H, CH3), 0.27 (s, 6H, CH3).  
13C NMR (CDCl3, 75 MHz); Mixture δ 135.4 (i-Ph), 134.2 (i-Ph), 129.0, 128.8, 128.7, 
127.8 (p-Ph, major), 127.5* (p-Ph), 123.5 (q, J = 283.8 Hz, CF3), 123.5* (q, J = 284.1 Hz, 
CF3), 90.7, 88.8, 72.7* (q, J = 32.1 Hz, β-C), 72.5 (q, J = 31.1 Hz, β-C), 35.4, 33.3, 25.5* 
(C(CH3)3), 25.4 (C(CH3)3), 18.1 (C(CH3)3), 18.0 (C(CH3)3), Silyl CH3 peaks were outside 
spectral window.  
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(2R*,3S*)-3-Amino-1,1,1-trifluoro-4-phenylbutan-2-ol hydrochloride (2.6) 
 
 
14
HCl.H2N
OH
2.6
CF3
Ph
Method 1: Reduction via Raney nickel  
 
The nitrocarbinol 2.3 (2.51 g, 10.1 mmol, 2:1 m  diastereomers) was dissolved in 
EtOH.ξ Raney nickel22 ushed with hydrogen, pressurised 
to 50 psi and then shaken in a Parr reacto  for 12 h. The suspension was filtered through 
elite, washed with distilled EtOH and concentrated in vacuo. The residue was redissolved 
 aqueous HCl (5 x 25 mL) and the combined 
queous extracts concentrated in vacuo to give an off-white solid. Recrystallisation from 
,
-C), 33.4 (PhCH2). 
F NMR (D O, 282 MHz); δ –74.3 (d, J = 7.4 Hz). 
HRMS (EI) 220.0957 (M-HCl)
 Reduction via lithium aluminium hydride23 
 
) was heated to reflux for 
3  silyl protected nitrocarbinol 2.5 (2.99 
s added dropwise to 
e hydride suspension and the reaction mixture continued to reflux for 30 min. After 
                                                
ixture of
 was added, the reaction vessel fl
r
c
in dichloromethane, extracted with 10 %
a
hot ethyl acetate/petroleum ether gave the hydrochloride salt 2.6 as very fine, fluffy white 
needles (0.88 g, 34 %  single diastereomer). 
mp 232-235 °C 
1H NMR (D2O, 500 MHz); δ 7.37-7.27 (m, 5H, o/m/p-Ph), 4.44 (m, 1H, β-H), 3.90 (m, 
1H, α-H). 3.19 (dd, 1H, J = 3.7, 14.9 Hz, PhCHa), 2.90 (dd, 1H, J = 10.7, 14.6 Hz, 
PhCHb). 
13C NMR (D2O, 75 MHz); δ 135.4 (i-Ph), 130.2, 130.1, 128.7 (p-Ph), 124.9 (q, J = 282.4 
Hz, CF ), 69.1 (q, J = 31.3 Hz, β-C), 53.6 (α3
19
2
+; C10 13 3H F NO requires 220.0949. 
 
Method 2:
A suspension of LiAlH4 (0.70 g, 18.4 mmol) in dry ether (25 mL
0 min under an inert atmosphere. A solution of the
g, 8.23 mmol, 3:2 mixture of diastereomers) in dry ether (25 mL) wa
th
 
ξ EtOH was distilled from Raney nickel to remove catalyst poisons prior to use. 
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stirring at rt for a further 16 h, the LiAlH4 was cautiously decomposed with a solution of 
turated aqueous Na2SO4 (10 mL). The resulting white precipitate was filtered off, 
 in a stirred solution of NaOH (8.4 g, 
10 mmol) in water (250 mL) at 0 °C. Distilled benzoyl chloride (11.6 mL, 100 mmol) 
was added dropwise to the solution. The reactio xture was stirred for a further 2 h then 
acidified with 6 M aqueous HCl. The ecipitate was filtered off, washed with 10 
% aqueous HCl, distilled water and  solid that retained significant 
mounts of water. The sample was recrystallised from hot water in batches to give 2.7 as 
sa
washed with ether and the washings combined with the filtrate. The aqueous layer was 
separated and back extracted with ether (25 mL). The combined ether layers were washed 
with brine then stirred with 10 % aqueous HCl for 10 min. The separated ether layer was 
further extracted with 10 % aqueous HCl (3 x 20 mL) and the combined aqueous acid 
extracts concentrated in vacuo to give a white solid. Recrystallisation from hot ethyl 
acetate/petroleum ether gave a single diastereomer identical to 2.6 isolated from the Raney 
nickel reduction (0.51 g, 24 %). The filtrate was concentrated in vacuo to afford a brown 
oil that solidified under high vacuum to give an off white solid (0.69 g, 33 %) as a mixture 
of diastereomers (1:2 by 19F NMR).  
 
7.2.2 Route 2: Trifluoromethyl carbinol synthesis via a modified Dakin-West 
reaction 24 
 
N-Benzoyl-L-phenylalanine (2.7) 
 
 
L-Phenylalanine (17.4 g, 105 mmol) was dissolved
N
H
OH
O
2.7
PhO
2
n mi
 resulting pr
 air-dried to give a white
a
fluffy white needles (24.5 g, 91 %). 
mp 141-142 °C 
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1H NMR (acetone-d6, 500 MHz); δ 7.95 (d, 3H, J = 7.3 Hz, o-Bz, NH), 7.62 (t, 1H, J = 7.4 
Hz, p-Bz), 7.54 (m, 2H, J = 7.5 Hz, m-Bz), 7.47 (d, 2H, J = 7.4 Hz, o-Ph), 7.39 (m, 2H, J = 
.31 (t, 1H, J = 7.3 Hz, p-Ph), 5.05 (m, 1H, α-H), 3.46 (dd, 1H, J = 4.8, 
Method 1: Cyclisation via EDCI 25 
 
N-Benzoyl-L-phenylalanine 2.7  (9.8 g, 50.0 mmol) were 
dissolved in dry dichloromethane (30 m °C under an inert atmosphere 
or 3 h. The reaction mixture was successively washed with ice water, saturated aqueous 
), 7.31 (t, 1H, J = 7.2 Hz, p-Ph), 5.01 (dd, 1H, J = 5.0, 6.9 Hz, α-H), 3.48 (dd, 
7.5 Hz, m-Ph), 7
13.9 Hz, PhCHa), 3.29 (dd, 1H, J = 9.3, 13.9 Hz, PhCHb). 
 
4-Benzyl-2-phenyl-4H-oxazol-5-one (2.8) 
 
 
N
O
Ph
OPh
2.8
 (13.5 g, 50.0 mmol) and EDCI
L) and stirred at 0 
f
NaHCO3 and brine, dried over MgSO4, filtered and concentrated in vacuo to give the 
oxazolone as a colourless oil. Rigorous drying on a high vacuum pump yielded a white 
solid (12.3 g, 98 %). Purified by flash chromatography (1:3 ethyl acetate/petroleum ether) 
where required. Recrystallisation from hot petroleum ether afforded 2.8 as fine white 
needles. 
1H NMR (acetone-d6, 500 MHz); δ 8.03 (d, 2H, J = 7.3 Hz, o-Ar), 7.74 (t, 1H, J = 7.5 Hz, 
p-Ar), 7.65 (t, 2H, J = 7.7 Hz, m-Ar), 7.42 (d, 2H, J = 7.2 Hz, o-Ph), 7.37 (t, 2H, J = 7.4 
Hz, m-Ph
1H, J = 5.0, 14.0 Hz, PhCHa), 3.30 (dd, 1H, J = 6.9, 14.1 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); δ 177.6, (CO), 161.2 (N=CO), 136.4, 132.8, 129.8, 129.1, 
128.3, 127.7, 127.1, 126.5, 66.4 (α-C), 37.0 (PhCH2). 
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Method 2: Cyclisation via DCC 
 
To a cooled (0 °C), stirred solution of N-benzoyl-L-phenylalanine 2.7 (17.5 g, 65.0 mmol) 
in dry THF (30 mL) under an inert atmosphere was added dropwise, a solution of 
dicyclohexylcarbodiimide (13.4 g, 65.0 mmol) in dry dichloromethane (100 mL). The 
reaction mixture was stirred a further 30 min then filtered to remove the precipitated 
dicyclohexylurea. The solution was concentrated in vacuo, redissolved in ethyl acetate and 
filtered to remove residual traces of the urea by-product. The ethyl acetate solution was 
successively washed with saturated aqueous NaHCO3, water and brine, dried over MgSO4, 
filtered and concentrated in vacuo to give the oxazolone as an oil which solidified upon 
cooling (11.2 g, 44.6 mmol, 69 %). Recrystallisation from hot petroleum ether afforded 2.8 
as fine white needles identical to the above product. 
 
N-(1S*-Benzyl-3,3,3-trifluoro-2-oxopropyl)benzamide (2.9) 
 
o a stirred solution of trifluoroacetic anhydride (8.0 mL, 57.0 mmol) was added, in small 
(>95 % by 19F NMR).  
Ph N
H
CF3
O Ph
O
2.9
 
T
portions, recrystallised oxazolone 2.8 (11.0 g, 43.8 mmol). The thick slurry was heated at 
40 °C for 3 days to give a yellow solution. Trifluoroacetic acid and excess trifluoroacetic 
anhydride was removed in vacuo at 80 °C before increasing the temperature to 120 °C. 
The resulting oil was treated, portionwise, with recrystallised anhydrous oxalic acid (5.9 g, 
65.8 mmol). Once the slurry had become too thick to stir, the mixture was diluted with 
ethyl acetate (50 mL) and the remaining oxalic acid added. The solution was heated until 
effervescence ceased, cooled to rt and further diluted with ethyl acetate (250 mL). The 
organics were washed with water (3 x 100 mL) and brine, dried over MgSO4 and 
concentrated in vacuo to give a pale yellow solid. Washing the solid with dry ether (3 x 50 
mL) afforded racemic 2.9 as a fluffy white solid (10.8 g, 77 %) comprising a mixture of 
ketone and hydrate (2:3 by 1H NMR). An analytical sample was obtained by 
recrystallisation from aqueous acetone to afford the hydrate as a white crystalline solid 
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1H NMR (acetone-d6, 500 MHz); From mixture δ 8.56 (br s, 1H, NH), 8.20* (d, 1H, J = 
6.9 Hz, NH), 7.94 (d, 2H, J = 7.5 Hz, o-Bz), 7.83* (d, 2H, J = 7.5 Hz, o-Bz), 7.69-7.28 (m, 
7.6, 126.6 (p-Ph), 124.3 (q, J = 289.2 Hz, CF3), 
-(1-Benzyl-3,3,3-trifluoro-2-hydroxypropyl)benzamide (2.10) 
 
 
To a cooled (0 °C), stirred suspen ixture 2.9 (4.45 g, 13.4 
mol) in EtOH (100 mL) was added NaBH4 (0.52 g, 13.7 mmol). The reaction mixture 
6, 500 MHz); Mixture (2:3) δ 7.92* (d, 2H, J = 7.3 Hz, o-Bz), 7.87 (d, 
NH, major), 7.80* (d, 1H, J = 7.9 Hz, NH), 7.66-7.27 (m, 
16H, m/p-Bz, o/m/p-Ph, ketone + hydrate), 5.30 (m, 1H, α-H), 4.43* (m, 1H, α-H), 3.50-
3.32 (m, 4H, PhCH2, ketone + hydrate).  
13C NMR (acetone-d6, 75 MHz); Hydrate (isolated) δ 170.2 (PhCO), 139.0 (i-Ph), 134.0 (i-
Bz), 132.0 (p-Bz), 129.5, 128.5 (x2), 12
94.8 (q, J = 29.9 Hz, β-C), 58.4 (α-C), 32.9 (PhCH2). 
19F NMR (acetone-d6); From Mixture (5:95) δ -74.9 (s, 3F), -80.7* (s, 3F). 
 
N
Ph N
H
CF3
O
OH
2.10
Ph
sion of the ketone/hydrate m
m
was stirred under an inert atmosphere for 12 h then quenched by the addition of 6 M 
aqueous HCl (30 mL). The EtOH was removed in vacuo and the residue taken up in ethyl 
acetate (50 mL). The ethyl acetate was successively washed with 10 % aqueous HCl, 
saturated aqueous NaHCO3 and brine, dried over MgSO4 and concentrated in vacuo to 
give 2.10 as a white solid (4.24 g, mmol, 98 %) comprising a mixture of diastereomers 
(2:3 by 1H NMR). 
[α]D = -0.40 (c = 1.0, MeOH) 
1H NMR (acetone-d
3H, J = 7.5 Hz, o-Bz, minor, 
16H, m/p-Bz, o/m/p-Ph, major + minor), 6.48* (d, 1H, J = 7.7 Hz, OH), 6.00 (d, 1H, J = 
6.7 Hz, OH), 4.73 (m, 2H, α-H, major + minor), 4.52 (m, 1H, β-H), 4.32* (m, 1H, β-H), 
3.36-3.21 (m, 4H, PhCH2, major + minor). 
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13C NMR (acetone-d6, 75 MHz); Mixture δ 167.5* (CO), 167.2 (CO), 138.7, 138.3*, 134.8, 
134.8*, 131.6*, 131.4, 129.5, 129.5*, 128.6, 128.5, 128.4 (x2), 127.4, 127.4*, 126.7*, 126.5, 
125.8 (q, J = 283.3 Hz, CF3), 125.5* (q, J = 282.2 Hz, CF3), 71.4 (q, J = 28.6 Hz, β-C), 
69.9* (q, J = 29.5 Hz, β-C), 52.0 (α-C), 51.6* (α-C), 37.1* (PhCH2), 34.9 (PhCH2). 
19F NMR (acetone-d6, 282 MHz) Mixture (57:43) δ -74.2 (d, J = 7.6 Hz), -75.6* (d, J = 7.5 
Hz).  
 
(2R*,3S*)-3-Amino-1,1,1-trifluoro-4-phenylbutan-2-ol hydrochloride (2.6) 
 
HCl.H2N
CF3
OH
Ph
2.6
 
Trifluoromethyl carbinol 2.10 (2.50 g, 7.73 mmol, 2:3 mixture of diastereomers) was 
suspended in a mixture of HCl/EtOH/H2O (2:1:1, 350 mL) and heated at reflux for 16 h. 
The solvents were removed in vacuo and the residue taken up in water (100 mL). 
Liberated benzoic acid was removed by extraction with dichloromethane (3 x 50 mL) and 
the aqueous layer concentrated in vacuo to give an off-white solid. Recrystallisation from 
hot ethyl acetate/petroleum ether afforded the hydrochloride salt as fine fluffy white 
needles (1.38 g, 70 %, 9:1 mixture of diastereomers). Further recrystallisation from ethyl 
acetate/petroleum ether afforded the major anti diastereomer which is identical to 2.6 by 
NMR. 
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7.3 Experimental work outlined in chapter three  
 
Synthesis of phenanthrenesulfonyl derivatives 
 
Potassium 2- and 3-phenanthrene sulfonates 26 
 
SO3K
SO3K
3.1 3.2
 
The sulfonates were prepared by direct sulfonation of recrystallised phenanthrene (25.0 g, 
140 mmol) with concentrated sulfuric acid (17 mL) following the procedure outlined by 
Fieser26 and isolated as the potassium salts. Recrystallisation of the crude sulfonates from 
hot water gave potassium phenanthrene-2-sulfonate (3.6 g, 9 %) as a very pale tan flakes 
and potassium phenanthrene-3-sulfonate (4.1 g, 10 %) as yellow flakes. 
2-Phen-SO3K; HRMS (ES) 257.0274 (M-K)-; C14H9O3S requires 257.0272. 
3-Phen-SO3K; HRMS (ES) 257.0269 (M-K)-; C14H9O3S requires 257.0272. 
 
7.3.1 Phenanthrene-2-sulfonyl derivatives 
 
Phenanthrene-2-sulfonyl chloride (3.3)  
 
SO2Cl
3.3
 
Potassium sulfonate 3.1 (2.96 g, 10.0 mmol) was treated with POCl3 (3.80 mL, 41.0 mmol) 
following General Method A to give the desired product as a dull yellow solid. The crude 
sulfonyl chloride was subjected to flash chromatography (dichloromethane) to afford 3.3 
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as a bright yellow powder (2.63 g, 95 %). An analytical sample was obtained by 
recrystallisation from aqueous acetone. 
1H NMR (CDCl3, 300 MHz); δ 8.83 (d, 1H, J = 8.9 Hz, ArH4), 8.68 (d, 1H, J = 9.5 Hz, 
ArH5), 8.57 (d, 1H, J = 2.1 Hz, ArH1), 8.17 (dd, 1H, J = 2.1, 8.9 Hz, ArH3), 7.95 (d, 1H, 
J = 9.3 Hz, ArH8), 7.90 (d, 1H, J = 8.9 Hz, ArH9), 7.81 (d, 1H, J = 8.9 Hz, ArH10), 7.75 
(m, 2H, ArH6, ArH7). 
13C NMR (CDCl3, 75 MHz); δ 141.5, 134.4, 133.3, 131.2, 129.7, 129.1, 129.0, 128.9, 
128.3, 127.7, 126.5, 124.6, 123.5, 122.7. 
HRMS (EI) 276.0016 (M+); C14H9ClO2S requires 276.0012. 
 
Phenanthrene-2-sulfonic acid (1S*,2R*)-(1-benzyl-3,3,3-trifluoro-2-hydroxypropyl) 
amide (3.4) 
 
O2S N
H
CF3
Ph
OH
3.4
 
Sulfonyl chloride 3.3 (100 mg, 0.36 mmol) and 2.6 (98 mg, 0.38 mmol) were coupled 
together in the presence of Hünigs base (0.15 mL, 0.86 mmol) following General Method 
C to give the desired product 3.4 as a pale yellow solid (165 mg, quantitative). 
Recrystallisation of the crude trifluoromethyl carbinol from aqueous EtOH gave a very 
pale yellow crystalline product as a single diastereomer. 
mp 176-177 °C. 
1H NMR (acetone-d6, 500 MHz); δ 8.96 (d, 1H, J = 8.0 Hz, ArH5), 8.80 (d, 1H, J = 8.8 
Hz, ArH4), 8.22 (s, 1H, ArH1), 8.18 (d, 1H, J = 7.6 Hz, ArH8), 8.07 (d, 1H, J = 8.9 Hz, 
ArH9), 7.95 (d, 1H, J = 8.9 Hz, ArH10), 7.89 (m, 2H, ArH6, ArH7), 7.74 (d, 1H, J = 8.8 
Hz, ArH3), 7.06 (m, 3H, NH, o-Ph), 6.84 (t, 2H, J = 7.5Hz, m-Ph), 6.76 (t, 1H, J = 7.3 Hz, 
p-Ph), 5.99 (d, 1H, J = 6.9 Hz, OH), 4.60 (m, 1H, β-H), 3.96 (m, 1H, α-H), 3.04 (dd, 1H, J 
= 2.7, 14.4 Hz, PhCHa), 2.93 (dd, 1H, J = 10.7, 14.4 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); δ 138.6, 137.4, 133.2, 132.5, 131.5, 129.8, 129.2, 129.0, 
128.4, 128.1 (x 2), 127.5 (x 2), 127.2, 126.1, 125.4 (q, J = 283.0 Hz, CF3), 124.2, 123.6, 
123.5, 73.0 (q, J = 28.6 Hz, β-C), 56.0 (α-C), 34.2 (PhCH2). 
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19F NMR (acetone-d6, 282 MHz); δ -74.2 (d, 3F, J = 8.0 Hz). 
HRMS (EI) 459.1128 (M+); C24H20F3NO3S requires 459.1116. 
 
Phenanthrene-2-sulfonic acid (1S*-benzyl-3,3,3-trifluoro-2-oxopropyl)amide (3.5) 
 
O2S N
H
CF3
Ph
O
3.5
 
Trifluoromethyl carbinol 3.4 (23 mg, 50 µmol) was oxidised with Dess-Martin periodinane 
(78 mg, 190 µmol) over 3 h following General Method F. The resulting brown oil was 
titurated with aqueous MeOH to give 3.5 as a white solid (13 mg, 56 %) comprising a 
racemic mixture of hydrate and ketone. One drop of D2O was added to the NMR sample to 
give the hydrate exclusively. 
1H NMR (acetone-d6, 500 MHz); Hydrate δ 8.93 (d, 1H, J = 8.1 Hz, ArH5), 8.74 (d, 1H, J 
= 8.8 Hz, ArH4), 8.16 (d, 1H, J = 7.5 Hz, ArH8), 8.11 (s, 1H, ArH1), 8.05 (d, 1H, J = 8.8 
Hz, ArH9), 7.91-7.83 (m, 3H, ArH6, ArH7, ArH10), 7.74 (dd, 1H, J = 2.0, 8.8 Hz, ArH3), 
7.01 (d, 2H, J = 7.3 Hz, o-Ph), 6.65 (t, 2H, J = 7.6 Hz, m-Ph), 6.45 (t, 1H, J = 7.4 Hz, p-
Ph), 4.05 (dd, 1H, J = 2.3, 10.8 Hz, α-H), 3.27 (dd, 1H, J = 2.5, 14.3 Hz, PhCHa), 2.75 
(dd, 1H, J = 11.0, 14.3 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); Hydrate δ 138.9, 137.6, 132.9, 132.3, 131.3, 129.5, 
129.0, 128.8, 128.1, 128.0, 127.7, 127.4, 127.1 (x 2), 125.6, 123.9 (q, J = 289.2 Hz, CF3), 
123.9, 123.4, 123.3, 93.5 (q, J = 30.0 Hz, β-C), 60.8 (α-C), 35.4 (PhCH2). 
19F NMR (acetone-d6, 282 MHz); Hydrate δ -79.0 (s, 3F). 
HRMS (ES) 458.1044 (MH)+; C24H19F3NO3S requires 458.1038. 
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3-Methyl-2S-(phenanthrene-2-sulfonylamino)butyric acid methyl ester (3.6) 
 
O2S N
H
OMe
O
3.6
 
Sulfonyl chloride 3.3 (150 mg, 0.54 mmol) and L-valine methyl ester hydrochloride (100 
mg, 0.60 mmol) were coupled together utilising Hünigs base (0.21 mL, 1.21 mmol) 
following General Method C to give the desired ester 3.6 as a yellow powder (201 mg, 
quantitative). An analytical sample of the ester was obtained by recrystallisation from 
aqueous MeOH resulting in pale yellow needles.  
mp 206-207 °C. 
1H NMR (CDCl3, 500 MHz); δ 8.79 (d, 1H, J = 8.8 Hz, ArH4), 8.71 (d, 1H, J = 7.8 Hz, 
ArH5), 8.40 (s, 1H, ArH1), 8.01 (dd, 1H, J = 2.0, 8.8 Hz, ArH3), 7.95 (d, 1H, J = 8.8 Hz, 
ArH8), 7.86 (d, 1H, J = 8.9 Hz, ArH9), 7.80 (d, 1H, J = 8.9 Hz, ArH10), 7.72 (m, 2H, 
ArH6, ArH7), 5.20 (d, 1H, J = 10.3 Hz, NH), 3.85 (m, 1H, α-H), 3.23 (s, 3H, OCH3), 2.04 
(m, 1H, ValCH), 0.93 (d, 3H, J = 6.8, Hz, ValCH3), 0.89 (d, 3H, J = 6.8 Hz, ValCH3). 
13C NMR (CDCl3, 75 MHz); δ 171.7 (CO), 137.0 (ArC2), 133.0, 132.9, 131.3, 129.4, 
128.8 (x 2), 128.4, 128.1, 127.3, 126.7, 123.9, 123.7, 123.3, 61.2 (α-C), 52.1 (OCH3), 31.7 
(ValCH), 19.0 (ValCH3), 17.5 (ValCH3). 
HRMS (EI) 371.1206 (M+); C20H21NO4S requires 371.1191. 
 
3-Methyl-2S-(phenanthrene-2-sulfonylamino)butyric acid (3.7) 
 
O2S N
H
OH
O
3.7
 
Methyl ester 3.6 (118 mg, 0.32 mmol) was treated with K2CO3 (69 mg, 0.50 mmol) in 
MeOH/H2O for 3 days following General Method H to give the free acid 3.7 as a white 
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solid. Recrystallisation of 3.7 from aqueous MeOH afforded a white powder (101 mg, 89 
%).ξ  
mp 195-196 °C 
1H NMR (CDCl3, 500 MHz); δ 8.72 (d, 1H, J = 8.8 Hz, ArH4), 8.63 (d, 1H, J = 7.9 Hz, 
1H, J = 1.9 Hz, ArH1), 8.01 (dd, 1H, J = 1.9, 8.8 Hz, ArH3), 7.88 (d, 1H, 
.3 (ValCH), 
S ,2R )-N-(1-Benzyl-3,3,3-trifluoro-2-hydroxypropyl)-3-methyl-2S-(phenanthrene-
2-sulfonylamino)butyramide (3.8) 
henanthrene 3.7 (100 mg, 0.28 mmol), 2.6 (75 mg, 0.29 mmol), EDCI (70 mg, 0.36 
mol), HOBt (57 mg, 0.42 mmol) and Hünigs base (0.11 mL, 0.63 mmol) were reacted 
), 9.04* (d, 1H, J = 
 9.0 Hz, ArH4, major + minor), 8.58* (s, 1H, ArH1), 8.54 
                                                
ArH5), 8.36 (d, 
J = 8.7 Hz, ArH8), 7.79 (d, 1H, J = 8.9 Hz, ArH9), 7.76 (d,1H, J = 8.9 Hz, ArH10), 7.69-
7.60 (m, 2H, ArH6, ArH7), 5.57 (d, 1H, J = 9.7 Hz, NH), 3.75 (m, 1H, α-H), 2.05 (m, 1H, 
ValCH), 0.96 (d, 3H, J = 6.7 Hz, ValCH3), 0.82 (d, 3H, J = 6.7 Hz, ValCH3). 
13C NMR (acetone-d6, 75 MHz); δ 171.8 (CO), 139.2 (ArC2), 133.2, 131.6, 129.9, 129.7, 
129.0, 128.7, 128.2, 128.1, 127.6, 127.1, 124.3, 124.1, 123.6, 61.4 (α-C), 31
18.9 (ValCH3), 17.3 (ValCH3). 
HRMS (ES) 358.1119 (MH+); C19H20NO4S requires 358.1113. 
 
* *(1
 
 
O2S N
H
H
N CF3
O Ph
OH
3.8
P
m
together following General Method D to give the dipeptide as a yellowish solid. Flash 
chromatography (1:9 ethyl acetate/dichloromethane) of the crude trifluoromethyl carbinol, 
followed by recrystallisation from aqueous MeOH afforded 3.8 as a white powder (112 
mg, 70 %) comprising a mixture of diastereomers (44:56 by 1H NMR). 
[α]D = +8.4 (c = 0.25, MeOH) 
1H NMR (acetone-d6); Mixture (44:56) δ 9.09 (d, 1H, J = 8.8 Hz, ArH5
8.8 Hz, ArH5), 8.99 (d, 2H, J =
 
ξ Contains traces of a plasticiser impurity from the ethyl acetate used during extraction. 
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(s, 1H, ArH1), 8.17-8.05 (m, 8H, ArH3, ArH8, ArH9, ArH10, major + minor), 7.87 (m, 
4H, ArH6, ArH7, major + minor), 7.54 (m, 2H, TFMC NH, major + minor), 7.34-7.04 (m, 
10H, o/m/p-Ph, major + minor), 6.72* (d, 1H, J = 8.4 Hz, ValNH), 6.52 (d, 1H, J = 9.1 Hz, 
ValNH), 5.83* (br s, 1H, OH), 5.51 (br s, 1H, OH), 4.42 (m, 1H, TFMC α-H), 4.32* (m, 
1H, TFMC α-H), 4.01* (m, 1H, TFMC β-H), 3.88 (m, 2H, Val α-H, major + minor), 3.75 
(m, 1H, TFMC β-H), 3.07 (m, 2H, PhCHa, major + minor), 2.86 (m, 2H, PhCHb, major + 
minor), 2.05* (m, 1H, ValCH), 1.84 (m, 1H, ValCH), 0.90* (d, 3H, J = 6.8 Hz, ValCH3), 
0.81 (m, 6H, ValCH3, major + minor), 0.52 (d, 3H, J = 6.8 Hz, ValCH3). 
13C NMR (acetone-d6, 75 MHz); Mixture δ 170.7* (CO), 170.2 (CO), 138.1, 137.5*, 133.2, 
133.2*, 132.8*, 132.7, 131.5, 129.7, 129.4, 129.3*, 129.0, 129.0*, 128.8*, 128.8, 128.4, 
 7.8 Hz).  
S-(phenanthrene-2-sulfonylamino)pentanoic acid methyl ester (3.9) 
 
 
Sulfonyl chloride 3.3 (159 mg, -leucine methyl ester hydrochloride (115 
g, 0.63 mmol) were coupled together utilising Hünigs base (0.22 mL, 1.26 mmol) 
128.3, 128.2 (x 2), 128.0, 127.6*, 127.5, 127.0*, 126.9, 126.5, 126.4*, 124.2, 124.1, 123.7*, 
123.7, 61.9*, 61.7, 51.1*, 50.6, 34.6*, 34.3, 31.7, 31.5*, 19.1, 19.0*, 16.4*, 16.2. The 
quartets for the β-C and CF3 carbons could not be accurately measured over the baseline 
noise. 
19F NMR (acetone-d6, 282 MHz); Mixture (35:65) δ -74.1* (d, 3F, J = 7.6 Hz), -74.6 (d, 
3F, J =
HRMS (EI) 558.1787 (M+); C29H29F3N2O4S requires 558.1800. 
 
4-Methyl-2
O2S N
H
OMe
O
3.9
 0.58 mmol) and L
m
following General Method C to give the ester 3.9 as a fluffy yellow solid (222 mg, 
quantitative). An analytical sample was obtained by recrystallisation from aqueous MeOH 
affording pale yellow fluffy needles.  
mp 187-189 °C. 
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1H NMR (CDCl3, 500 MHz); δ 8.79 (d, 1H, J = 8.8 Hz, ArH4), 8.71 (d, 1H, J = 8.1 Hz, 
72.6 (CO), 137.0 (ArC2), 133.0, 132.9, 131.3, 129.4, 
. 
4-Methyl-2S-(phenanthrene-2-sulfonylamino)pentanoic acid (3.10) 
 
ethyl ester 3.9 (136 mg, 0.35 mmol) was treated with K2CO3 (74 mg, 0.54 mmol) in 
°C. 
, 500 MHz); δ 8.73 (d, 1H, J = 8.8 Hz, ArH4), 8.68 (d, 1H, J = 7.9 Hz, 
                                                
ArH5), 8.41 (d, 1H, J = 1.9 Hz, ArH1), 8.02 (dd, 1H, J = 1.9, 8.8 Hz, ArH3), 7.95 (d, 1H, 
J = 7.4 Hz, ArH8), 7.87 (d, 1H, J = 8.9 Hz, ArH9), 7.81 (d, 1H, J = 8.9 Hz, ArH10), 7.72 
(m, 2H, ArH6, ArH7), 5.13 (d, 1H, J = 10.1 Hz, NH), 4.05 (m, 1H, α-H), 3.21 (s, 3H, 
OCH3), 1.81 (m, 1H, LeuCH), 1.50 (m, 2H, LeuCH2), 0.91 (d, 3H, J = 7.0 Hz, LeuCH3), 
0.89 (d, 3H, J = 6.8 Hz, LeuCH3). 
13C NMR (CDCl3, 75 MHz); δ 1
128.9 (x 2), 128.4, 128.1, 127.4, 126.7, 123.9, 123.7, 123.3, 54.5 (α-C), 52.2 (OCH3), 42.4 
(LeuCH), 24.3 (LeuCH2), 22.7 (LeuCH3), 21.4 (LeuCH3). 
HRMS (EI) 385.1358 (M+); C21H23NO4S requires 385.1348
 
 
O2S N
H
OH
O
3.10
M
MeOH/H2O for 3 days following General Method H to give the free acid 3.10 as a white 
solid. Recrystallisation of 3.10 from aqueous MeOH gave a white crystalline solid (117 
mg, 93 %).ξ
mp 157-162 
1H NMR (CDCl3
ArH5), 8.37 (s, 1H, ArH1), 7.95 (t, 2H, J = 8.3 Hz, ArH3, ArH8), 7.85 (d, 1H, J = 8.9 Hz, 
ArH9), 7.77 (d, 1H, J = 8.8 Hz, ArH10), 7.72 (m, 2H, ArH6, ArH7), 4.93 (d, 1H, J = 9.9 
Hz, NH), 3.94 (m, 1H, α-H), 1.73 (m, 1H, LeuCH), 1.31 (m, 2H, LeuCH2), 0.85 (d, 3H, J 
= 6.6, LeuCH3), 0.79 (d, 3H, J = 6.5, LeuCH3). 
 
ξ Contains traces of a plasticiser impurity from the ethyl acetate used during extraction. 
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13C NMR (acetone-d6, 75 MHz); δ 172.8 (CO), 139.3 (ArC2), 133.2, 132.7, 131.6, 129.7, 
129.0, 128.7, 128.2, 128.0, 127.6, 127.2, 124.3, 124.2, 123.7, 54.6 (α-C), 42.0 (LeuCH), 
24.4 (LeuCH2), 22.4 (LeuCH3), 20.9 (LeuCH3). 
HRMS (ES) 372.1268 (MH+); C20H22NO4S requires 372.1270. 
 
4-Methyl-2S-(phenanthrene-2-sulfonylamino)pentanoic acid (1S*,2R*)-(1-benzyl-
3,3,3-trifluoro-2-hydroxypropyl)amide (3.11) 
 
O2S N
H
H
N CF3
O Ph
OH
3.11
 
Phenanthrene 3.10 (100 mg, 0.27 mmol), 2.6 (72 mg, 0.28 mmol), EDCI (67 mg, 0.35 
mmol), HOBt (55 mg, 0.41 mmol) and Hünigs base (0.10 mL, 0.57 mmol) were reacted 
together following General Method D to give the dipeptide as a yellowish solid. Flash 
chromatography (1:9 ethyl acetate/dichloromethane) of the crude trifluoromethyl carbinol, 
followed by recrystallisation from aqueous MeOH afforded 3.11 as a white powder (127 
mg, 80 %) comprising a mixture of diastereomers (45:55 by 1H NMR). 
[α]D = -29.8 (c = 0.51, MeOH) 
1H NMR (acetone-d6); Mixture (45:55) δ 9.10 (d, 1H, J = 8.8 Hz, ArH5), 9.07* (d, 1H, J = 
8.8 Hz, ArH5), 8.99 (d, 2H, J = 8.0 Hz, ArH5, major + minor), 8.59* (s, 1H, ArH1), 8.56 
(s, 1H, ArH1), 8.16-8.07 (m, 8H, ArH3, ArH8, ArH9, ArH10, major + minor), 7.91-7.84 
(m, 4H, ArH6, ArH7, major + minor), 7.61 (m, 2H, TFMC NH, major + minor), 7.37-7.16 
(m, 10H, o/m/p-Ph, major + minor), 6.95* (d, 1H, J = 8.0 Hz, LeuNH), 6.81 (d, 1H, J = 8.7 
Hz, LeuNH), 5.86* (br s, 1H, OH), 5.65 (br s, 1H, OH), 4.40 (m, 1H, TFMC α-H), 4.30* 
(m, 1H, TFMC α-H), 4.04* (m, 1H, TFMC β-H), 3.98 (m, 2H, Leu α-H, major + minor), 
3.90 (m, 1H, TFMC β-H), 3.10-2.90 (m, 4H, PhCHa + PhCHb, major + minor), 1.68* (m, 
1H, LeuCH), 1.52 (m, 1H, LeuCH), 1.39* (m, 2H, LeuCH2), 1.17 (m, 2H, LeuCH2), 0.83 
(d, 3H, J = 6.7 Hz, LeuCH3), 0.78 (d, 3H, J = 6.7 Hz, LeuCH3), 0.69 (d, 3H, J = 6.5 Hz, 
LeuCH3), 0.67 (d, 3H, J = 6.5 Hz, LeuCH3). 
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13C NMR (acetone-d6, 75 MHz); Mixture (45:55) δ 171.9* (CO), 171.4 (CO), 139.3, 
138.8*, 138.1, 137.8*, 133.2, 133.2*, 132.8*, 132.7, 131.5, 131.5*, 129.7, 129.6 (x 2), 
129.5, 129.0, 129.0*, 128.9*, 128.8, 128.4, 128.4*, 128.2 (x 3), 128.0, 127.6*, 127.5, 
127.0*, 126.9, 126.5, 126.5*, 124.3, 124.1 (x 3), 123.7*, 123.6, 71.5 (q, J = 29.0 Hz, β-C), 
70.9* (q, J = 28.9 Hz, β-C), 55.6*, 55.4, 51.2*, 50.5, 42.2, 42.2*, 34.6*, 34.3, 24.1, 24.1*, 
22.6, 22.6*, 20.9, 20.8*. The two CF3 quartets could not be accurately determined as the 
signals were buried amongst the aromatic carbon peaks. 
19F NMR (acetone-d6, 282 MHz); Mixture (46:54) δ -74.2* (d, 3F, J = 7.4 Hz), -74.5 (d, 
3F, J = 7.7 Hz).  
HRMS (EI) 572.1957 (M+); C30H31F3N2O4S requires 572.1967. 
 
7.3.2 Phenanthrene-3-sulphonyl derivatives 
 
Phenanthrene-3-sulfonyl chloride (3.12)  
 
SO2Cl
3.12
 
Potassium sulfonate 3.2 (2.96 g, 10.0 mmol) was treated with POCl3 (3.80 mL, 41.0 mmol) 
following General Method A to give the desired product as a dull yellow solid. The crude 
sulfonyl chloride was subjected to flash chromatography (1:4 ethyl acetate/ petroleum 
ether) to afford 3.12 as a pale yellow powder (2.71 g, 98 %). An analytical sample was 
obtained by recrystallisation from aqueous acetone. 
mp 110-111 °C 
1H NMR (CDCl3, 500 MHz); δ 9.27 (d, 1H, J = 1.4 Hz, ArH4), 8.64 (d, 1H, J = 8.1 Hz, 
ArH5), 8.11 (dd, 1H, J = 1.8, 8.5 Hz, ArH2), 8.02 (d, 1H, J = 8.5 Hz, ArH3), 7.92 (d, 1H, 
J = 8.6 Hz, ArH8), 7.95 (d, 1H, J = 8.8 Hz, ArH9), 7.77 (d, 1H, J = 8.8 Hz, ArH10), 7.70 
(m, 2H, ArH6, ArH7). 
13C NMR (CDCl3, 75 MHz); δ 141.4, 135.6, 132.2, 131.7, 130.2, 129.8, 129.7, 128.9, 
128.1, 128.0, 125.6, 122.9, 122.7 (x 2). 
Chapter Seven: Experimental 199
HRMS (EI) 276.0008 (M+); C14H9ClO2S requires 276.0012.  
 
Phenanthrene-3-sulfonic acid (1S*,2R*)-(1-benzyl-3,3,3-trifluoro-2-hydroxypropyl) 
amide (3.13) 
 
H
N CF3
Ph
OH
S
O2
3.13
 
Sulfonyl chloride 3.12 (101 mg, 0.37 mmol) and 2.6 (98 mg, 0.38 mmol) were coupled 
together utilising Hünigs base (0.15 mL, 0.86 mmol) following General Method C to give 
the desired product as a pale yellow solid. Recrystallisation of the crude trifluoromethyl 
carbinol from aqueous EtOH gave 3.13 as a very pale yellow powder (165 mg, 
quantitative, single diastereomer). 
mp 167-169 °C. 
1H NMR (acetone-d6, 500 MHz); δ 9.01 (s, 1H, ArH4), 8.80 (d, 1H, J = 8.2 Hz, ArH5), 
8.18 (d, 1H, J = 7.8 Hz, ArH8), 8.13 (d, 1 H, J = 8.8 Hz, ArH9), 8.00 (d, 2H, J = 8.8 Hz, 
ArH1, ArH10), 7.89 (m, 2H, ArH6, ArH7), 7.74 (dd, 1H, J = 1.2, 8.3 Hz, ArH2), 7.06 (d, 
1H, J = 8.0 Hz, NH), 7.02 (d, 2H, J = 7.5 Hz, o-Ph), 6.73 (t, 3H, J = 7.6 Hz, m-Ph), 6.59 (t, 
1H, J = 7.4 Hz, p-Ph), 5.99 (br s, 1H, OH), 4.57 (m, 1H, β-H), 3.99 (m, 1H, α-H), 3.02 (m, 
1H, PhCHa), 2.90 (m, 1H, PhCHb). 
13C NMR (acetone-d6, 75 MHz); δ 138.7, 137.3, 134.2, 132.6, 130.4, 129.9, 129.7 (x 2), 
129.0, 128.0, 127.7, 127.6 (x 2), 126.4, 126.0, 125.4 (q, J = 282.8 Hz, CF3), 123.6, 123.1, 
122.0, 72.9 (q, J = 28.7 Hz, β-C), 56.0 (α-C), 34.3 (PhCH2). 
19 F NMR (acetone-d6, 282 MHz); δ -74.2 (d, 3F, J = 7.8 Hz). 
HRMS (EI) 459.1113 (M+); C24H20F3NO3S requires 459.1116. 
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Phenanthrene-3-sulfonic acid (1S*-benzyl-3,3,3-trifluoro-2-oxopropyl)amide (3.14) 
 
H
N CF3
Ph
O
S
O2
3.14
 
Phenanthrene 3.13 (23 mg, 50 µmol) was oxidised with Dess-Martin periodinane (78 mg, 
190 µmol) following General Method F. The crude ketone was recrystallised from aqueous 
MeOH to give 3.14 as pale brown needles (11 mg, 48 %) comprising a racemic mixture of 
hydrate and ketone (9:1 by 1H NMR). One drop of D2O was added to the NMR sample to 
give the hydrate exclusively. 
1H NMR (acetone-d6, 500 MHz); Hydrate δ 8.87 (s, 1H, ArH4), 8.75 (d, 1H, J = 8.2 Hz, 
ArH5), 8.14 (d, 1H, J = 7.8 Hz, ArH8), 8.09 (d, J = 8.8 Hz, ArH9), 7.95 (m, 2H, ArH1, 
ArH10), 7.85 (m, 2H, ArH6, ArH7), 7.75 (dd, 1H, J = 1.7, 8.3 Hz, ArH2), 6.97 (d, 2H, J = 
7.3 Hz, o-Ph), 6.51 (t, 2H, J = 7.7 Hz, m-Ph), 6.26 (t, 1H, J = 7.4 Hz, p-Ph), 4.10 (dd, 1H, J 
= 2.3, 10.8 Hz, α-H), 3.26 (dd, 1H, J = 2.6, 14.4 Hz, PhCHa), 2.72 (dd, 1H, J = 10.9, 14.4 
Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); Hydrate δ 138.9, 137.6, 134.2, 132.5, 130.4, 129.9 (x 2), 
129.7, 129.5, 128.9, 127.7, 127.6, 127.5, 126.4, 125.6, 124.1 (q, J = 289.2 Hz, CF3), 123.6, 
123.2, 121.9, 61.1 (α-C), 35.6 (PhCH2). The quartet due to the β-C could not be measured 
over the baseline noise. 
19F NMR (acetone-d6, 282 MHz); Hydrate δ -78.8 (s, 3F). 
HRMS (ES) 458.1031 (MH+); C24H19F3NO3S requires 458.1038. 
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3-Methyl-2S-(phenanthrene-3-sulfonylamino)butyric acid methyl ester (3.15) 
 
S
O2
H
N OMe
O
3.15
 
Sulfonyl chloride 3.12 (150 mg, 0.54 mmol) and L-valine methyl ester hydrochloride (107 
mg, 0.64 mmol) were coupled together utilising Hünigs base (0.22 mL, 1.26 mmol) 
following General Method C to give the desired ester 3.15 as a white solid. 
Recrystallisation of the ester from aqueous MeOH afforded a white crystalline solid (175 
mg, 88 %).  
[α]D = -50.7 (c = 0.68, MeOH) 
mp 131-132 °C. 
1H NMR (CDCl3, 500 MHz); δ 9.16 (s, 1H, ArH4), 8.74 (d, 1H, J = 8.3 Hz, ArH5), 7.98 
(m, 2H, ArH1, ArH2), 7.94 (d, 1H, J = 7.8 Hz, ArH8), 7.86 (d, 1H, J = 8.8 Hz, ArH9), 
7.73 (d, 1H, J = 8.8 Hz, ArH10), 7.72 (m, 2H, ArH6, ArH7), 5.26 (d, 1H, J = 10.2 Hz, 
NH), 3.87 (m, 1H, α-H), 3.18 (s, 3H, OCH3), 2.04 (m, 1H, ValCH), 0.97 (d, 3H, J = 6.8 
Hz, ValCH3), 0.90 (d, 3H, J = 6.8 Hz, ValCH3). 
13C NMR (CDCl3, 75 MHz); δ 171.7 (CO), 137.0 (ArC3), 134.2, 132.1, 130.1, 129.9, 
129.7, 129.5, 128.7, 127.6, 127.5, 125.9, 123.7, 122.8 (x 2), 61.2 (α-C), 52.0 (OCH3), 31.6 
(ValCH), 18.9 (ValCH3), 17.5 (ValCH3). 
HRMS (EI) 371.1200 (M+); C20H21NO4S requires 371.1191. 
 
3-Methyl-2S-(phenanthrene-3-sulfonylamino)butyric acid (3.16) 
 
S
O2
H
N OH
O
3.16
 
The methyl ester 3.15 (171 mg, 0.46 mmol) was treated with K2CO3 (115 mg, 0.83 mmol) 
in MeOH/H2O for 2 days following General Method H to give free acid 3.16 as a pale 
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yellow solid. Recrystallisation of 3.16 from aqueous EtOH gave a white powder (160 mg, 
97 %).  
mp 91-92 °C. 
1H NMR (CDCl3, 500 MHz); δ 9.08 (s, 1H, ArH4), 8.65 (d, 1H, J = 8.2 Hz, ArH5), 7.92-
7.86 (m, 2H, ArH1, ArH2), 7.82 (d, 1H, J = 7.9 Hz, ArH8), 7.77 (d, 1H, J = 8.8 Hz, 
ArH9), 7.64 (m, 2H, ArH10, ArH6), 7.56 (t, 1H, ArH7), 5.95 (d, 1H, J = 9.6 Hz, NH), 
3.69 (m, 1H, α-H), 2.00 (m, 1H, ValCH), 0.90 (d, 3H, J = 6.7 Hz, ValCH3), 0.78 (d, 3H, J 
= 6.7 Hz, ValCH3). 
13C NMR (CDCl3, 75 MHz); δ 172.6 (CO), 137.5, 133.8, 131.8, 129.9, 129.5, 129.4, 
129.1, 128.4, 127.3, 127.3, 125.8, 123.9, 122.8, 122.4, 60.8 (α-C), 31.0 (ValCH), 18.9 
(ValCH3), 17.0 (ValCH3). 
HRMS (ES) 358.1109 (MH+); C19H20NO4S requires 358.1113. 
 
(1S*,2R*)-N-(1-Benzyl-3,3,3-trifluoro-2-hydroxypropyl)-3-methyl-2S-(phenanthrene-
3-sulfonylamino)butyramide (3.17) 
 
S
O2
H
N N
H
CF3
OH
PhO
3.17
 
Phenanthrene 3.16 (100 mg, 0.28 mmol), 2.6 (75 mg, 0.29 mmol), EDCI (70 mg, 0.36 
mmol), HOBt (57 mg, 0.42 mmol) and Hünigs base (0.11 mL, 0.63 mmol) were reacted 
together following General Method D to give the dipeptide as a yellowish solid. Flash 
chromatography (1:9 ethyl acetate/dichloromethane) of the crude trifluoromethyl carbinol, 
followed by recrystallisation from aqueous MeOH afforded 3.17 as a white clumping solid 
(113 mg, 70 %) comprising a mixture of diastereomers (1:1 by 1H NMR). 
[α]D = +73.3 (c = 0.54, MeOH) 
1H NMR (acetone-d6, 500 MHz); Mixture (1:1) δ 9.39 (s, 1H, ArH4), 9.37 (s, 1H, ArH4), 
8.99 (d, 1H, J = 9.2 Hz, ArH5), 8.97 (d, 1H, J = 9.3 Hz, ArH5), 8.25-7.83 (m, 14H, 2 x 
(ArH1, ArH2, ArH6, ArH7, ArH8, ArH9, ArH10)), 7.52 (m, 2H, 2 x TFMC NH), 7.34-
7.26 (m, 5H, Ph), 7.07 (m, 3H, Ph), 6.95 (d, 2H, J = 7.8 Hz, Ph), 6.82 (d, 1H, J = 8.5 Hz, 
ValNH), 6.66 (d, 1H, J = 9.1 Hz, ValNH), 5.82 (br s, 1H, OH), 5.41 (br s, 1H, OH), 4.42 
Chapter Seven: Experimental 203
(m, 1H, TFMC α-H), 4.34 (m, 1H, TFMC α-H), 4.00 (m, 1H, TFMC β-H), 3.93 (dd, 1H, J 
= 4.6, 8.5 Hz, Val α-H), 3.88 (dd, 1H, J = 4.6, 9.1 Hz, Val α-H), 3.69 (m, 1H, TFMC β-
H), 3.07 (br m, 6H, 2 x PhCHa, 2 x H2O), 2.80 (m, 2H, 2 x PhCHb), 2.06 (m, 1H, ValCH), 
1.84 (m, 1H, ValCH), 0.93 (d, 3H, J = 6.8 Hz, ValCH3), 0.85 (d, 3H, J = 6.8 Hz, ValCH3), 
0.82 (d, 3H, J = 6.8 Hz, ValCH3), 0.54 (d, 3H, J = 6.8 Hz, ValCH3). 
13C NMR (acetone-d6, 75 MHz); δ 170.8, 170.3, 139.2, 139.0, 138.1, 137.3, 134.4, 134.3, 
132.7, 132.6, 130.4, 130.3, 130.0, 129.9, 129.8 (x 2), 129.7, 129.5, 129.4, 129.3, 129.1 (x 
2), 128.4, 128.2, 127.9, 127.8, 127.7 (x 2), 126.5, 126.4 (x 2), 126.3, 124.2 (x 2), 123.2 (x 
2), 122.6 (x 2), 71.6 (q, J = 29.1 Hz, β-C), 70.5 (q, J = 28.9 Hz, β-C), 61.8, 61.7, 50.9, 
50.5, 34.5, 34.2, 31.7, 31.6, 19.1 (x 2), 16.4, 16.2. The peaks for the two CF3 quartets 
could not be identified as they were obscured by other aromatic carbon signals. 
19F NMR (acetone-d6, 282 MHz); Mixture (47:53) δ -74.1 (d, 3F, J = 7.5 Hz), -74.7 (d, 3F, 
J = 7.7 Hz). 
HRMS (EI) 558.1781 (M+); C29H29F3N2O4S requires 558.1800. 
 
4-Methyl-2S-(phenanthrene-3-sulfonylamino)pentanoic acid methyl ester (3.18) 
 
S
O2
H
N OMe
O
3.18
 
Sulfonyl chloride 3.12 (153 mg, 0.55 mmol) and L-leucine methyl ester hydrochloride 
(115 mg, 0.63 mmol) were coupled together utilising Hünigs base (0.22 mL, 1.26 mmol) 
following General Method C to give the desired product as a white solid. Recrystallisation 
of the ester from aqueous MeOH afforded 3.18 as a fluffy white solid (212 mg, 
quantitative). 
[α]D = -66.8 (c = 0.85, MeOH) 
mp 91-92 °C. 
1H NMR (CDCl3, 500 MHz); δ 9.17 (s, 1H, ArH4), 8.74 (d, 1H, J = 8.3 Hz, ArH5), 7.98 
(m, 2H, ArH1, ArH2), 7.94 (d, 1H, J = 7.8 Hz, ArH8), 7.90 (d, 1H, J = 8.8 Hz, ArH9), 
7.77 (d, 1H, J = 8.8 Hz, ArH10), 7.75 (m, 1H, ArH6), 7.69, (t, 1H, J = 7.4 Hz, ArH7), 
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5.18 (d, 1H, J = 9.8 Hz, NH), 4.08 (m, 1H, α-H), 3.16 (s, 3H, OCH3), 1.82 (m, 1H, 
LeuCH), 1.54 (m, 2H, LeuCH2), 0.90 (t, 6H, J = 6.3 Hz, LeuCH3). 
13C NMR (CDCl3, 75 MHz); δ 172.6 (CO), 137.0, 134.3, 132.2, 130.1, 130.0, 129.7, 
129.6, 128.8, 127.6, 127.5, 125.9, 123.7, 122.9, 122.8, 54.5 (α-C), 52.1 (OCH3), 42.3 
(LeuCH), 24.3 (LeuCH2), 22.7 (LeuCH3), 21.4 (LeuCH3). 
HRMS (EI) 385.1349 (M+); C21H23NO4S requires 385.1348. 
 
4-Methyl-2S-(phenanthrene-3-sulfonylamino)pentanoic acid (3.19) 
 
S
O2
H
N OH
O
3.19
 
The methyl ester 3.18 (207 mg, 0.54 mmol) was treated with K2CO3 (153 mg, 1.11 mmol) 
in MeOH/H2O for 24 h following General Method H to afford a white solid containing 
minor traces of the ester. Recrystallisation of the free acid from aqueous MeOH gave pure 
acid 3.19 as a white crystalline solid (179 mg, 90 %).  
1H NMR (CDCl3, 500 MHz); δ 9.13 (s, 1H, ArH4), 8.69 (d, 1H J = 7.8 Hz, ArH5), 7.98-
7.90 (m, 2H, ArH2, ArH8), 7.85 (d, 1H, J = 7.9 Hz, ArH1), 7.80 (d, 1H, J = 8.9 Hz, 
ArH9), 7.69 (d, 1H, J = 8.9 Hz, ArH10), 7.67 (m, 1H, ArH6), 7.60 (m, 1H, ArH7), 5.90 
(d, 1H, J = 9.9 Hz, NH), 3.93 (m, 1H, α-H), 1.81 (m, 1H, LeuCH), 1.48 (m, 2H, LeuCH2), 
0.83 (dd, 6H, J = 6.6, 10.4 Hz, 2 x LeuCH3). 
13C NMR (CDCl3, 75 MHz); δ 173.9 (CO), 137.5, 134.0, 131.9, 130.0, 129.6, 129.5, 
129.3, 128.5, 127.4, 127.4, 125.9, 123.9, 122.9, 122.5, 54.3 (α-C), 42.1 (LeuCH), 24.1 
(LeuCH2), 22.7 (LeuCH3), 21.2 (LeuCH3). 
HRMS (ES) 372.1271 (MH+); C20H22NO4S requires 372.1270. 
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4-Methyl-2S-(phenanthrene-3-sulfonylamino)pentanoic acid (1S*,2R*)-(1-benzyl-
3,3,3-trifluoro-2-hydroxypropyl)amide (3.20) 
 
S
O2
H
N N
H
CF3
OH
PhO
3.20
 
Phenanthrene 3.19 (60 mg, 0.16 mmol), 2.6 (43 mg, 0.17 mmol), EDCI (40 mg, 0.21 
mmol), HOBt (33 mg, 0.24 mmol) and Hünigs base (60 µL, 0.34 mmol) were reacted 
together following General Method D to give the dipeptide as a yellowish solid. Flash 
chromatography (1:9 ethyl acetate/dichloromethane) of the crude trifluoromethyl carbinol, 
followed by recrystallisation from aqueous EtOH afforded 3.20 as fine white needles (74 
mg, 78 %) comprising a mixture of diastereomers (1:1 by 1H NMR). 
[α]D = +33.2 (c = 0.43, MeOH) 
1H NMR (acetone-d6, 500 MHz); Mixture (1:1) δ 9.40 (s, 1H, ArH4), 9.39 (s, 1H, ArH4), 
8.98 (d, 1H, J = 8.1 Hz, ArH5), 8.97 (d, 1H, J = 8.1 Hz, ArH5), 8.27-8.02 (m, 10H, 2 x 
(ArH1, ArH2, ArH8, ArH9, ArH10)), 7.89 (m, 4H, 2 x (ArH6, ArH7)), 7.62 (d, 1H, J = 
8.4 Hz, TFMC NH), 7.58 (d, 1H, J = 8.8 Hz, TFMC NH), 7.31 (m, 5H, Ph), 7.21 (m, 3H, 
Ph), 7.11 (d, 2H, J = 7.5 Hz, Ph), 7.01 (d, 1H, J = 8.1 Hz, LeuNH), 6.89 (d, 1H, J = 8.7 Hz, 
LeuNH), 4.40 (m, 1H, TFMC α-H), 4.30 (m, 1H, TFMC α-H), 4.00 (m, 3H, 2 x Leu α-H, 
TFMC β-H), 3.84 (m, 1H, TFMC β-H), 3.07 (dd, 2H, J = 3.5, 14.3 Hz, 2 x PhCHa), 2.90 
(m, 4H, 2 x PhCHb, H2O), 1.71 (m, 1H, LeuCH), 1.52 (m, 1H, LeuCH), 1.41 (m, 2H, 
LeuCH2), 1.17 (m, 2H, LeuCH2), 0.83 (d, 3H, J = 6.7 Hz, LeuCH3), 0.77 (d, 3H, J = 6.6 
Hz, LeuCH3), 0.68 (dd, 6H, J = 3.7, 6.5 Hz, LeuCH3). 
13C NMR (acetone-d6, 75 MHz); Mixture (1:1) δ 171.9 (CO), 171.5 (CO), 139.4, 139.0, 
138.2, 137.7, 134.4, 134.3, 132.7 (x 2), 130.3 (x 2), 130.0, 129.9, 129.8 (x 2), 129.6 (x 2), 
129.5, 129.1 (x 2), 128.4, 128.3, 127.9 (x 2), 127.8 (x 2), 126.5, 126 (x 2), 126.3, 124.2 (x 
2), 123.2, 123.1, 122.6, 71.5 (q, J = 29.2 Hz, β-C), 70.8 (q, J = 29.0 Hz, β-C), 55.6, 55.4, 
51.1, 50.5, 42.3 (x 2), 34.5, 34.2, 24.1 (x 2), 22.6 (x 2), 21.0, 20.8. 
19F NMR (acetone-d6, 282 MHz); Mixture (1:1) δ -74.2 (d, 3F, J = 7.5 Hz), -74.6 (d, 3F, J 
= 7.8 Hz). 
HRMS (EI) 572.1963 (M+); C30H31F3N2O4S requires 572.1957. 
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7.4 Experimental work outlined in chapter four 
 
Synthesis of E-azobenzene derivatives  
.4.1 E-Azobenzene-3-carbonyl derivatives 6 
thyl-3-aminobenzoate (4.1) 
 
3-Aminobenzoic acid (10.3 g, 75.0 mmol) was added to a stirred solution of dry EtOH 
turated with gaseous HCl (100 mL) and heated at reflux for 36 h. Water (100 mL) was 
3
H5), 6.83 (d, 1H, J = 7.8 Hz, ArH6), 4.34 (q, 2H, J = 7.1 Hz, 
C
 
 
7
 
E
 
H N OEt2
O
4.1
sa
added to the cooled solution and treated with solid K2CO3 until basic to litmus. The 
reaction mixture was further cooled by the addition of ice, which induced the ester to 
separate out as an oil. The oil was taken up in dichloromethane and the aqueous layer 
extracted with dichloromethane (4 x 25 mL). The combined organic extracts were washed 
with brine, dried over MgSO4 and concentrated in vacuo to give 4.1 as a brown oil (10.3 g, 
83 %). 
1H NMR (CDCl , 500 MHz); δ 7.42 (d, 1H, J = 7.8 Hz, ArH4), 7.35 (s, 1H, ArH2), 7.19 
(t, 1H, J = 7.8 Hz, Ar
H3CH2), 3.84 (b, 2H, NH2), 1.36 (t, 3H, J = 7.2 Hz, CH3CH2). 
13C NMR (CDCl3, 75 MHz); 166.7 (CO), 146.5 (ArC1), 131.2 (ArC3), 129.0 (ArC5), 
119.4, 119.1, 115.5 (ArC2), 60.7 (CH2), 14.2 (CH3). 
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E-3-Phenylazobenzoic acid ethyl ester (4.2) 
 
N OEt
O
N
4.2
 
Nitrosobenzene (5.00 g, 46.7 mmol) and ethyl-3-aminobenzoate 4.1 (7.71 g, 46.7 mmol) in 
glacial acetic acid (187 mL) were condensed following General Method K to give an 
almost black oil. Flash chromatography of the crude azobenzene on alumina (1:1 
dichloromethane/petroleum ether) removed most of the black impurities affording an 
orange oil. Further purification by flash chromatography on silica (1:9 ethyl 
acetate/petroleum ether) gave 4.2 as an orange/red oil (8.80 g, 74 %). 
1H NMR (CDCl3, 500 MHz); δ 8.57 (s, 1H), 8.15 (d, 1H, J = 7.7 Hz), 8.08 (d, 1H, J = 7.9 
Hz), 7.94 (d, 2H, J = 7.1 Hz), 7.57 (t, 1H, J = 7.8 Hz), 7.51 (m, 3H), 4.42 (q, 2H, J = 7.1 
Hz, CH3CH2), 1.42 (t, 3H, J = 7.1 Hz, CH3CH2). 
13C NMR (CDCl3, 75 MHz); δ 165.9 (CO2Et), 152.5, 152.4, 131.6 (ArC4’), 131.3 (ArC4), 
129.1 (x 2), 126.5, 124.2, 123.0, 61.2 (CH3CH2), 14.3 (CH3CH2). 
 
E-3-Phenylazobenzoic acid (4.3) 
 
N OH
O
N
4.3
 
The ester 4.2 (7.63 g, 30.0 mmol) and KOH (3.37 g, 60.0 mmol) were suspended in a 
solution of EtOH/H2O (4:1, 300mL) and heated at reflux for 12 h. The reaction mixture 
was cooled to rt and the solvent removed in vacuo. The orange residue was suspended in 
water and acidified with 10 % aqueous H2SO4. The precipitated free acid was taken up in 
ethyl acetate, washed with distilled water and brine, dried over MgSO4, filtered and 
concentrated in vacuo. The resulting solid was resuspended in water, vigorously stirred for 
1 h, filtered, washed with water, and air-dried to give 4.3 as a fluffy orange solid (5.60 g, 
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83 %). An analytical sample was obtained by recrystallisation from aqueous EtOH to give 
fine orange needles. 
mp 169-170 °C 
1H NMR (acetone-d6, 500 MHz); δ 8.67 (s, 1H, ArH2), 8.32 (dd, 2H, J = 7.6, 13.9 Hz, 
ArH4, ArH6), 8.11 (dd, 2H, J = 1.5, 8.1 Hz, ArH2’), 7.87 (t, 1H, J = 7.8 Hz, ArH5), 7.76-
7.70 (m, 3H, ArH3’, ArH4’). 
13C NMR (acetone-d6, 75 MHz); δ 166.4, 152.7, 152.6, 141.4, 132.1, 131.9, 129.9, 129.5, 
127.2, 123.6, 123.1. 
 
E-[2R-Hydroxy-4-phenyl-3S-(3-phenylazobenzoylamino)butyric acid methyl ester] 
(4.4) 
 
N
H
N
O
N
Ph
OH
OMe
O
4.4
 
3-Phenylazobenzoic acid 4.3 (77 mg, 0.34 mmol) and 3S-amino-2R-hydroxy-4-
phenylbutyric acid methyl esterξ (102 mg, 0.35 mmol) were coupled together utilising 
BOP (155 mg, 0.35 mmol) and Hünigs base (122 µL, 0.70 mmol) in dry dichloromethane 
(5 mL) following General Method E. The crude α-hydroxy ester was subjected to flash 
chromatography (1:4 ethyl acetate/dichloromethane) followed by recrystallisation from 
aqueous acetone to afford 4.4 as fine orange needles (93 mg, 66 %). 
[α]D = -113.0 (c = 0.39, MeOH) 
mp 141-142 °C 
1H NMR (CDCl3, 500 MHz); δ 8.18 (s, 1H, ArH2), 8.03 (d, 1H, J = 7.8 Hz, ArH6), 7.94 
(d, 2H, J = 6.8 Hz, ArH2’), 7.82 (d, 1H, J = 7.8 Hz, ArH4), 7.58-7.50 (m, 4H, ArH3’, 
ArH4’, ArH5), 7.37-7.32 (m, 4H, o/m-Ph), 7.25 (t, 1H, J = 6.9 Hz, p-Ph), 6.58 (d, 1H, J = 
9.2 Hz, NH), 4.84 (m, 1H, α-H), 4.23 (m, 1H, β-H), 3.76 (s, 3H, OCH3), 3.44 (d, 1H, J = 
2.4 Hz, OH), 3.12 (dd, 1H, J = 6.7, 13.5 Hz, PhCHa), 3.05 (dd, 1H, J = 9.3, 13.5 Hz, 
PhCHb). 
                                                 
ξ Kindly gifted by A Harvey. 
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13C NMR (CDCl3, 75 MHz); δ 174.1 (CO2Me), 166.7 (CONH), 152.2 (ArC1’), 137.2 (i-
Ph), 135.2 (ArC3), 131.3 (ArC4’), 129.3, 129.3, 129.0, 128.7, 128.6, 126.7, 125.3, 122.9 
(ArC2’), 121.4 (ArC2), 70.2 (β-C), 53.5 (α-C), 52.9 (OCH3), 37.7 (PhCH2). 
HRMS (ES) 418.1755 (MH+); C24H24N3O4 requires 418.1767. 
 
E-[2-Oxo-4-phenyl-3S-(3-phenylazobenzoylamino)butyric acid methyl ester] (4.5) 
 
N
H
N
O
N
Ph
O
OMe
O
4.5
 
α-Hydroxy ester 4.4 (65 mg, 156 µmol) was oxidised with TEMPO/NaOCl over 2.5 h 
following General Method G. Recrystallisation of the α-keto ester from aqueous acetone 
gave 4.5 as fluffy orange needles (36 mg, 56 %) comprising a mixture of ketone and 
hydrate (45:55 by 1H NMR). After 1 day in a solution of CDCl3 all hydrate had reverted to 
the ketone form.  
[α]D = -106.8 (c = 0.22, MeOH), Lit. ( -53, c = 0.67, acetonitrile)6 
1H NMR (CDCl3, 500 MHz); From mixture δ 8.21 (s, 1H), 8.07 (d, 1H, J = 8.0 Hz) 8.03* 
(d, 2H, J = 6.7 Hz), 7.94 (m, 4H), 7.84 (d, 1H, J = 7.6 Hz), 7.70 (d, 1H, J = 7.7 Hz), 7.59 
(t, 1H, J = 7.8 Hz), 7.56-7.51 (m, 6H), 7.34-7.22 (m, 9H), 7.18 (d, 2H, J = 7.1 Hz), 6.72 (d, 
1H, J = 6.9 Hz, NH), 6.48* (d, 1H, J = 8.2 Hz, NH), 5.66 (m, 1H, α-H), 5.49* (s, 1H, OH), 
4.84* (m, 1H, α-H), 4.79* (s, 1H, OH), 3.91 (s, 3H, OCH3), 3.83* (s, 3H, OCH3), 3.41 (dd, 
1H, J = 6.2, 14.1 Hz, PhCHa), 3.26 (dd, 1H, J = 6.7, 14.1 Hz, PhCHb), 3.14* (dd, 1H, J = 
4.4, 14.3 Hz, PhCHa), 2.92* (dd, 1H, J = 10.3, 14.3 Hz, PhCHb).  
13C NMR (CDCl3, 75 MHz); Ketone (eqm) δ 191.5 (COCO2Me), 166.4 (CONH), 160.6 
(CO2Me), 152.5 (ArC1), 152.4 (ArC1’), 134.9 (i-Ph), 134.3 (ArC3), 131.5 (ArC4’), 129.6 
(ArC4), 129.4 (ArC3’, ArC5), 129.2 (m-Ph), 128.9 (o-Ph), 127.5 (ArC6), 126.4 (p-Ph), 
123.0 (ArC2’), 121.0 (ArC2), 57.0 (α-C), 53.4 (OCH3), 36.9 (PhCH2). 
HRMS (ES) 416.1608 (MH+); C24H22N3O4 requires 416.1610. 
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E-(1S*,2R*)-[N-(1-Benzyl-3,3,3-trifluoro-2-hydroxypropyl)-3-phenylazobenzamide] 
(4.6) 
 
N
H
N
O
N
Ph
CF3
OH
4.6
 
3-Phenylazobenzoic acid 4.3 (88 mg, 0.39 mmol) and 2.6 (102 mg, 0.40 mmol) were 
coupled together utilising BOP (176 mg, 0.40 mmol) and Hünigs base (139 µL, 0.80 
mmol) in dry dichloromethane (5 mL) following General Method E. Recrystallisation of 
the crude trifluoromethyl carbinol from aqueous acetone gave 4.6 as an orange powder 
(162 mg, 98 %, single diastereomer).  
mp 187-188 °C 
1H NMR (acetone-d6, 500 MHz); δ 8.40 (t, 1H, J = 1.6 Hz, ArH2), 8.15 (dd, 2H, J = 1.7, 
7.8 Hz, ArH6, NH), 8.07 (dd, 2H, J = 1.2, 8.0 Hz, ArH2’), 8.04 (d, 1H, J = 7.8 Hz, ArH4), 
7.76-7.69 (m, 4H, ArH3’, ArH4’, ArH5), 7.48 (d, 2H, J = 7.4 Hz, o-Ph), 7.39 (t, 2H, J = 
7.6 Hz, m-Ph), 7.29 (t, 1H, J = 7.4 Hz, p-Ph), 4.79 (m, 1H, α-H), 4.56 (m, 1H, β-H), 3.38 
(dd, 1H, J = 3.6, 14.2 Hz, PhCHa), 3.28 (dd, 1H, J = 10.8, 14.2 Hz, PhCHb). 
13C NMR (acetone-d6); δ 166.4 (CO), 152.6 (ArC1, ArC1’), 138.6 (i-Ph), 136.3 (ArC3), 
131.9, 130.0, 129.6, 128.5 (o-Ph), 126.5 (ArC6), 125.8 (q, J = 283.2 Hz, CF3), 125.3 (p-
Ph), 123.0 (ArC2’), 121.8 (ArC2), 71.3 (q, J = 28.6 Hz, β-C), 52.3 (α-C), 35.0 (PhCH2). 
19F NMR (CDCl3, 282 MHz); δ -74.4 (d, 3F, J = 7.4 Hz). 
HRMS (ES) 428.1595 (MH+); C23H21F3N3O2 requires 428.1586. 
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E-[N-(1S*-Benzyl-3,3,3-trifluoro-2-oxopropyl)-3-phenylazobenzamide] (4.7) 
 
N
H
N
O
N
Ph
CF3
O
4.7
 
Trifluoromethyl carbinol 4.6 (43 mg, 0.10 mmol) was oxidised with TEMPO/NaOCl 
following General Method G. The crude product was purified by column chromatography 
(1:9 ethyl acetate/dichloromethane) followed by recrystallisation from aqueous MeOH to 
afford 4.7 as an orange solid (37 mg, 87 %). One drop of D2O was added to the NMR 
sample to give exclusively hydrate in solution. 
mp 154-156 °C 
1H NMR (acetone-d6, 500 MHz); Hydrate δ 8.30 (s, 1H, ArH2), 8.11 (d, 1H, J = 7.9 Hz, 
ArH6), 8.02 (dd, 2H, J = 1.5, 8.2 Hz, ArH2’), 7.95 (d, 1H, J = 7.7 Hz, ArH4), 7.76-7.65 
(m, 4H, ArH3’, ArH4’, ArH5), 7.44 (d, 2H, J = 7.2 Hz, o-Ph), 7.32 (t, 2H, J = 7.5 Hz, m-
Ph), 7.23 (t, 1H, J = 7.4 Hz, p-Ph), 6.91 (d, J = 8.5 Hz, OH), 4.73 (dd, 1H, J = 2.6, 11.8 Hz, 
α-H), 3.47 (dd, J = 3.0, 14.1 Hz, PhCHa), 3.19 (dd, J = 12.3, 13.7 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); Hydrate δ 167.9 (CONH), 152.4 (ArC1, ArC1’), 138.7 (i-
Ph), 135.6 (ArC3), 131.8 (ArC4’), 130.0 (ArC4), 129.6 (ArC5), 129.5 (ArC3’, Ph), 128.3 
(Ph), 126.3 (ArC6), 125.4 (p-Ph), 124.2 (q, J = 289.7 Hz, CF3), 122.9 (ArC2’), 121.7 
(ArC2), 94.1 (q, J = 29.9 Hz, β-C), 56.2 (α-C), 33.4 (PhCH2). 
19F NMR (acetone-d6, 282 MHz); Hydrate δ -80.5 (s, 3F). 
HRMS (ES) 444.1528 (MH+); C23H21F3N3O3 requires 444.1535. 
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7.4.2 E-4-Azobenzenesulfonamide derivatives 
 
E-[4-Phenylazobenzenesulfonyl chloride] (4.8) 27  
 
N N
SO2Cl
4.8
 
Finely ground recrystallised azobenzene (13.7 g, 75.0 mmol) was added slowly in small 
portions to a stirred solution of freshly distilled chlorosulfonic acid (45 mL) at rt then 
heated to 100 °C until evolution of HCl had ceased (ca. 4 h). The mixture was cooled to rt, 
then poured into a 1L beaker half filled with water and ice. The resulting brown precipitate 
was filtered, washed with copious amounts of water and air-dried. The soil-like solid was 
ground up and repeatedly extracted with hot petroleum ether to isolate the sulfonyl 
chloride. The solvent was removed in vacuo, and the crude product purified through a 
silica plug (dichloromethane) to give pure azobenzenesulfonyl chloride 4.8 as an orange 
solid (8.7 g, 41 %). An analytical sample was obtained by recrystallisation from petroleum 
ether to afford orange/red flakes. 
mp 120-121 °C 
1H NMR (CDCl3, 500 MHz) δ 8.15 (d, 2H, J = 8.8 Hz, ArH3), 8.03 (d, 2H, J = 8.8 Hz, 
ArH2), 7.95 (m, 2H, ArH2’), 7.54 (m, 3H, ArH3’, ArH4’). 
13C NMR (CDCl3, 75 MHz); δ 155.9 (ArC1), 152.3 (ArC2), 145.0 (ArC4), 132.6 (ArC4’), 
129.3 (ArC3’), 128.2 (ArC2’), 123.7 (ArC2), 123.5 (ArC2’). 
Microanalysis; C, 51.49; H, 2.98; N, 10.01; Cl, 12.80; S, 11.54; C12H9ClN2O2S requires C, 
51.34; H, 3.23; N, 9.98; Cl 12.63; S, 11.42. 
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E-[3-Phenyl-2S-(4-phenylazobenzenesulfonylamino)propionic acid methyl ester] (4.9) 
 
N N
O2S N
H
OMe
Ph
O
4.9
 
Method 1: Pyridine 
 
A solution of 4.8 (1.26 g, 4.49 mmol) and L-phenylalanine methyl ester hydrochloride 
(1.00 g, 4.63 mmol) in dry pyridine (10 mL) were heated at reflux following General 
Method B to give the ester 4.9 as an orange solid (1.79 g, 94 %). An analytical sample was 
obtained by recrystallisation from aqueous MeOH affording fluffy orange needles. 
[α]D = +20.7 (c = 0.51, MeOH) 
mp 140-142 °C 
1H NMR (acetone-d6, 500 MHz); δ 8.10 (m, 4H, ArH2’, ArH), 8.00 (d, 2H, J = 8.5 Hz, 
ArH), 7.75 (m, 3H, ArH3’, ArH4’), 7.32 (m, 6H, o/m/p-Ph, NH), 4.36 (m, 1H, α-H), 3.58 
(s, 3H, OCH3), 3.19 (dd, 1H, J = 6.1, 13.7 Hz, PhCHa), 3.07 (dd, 1H, J = 8.4, 13.7 Hz, 
PhCHb), 2.96 (s, 4H, 2 x H2O). 
13C NMR (acetone-d6, 75 MHz); δ 171.3 (CO), 154.4, 152.6, 143.1 (ArC4), 136.4 (i-Ph), 
132.3 (ArC4’), 129.6, 129.5, 128.5, 128.3, 127.0 (p-Ph), 123.2, 123.1, 57.9 (α-C), 51.7 
(OCH3), 38.7 (PhCH2). 
HRMS (EI) 423.1265 (M+); C22H21N3O4S requires 423.1253. 
 
Method 2: Hünigs base 
 
A solution of 4.8 (1.00 g, 3.56 mmol), L-phenylalanine methyl ester hydrochloride (845 
mg, 3.92 mmol) and Hünigs base (1.40 mL, 8.03 mmol) in dry dichloromethane (50 mL) 
were heated at reflux following General Method C to give the ester 4.9 as an orange solid 
(1.47 g, 97 %). The product and NMR data were identical to the above sample. 
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E-[3-Phenyl-2S-(4-phenylazobenzenesulfonylamino)propionic acid] (4.10) 
 
N N
O2S N
H
OH
Ph
O
4.10
 
Hydrolysis of methyl ester 4.9 (1.47 g, 3.46 mmol) with K2CO3 (725 mg, 5.25 mmol) in 
MeOH/H2O over a period of 9 h following General Method H gave the free acid as an 
orange solid. Recrystallisation of the free acid from aqueous acetone afforded 4.10 as fine 
orange needles (1.37 g, 97 %).  
[α]D = +10.8 (c = 0.23, MeOH) 
mp 169-170 °C 
1H NMR (acetone-d6, 500 MHz); δ 8.11 (dd, 2H, J = 1.8, 7.7 Hz, ArH2’), 8.06 (d, 2H, J = 
8.5 Hz, ArH), 8.00 (d, 2H, J = 8.5 Hz, ArH), 7.75 (m, 3H, ArH3’, ArH4’), 7.31 (m, 5H, 
o/m/p-Ph), 7.16 (d, 1H, J = 8.7 Hz, NH), 4.36 (m, 1H, α-H), 3.26 (dd, 1H, J = 5.4, 13.8 
Hz, PhCHa), 3.08 (dd, 1H, J = 8.4, 13.8 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); δ 171.8 (CO), 154.3, 152.5, 143.1 (ArC4), 136.6 (i-Ph), 
132.3 (ArC4’), 129.6 (x 2), 128.4, 128.2, 126.9 (p-Ph), 123.2, 123.1, 57.6 (α-C), 38.7 
(PhCH2). 
HRMS (EI) 409.1091 (M+); C21H19N3O4S requires 409.1096. 
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E-(1S*,2R*)-[N-(1-Benzyl-3,3,3-trifluoro-2-hydroxypropyl)-4-phenylazobenzene 
sulfonamide] (4.11) 
 
N N
O2S N
H
CF3
Ph
OH
4.11
 
Method 1: Pyridine 
 
A solution of 4.8 (203 mg, 0.72 mmol) and 2.6 (204 mg, 0.80 mmol) in dry pyridine (8 
mL) were heated at reflux as described in General Method B to give the desired product 
4.11 as an oily orange solid (280 mg, 84 %). An analytical sample was obtained by 
recrystallisation from aqueous MeOH to afford fluffy orange needles (single 
diastereomer). 
mp 143-144 °C 
1H NMR (CDCl3, 500 MHz); δ 8.12 (dd, 2H, J = 1.7, 7.9 Hz, ArH2’), 7.90 (d, 2H, J = 8.5 
Hz, ArH), 7.74 (m, 5H, ArH, ArH3’, ArH4’), 7.18 (m, 3H, m-Ph, NH), 7.14 (m, 3H, o/p-
Ph), 6.02 (d, 1H, J = 6.9 Hz, OH), 4.57 (m, 1H, β-H), 3.93 (m, 1H, α-H), 3.08 (dd, 1H, J = 
3.1, 14.4 Hz, PhCHa), 2.96 (dd, 1H, J = 10.8, 14.4 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); δ 154.1, 152.7, 142.7 (ArC1), 137.5 (ArC1’), 132.3 
(ArC4’), 129.6, 129.4, 128.4, 127.7, 126.5 (p-Ph), 125.4 (q, J = 283.5 Hz, CF3), 123.2, 
123.1, 73.0 (q, J = 28.8 Hz, β-C), 56.1 (α-C), 34.2 (PhCH2). 
19F NMR (acetone-d6, 282 MHz); δ -74.2 (d, 3F, J = 8.0 Hz). 
HRMS (EI) 463.1191 (M+); C22H20F3N3O3S requires 463.1178. 
 
Method 2: Hünigs base 
 
A solution of 4.8 (285 mg, 1.02 mmol), 2.6 (288 mg, 1.13 mmol) and Hünigs base (0.39 
mL, 2.24 mmol) in dry dichloromethane (10 mL) were heated at reflux following General 
Method C to give the desired product 4.11 as an orange solid (473 mg, quantitative, single 
diastereomer). The product and NMR data were identical to the above sample. 
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E-[N-(1S*-Benzyl-3,3,3-trifluoro-2-oxopropyl)-4-phenylazobenzenesulfonamide] 
(4.12) 
 
N N
O2S N
H
Ph
CF3
O
4.12
 
Method 1: TEMPO oxidation 
 
A solution of 4.11 (50 mg, 0.11 mmol) in dichloromethane (4 mL) was oxidised with 
TEMPO/NaOCl in 2 h following General Method G. Flash chromatography (3:7 ethyl 
acetate/petroleum ether) of the crude product afforded an oily solid. Recrystallisation of 
the racemic ketone/hydrate mixture from aqueous MeOH gave 4.12 as fluffy orange 
needles (40 mg, 80 %). 
1H NMR (acetone-d6, 500 MHz); Hydrate δ 8.13 (dd, 2H, J = 1.5, 7.7 Hz, ArH2’), 7.85 (d, 
2H, J = 8.5 Hz, ArH2), 7.77 (m, 3H, ArH3’, ArH4’), 7.71 (d, 2H, J = 8.4 Hz, ArH3), 7.35 
(d, 1H, J = 9.0 Hz, NH), 7.18 (m, 2H, m-Ph), 7.06 (m, 3H, o/p-Ph), 6.40 (s, 1H, OH), 6.35 
(s, 1H, OH), 4.05 (m, 1H, α-H), 3.36 (dd, 1H, J = 2.3, 14.3 Hz, PhCHa), 2.86 (dd, 1H, J = 
11.3, 14.3 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); Hydrate δ 154.0 (ArC1), 152.8 (ArC1’), 143.1 (ArC4), 
137.9 (i-Ph), 132.2 (ArC4’), 129.7, 129.4, 128.4, 127.7, 126.4 (p-Ph), 124.1 (q, J = 289.2 
Hz, CF3), 123.2, 123.0, 93.6 (q, J = 29.4 Hz, β-C), 61.1 (α-C), 35.6 (PhCH2). 
19F NMR (acetone-d6, 282 MHz); Hydrate δ -78.9 (s, 3F). 
HRMS (EI) 461.1031 (M+, ketone); C22H18F3N3O3S requires 461.1021. 
 
Method 2: Dess-Martin oxidation 
 
A solution of 4.11 (20 mg, 43 µmol) in dichloromethane (10 mL) was oxidised with Dess-
Martin periodinane (69 mg, 162 µmol) following General Method F. The crude product 
was purified down a silica plug (1:9 ethyl acetate). Recrystallisation of the racemic 
ketone/hydrate mixture from aqueous MeOH gave 4.12 as fluffy orange needles (15 mg, 
74 %). The product and NMR data were identical to the above sample. 
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E-[4-Methyl-2S-(4-phenylazobenzenesulfonylamino)pentanoic acid methyl ester] 
(4.13) 
 
N N
O2S N
H
OMe
O
4.13
 
Method 1: Pyridine 
 
A solution of 4.8 (702 mg, 2.50 mmol) and L-leucine methyl ester hydrochloride (556 mg, 
3.06 mmol) in dry pyridine (15 mL) were heated at reflux following General Method B to 
give ester 4.13 as an orange solid (820 mg, 84 %). An analytical sample of the ester was 
obtained by recrystallisation from aqueous MeOH (fluffy orange needles). 
[α]D = +23.8 (c = 0.99, MeOH) 
mp 135-136 °C 
1H NMR (CDCl3, 500 MHz); δ 8.00 (m, 4H, ArH2, ArH3), 7.96 (dd, 2H, J = 2.1, 7.5 Hz, 
ArH2’), 7.55 (m, 3H, ArH3’, ArH4’), 5.12 (d, 1H, J = 10.1 Hz, NH), 4.01 (m, 1H, α-H), 
3.45 (s, 3H, OCH3), 1.80 (m, 1H, LeuCH), 1.52 (t, 2H, J = 7.1 Hz, LeuCH2), 0.92 (t, 6H, J 
= 6.0 Hz, LeuCH3). 
13C NMR (CDCl3, 75 MHz); δ 172.6, 154.7, 152.3, 141.0, 132.1, 129.2, 128.4, 123.3, 
123.2, 54.5(α-C), 52.4 (OCH3), 42.3 (LeuCH), 24.3 (LeuCH2), 22.7 (LeuCH3), 21.4 
(LeuCH3). 
HRMS (EI) 389.1408 (M+); C19H23N3O4S requires 389.1409. 
 
Method 2: Hünigs base 
 
A solution of 4.8 (152 mg, 0.54 mmol), L-leucine methyl ester hydrochloride (107 mg, 
0.59 mmol) and Hünigs base (0.20 mL, 1.15 mmol) in dry dichloromethane (10 mL) were 
heated at reflux following General Method C to give ester 4.13 as an orange solid (207 mg, 
98 %). The product and NMR data were identical to the above sample. 
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E-[4-Methyl-2S-(4-phenylazobenzenesulfonylamino)pentanoic acid] (4.14) 
 
N N
O2S N
H
OH
O
4.14
 
Hydrolysis of methyl ester 4.13 (812 mg, 2.08 mmol) with K2CO3 (450 mg, 3.26 mmol) in 
MeOH/H2O over a period of 24 h following General Method H gave the free acid 4.14 as 
an orange solid (759 mg, 97 %).  
[α]D = +35.6 (c = 0.30, MeOH) 
mp 149 °C 
1H NMR (acetone-d6, 500 MHz); δ 8.18 (m, 4H, ArH2, ArH3), 8.11 (dd, 2H, J = 1.9, 7.7 
Hz, ArH2’), 7.75 (m, 3H, ArH3’, ArH4’), 7.14 (d, 1H, J = 8.2 Hz, NH), 4.12 (m, 1H, α-
H), 1.94 (m, 1H, LeuCH), 1.70 (m, 2H, LeuCH2), 1.03 (d, 1H, J = 6.6 Hz, LeuCH3), 0.99 
(d, 1H, J = 6.6 Hz, LeuCH3). 
13C NMR (acetone-d6, 75 MHz); δ 172.7 (CO), 154.5, 152.6, 143.4 (ArC4), 132.4 (ArC4’), 
129.7, 128.5, 123.2, 123.2, 54.5 (α-C), 41.9 (LeuCH), 24.4 (LeuCH2), 22.5 (LeuCH3), 
20.9 (LeuCH3). 
HRMS (EI) 375.1261 (M+); C18H21N3O4S requires 375.1253. 
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E-[4-Methyl-2S-(4-phenylazobenzenesulfonylamino)pentanoic acid (1S*,2R*)-(1-
benzyl-3,3,3-trifluoro-2-hydroxypropyl)amide] (4.15) 
 
N N
O2S N
H
H
N
O
CF3
OH
Ph
4.15
 
Method 1: 
 
The free acid 4.14 (76 mg, 0.20 mmol), 2.6 (57 mg, 0.22 mmol), BOP (100 mg, 0.22 
mmol) and Hünigs base (80 µL, 0.46 mmol) in dry dichloromethane (8 mL) were reacted 
together following General Method E to give the dipeptide as an orange solid. Column 
chromatography (1:9 ethyl acetate/dichloromethane) of the crude trifluoromethyl carbinol 
gave 4.15 as an orange solid (69 mg, 59 %) comprising a mixture of diastereomers (1:2 by 
1H and 19F NMR). 
[α]D = -19.7 (c = 0.97, MeOH) 
1H NMR (acetone-d6, 500 MHz); Mixture (1:2) δ 8.17-8.08 (m, 12H, ArH2, ArH2’, ArH3, 
major + minor), 7.75 (m, 6H, ArH3’, ArH4’, major + minor), 7.38-7.29 (m, 10H, o/m/p-
Ph, major + minor), 7.66* (d, 1H, J = 8.4 Hz, TFMC NH), 7.62 (d, 1H, J = 8.8 Hz, TFMC 
NH), 6.96* (br s, 1H, LeuNH), 6.81 (br s, 1H, LeuNH), 5.89* (d, 1H, J = 6.5 Hz, OH), 
5.73 (d, 1H, J = 6.4 Hz, OH), 4.44 (m, 1H, TFMC α-H), 4.35* (m, 1H, TFMC α-H), 4.13* 
(m, 1H, TFMC β-H), 3.96 (m, 3H, Leu α-H, major + minor, TFMC β-H, major), 3.08 (m, 
2H, PhCHa, major + minor), 2.95 (m, 2H, PhCHb, major + minor), 1.73* (m, 1H, LeuCH), 
1.57 (m, 1H, LeuCH), 1.41* (m, 2H, LeuCH2), 1.14 (m, 2H, LeuCH2), 0.90* (d, 3H, J = 
6.7 Hz, LeuCH3), 0.84 (d, 3H, J = 6.6 Hz, LeuCH3), 0.80 (t, 6H, J = 6.2 Hz, LeuCH3, 
major + minor). 
13C NMR (acetone-d6, 75 MHz); Mixture δ 171.7* (CO), 171.2 (CO), 154.6, 154.5*, 152.6, 
152.6*, 143.3 (ArC4), 143.0* (ArC4), 138.2 (i-Ph), 138.0* (i-Ph), 132.3 (ArC4’), 132.3* 
(ArC4’), 129.6 (m), 128.5 (m), 128.4, 126.6* (p-Ph), 126.5 (p-Ph), 125.5* (q, J = 283.4 Hz, 
CF3), 125.3 (q, J = 284.4 Hz, CF3), 123.2 (m), 123.1, 71.6 (q, J = 29.0 Hz, β-C), 71.0* (q, J 
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= 28.8 Hz, β-C), 55.6*, 55.4, 51.3*, 50.4, 42.3, 42.3*, 34.6*, 34.2, 24.2*, 24.1, 22.6, 22.6*, 
20.9, 20.8*.  
19F NMR (acetone-d6, 282 MHz); Mixture (1:2) δ -74.2* (d, 3F, J = 7.7 Hz), -74.4 (d, 3F, J 
= 7.9 Hz). 
HRMS (EI) 576.2025 (M+); C28H31F3N4O4S requires 576.2018. 
 
Method 2: 
 
A solution of 4.8 (150 mg, 0.53 mmol), L-Leu-TFMC.HCl (230 mg, 0.62 mmol) and 
Hünigs base (0.24 mL, 1.38 mmol) in dry dichloromethane (15 mL) were heated to reflux 
for 16 h following General Method C. Column chromatography (1:9 ethyl 
acetate/dichloromethane) of the crude trifluoromethyl carbinol gave 4.15 as an orange 
solid (179 mg, 61 %) as a mixture of diastereomers. The product and NMR data was 
identical to the above compound. 
 
E-[4-Methyl-2S-(4-phenylazobenzenesulfonylamino)pentanoic acid (1S*-benzyl-3,3,3-
trifluoro-2-oxopropyl)amide] (4.16) 
 
N N
O2S N
H
H
N
O
CF3
O
Ph
4.16
 
A solution of 4.15 (29 mg, 50 µmol) in dichloromethane (10 mL) was oxidised with Dess-
Martin periodinane (79 mg, 186 µmol) following General Method F. The crude product 
was purified down a silica plug (1:4 ethyl acetate/dichloromethane). Recrystallisation of 
the ketone/hydrate mixture from aqueous MeOH gave 4.16 as an orange solid (20 mg, 70 
%) comprising a mixture of diastereomers (65:35 by 1H NMR). 
1H NMR (acetone-d6, 500 MHz); Hydrate, mixture of diastereomers (65:35) δ 8.14-8.08 
(m, 8H, ArH2, ArH3, major + minor), 7.84 (d, 2H, J = 8.7 Hz, TFMK NH, major + 
minor), 7.74 (m, 6H, ArH3’, ArH4’, major + minor), 7.38 (m, 8H, o/m-Ph, major + 
minor), 7.30 (m, 2H, p-Ph, major + minor), 7.13* (d, 1H, J = 7.1 Hz, LeuNH), 7.07 (d, 1H, 
Chapter Seven: Experimental 221
J = 8.5 Hz, LeuNH), 6.72* (s, 1H, OH), 6.59 (s, 2H, OH, major + minor), 6.54 (s, 1H, 
OH), 4.43 (m, 2H, TFMK α-H, major + minor), 4.03 (m, 1H, Leu α-H), 3.95* (m, 1H, Leu 
α-H), 3.39 (d, 2H, J = 14.1 Hz, PhCH2, major + minor), 2.96 (m, 2H, PhCH2, major + 
minor), 1.62* (m, 1H, LeuCH), 1.55 (m, 1H, LeuCH), 1.40* (m, 1H, LeuCHa), 1.31* (m, 
1H, LeuCHb), 1.22 (m, 1H, LeuCHa), 1.12 (m, 1H, LeuCHb), 0.84* (d, 3H, J = 6.7 Hz, 
LeuCH3a), 0.81 (d, 3H, J = 6.6 Hz, LeuCH3a), 0.75 (d, 3H, J = 6.5 Hz, LeuCH3b), 0.70* (d, 
3H, J = 6.5 Hz, LeuCH3b). 
13C NMR (acetone-d6, 75 MHz); δ 173.8, 173.5*, 154.5*, 154.5, 152.6*, 152.6, 143.3, 
142.7*, 138.6*, 138.5, 132.3*, 132.3, 129.6*, 129.6, 129.5, 129.5*, 128.5, 128.4 (x2), 128.3, 
126.5, 126.4*, 124.1* (q, J = 289.0 Hz, CF3), 123.9 (q, J = 289.1 Hz, CF3), 123.3, 123.2*, 
123.2*, 123.2, 94.4* (q, J = 30.3 Hz, β-C), 94.2 (q, J = 30.0 Hz, β-C), 56.4, 56.0*, 55.7*, 
55.2, 42.2, 42.0*, 34.3, 34.1*, 24.1*, 24.0, 22.6, 22.5*, 20.8*, 20.7. 
LRMS (ES) (MH+) 575.2; C28H30F3N4O4S requires 575.2. 
 
E-[3-Methyl-2S-(4-phenylazobenzenesulfonylamino)butyric acid methyl ester] (4.17) 
 
N N
O2S N
H
OMe
O
4.17
 
Method 1: Pyridine 
 
A solution of 4.8 (563 mg, 2.00 mmol) and L-valine methyl ester hydrochloride (369 mg, 
2.20 mmol) in dry pyridine (15 mL) were heated at reflux following General Method B to 
give ester 4.17 as an orange solid (752 mg, quantitative). An analytical sample of the ester 
was obtained by recrystallisation from aqueous MeOH to afford fine orange crystals. 
[α]D = +28.2 (c = 1.0, MeOH) 
mp 145-146 °C 
1H NMR (CDCl3, 500 MHz); δ 8.00 (s, 4H, ArH2, ArH3), 7.95 (dd, 2H, J = 1.9, 7.2 Hz, 
ArH2’), 7.54 (m, 3H, ArH3’, ArH4’), 5.39 (d, 1H, J = 10.1 Hz, NH), 3.83 (dd, 1H, J = 5.1, 
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10.1 Hz, α-H), 3.46 (s, 3H, OCH3), 2.07 (m, 1H, ValCH), 0.98 (d, 3H, J = 6.8 Hz, 
ValCH3), 0.90 (d, 3H, J = 6.8 Hz, ValCH3). 
13C NMR (CDCl3, 75 MHz); δ 171.6 (CO), 154.6, 152.3, 141.0 (ArC4), 132.0 (ArC4’), 
129.2, 128.3, 123.2, 123.1, 61.1 (α-C), 52.3 (OCH3), 31.6 (ValCH), 18.9 (ValCH3), 17.4 
(ValCH3). 
HRMS (EI) 375.1266 (M+); C18H21N3O4S requires 375.1253. 
 
Method 2: Hünigs base 
 
A solution of 4.8 (152 mg, 0.54 mmol), L-valine methyl ester hydrochloride (117 mg, 0.79 
mmol) and Hünigs base (0.20 mL, 1.15 mmol) in dry dichloromethane (10 mL) were 
heated at reflux following General Method C to give ester 4.17 as an orange solid (203 mg, 
quantitative). The product and NMR data were identical to the above sample. 
 
E-[3-Methyl-2S-(4-phenylazobenzenesulfonylamino)butyric acid] (4.18) 
 
N N
O2S N
H
OH
O
4.18
 
Hydrolysis of the methyl ester 4.17 (206 mg, 0.55 mmol) with K2CO3 (114 mg, 0.83 
mmol) in MeOH/H2O over a period of 48 h following General Method H gave free acid 
4.18 as an orange solid (196 mg, 99 %). 
[α]D = +23.6 (c = 0.22, MeOH) 
mp 230 °C 
1H NMR (acetone-d6, 500 MHz); δ 8.17 (m, 4H, ArH2, ArH3), 8.10 (d, 2H, J = 6.0 Hz, 
ArH2’), 7.74 (m, 3H, ArH3’, ArH4’), 6.96 (d, 1H, J = 9.4 Hz, NH), 3.97 (m, 1H, α-H), 
2.25 (m, 1H, ValCH), 1.11 (d, 3H, J = 6.6 Hz, ValCH3), 1.04 (d, 3H, J = 6.7 Hz, ValCH3). 
13C NMR (acetone-d6, 75 MHz); δ 171.7 (CO), 154.5, 152.7, 143.3 (ArC4), 132.4 (ArC4’), 
129.7, 128.6, 123.2, 123.1, 61.5 (α-C), 31.3 (ValCH), 18.9 (ValCH3), 17.3 (ValCH3). 
HRMS (EI) 361.1113 (M+); C17H19N3O4S requires 361.1096. 
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E-[(1S*,2R*)-N-(1-Benzyl-3,3,3-trifluoro-2-hydroxypropyl)-3-methyl-2S-(4-phenyl 
azobenzenesulfonylamino)butyramide] (4.19) 
 
N N
O2S N
H
H
N
O
CF3
OH
Ph
4.19
 
Method 1: 
 
The free acid 4.18 (73 mg, 0.20 mmol), 2.6 (57 mg, 0.22 mmol), BOP (100 mg, 0.22 
mmol) and Hünigs base (80 µL, 0.46 mmol) in dry dichloromethane (8 mL) were reacted 
together following General Method E to give the dipeptide as an oily orange solid. Column 
chromatography (1:9 ethyl acetate/dichloromethane) of the crude trifluoromethyl carbinol, 
followed by recrystallisation from aqueous MeOH gave 4.19 as an orange powder (79 mg, 
70 %) comprising a mixture of diastereomers (2:3 by 1H and 19F NMR). 
[α]D = +4.9 (c = 0.97, MeOH) 
1H NMR (acetone-d6, 500 MHz); Mixture (2:3) δ 8.15-8.07 (m, 12H, ArH2, ArH2’, ArH3, 
major + minor), 7.75 (m, 6H, ArH3’, ArH4’, major + minor), 7.62* (d, 1H, J = 8.3 Hz, 
TFMC NH), 7.57 (d, 1H, J = 8.9 Hz, TFMC NH), 7.37-7.24 (m, 10H, o/m/p-Ph, major + 
minor), 6.75* (br s, 1H, ValNH), 6.54 (d, 1H, J = 8.6 Hz, ValNH), 5.87* (d, 1H, J = 6.5 
Hz, OH), 5.66 (d, 1H, J = 6.4 Hz, OH), 4.48 (m, 1H, TFMC α-H), 4.39* (m, 1H, TFMC α-
H), 4.12* (m, 1H, TFMC β-H), 3.89* (m, 1H, Val α-H), 3.85 (m, 2H, TFMC β-H, major, 
Val α-H, major), 3.18-2.87 (m, 4H, PhCHa, PhCHb, major + minor), 2.08* (m, 1H, 
ValCH), 1.83 (m, 1H, ValCH), 0.94* (d, 3H, J = 6.8 Hz, ValCH3), 0.84 (dd, 6H, J = 6.9, 
8.7 Hz, ValCH3, major + minor), 0.53 (d, 3H, J = 6.8 Hz, ValCH3). 
13C NMR (acetone-d6, 75 MHz); Mixture δ 170.6 (CO), 170.0 (CO), 154.6*, 154.5, 152.7, 
152.7*, 143.2 (ArC4), 143.0* (ArC4), 138.2 (i-Ph), 137.9* (i-Ph), 132.3 (ArC4’), 132.3* 
(ArC4’), 129.6, 129.6*, 129.5*, 129.4, 128.6 (x 2), 128.5 (x 2), 126.6* (p-Ph), 126.5 (p-Ph), 
125.5* (q, J = 283.5 Hz, CF3), 125.2 (q, J = 284.0 Hz, CF3), 123.2 (x 3), 123.0, 71.8 (q, J = 
29.1 Hz, β-C), 71.3* (q, J = 29.0 Hz, β-C), 61.9*, 61.7, 51.3*, 50.5, 34.5*, 34.2, 31.7, 31.6*, 
19.1, 19.1*, 16.5*, 16.2.  
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19F NMR (acetone-d6, 282 MHz) Mixture (2:3) δ -74.2* (d, 3F, J = 7.6 Hz), -74.5 (d, 3F, J 
= 7.9 Hz). 
HRMS (EI) 562.1875 (M+); C28H31F3N4O4S requires 562.1862. 
 
Method 2: 
 
A solution of 4.8 (38 mg, 0.14 mmol), L-Val-TFMC (46 mg, 0.15 mmol) and Hünigs base 
(30 µL, 0.17 mmol) in dry dichloromethane (10 mL) were heated at reflux for 16 h 
following General Method C. Column chromatography (1:9 ethyl acetate/ 
dichloromethane) of the crude trifluoromethyl carbinol gave 4.19 as an orange solid (60 
mg, 79 %) comprising a mixture of diastereomers. The product and NMR data was 
identical to the above compound. 
 
7.4.3 Synthesis of 4-substituted nitrosobenzenes 
 
4-Nitrobenzylphthalimide (4.20)28 
 
NO2
N
O
O
4.20
 
A suspension of recrystallised 4-nitrobenzyl chloride (17.1 g, 99.7 mmol) and potassium 
phthalimide (18.5 g, 99.9 mmol) in DMF (300 mL) was stirred at 50 °C for 2 h. The 
resulting purple mixture was poured into cold water (1 L) to precipitate out a pale yellow 
solid. The crude product was recrystallised from EtOH to afford 4.20 as fine pale yellow 
needles (25.1 g, 89 %). 
1H NMR (CDCl3, 500 MHz); δ 8.18 (d, 2H, J = 8.7 Hz), 7.88 (dd, 2H, J = 3.0, 5.4 Hz), 
7.75 (dd, 2H, J = 3.0, 5.4 Hz), 7.59 (d, 2H, J = 8.7 Hz), 4.94 (s, 2H, CH2). 
13C NMR (CDCl3, 75 MHz); δ 167.7, 147.5, 143.3, 134.3, 131.8, 129.3, 123.9, 123.6, 40.8. 
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4-Nitrobenzylamine hydrochloride (4.21)28 
 
NO2
HCl.H2N
4.21
 
4-Nitrobenzylphthalimide 4.20 (5.64 g, 20.0 mmol) and hydrazine hydrate (4.40 mL, 91.0 
mmol) in EtOH (350 mL) were heated at reflux for 16 h.ξ The suspension was cooled to rt 
and most of the solvent removed in vacuo before dissolving the precipitate in water (600 
mL) and acidifying with acetic acid. The resulting precipitate of phthalazine-1,4-dione was 
removed by filtration through a celite plug. The filtrate was concentrated in vacuo and 
crystallisation induced by scratching. Filtering off the solid proved difficult so the solid 
was redissolved in distilled water, basified with NaOH, extracted with dichloromethane (5 
x 50 mL), dried over MgSO4 and filtered. The volume of solution was reduced to ca. 100 
mL and cooled in an ice bath. Dry, gaseous HCl was bubbled into the solution for 30 min. 
The resulting precipitate was filtered, washed with dry ether and petroleum ether and air 
dried to afford 4.21 as a pale brown solid (3.11g, 82 %). 
1H NMR (D2O, 300 MHz); δ 8.24 (d, 2H, J = 8.6 Hz, ArH2), 7.64 (d, 2H, J = 8.6 Hz, 
ArH3), 4.30 (s, 2H, CH2). 
13C NMR (D2O, 75 MHz); δ 148.7, 140.7, 130.7, 125.1, 43.1. 
 
(4-Nitrobenzyl)carbamic acid 9H-fluoren-9-ylmethyl ester (4.22)6 
 
NO2
H
NO
O
4.22
 
A suspension of hydrochloride 4.21 (2.03 g, 11.0 mmol) and FmocCl (2.66 g, 10.0 mmol) 
in dry dichloromethane (15 mL) was cooled in an ice bath. Hünigs base (3.80 mL, 22.0 
                                                 
ξ After ca.1 h a thick yellow precipitate began to form. 
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mmol) was added dropwise to complete dissolution and the resulting solution stirred for 5 
h under an inert atmosphere at rt.ξ The solvent was removed in vacuo, redissolved in ethyl 
acetate (300 mL) and successively extracted with 10 % aqueous HCl, saturated aqueous 
NaHCO3 and brine, dried over MgSO4, filtered and concentrated in vacuo to afford 4.22 as 
a pale yellow solid (2.66 g, 71 %). An analytical sample was recrystallised from aqueous 
EtOH. 
mp 155-156 °C (lit. 155-156 °C)6  
1H NMR (acetone-d6, 500, MHz); δ 8.32 (d, 2H, J = 8.6 Hz, ArH2), 7.99 (d, 2H, J = 7.6 
Hz, FmocHa), 7.82 (d, 2H, J = 7.5 Hz, FmocHd), 7.68 (d, 2H, J = 8.5 Hz, ArH3), 7.54 (t, 
2H, J = 7.5 Hz, FmocHb), 7.45 (t, 2H, J = 7.4 Hz, FmocHc), 7.29 (br m, 1H, CO2NH), 4.61 
(d, 2H, J = 6.3 Hz, NHCH2), 4.56 (d, 2H, J = 6.8 Hz, FmocCH2), 4.37 (t, 1H, J = 6.7 Hz, 
FmocCH). 
13C NMR (acetone-d6, 75 MHz); δ 156.8 (CO2NH), 148.0, 144.4, 141.5 (x 2), 128.3, 
127.9, 127.3, 125.4, 123.7, 120.2, 66.2, 47.5, 44.0. 
 
(4-Aminobenzyl)carbamic acid 9H-fluoren-9-ylmethyl ester (4.23)6 
 
NH2
H
NO
O
4.23
 
A suspension of 4.22 (2.35 g, 6.28 mmol) in ethyl acetate was reduced under an 
atmosphere of hydrogen for 36 h following General Method I to afford 4.23 as a white 
solid containing a minor impurity (2.16 g, quantitative). Recrystallisation from EtOH 
yielded the pure product as fine white needles. 
mp 152-153 °C (lit. 147-148 ºC)6 
1H NMR (acetone-d6, 500 MHz); δ 7.97 (d, 2H, J = 7.6 Hz, FmocHa), 7.82 (d, 2H, J = 7.4 
Hz, FmocHd), 7.52 (t, 2H, J = 7.5 Hz, FmocHb), 7.43 (t, 2H, J = 7.2 Hz, FmocHc), 7.13 (d, 
2H, J = 8.1 Hz, ArH3), 6.86 (br m, 1H, CO2NH), 6.73 (d, 2H, J = 8.3 Hz, ArH2), 4.66 (br 
                                                 
ξ During the course of the reaction a precipitate of diisopropylethylamine hydrochloride formed. 
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s, 2H, NH2), 4.46 (d, 2H, J = 7.2 Hz, FmocCH2), 4.34 (t, 1H, J = 7.1 Hz, FmocCH), 4.30 
(d, 2H, J = 6.1 Hz, NHCH2). 
13C NMR (acetone-d6, 75 MHz); δ 156.6 (CO2NH), 147.7 (ArC1), 144.5, 141.4, 128.7 
(ArC3), 127.9 (ArC4), 127.8, 127.2, 125.5, 120.1, 114.4 (ArC2), 66.2 (FmocCH2), 47.5 
(NHCH2), 44.4 (FmocCH). 
HRMS (EI) 344.1527 (M+); C22H20N2O2 requires 344.1525. 
 
(4-Nitrosobenzyl)carbamic acid 9H-fluoren-9-ylmethyl ester (4.24) 
 
NO
H
NO
O
4.24
 
A suspension of 4.23 (1.03 g, 3.00 mmol) in dichloromethane (15 mL) was oxidised with 
MoVI/hydrogen peroxide over 14 h following General Method J. The crude nitrosobenzene 
was subjected to flash chromatography (1:9 ethyl acetate/dichloromethane) to afford 4.24 
as a green solid (1.06 g, 98 %). An analytical sample was obtained by recrystallisation 
from aqueous EtOH resulting in bright green crystals. 
The 1H and 13C NMR’s had extra aromatic peaks that correspond to the nitro derivative 
4.22, presumably due to over-oxidation of the aniline or atmospheric oxidation of the 
nitrosobenzene. These peaks have been omitted from the data below. 
mp 134 °C (dec) 
1H NMR (CDCl3, 500 MHz); δ 7.86 (d, 2H, J = 7.9 Hz, ArH2), 7.77 (d, 2H, J = 7.5 Hz, 
FmocHa), 7.60 (d, 1H, J = 7.2 Hz, FmocHd), 7.42 (m, 4H, ArH3, FmocHb), 7.32 (t, 2H, J 
= 7.3 Hz, FmocHc), 5.19 (br s, 1H, NH), 4.53 (d, 2H, J = 6.4 Hz, FmocCH2), 4.44 (d, 2H, 
J = 5.9 Hz, NHCH2), 4.22 (m, 1H, FmocCH). 
13C NMR (CDCl3, 75 MHz); δ 165.4 (ArC1), 156.5 (CO2NH), 146.6, 143.7, 141.3, 127.7, 
127.0, 124.9, 123.8, 121.4, 120.0, 66.6, 47.3, 44.5. 
HRMS (ES) 359.1401 (MH+); C22H19N2O3 requires 359.1396. 
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1-Bromo-4-nitrosobenzene (4.25) 
 
Br
NO
4.25
 
A solution of 4-bromoaniline (4.30 g, 25.0 mmol) in dichloromethane (125 mL) was 
oxidised with MoVI/hydrogen peroxide over 18 h following General Method J. The crude 
nitrosobenzene was subjected to flash chromatography (dichloromethane). Only the green 
band of interest was collected. A second column (1:3 ethyl acetate/petroleum ether) 
afforded 4.25 as a yellowish solid (2.36 g, 51 %). An analytical sample was obtained by 
recrystallisation from aqueous EtOH to give pale tan crystals. 
mp 93-94 °C 
1H NMR (CDCl3, 500 MHz); δ 7.78 (br s, 4H, ArH2, ArH3). 
13C NMR (CDCl3, 75 MHz); δ 163.8 (CNO), 132.7 (ArC2), 131.7 (ArC3), 122.1 (ArC1). 
HRMS (EI) 184.9480 (M+); C6H4BrNO requires 184.9476. 
 
1-Iodo-4-nitrosobenzene (4.26) 
 
I
NO
4.26
 
A solution of 4-iodoaniline (4.99 g, 22.8 mmol) in dichloromethane (120 mL) was 
oxidised with MoVI/hydrogen peroxide over 16 h according to General Method J. The 
crude nitrosobenzene was subjected to flash chromatography, eluting with progressively 
more polar solvent systems (petroleum ether to 1:1 dichloromethane/petroleum ether), to 
remove multiple by-products. Only the green band of interest was collected. A second 
column (1:1 dichloromethane/petroleum ether) afforded 4.26 as a green solid (1.00 g, 19 
%). An analytical sample was obtained by recrystallisation from aqueous EtOH resulting 
in green needles. 
mp 101-102 °C 
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1H NMR (CDCl3, 500 MHz); δ 8.03 (d, 2H, J = 8.5 Hz, ArH2), 7.60 (d, 2H, J = 8.5 Hz, 
ArH3). 
13C NMR (CDCl3, 75 MHz); δ 164.2 (CNO), 138.7 (ArC2), 121.8 (ArC3), 105.5 (ArC1). 
HRMS (EI) 232.9346 (M+); C6H4INO requires 232.9338. 
 
4-Nitrosobenzoic acid ethyl ester (4.27) 
 
NO
EtO
O
4.27
 
A suspension of 4-aminobenzoic acid ethyl esterξ (825 mg, 5.00 mmol) in 
dichloromethane (25 mL) was oxidised with MoVI/hydrogen peroxide following General 
Method J. The crude nitrosobenzene was subjected to flash chromatography (1:9 ethyl 
acetate/dichloromethane) to afford 4.27 as a yellow/green solid (569 mg, 64 %). An 
analytical sample was recrystallised from aqueous EtOH affording a yellow solid. 
mp 79-80 °C 
1H NMR (CDCl3, 500 MHz); δ 8.30 (d, 2H, J = 8.0 Hz, ArH3), 7.93 (d, 2H, J = 8.0 Hz, 
ArH2), 4.44 (dd, 2H, J = 6.7, 13.7 Hz, CH2), 1.44 (t, 3H, J = 6.8 Hz, CH3). 
13C NMR (CDCl3, 75 MHz); δ 165.2, 164.2, 130.9 (ArC3), 120.3 (ArC2), 61.8 (CH2), 14.2 
(CH3). 
HRMS (EI) 179.0590 (M+); C9H9NO3 requires 179.0582. 
 
                                                 
ξ Kindly gifted by T. Cain. 
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7.4.4 Synthesis of Metanilamides 
 
2S-(3-Nitrobenzenesulfonylamino)-3-phenylpropionic acid methyl ester (4.28) 
 
O2S N
H
OMe
O
NO2
Ph
4.28
 
3-Nitrobenzenesulfonyl chloride (1.08 g, 4.87 mmol), L-phenylalanine methyl ester 
hydrochloride (1.21 g, 5.61 mmol) and Hünigs base (1.96 mL, 11.2 mmol) in dry 
dichloromethane (20 mL) were heated at reflux following General Method C to give the 
desired product as a pale yellow oil. Flash chromatography (dichloromethane) of the crude 
ester afforded 4.28 as a pale yellow solid (1.71 g, 96 %). 
[α]D = -28.5 (c = 0.78, MeOH) 
mp 91-92 °C 
1H NMR (CDCl3, 500 MHz); δ 8.46 (s, 1H, ArH2) 8.33 (dd, 1H, J = 2.3, 8.3 Hz, ArH6) 
8.00 (d, 1H, J = 7.8 Hz, ArH4), 7.60 (t, 1H, J = 8.0 Hz, ArH5), 7.16 (m, 3H, o/p-Ph), 7.04 
(dd, 1H, J = 1.8, 7.4 Hz, m-Ph), 5.63 (d, 1H, J = 9.4 Hz, NH), 4.27 (m, 1H, α-H), 3.63 (s, 
3H, OCH3), 3.11 (dd, 1H, J = 5.2, 13.9 Hz, PhCHa), 2.95 (dd, 1H, J = 7.8, 13.8 Hz, 
PhCHb). 
13C NMR (CDCl3, 75 MHz); δ 171.2 (CO2Me), 148.0 (ArC3), 141.9 (ArC1), 134.8 (i-Ph), 
132.4 (ArC6) 130.2 (ArC5), 129.2 (m-Ph), 128.6 (o-Ph), 127.2, 126.9, 122.1 (ArC2), 57.2 
(α-C), 52.7 (OCH3), 39.0 (PhCH2). 
HRMS (ES); 365.0820 (MH+); C16H17N2O6S requires 365.0807. 
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2S-(3-Aminobenzenesulfonylamino)-3-phenylpropionic acid methyl ester (4.29) 
 
O2S N
H
OMe
O
NH2
Ph
4.29
 
Ester 4.28 (1.46 g, 4.00 mmol) was reduced under an atmosphere of hydrogen as described 
in General Method I to give metanilamide 4.29 as a glassy off-white solid (1.28g, 96 %). 
1H NMR (acetone-d6, 500 MHz); δ 7.38-7.27 (m, 6H, o/m/p-Ph, NH), 7.16 (t, 1H, J = 1.9 
Hz, ArH2), 7.05 (d, 1H, J = 7.7 Hz, ArH6), 6.97 (dd, 1H, J = 2.1, 8.0 Hz, ArH5), 6.85 (d, 
1H, J = 9.3 Hz, ArH4), 5.20 (br s, 2H, ArNH2), 4.23 (m, 1H, α-H), 3.56 (s, 3H, OCH3), 
3.11 (dd, 1H, J = 6.9, 13.6 Hz, PhCHa) 3.03 (dd, 1H, J = 7.4, 13.6 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); δ 171.4 (CO2Me), 149.3 (ArC3), 141.7 (ArC1), 136.5 (i-
Ph), 129.7 (ArC5), 129.5 (m-Ph), 128.5 (o-Ph), 127.0 (p-Ph), 118.0 (ArC4), 114.7 (ArC6), 
112.1 (ArC2), 57.8 (α-C), 51.5 (OCH3), 38.9 (PhCH2). 
HRMS (ES); 335.1060 (MH+); C16H19N2O4S requires 335.1066. 
 
(1S*,2R*)-N-(1-Benzyl-3,3,3-trifluoro-2-hydroxypropyl)-3-nitrobenzenesulfonamide 
(4.30) 
 
O2S N
H
Ph
CF3
OH
NO2 4.30
 
3-Nitrobenzenesulfonyl chloride (222 mg, 1.00 mmol), 2.6 (269 mg, 1.05 mmol) and 
Hünigs base (0.37 mL, 2.12 mmol) in dry dichloromethane (10 mL) were heated at reflux 
following General Method C to give the desired product as a pale brown oil. Flash 
chromatography (dichloromethane) of the crude trifluoromethyl carbinol gave 4.30 as a 
pale yellow solid (400 mg, 99 %, single diastereomer). 
mp 116-118 °C 
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1H NMR (CDCl3, 500 MHz); δ 8.26 (d, 1H, J = 8.2 Hz, ArH6), 8.12 (s, 1H, ArH2), 7.78 
(d, 1H, J = 7.9 Hz, ArH4), 7.48 (t, 1H, J = 8.0 Hz, ArH5), 6.97-6.94 (m, 3H, o/p-Ph), 6.85 
(dd, 2H, J = 2.8, 6.3 Hz, m-Ph), 5.44 (d, 1H, J = 8.1 Hz, NH), 4.55 (m, 1H, β-H), 3.71 (m, 
1H, α-H), 3.70 (br s, OH), 2.97 (dd, 1H, J = 3.3, 14.4 Hz, PhCHa), 2.68 (dd, 1H, J = 11.6, 
14.4 Hz, PhCHb). 
13C NMR (CDCl3, 75 MHz); δ 148.2 (ArC3), 140.6 (ArC1), 136.0 (i-Ph), 132.1 (ArC6), 
130.0 (ArC5), 128.8 (Ph), 128.6 (Ph), 127.0, 126.7, 124.1 (q, J = 283.3 Hz, CF3), 122.0 
(ArC2), 72.7 (q, J = 30.1 Hz, β-C), 56.3 (α-C), 34.2 (PhCH2). 
19F NMR (CDCl3, 282 MHz); δ -74.7 (d, 3F, J = 7.4 Hz). 
Could not obtain LRMS or HRMS using ES. 
 
3-Amino-(1S*,2R*)-N-(1-Benzyl-3,3,3-trifluoro-2-hydroxypropyl)benzenesulfonamide 
(4.31) 
 
O2S N
H
Ph
CF3
OH
NH2 4.31
 
A solution of 4.30 (302 mg, 0.75 mmol) was reduced under an atmosphere of hydrogen as 
described in General Method I to give the metanilamide 4.31 as a foamy off-white solid 
(267 mg, 95 %, single diastereomer). Recrystallisation of the crude metanilamide from 
ethyl acetate gave pale yellow shingles. 
mp 131-134 °C 
1H NMR (CDCl3, 500 MHz); δ 7.02 (m, 3H, m/p-Ph), 6.92 (t, 1H, J = 7.9 Hz, ArH5), 6.88 
(dd, 2H, J = 2.5, 6.0 Hz, o-Ph), 6.70 (d, 1H, J = 7.7 Hz, ArH6), 6.61 (d, 1H, J = 8.0 Hz, 
ArH4), 6.57 (s, 1H, ArH2), 5.92 (d, 1H, J = 8.0 Hz, NH), 5.84 (br s, 1H, OH), 4.22 (m, 
1H, β-H), 3.94 (b, 2H, ArNH2), 3.58 (m, 1H, α-H), 2.81 (dd, 1H, J = 3.6, 14.4 Hz, 
PhCHa), 2.64 (dd, 1H, J = 10.7, 14.4 Hz, PhCHb). 
13C NMR (CDCl3, 75 MHz); δ 147.1 (ArC3), 139.9 (ArC1), 136.7 (i-Ph), 129.3 (ArC5), 
128.9 (Ph), 128.0 (Ph), 126.2 (p-Ph), 124.5 (q, J = 283.6 Hz, CF3), 118.4 (ArC4), 115.7 
(ArC6), 112.1(ArC2), 71.7 (q, J = 29.2 Hz, β-C), 55.6 (α-C), 33.9 (PhCH2). 
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19F NMR (CDCl3, 282 MHz); δ -74.1 (d, 3F, J = 8.0 Hz). 
HRMS (ES); 375.0991 (MH+); C16H18F3N2O3S requires 375.0990. 
 
4-(Methyl-2S-(3-nitrobenzenesulfonylamino)pentanoic acid methyl ester (4.32) 
 
O2S N
H
OMe
O
NO2
4.32
 
3-Nitrobenzenesulfonyl chloride (2.22 g, 10.0 mmol), L-leucine methyl ester 
hydrochloride (2.04 g, 11.0 mmol) and Hünigs base (3.83 mL, 22.0 mmol) in dry 
dichloromethane (50 mL) were heated at reflux following General Method C to give the 
desired product as a thick yellow oil. Flash chromatography (2:3 ethyl acetate/petroleum 
ether) of the crude ester gave 4.32 as a very pale yellow solid (3.10 g, 94 %, single 
enantiomer). 
[α]D = +2.8 (c = 1.01, MeOH) 
1H NMR (CDCl3, 500 MHz); δ 8.67 (s, 1H, ArH2), 8.42 (d, 1H, J = 8.1 Hz, ArH6), 8.18 
(d, 1H, J = 7.9 Hz, ArH4), 7.73 (t, 1H, J = 8.0 Hz, ArH5), 5.49 (d, 1H, J = 9.9 Hz, NH), 
4.04 (dd, 1H, J = 7.3, 17.2 Hz, α-H), 3.48 (s, 3H, OCH3), 1.76 (m, 1H, LeuCH), 1.53 (t, 
2H, J = 7.2 Hz, LeuCH2), 0.89 (dd, 6H, J = 6.6, 9.5 Hz, LeuCH3). 
13C NMR (CDCl3, 75 MHz); δ 172.3 (CO2Me), 148.0 (ArC3), 142.1 (ArC1), 132.7 
(ArC6), 130.4 (ArC5), 127.1 (ArC4), 122.3 (ArC2), 54.5 (α-C), 52.4 (OCH3), 41.9 
(LeuCH2), 24.2 (LeuCH), 22.6 (LeuCH3), 21.2 (LeuCH3). 
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4-Methyl-2S-(3-nitrobenzenesulfonylamino)pentanoic acid (4.33) 
 
O2S N
H
OH
O
NO2 4.33
 
Methyl ester 4.32 (2.31 g, 6.99 mmol) was hydrolysed with K2CO3 (1.45 g, 10.5 mmol) in 
MeOH/H2O as described in General Method H affording the free acid 4.33 as a white solid 
(2.00 g, 90 %). 
[α]D = +12.4 (c = 1.01, MeOH) 
mp 144-146 °C 
1H NMR (acetone-d6, 500 MHz); δ 8.76 (s, 1H, ArH2), 8.60 (d, 1H, J = 8.3 Hz, ArH6), 
8.39 (d, 1H, J = 7.8 Hz, ArH4), 8.02 (t, 1H, J = 8.0 Hz, ArH5), 7.40 (d, 1H, J = 9.5 Hz, 
NH), 4.16 (m, 1H, α-H), 1.92 (m, 1H, LeuCH), 1.71 (m, 2H, LeuCH2), 1.02 (dd, 6H, J = 
6.6, 16.5 Hz, LeuCH3). 
13C NMR (acetone-d6, 75 MHz); 172.4 (CO2H), 148.4 (ArC3), 143.4 (ArC1), 133.0 
(ArC6), 131.0 (ArC5), 127.0 (ArC4), 122.1 (ArC2), 54.6 (α-C), 41.6 (LeuCH2), 24.4 
(LeuCH), 22.4 (LeuCH3), 20.8 (LeuCH3). 
 
4-Methyl-2S-(3-nitrobenzenesulfonylamino)pentanoic acid (1S*-benzyl-3,3,3-tri-
fluoro-2-hydroxypropyl)amide (4.34) 
 
O2S N
H
H
N
O
CF3
Ph
OH
NO2 4.34
 
The free acid 4.33 (1.58 g, 5.00 mmol) and 2.6 (1.40 g, 5.48 mmol) were coupled together 
utilising BOP (2.21 g, 5.00 mmol) and Hünigs base (1.92 mL, 11.0 mmol) in 
dichloromethane (20 mL) following General Method E to give the desired product as a 
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yellow solid. The crude trifluoromethyl carbinol was purified by flash chromatography 
(2:3 ethyl acetate/petroleum ether) to afford 4.34 as an off-white solid (2.21 g, 85 %) 
comprising a mixture of diastereomers (49:51 by 1H NMR). 
[α]D = +4.9 (c = 1.01, MeOH) 
mp 162-163 °C 
1H NMR (acetone-d6, 500 MHz); Mixture (49:51) δ 8.73 (t, 1H, J = 1.9 Hz, ArH2), 8.71* 
(t, 1H, J = 1.9 Hz, ArH2), 8.57 (m, 2H, ArH4, major + minor), 8.33* (d, 1H, J = 7.8 Hz, 
ArH6), 8.23 (d, 1H, J = 7.8 Hz, ArH6), 7.99* (t, 1H, J = 8.0 Hz, ArH5), 7.89 (t, 1H, J = 8.0 
Hz, ArH5), 7.66 (d, 1H, J = 8.2 Hz, TFMC NH), 7.59* (d, 1H, J = 8.7 Hz, TFMC NH), 
7.40-7.29 (m, 10H, o/m/p-Ph, major + minor), 7.21 (d, 1H, J = 8.5 Hz, LeuNH), 7.12* (d, 
1H, J = 9.2 Hz, LeuNH), 5.85 (d, 1H, J = 6.6 Hz, OH), 5.69* (d, 1H, J = 6.7 Hz, OH), 
4.42* (m, 1H, TFMC α-H), 4.31 (m, 1H, TFMC α-H), 4.14 (m, 1H, TFMC β-H), 4.01 (m, 
2H, Leu α-H, major + minor), 3.89* (m, 1H, β-H), 3.16-2.88 (m, 4H, PhCH2, major + 
minor), 1.73 (m, 1H, LeuCH), 1.56* (m, 1H, LeuCH), 1.44 (m, 2H, LeuCH2), 1.12* (m, 
1H, LeuCH2), 0.90 (d, 3H, J = 6.7 Hz, LeuCH3), 0.84* (d, 3H, J = 6.6 Hz, LeuCH3), 0.81 
(d, 3H, J = 6.5 Hz, LeuCH3), 0.80* (d, 3H, J = 6.6 Hz, LeuCH3). 
13C NMR (acetone-d6, 75 MHz); Mixture δ 171.4 (CONH), 171.0* (CONH), 148.3 (ArC3) 
148.3* (ArC3), 143.5* (ArC1), 143.3 (ArC1), 138.1* (i-Ph), 138.0 (i-Ph), 132.9 (ArC6,) 
132.9* (ArC6), 131.0 (ArC5), 130.9* (ArC5), 129.6, 129.6*, 128.5, 128.5*, 127.0, 127.0*, 
126.6, 126.6*, 125.5 (q, J = 283.4 Hz, CF3), 125.2* (q, J = 283.6 Hz, CF3), 122.1 (ArC2,) 
122.1* (ArC2), 71.7* (q, J = 29.1 Hz, β-C), 70.9 (q, J = 28.9 Hz, β-C), 55.6, 55.3*, 51.3, 
50.6*, 42.3* (LeuCH2), 42.2 (LeuCH2), 34.5 (PhCH2), 34.5* (PhCH2), 24.2, 24.1*, 22.6 
(LeuCH3), 22.6* (LeuCH3), 20.8* (LeuCH3), 20.7 (LeuCH3). 
19F NMR (acetone-d6, 282 MHz); Mixture (48:52) δ -74.3* (d, 3F, J = 7.1 Hz), -74.5 (d, 
3F, J = 7.3 Hz). 
HRMS (ES) 518.1569 (MH+); C22H27F3N3O6S requires 518.1573. 
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7.4.5 Synthesis of Sulfanilamides 
 
2S-(4-Nitrobenzenesulfonylamino)-3-phenylpropionic acid methyl ester (4.35) 
 
O2N
O2S N
H
Ph
OMe
O
4.35
 
4-Nitrobenzenesulfonyl chloride (886 mg, 4.00 mmol), L-phenylalanine (950 mg, 4.40 
mmol) and Hünigs base (1.53 mL, 8.80 mmol) in dry dichloromethane (25 mL) were 
heated at reflux following General Method C. Flash chromatography (dichloromethane) of 
the crude ester, followed by recrystallisation from aqueous MeOH gave 4.35 as a pale 
yellow solid (1.18 g, 81 %). 
[α]D = -17.5 (c = 0.50, MeOH) 
mp 151-152 °C 
1H NMR (acetone-d6,500 MHz); δ 8.39 (d, 2H, J = 8.7 Hz, ArH3), 8.00 (d, 2H, J = 8.7 Hz, 
ArH2), 7.59 (d, 1H, J = 9.3 Hz, NH), 7.29 (m, 5H, o/m/p-Ph), 4.38 (m, 1H, α-H), 3.65 (s, 
3H, OCH3), 3.21 (dd, 1H, J = 5.4, 13.8 Hz, PhCHa), 3.02 (dd, 1H, J = 9.1, 13.8 Hz, 
PhCHb). 
13C NMR (acetone-d6, 75 MHz); δ 171.3 (CO2Me), 150.0 (ArC4), 146.9 (ArC1), 136.5 (i-
Ph), 129.5, 128.5, 128.2, 127.0 (p-Ph), 124.3 (ArC3), 58.0 (α-C), 51.8 (OCH3), 38.5 
(PhCH2). 
HRMS (ES); 365.0812 (MH+); C16H17N2O6S requires 365.0807. 
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2S-(4-Aminobenzenesulfonylamino)-3-phenylpropionic acid methyl ester (4.36) 
 
H2N
O2S N
H
Ph
OMe
O
4.36
 
Ester 4.35 (729 mg, 2.00 mmol) was reduced in an atmosphere of hydrogen following 
General Method I to give sulfanilamide 4.36 as a pale yellow solid. Flash chromatography 
(1:9 ethyl acetate/dichloromethane gave a white solid (655 mg, 98 %). 
[α]D = +8.8 (c = 1.0, MeOH) 
mp 111-112 °C 
1H NMR (acetone-d6,500 MHz); δ 7.54 (d, 2H, J = 8.7 Hz, ArH2), 7.34 (m, 2H, m/p-Ph), 
7.27 (d, 2H, J = 6.9 Hz, o-Ph), 6.79 (d, 2H, J = 8.7 Hz, ArH3), 6.59 (d, 1H, J = 9.3 Hz, 
NH), 5.58 (s, 2H, ArNH2), 4.16 (m, 1H, α-H), 3.54 (s, 3H, OCH3), 3.08 (dd, 1H, J = 6.9, 
13.6 Hz, PhCHa), 3.04 (m, 1H, PhCHb). 
13C NMR (acetone-d6, 75 MHz); δ 171.6 (CO2Me), 152.7 (ArC4), 136.6 (i-Ph), 129.5, 
129.2, 128.5, 127.1 (ArC1), 126.9 (p-Ph), 113.2 (ArC3), 57.6 (α-C), 51.5 (OCH3), 38.9 
(PhCH2). 
HRMS (ES); 335.1067 (MH+); C16H19N2O4S requires 335.1066. 
 
(1S*,2R*)-N-(1-Benzyl-3,3,3-trifluoro-2-hydroxypropyl)-4-nitrobenzenesulfonamide 
(4.37) 
 
O2S N
H
Ph
CF3
OHO2N
4.37
 
4-Nitrobenzenesulfonyl chloride (228 mg, 1.00 mmol), 2.6 (281 mg, 1.10 mmol) and 
Hünigs base (0.38 mL, 2.18 mmol) in dry dichloromethane (10 mL) were heated at reflux 
following General Method C. Flash chromatography (dichloromethane) of the crude 
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trifluoromethyl carbinol gave 4.37 as a pale yellow solid (403 mg, quantitative, single 
diastereomer). 
mp 129-131 °C 
1H NMR (acetone-d6, 500 MHz); δ 8.17 (d, 2H, J = 8.9 Hz, ArC3), 7.73 (d, 2H, J = 8.9 Hz, 
ArH2), 7.40 (d, 1H, J = 8.3 Hz, NH), 7.13-7.07 (m, 5H, o/m/p-Ph), 6.05 (d, 1H, J = 6.9 
Hz, OH), 4.56 (m, 1H, β-H), 3.92 (m, 1H, α-H), 3.06 (dd, 1H, J =2.9, 14.4 Hz, PhCHa), 
2.90 (dd, 1H, J = 11.2, 14.4 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); δ 149.6 (ArC4), 146.4 (ArC1), 137.4 (i-Ph), 129.4, 128.4, 
127.7, 126.3 (p-Ph), 125.2 (q, J = 283.5, CF3), 124.2 (ArC3), 73.3 (q, J = 29.0 Hz, β-C), 
56.5 (α-C), 34.1 (PhCH2). 
19F NMR (acetone-d6, 282 MHz); δ -74.2 (d, 3F, J = 8.0 Hz). 
Could not obtain LRMS or HRMS using ES. 
 
4-Amino-(1S*,2R*)-N-(1-benzyl-3,3,3-trifluoro-2-hydroxypropyl)benzenesulfonamide 
(4.38) 
 
O2S N
H
Ph
CF3
OHH2N
4.38
 
A solution of 4.37 (1.32 g, 3.62 mmol) was reduced in an atmosphere of hydrogen 
following General Method I to give the sulfanilamide 4.38 as a pale yellow solid (1.20 g, 
99 %, single diastereomer). 
mp 175-180 °C 
1H NMR (acetone-d6, 500 MHz); δ 7.29-7.24 (m, 5H, ArH2, o/p-Ph), 7.17 (dd, 2H, J = 
3.0, 6.5 Hz, m-Ph), 6.63 (d, 2H, J = 8.7 Hz, ArH3), 6.32 (d, 1H, J = 7.8 Hz, NH), 5.85 (d, 
1H, J = 6.9 Hz, OH), 5.50 (s, 2H, ArNH2), 4.52 (m, 1H, β-H), 3.77 (m, 1H, α-H), 3.04 
(dd, 1H, J = 3.5, 14.5 Hz, PhCHa), 2.92 (dd, 1H, J = 10.2, 14.5 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); δ 152.5 (ArC4), 137.6 (i-Ph), 129.4 (ArC2), 128.8, 128.4, 
126.6 (ArC1), 126.4 (p-Ph), 125.5 (q, J = 283.3 Hz, CF3), 113.3 (ArC3), 71.1 (q, J = 28.8 
Hz, β-C), 55.2 (α-C), 34.3 (PhCH2). 
19F NMR (acetone-d6, 282 MHz); δ -74.1 (d, 3F, J = 8.1 Hz). 
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HRMS (EI) 374.0900 (M+); C16H17F3N2O3S requires 374.0912. 
 
4-(Methyl-2S-(4-nitrobenzenesulfonylamino)pentanoic acid methyl ester (4.39) 
 
O2S N
H
OMe
OO2N
4.39
 
4-Nitrobenzenesulfonyl chloride (2.22 g, 10.0 mmol), L-leucine methyl ester 
hydrochloride (2.04 g, 11.0 mmol) and Hünigs base (3.83 mL, 22.0 mmol) in dry 
dichloromethane (50 mL) were heated at reflux following General Method C to give the 
desired product as a pale brown solid. Flash chromatography (2:3 ethyl acetate/petroleum 
ether) of the crude ester gave 4.39 as a pale yellow solid (3.24 g, 98 %). 
[α]D = +5.8 (c = 1.02, MeOH) 
mp 91-92 °C 
1H NMR (CDCl3, 500 MHz); 8.34 (d, 2H, J = 8.9 Hz, ArH3), 8.03 (d, 2H, J = 8.9 Hz, 
ArH2), 5.32 (d, 1H, J = 9.9 Hz, NH), 4.02 (m, 1H, α-H), 3.49 (s, 3H, OCH3), 1.76 (m, 1H, 
LeuCH) 1.53 (m, 2H, LeuCH2), 0.90 (dd, 6H, J = 6.7, 8.0 Hz, LeuCH3). 
13C NMR (CDCl3, 75 MHz); δ 171.9 (CO2Me), 150.3 (ArC4), 147.1 (ArC1), 128.6 
(ArC2), 124.4 (ArC3), 54.8 (α-C), 51.7 (OCH3), 41.5 (LeuCH2), 24.4 (LeuCH), 22.3 
(LeuCH3), 20.8 (LeuCH3). 
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4-(Methyl-2S-(4-nitrobenzenesulfonylamino)pentanoic acid (4.40) 
 
O2S N
H
OH
OO2N
4.40
 
Methyl ester 4.39 (2.31 g, 6.99 mmol) was hydrolysed with K2CO3 (1.45 g, 10.5 mmol) in 
MeOH/H2O following General Method H to afford the free acid 4.40 as a white solid (1.57 
g, 72 %).ξ
[α]D = +16.7 (c = 1.01, MeOH) 
mp 160-162 °C 
1H NMR (acetone-d6, 500 MHz); δ 8.53 (d, 2H, J = 8.9 Hz, ArH3), 8.25 (d, 2H, J = 8.9 
Hz, ArH2), 7.37 (d, 1H, J = 9.6 Hz, NH), 4.16 (m, 1H, α-H), 1.92 (m, 1H, LeuCH), 1.70 
(m, 1H, LeuCH2), 1.03 (d, 3H, J = 6.6 Hz, LeuCH3), 1.00 (d, 3H, J = 6.6 Hz, LeuCH3). 
13C NMR (acetone-d6, 75 MHz); δ 172.4 (CO2H), 150.2 (ArC4), 147.1 (ArC1), 128.7 
(ArC2), 124.3 (ArC3), 54.6 (α-C), 41.6 (LeuCH2), 24.4 (LeuCH), 22.4 (LeuCH3), 20.7 
(LeuCH3). 
 
4-Methyl-2S-(4-nitrobenzenesulfonylamino)pentanoic acid (1S*,2R*)-(1-benzyl-3,3,3-
trifluoro-2-hydroxypropyl)amide (4.41) 
 
O2S N
H
H
N
OO2N
CF3
Ph
OH
4.41
 
The free acid 4.40 (1.00 g, 3.16 mmol) and 2.6 (0.89 g, 3.48 mmol) were coupled together 
utilising BOP (1.40 g, 3.17 mmol) and Hünigs base (1.21 mL, 6.32 mmol) in 
dichloromethane (20 mL) following General Method E to give the desired product as a 
                                                 
ξ Lower than expected yield due to spillage of reaction mixture! 
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pale orange solid. The crude trifluoromethyl carbinol was purified twice by flash 
chromatography (1:9 ethyl acetate/dichloromethane) to afford 4.41 as an off-white solid 
(1.26 g, 77 %) comprising a mixture of diastereomers (2:3 by 1H NMR). 
[α]D = +3.5 (c = 1.0, MeOH) 
1H NMR (acetone-d6, 500 MHz); Mixture (2:3) δ 8.50 (d, 2H, J = 8.8 Hz, ArH3), 8.38* (d, 
2H, J = 8.8 Hz, ArH3), 8.18 (d, 2H, J = 8.8 Hz, ArH2), 8.09* (d, 2H, J = 8.8 Hz, ArH2), 
7.69* (d, 1H, J = 8.0 Hz, TFMC NH), 7.62 (d, 1H, J = 8.7 Hz, TFMC NH), 7.42-7.28 (m, 
10H, o/m/p-Ph, major + minor), 7.19* (d, 1H, J = 9.3 Hz, LeuNH), 7.10 (d, 1H, J = 9.2 Hz, 
LeuNH), 5.88* (d, 1H, J = 6.4 Hz, OH), 5.77 (d, 1H, J = 6.5 Hz, OH), 4.44 (m, 1H, TFMC 
α-H), 4.29* (m, 1H, TFMC α-H), 4.15* (m, 1H, TFMC β-H), 4.02 (m, 2H, Leu α-H, 
major + minor), 3.91 (m, 1H, TFMC β-H), 3.12 (m, 1H, PhCHa), 3.02* (m, 1H, PhCH2), 
2.92 (dd, 1H, J = 11.7, 13.9 Hz, PhCHb), 1.76* (m, 1H, LeuCH), 1.56 (m, 1H, LeuCH), 
1.47* (m, 1H, LeuCHa), 1.41* (m, 1H, LeuCHb), 1.19 (m, 1H, LeuCHa), 1.06 (m, 1H, 
LeuCHb), 0.92* (d, 3H, J = 6.7 Hz, LeuCH3), 0.83 (m, 9H, LeuCH3, major + minor). 
13C NMR (acetone-d6, 75 MHz); Mixture δ 171.4* (CONH), 171.0 (CONH), 150.2 (ArC4), 
150.1* (ArC4), 147.3 (ArC1), 147.1* (ArC1), 138.2* (i-Ph), 138.1 (i-Ph), 129.6 (x2), 128.6 
(x2), 128.5 (x2), 126.6* (p-Ph), 126.6 (p-Ph), 125.5* (q, J = 285.3 Hz, CF3), 125.3 (q, J = 
283.5 Hz, CF3), 124.3* (ArC3), 124.3 (ArC3), 71.7 (q, J = 29.1 Hz, β-C), 71.0* (q, J = 28.8 
Hz, β-C), 55.6*, 55.4, 51.5*, 50.6, 42.3 (LeuCH2), 42.3* (LeuCH2), 34.5* (PhCH2), 34.4 
(PhCH2), 24.2* (LeuCH), 24.1 (LeuCH), 22.6 (LeuCH3), 22.6* (LeuCH3), 20.8 (LeuCH3), 
20.7* (LeuCH3).  
19F NMR (acetone-d6, 282 MHz); Mixture (2:3) δ -74.3 (d, 3F, J = 7.6 Hz), -74.5 (d, 3F, J 
= 7.8 Hz). 
HRMS (ES) 518.1576 (MH+); C22H27F3N3O6S requires 518.1573. 
 
Chapter Seven: Experimental 242
4-Methyl-2S-(4-aminobenzenesulfonylamino)pentanoic acid (1S*,2R*)-(1-benzyl-3,3,3-
trifluoro-2-hydroxypropyl)amide (4.42) 
 
O2S N
H
H
N
OH2N
CF3
Ph
OH
4.42
 
A solution of 4.41 (1.05 g, 2.03 mmol, ) was reduced under an atmosphere of hydrogen 
following General Method I. Flash chromatography (1:4 ethyl acetate/dichloromethane) of 
the crude sulfanilamide afforded 4.42 as a white solid (858 mg, 87 %) comprising a 
mixture of diastereomers (2:3 by 1H NMR). 
[α]D = -26.2 (c = 1.0, MeOH) 
1H NMR (acetone-d6, 500 MHz); Mixture (2:3) δ 7.61 (dd, 4H, J = 3.3, 8.7 Hz, ArH2, 
major + minor), 7.51 (m, 2H, TFMC NH, major + minor), 7.40-7.30 (m, 10H, o/m/p-Ph, 
major + minor), 6.84 (t, 4H, J = 8.3 Hz, ArH3, major + minor), 6.36* (d, 1H, J = 7.0 Hz, 
LeuNH), 6.14 (d, 1H, J = 8.5 Hz, LeuNH), 5.86* (d, 1H, J = 6.5 Hz, OH), 5.65 (d, 1H, J = 
6.3 Hz, OH), 5.60* (s, 2H, ArNH2), 5.57 (s, 2H, ArNH2), 4.46 (m, 2H, TFMC α-H, major 
+ minor), 4.19* (m, 1H, TFMC β-H), 4.07 (m, 1H, TFMC β-H), 3.73 (m, 1H, Leu α-H), 
3.68* (m, 1H, Leu α-H), 3.09 (m, 2H, PhCHa, major + minor), 2.98 (m, 2H, PhCHa, major 
+ minor), 1.61* (m, 1H, LeuCH), 1.53 (m, 1H, LeuCH), 1.31* (m, 2H, LeuCH2), 1.15 (m, 
2H, LeuCH2), 0.83* (d, 3H, J = 6.7 Hz, LeuCH3), 0.81 (d, 3H, J = 6.6 Hz, LeuCH3), 0.74 
(d, 3H, J = 6.5 Hz, LeuCH3), 0.69* (d, 3H, J = 6.5 Hz, LeuCH3). 
13C NMR (acetone-d6, 75 MHz); Mixture δ 172.3* (CONH), 172.0 (CONH), 152.9* 
(ArC4), 152.7 (ArC4), 138.2 (i-Ph), 138.0* (i-Ph), 129.6* (ArC2), 129.6 (ArC2), 129.4, 
129.4*, 128.4, 128.4*, 127.2 (ArC1), 127.2* (ArC1), 126.5 (p-Ph) 126.5* (p-Ph), 125.5* (q, 
J = 283.2 Hz, CF3), 125.4 (q, J = 283.4 Hz, CF3), 113.2 (ArC3), 113.2* (ArC3), 71.5 (q, J = 
29.1 Hz, β-C), 71.0* (q, J = 28.9 Hz, β-C), 55.5*, 55.1, 50.9*, 50.5, 42.3(LeuCH2), 42.1* 
(LeuCH2), 34.5* (PhCH2), 34.2 (PhCH2), 24.1* (LeuCH), 24.0 (LeuCH), 22.6 (LeuCH3), 
22.5* (LeuCH3), 21.0 (LeuCH3), 20.9* (LeuCH3). 
19F NMR (acetone-d6, 282 MHz); Mixture (43:57) δ -74.2* (d, 3F, J = 7.3 Hz), -74.4 (d, 
3F, J = 7.8 Hz).  
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HRMS (EI) 487.1757 (M+); C22H28F3N3O4S requires 487.1753. 
 
7.4.6 Synthesis of 4’,3-disubstituted azobenzenes 
 
E-[(1S*,2R*)-N-(1-Benzyl-3,3,3-trifluoro-2-hydroxypropyl)-3-(4-bromophenylazo) 
benzenesulfonamide] (4.43) 
 
N N
Br
S
O2
H
N CF3
OH
Ph
4.43
 
Metanilamide 4.31 (103 mg, 0.30 mmol) and 4-bromonitrosobenzene 4.25 (56 mg, 0.30 
mmol) in glacial acetic acid (1.2 mL) were condensed following General Method K. 
Column chromatography of the crude azobenzene (1:9 ethyl acetate/dichloromethane) 
gave 4.43 as an orange solid (123 mg, 76 %, single diastereomer). 
mp 140-141 °C 
1H NMR (acetone-d6, 500 MHz); δ 8.14 (d, 1H, J = 7.9 Hz, ArH4), 8.05 (d, 2H, J = 8.7 
Hz, ArH2’), 8.01 (s, 1H, ArH2), 7.95 (d, 2H, J = 8.7 Hz, ArH3’), 7.73 (d, 1H, J = 7.9 Hz, 
ArH6), 7.67 (t, 1H, J = 6.1 Hz, ArH5), 7.17 (d, 1H, J = 8.2 Hz, NH), 7.13 (d, 2H, J = 7.2 
Hz, o-Ph), 7.05 (t, 2H, J = 7.3 Hz, m-Ph), 7.00 (m, 1H, J = 7.3 Hz, p-Ph), 6.04 (d, 1H, J = 
6.9 Hz, OH), 4.58 (m, 1H, β-H), 3.94 (m, 1H, α-H), 3.06 (dd, 1H, J = 3.0, 14.4 Hz, 
PhCHa) 2.94 (dd, 1H, J = 10.9, 14.4 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); δ 152.3, 151.5, 142.4 (ArC3), 137.4 (i-Ph), 132.9 
(ArC3’), 130.3, 129.3 (Ph), 129.1, 128.3 (Ph), 127.1, 126.7 (p-Ph), 125.9 (ArC4’), 125.4 
(q, J = 283.5 Hz, CF3), 124.9 (ArC2’), 120.0 (ArC2), 73.0 (q, J = 28.8 Hz, β-C), 56.2 (α-
C), 34.2 (PhCH2). 
19F NMR (acetone-d6, 282 MHz); δ -74.2 (d, 3F, J = 8.0 Hz). 
HRMS (EI) 541.0278 (M+); C22H19BrF3N3O3S requires 541.0283. 
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E-[N-(1S*-Benzyl-3,3,3-trifluoro-2-oxopropyl)-3-(4-bromophenylazo)benzene 
sulfonamide] (4.44) 
 
N N
Br
S
O2
H
N CF3
O
Ph4.44
 
A solution of 4.43 (22 mg, 40 µmol) in dichloromethane (0.5 mL) was oxidised with 
TEMPO/NaOCl in 2 h following Modified General Method G. Flash chromatography (1:9 
ethyl acetate/dichloromethane) of the crude product, followed by recrystallisation from 
aqueous MeOH gave the hydrate of 4.44 as an orange solid (18 mg, 83 %, racemic). 
mp 86-88 ºC 
1H NMR (acetone-d6, 500 MHz); Hydrate δ 8.06 (d, 1H, J = 7.9 Hz, ArH4), 8.01 (d, 2H, J 
= 8.7 Hz, ArH2’), 7.91 (d, 3H, J = 8.8 Hz, ArH3’, ArH2), 7.74 (d, 1H, J = 7.9 Hz, ArH6), 
7.62 (t, 1H, J = 7.9 Hz, ArH5), 7.10 (d, 2H, J = 7.2 Hz, o-Ph), 6.95 (t, 2H, J = 7.4 Hz, m-
Ph), 6.89 (t, 1H, J = 7.3 Hz, p-Ph), 4.08 (dd, 1H, J = 2.5, 11.0 Hz, α-H), 3.31 (dd, 1H, J = 
2.6, 14.3 Hz, PhCHa), 2.76 (dd, 1H, J = 11.1, 14.3 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); Hydrate δ 151.8, 151.2, 143.2 (ArC3), 137.8 (i-Ph), 132.7 
(ArC3’), 130.0, 129.2 (Ph), 128.9, 128.1 (Ph), 126.8, 126.4, 125.7 (ArC4’), 124.7 (ArC2’), 
119.6 (ArC2), 93.5 (q, J = 29.7 Hz, β-C), 60.8 (α-C), 35.4 (PhCH2). Couldn’t detect CF3 
quartet over baseline noise. 
19F NMR (acetone-d6, 282 MHz); Hydrate δ -78.9 (s, 3F). 
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E-[(1S*,2R*)-N-(1-Benzyl-3,3,3-trifluoro-2-hydroxypropyl)-3-(4-iodophenylazo) 
benzenesulfonamide] (4.45) 
 
N N
I
S
O2
H
N CF3
OH
Ph
4.45
 
Metanilamide 4.31 (103 mg, 0.30 mmol) and 4-iodonitrosobenzene 4.26 (70 mg, 0.30 
mmol) in glacial acetic acid (1.2 mL) were condensed following General Method K. 
Column chromatography of the crude azobenzene (1:9 ethyl acetate/dichloromethane) 
gave the 4.45 as an orange solid (137 mg, 77 %, single diastereomer). 
mp 134-137 °C 
1H NMR (acetone-d6, 500 MHz); δ 8.16 (d, 2H, J = 8.7 Hz, ArH3’), 8.14 (d, 1H, J = 7.9 
Hz, ArH4), 8.01 (s, 1H, ArH2), 7.89 (d, 2H, J = 8.6 Hz, ArH2’), 7.73 (d, 1H, J = 7.8 Hz, 
ArH6), 7.66 (t, 1H, J = 7.8 Hz, ArH5), 7.17 (d, 1H, J = 8.2 Hz, NH), 7.13 (d, 2H, J = 7.1 
Hz, o-Ph), 7.05 (t, 2H, J = 7.3 Hz, m-Ph), 6.99 (t, 1H, J = 7.2 Hz, p-Ph), 6.02 (d, 1H, J = 
6.9 Hz, OH), 4.59 (m, 1H, β-H), 3.94 (m, 1H, α-H), 3.06 (dd, 1H, J = 2.9, 14.4 Hz, 
PhCHa), 2.94 (dd, 1H, J = 10.9, 14.4 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); δ 152.2, 151.9, 142.4 (ArC3), 139.0 (ArC3’), 137.4 (i-
Ph), 130.2, 129.2 (Ph), 129.1, 128.3 (Ph), 127.1, 126.6, 125.4 (q, J = 283.4 Hz, CF3), 124.8 
(ArC2’), 120.0 (ArC2), 98.5 (ArC4’), 73.0 (q, J = 28.7 Hz, β-C), 56.2 (α-C), 34.1 
(PhCH2). 
19F NMR (acetone-d6, 282 MHz); δ -74.2 (d, 3F, J = 8.0 Hz). 
HRMS (EI) 589.0146 (M+); C22H19F3IN3O3S requires 589.0144. 
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E-[N-(1S*-Benzyl-3,3,3-trifluoro-2-oxopropyl)-3-(4-iodophenylazo)benzene 
sulfonamide] (4.46) 
 
N N
I
S
O2
H
N CF3
O
Ph
4.46
 
A solution of 4.45 (24 mg, 40 µmol) in dichloromethane (0.5 mL) was oxidised with 
TEMPO/NaOCl in 2 h following Modified General Method G. Flash chromatography (1:9 
ethyl acetate/dichloromethane) of the crude product, followed by recrystallisation from 
aqueous MeOH gave the ketone/hydrate mixture 4.46 as an orange solid (19 mg, 81 %, 
racemic). One drop of D2O was added to the NMR mixture to give the hydrate exclusively. 
mp 109-112 °C 
1H NMR (acetone-d6, 500 MHz); Hydrate δ 8.14 (d, 2H, J = 8.5 Hz, ArH3’), 8.07 (d, 1H, J 
= 7.8 Hz, ArH4), 7.92 (s, 1H, ArH2), 7.87 (d, 2H, J = 8.5 Hz, ArH2’), 7.73 (d, 1H, J = 7.9 
Hz, ArH6), 7.63 (t, 1H, J = 7.8 Hz, ArH5), 7.10 (d, 2H, J = 7.4 Hz, o-Ph), 6.96 (t, 2H, J = 
7.5 Hz, m-Ph), 6.89 (t, 1H, J = 7.4 Hz, p-Ph), 4.08 (dd, 1H, J =2.2, 11.0 Hz, α-H), 3.30 
(dd, 1H, J = 2.4, 14.2 Hz, PhCHa), 2.76 (dd, 1H, J = 11.3, 14.1 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); Hydrate δ 152.0, 151.9, 143.0 (ArC3), 138.9 (ArC3’), 
137.8 (i-Ph), 130.1, 129.3 (Ph), 129.0, 128.2 (Ph), 127.0, 126.6, 124.7 (ArC2’), 124.0 (q, J 
= 289.2 Hz, CF3), 119.8 (ArC2), 98.4 (ArC4’), 93.8 (q, J = 29.6 Hz, β-C) 61.0 (α-C), 35.5 
(PhCH2). 
19F NMR (acetone-d6, 282 MHz); Hydrate δ -78.9 (s, 3F). 
HRMS (ES) 606.0165 (MH+); C22H20F3IN3O4S requires 606.0171. 
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7.4.7 Synthesis of 4’,4-disubstituted azobenzenes 
 
E-{2S-[4-(4-Bromophenylazo)benzenesulfonylamino]-3-phenylpropionic acid methyl 
ester} (4.47) 
 
N N
Br
O2S N
H
OMe
O
Ph
4.47
 
Sulfanilamide 4.36 (251 mg, 0.75 mmol) and 4-bromonitrosobenzene 4.25 (140 mg, 0.75 
mmol) in glacial acetic acid (3.0 mL) were condensed following General Method K. 
Column chromatography of the crude azobenzene (1:9 ethyl acetate/dichloromethane), 
followed by recrystallisation from aqueous MeOH gave 4.47 as an orange crystalline solid 
(261 mg, 69 %). 
[α]D = +20.0, (c = 0.20, MeOH) 
mp 163-165 °C 
1H NMR (acetone-d6, 500 MHz); 8.10 (d, 2H, J = 8.5 Hz, ArH2), 8.05 (d, 2H, J = 8.6 Hz, 
ArH2’), 8.00 (d, 2H, J = 8.5 Hz, ArH3), 7.95 (d, 2H, J = 8.6 Hz, ArH3’), 7.32 (m, 6H, 
o/m/p-Ph, NH), 4.36 (m, 1H, α-H), 3.58 (s, 3H, OCH3), 3.19 (dd, 1H, J = 6.2, 13.6 Hz, 
PhCHa), 3.06 (dd, 1H, J = 8.4, 13.7 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); δ 171.3 (CO2Me), 154.3, 151.5, 143.4 (ArC4), 136.5 (i-
Ph), 132.9 (ArC3’), 129.5, 128.6, 128.3, 127.0 (p-Ph), 126.2 (ArC4’), 125.0 (ArC2’), 
123.3 (ArC2), 57.9 (α-C), 51.7 (OCH3), 38.7 (PhCH2). 
HRMS (ES) 502.0447 (MH+); C22H21BrN3O4S requires 502.0436. 
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E-[(1S*,2R*)-N-(1-Benzyl-3,3,3-trifluoro-2-hydroxypropyl)-4-(4-bromophenylazo) 
benzenesulfonamide] (4.48) 
 
N N
Br
O2S N
H
Ph
CF3
OH
4.48
 
Sulfanilamide 4.38 (206 mg, 0.60 mmol, single diastereomer) and 4-bromonitrosobenzene 
4.25 (113 mg, 0.60 mmol) in glacial acetic acid (2.4 mL) were condensed following 
General Method K. Column chromatography of the crude azobenzene (1:9 ethyl 
acetate/dichloromethane) gave 4.48 as an orange solid (208 mg, 64 %, single 
diastereomer). An analytical sample was recrystallised from aqueous MeOH to afford an 
orange crystalline solid. 
mp 135-138 °C 
1H NMR (acetone-d6, 500 MHz); δ 8.06 (d, 2H, J = 8.6 Hz, ArH2’), 7.95 (d, 2H, J = 8.6 
Hz, ArH3’), 7.90 (d, 2H, J = 8.5 Hz, ArH2), 7.72 (d, 2H, J = 8.5 Hz, ArH3), 7.16 (m, 3H, 
m-Ph, NH), 7.12 (m, 3H, o/p-Ph), 6.03 (d, 1H, J = 6.9 Hz, OH), 4.56 (m, 1H, β-H), 3.93 
(m, 1H, α-H), 3.07 (dd, 1H, J = 3.0, 14.4 Hz, PhCHa), 3.01 (s, 2H, H2O), 2.95 (dd, 1H, J = 
10.9, 14.6 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); δ 154.0, 151.6, 143.1 (ArC4), 137.5 (i-Ph), 132.9 
(ArC3’), 129.4, 128.5, 127.8, 126.5 (p-Ph), 126.2 (ArC4’), 125.4 (q, J = 283.5 Hz, CF3), 
125.0 (ArC2’), 123.3 (ArC2), 73.0 (q, J = 28.9 Hz, β-H), 56.1 (α-C), 34.2 (PhCH2). 
19F NMR (acetone-d6, 282 MHz); δ -74.2 (d, 3F, J = 8.0 Hz). 
HRMS (EI) 541.0280 (M+); C22H19BrF3N3O3S requires 541.0283. 
 
Chapter Seven: Experimental 249
E-[N-(1S*-Benzyl-3,3,3-trifluoro-2-oxopropyl)-4-(4-bromophenylazo)benzene 
sulfonamide] (4.49) 
 
N N
Br
O2S N
H
Ph
CF3
O
4.49
 
Trifluoromethyl carbinol 4.48 (81 mg, 0.15 mmol, single diastereomer) was oxidised with 
TEMPO/NaOCl over 3 h in a mixture of ethyl acetate/dichloromethane (2:1, 15 mL) 
following General Method G. The crude product was recrystallised from aqueous MeOH 
to afford the hydrate of 4.49 as an orange solid (57 mg, 70 %, racemic). 
1H NMR (acetone-d6, 500 MHz); Hydrate δ 8.08 (d, 2H, J = 8.7 Hz, ArH2’), 7.96 (d, 2H, J 
= 8.7 Hz, ArH3’), 7.86 (d, 2H, J = 8.6 Hz, ArH2), 7.71 (d, 2H, J = 8.6 Hz, ArH3), 7.35 (br 
s, 1H, NH), 7.17 (dd, 2H, J = 1.9, 7.1 Hz, m-Ph), 7.05 (m, 3H, o/p-Ph), 6.37 (br s, 1H, 
OH), 4.05 (d, 1H, J = 9.9 Hz, α-H), 3.37 (dd, 1H, J = 2.4, 14.3 Hz, PhCHa), 2.85 (dd, 1H, 
J = 11.3, 14.3 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); Hydrate δ 153.5, 151.4, 143.7 (ArC4), 137.9 (i-Ph), 
132.8, 129.4, 128.2, 127.5, 126.2 (p-Ph), 125.9 (ArC4’), 124.8, 123.9 (q, J = 289.1 Hz, 
CF3), 123.0, 93.5 (q, J = 29.9 Hz, β-C), 60.8 (α-C), 35.4 (PhCH2). 
19F NMR (acetone-d6, 282 MHz); Hydrate δ -79.0 (s, 3F). 
HRMS (ES) 558.0311 (MH+); C22H20BrF3N3O4S requires 558.0310. 
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E-{2S-[4-(4-Iodophenylazo)benzenesulfonylamino]-3-phenylpropionic acid methyl 
ester} (4.50) 
 
N N
I
O2S N
H
OMe
O
Ph
4.50
 
Sulfanilamide 4.36 (100 mg, 0.30 mmol) and 4-iodonitrosobenzene 4.26 (70 mg, 0.30 
mmol) in glacial acetic acid (1.2 mL) were condensed following General Method K. 
Column chromatography of the crude azobenzene (1:9 ethyl acetate/dichloromethane), 
followed by recrystallisation from aqueous MeOH gave 4.50 as an orange crystalline solid 
(105 mg, 64 %). 
[α]D = +16.3, (c = 0.22, MeOH) 
mp 177-179 °C 
1H NMR (acetone-d6, 500 MHz); δ 8.16 (d, 2H, J = 8.5 Hz, ArH3’), 8.09 (d, 2H, J = 8.4 
Hz, ArH2), 8.00 (d, 2H, J = 8.4 Hz, ArH3), 7.89 (d, 2H, J = 8.5 Hz, ArH2’), 7.31 (m, 6H, 
o/m/p-Ph, NH), 4.35 (m, 1H, α-H), 3.58 (s, 3H, OCH3), 3.19 (dd, 1H, J = 6.2, 13.6 Hz, 
PhCHa), 3.06 (dd, 1H, J = 8.4, 13.6 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); δ 171.3 (CO2Me), 154.3, 152.0, 143.4 (ArC4), 139.0 
(ArC3’), 136.5 (i-Ph), 129.5, 128.6, 128.3, 127.0 (p-Ph), 124.9 (ArC2’), 123.3 (ArC2), 
98.9 (ArC4’), 57.9 (α-C), 51.7 (OCH3), 38.7 (PhCH2). 
HRMS (EI) 550.0313 (MH+);C22H21IN3O4S requires 550.0297. 
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E-[(1S*,2R*)-N-(1-Benzyl-3,3,3-trifluoro-2-hydroxypropyl)-4-(4-iodophenylazo) 
benzenesulfonamide] (4.51) 
 
N N
I
O2S N
H
Ph
CF3
OH
4.51
 
Sulfanilamide 4.38 (127 mg, 0.339 mmol, single diastereomer) and 4-iodonitrosobenzene 
4.26 (79 mg, 0.34 mmol) in glacial acetic acid (1.5 mL) were condensed following General 
Method K. Column chromatography of the crude azobenzene (1:9 ethyl 
acetate/dichloromethane) gave 4.51 as an orange solid (134 mg, 67 %, single 
diastereomer). 
mp 149-150 °C 
1H NMR (acetone-d6, 500 MHz); δ 8.17 (d, 2H, J = 8.5 Hz, ArH3’), 7.91 (d, 2H, J = 8.5 
Hz, ArH2’), 7.90 (d, 2H, J = 8.4 Hz, ArH2), 7.72 (d, 2H, J = 8.4 Hz, ArH3), 7.16 (m, 3H, 
m-Ph, NH), 7.12 (m, 3H, o/p-Ph), 4.56 (m, 1H, β-H), 3.92 (m, 1H, α-H), 3.07 (dd, 1H, J = 
2.9, 14.4 Hz, PhCHa), 2.95 (dd, 1H, J = 10.9, 14.4 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); δ 153.9, 152.0, 143.1 (ArC4), 139.0 (ArC3’), 137.5 (i-
Ph), 129.4, 128.4, 127.7, 126.5 (p-Ph), 125.4 (q, J = 283.4 Hz, CF3), 124.9 (ArC2’), 123.2 
(ArC2), 98.7 (ArC4’), 73.0 (q, J = 28.7 Hz, β-C), 56.1 (α-C), 34.2 (PhCH2). 
19F NMR (acetone-d6, 282 MHz); -74.2 (d, 3F, J = 7.9 Hz). 
HRMS (EI) 589.0155 (M+); C22H19F3IN3O3S requires 589.0144. 
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E-[N-(1S*-Benzyl-3,3,3-trifluoro-2-oxopropyl)-4-(4-iodophenylazo)benzene 
sulfonamide] 4.52 
 
N N
I
O2S N
H
Ph
CF3
O
4.52
 
Trifluoromethyl carbinol 4.51 (88 mg, 0.15 mmol, single diastereomer) was oxidised with 
TEMPO/NaOCl over 3 h in a mixture of ethyl acetate/dichloromethane (2:1, 15 mL) 
following General Method G. The crude product was recrystallised from aqueous MeOH 
to afford the hydrate of 4.52 as an orange solid (53 mg, 60 %, racemic).  
mp 154-156 °C 
1H NMR (acetone-d6, 500 MHz); Hydrate δ 8.17 (d, 2H, J = 8.5 Hz, ArH3’), 7.91 (d, 2H, J 
= 8.5 Hz, ArH2’), 7.85 (d, 2H, J = 8.6 Hz, ArH2), 7.70 (d, 2H, J = 8.6 Hz, ArH3), 7.34 (br 
s, 1H, NH), 7.17 (dd, 2H, J = 1.8, 7.0 Hz, m-Ph), 7.05 (m, 3H, o/p-Ph), 6.38 (br s, 1H, 
OH), 4.05 (d, 1H, J = 10.5 Hz, α-H), 3.36 (dd, 1H, J = 2.2, 14.3 Hz, PhCHa), 2.85 (dd, 1H, 
J = 11.3, 14.3 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); Hydrate δ 153.4, 151.8, 143.7 (ArC4), 138.8 (ArC3’), 
137.8 (i-Ph), 129.3, 128.2, 127.4, 126.1 (p-Ph), 124.6 (ArC2’), 124.8 (q, J = 289.2, CF3), 
122.9 (ArC2), 98.6 (ArC4’), 93.4 (q, J = 29.8 Hz, β-C), 60.6 (α-C), 35.3 (PhCH2). 
19F NMR (acetone-d6, 282 MHz); Hydrate δ -79.0 (s, 3F). 
HRMS (EI) 586.9992 (M+); C22H17F3IN3O3S requires 586.9987. 
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E-{4-[4-(1S*,2R*)-(1-Benzyl-3,3,3-trifluoro-2-hydroxypropylsulfamoyl)phenylazo) 
benzyl] carbamic acid 9H-fluoren-9-yl methyl ester} (4.53) 
 
N N
O2S N
H OH
H
NO
O
CF3
Ph
4.53
 
Sulfanilamide 4.38 (205 mg, 0.60 mmol, single diastereomer) and nitrosobenzene 4.24 
(215 mg, 0.60 mmol) in glacial acetic acid (2.4 mL) were condensed following General 
Method K. Column chromatography of the crude azobenzene (1:4 ethyl acetate/ 
dichloromethane) gave 4.53 as an orange solid (126 mg, 29 %, single diastereomer). 
mp 110-112 °C 
1H NMR (acetone-d6, 500 MHz); δ 8.08 (d, 2H, J = 8.1 Hz, ArH2’), 7.99 (d, 2H, J = 7.4 
Hz, FmocHa), 7.89 (d, 2H, J = 8.4 Hz, ArH2), 7.84 (d, 2H, J = 7.4 Hz, FmocHd), 7.72 (d, 
2H, J = 8.4 Hz ArH3), 7.68 (d, 2H, J = 8.1 Hz, ArH3’), 7.54 (t, 2H, J = 7.4 Hz, FmocHb), 
7.45 (t, 2H, J = 7.4 Hz, FmocHc), 7.26 (t, 1H, J = 5.6 Hz, FmocNH), 7.17 (m, 3H, m-Ph, 
NH), 7.13 (m, 3H, o/p-Ph), 6.03 (d, 1H, J = 6.8 Hz, OH), 4.60 (d, 2H, J = 6.2 Hz, 
NHCH2), 4.56 (d, 3H, J = 6.9 Hz, β-H, FmocCH2), 4.39 (t, 1H, J = 6.9 Hz, FmocCH), 
3.93 (m, 1H, α-H), 3.08 (dd, 1H, J = 2.7, 14.4 Hz, PhCHa), 2.95 (t, 1H, J = 7.2 Hz, 
PhCHb). 
13C NMR (acetone-d6, 75 MHz); δ 154.2, 151.8, 144.7, 144.5, 142.7, 141.5, 137.5, 129.4, 
128.5, 128.4, 127.9, 127.8, 127.3, 126.5, 125.4, 125.4 (q, J = 282.6 Hz, CF3), 123.4, 123.1, 
120.2, 73.0 (q, J = 28.8 Hz, β-C), 66.3 (FmocCH2), 56.1 (α-C), 47.5 (NHCH2), 44.3 
(FmocCH), 34.2 (PhCH2). Could not detect the carbamate peak over the baseline noise. 
19F NMR (acetone-d6, 282 MHz); δ -74.2 (d, 3F, J = 8.0 Hz). 
LRMS (ES) 715.2 (MH+); C38H34F3N4O5S requires 715.2. 
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E-{4-[4-(1S*-Benzyl-3,3,3-trifluoro-2-oxopropylsulfamoyl)phenylazo)benzyl] 
carbamic acid 9H-fluoren-9-ylmethyl ester} 4.54 
 
N N
O2S N
H O
H
NO
O
CF3
Ph
4.54
 
Trifluoromethyl carbinol 4.53 (72 mg, 100 µmol, single diastereomer) was oxidised with 
TEMPO/NaOCl over 3 h in a mixture of ethyl acetate/dichloromethane (2:1, 15 mL) 
following General Method G. The crude product was recrystallised from aqueous MeOH 
to afford the hydrate of 4.54 as an orange solid (28 mg, 39 %, racemic). 
mp 147-148 °C 
1H NMR (acetone-d6, 500 MHz); Hydrate δ 8.09 (d, 2H, J = 7.8 Hz, ArH2’), 7.99 (d, 2H, J 
= 7.4 Hz, FmocHa), 7.84 (d, 4H, J = 7.2 Hz, ArH2, FmocHd), 7.69 (m, 4H, ArH3, ArH3’), 
7.55 (t, 2H, J = 7.3 Hz, FmocHb), 7.46 (t, 2H, J = 7.2 Hz, FmocHc), 7.34 (d, 1H, J = 8.9 
Hz, NH), 7.26 (br m, 1H, FmocNH), 7.17 (d, 2H, J = 4.4 Hz, Ph), 7.05 (s, 3H, Ph), 6.38 (d, 
1H, J = 18.5 Hz, 2 x OH), 4.60 (s, 2H, NHCH2), 4.56 (d, 2H, J = 6.8 Hz, FmocCH2), 4.39 
(t, 1H, J = 6.6 Hz, FmocCH), 4.05 (t, 1H, J = 9.2 Hz, α-H), 3.37 (d, 1H, J = 14.2 Hz, 
PhCHa), 2.86 (dd, 1H, J = 12.4, 13.1 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); Hydrate δ 156.9 (OCONH), 154.0 (ArC1), 151.8 
(ArC1’), 144.6, 144.4, 142.9, 141.4, 137.8, 129.4, 128.4 (x 2), 127.8, 127.7, 127.2, 126.4, 
125.4, 124.1 (q, J = 289.2 Hz, CF3), 123.3, 123.0, 120.1, 93.6 (q, J = 29.7 Hz, β-C), 66.3 
(FmocCH2), 61.1 (α-C), 47.4 (NHCH2), 44.1 (FmocCH), 35.6 (PhCH2). 
19F NMR (acetone-d6, 282 MHz); Hydrate δ -79.0 (s, 3F). 
LRMS (ES) 731.3 (MH+); C38H34F3N4O6S requires 731.2. 
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E-{4-[4-(1S*,2R*)-(1-Benzyl-3,3,3-trifluoro-2-hydroxypropylsulfamoyl)phenylazo] 
benzoic acid ethyl ester} (4.55) 
 
N
EtO
O
N
O2S N
H
Ph
CF3
OH
4.55
 
Sulfanilamide 4.38 (264 mg, 0.70 mmol, single diastereomer) and 4-nitrosobenzoic acid 
ethyl ester 4.27 (126 mg, 0.70 mmol) in glacial acetic acid (2.8 mL) were condensed 
following General Method K for 5.5 h. Column chromatography of the crude azobenzene 
(3:7 ethyl acetate/petroleum ether) gave 4.55 as an orange solid (247 mg, 66 %, single 
diastereomer). An analytical sample was recrystallised from aqueous MeOH to give 
orange needles.  
mp 187-188 °C 
1H NMR (acetone-d6, 500 MHz); δ 8.38 (d, 2H, J = 8.3 Hz, ArH3’), 8.21 (d, 2H, J = 8.3 
Hz, (ArH2’), 7.94 (d, 2H, J = 8.3 Hz, ArH2), 7.74 (d, 2H, J = 8.3 Hz, ArH3), 7.20 (br s, 
1H, NH), 7.17 (m, 2H, m-Ph), 7.13 (m, 3H, o/p-Ph), 6.05 (d, 1H, J = 6.1 Hz, OH), 4.54 
(m, 3H, β-H, CH3CH2), 3.93 (m, 1H, α-H), 3.07 (dd, 1H, J = 2.8, 14.4 Hz, PhCHa), 2.95 
(dd, 1H, J = 10.8, 14.3 Hz, PhCHb), 1.53 (t, 1H, J = 7.1 Hz, CH3CH2). 
13C NMR (acetone-d6, 75 MHz); δ 165.4 (CO2Et), 155.1, 154.0, 143.4 (ArC4), 137.5 (i-
Ph), 133.3 (ArC4’), 130.8, 129.4, 128.5, 127.8, 126.6 (p-Ph), 125.4 (q, J = 283.8 Hz, CF3), 
123.5, 123.2, 73.1 (q, J = 29.1 Hz, β-H), 61.3 (CH3CH2O), 56.2 (α-C), 34.2 (PhCH2), 13.9 
(CH3CH2O). 
19F NMR (acetone-d6, 282 MHz); δ -74.2 (d, 3F, J = 8.0 Hz). 
HRMS (EI) 535.1380 (M+); C25H25F3N3O5S requires 535.1389. 
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E-[Azo-4,4’-bis(benzoic acid ethyl ester)] (4.56) 
 
N
EtO
O
N
OEt
O
4.56
 
A second orange product was isolated from the reaction mixture. From the 1H and 13C 
NMR spectra, the structure has been proposed to be the symmetrical azobenzene formed 
by self-condensation of 4.27. Recrystallisation from aqueous MeOH afforded 4.56 as fine 
orange needles (76 mg, 33 %) 
mp 137-138 °C 
1H NMR (acetone-d6, 500 MHz); δ 8.36 (d, 4H, J = 8.4 Hz, ArH3), 8.19 (d, 4H, J = 8.4 
Hz, ArH2), 4.53 (q, 4H, J = 7.1 Hz, CH2), 1.53 (t, 6H, J = 7.1 Hz, CH3). 
13C NMR (acetone-d6, 75 MHz); δ 165.3 (CO2Et), 155.0 (ArC1), 133.2 (ArC4), 130.7 
(ArC3), 123.1 (ArC2), 61.2 (CH3CH2), 13.9 (CH3CH2). 
HRMS (ES) 327.1356 (MH+); C18H19N2O4 requires 327.1345. 
 
E-{4-[4-(1S*-Benzyl-3,3,3-trifluoro-2-oxopropylsulfamoyl)phenylazo]benzoic acid 
ethyl ester} (4.57) 
 
N
EtO
O
N
O2S N
H
Ph
CF3
O
4.57
 
A solution of trifluoromethyl carbinol 4.56 (30 mg, 56 µmol) in dichloromethane (10 mL) 
was oxidised with Dess-Martin periodinane (ca. 60 %, 147 mg, 207 µmol) following 
General Method F. The crude product was purified down a silica plug (1:4 ethyl 
acetate/dichloromethane) and concentrated in vacuo to give 4.57 as an orange solid (25 
mg, 84 %, racemic).  
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1H NMR (acetone-d6, 500 MHz); Hydrate δ 8.38 (d, 2H, J = 8.5 Hz, ArH3’), 8.21 (d, 2H, J 
= 8.5 Hz, ArH2’), 7.90 (d, 2H, J = 8.5 Hz, ArH2), 7.73 (d, 2H, J = 8.5 Hz, ArH3), 7.36 (d, 
1H, J = 8.9 Hz, NH), 7.18 (m, 2H, m-Ph), 7.05 (m, 3H, o/p-Ph), 6.40 (s, 1H, OH), 6.36 (s, 
1H, OH), 4.54 (q, 2H, J = 7.1 Hz, CH3CH2), 4.06 (t, 1H, J = 8.7 Hz, α-H), 3.37 (dd, 1H, J 
= 2.2, 14.4 Hz, PhCHa), 2.86 (dd, 1H, J = 11.3, 14.2 Hz, PhCHb), 1.53 (t, 3H, J = 7.1 Hz, 
CH3CH2). 
13C NMR (acetone-d6, 75 MHz); Hydrate δ 165.6 (CO2Et), 154.9, 153.5, 144.0 (ArC4), 
137.8 (i-Ph), 132.9 (ArC4’), 130.6 (ArC3’), 129.3, 128.2, 127.5, 126.2 (p-Ph), 123.9 (q, J 
= 289.8 Hz, CF3), 123.2, 122.9, 93.5 (q, J = 29.8 Hz, β-C), 61.4 (CH3CH2O), 60.8 (α-C), 
35.4 (PhCH2), 13.8 (CH3CH2O). 
19F NMR (acetone-d6, 282 MHz); Hydrate δ -79.1 (s, 3F). 
HRMS (ES) 552.1395 (MH+); C25H25F3N3O6S requires 552.1416. 
 
E-{4-[4-(1S*,2R*)-(1-Benzyl-3,3,3-trifluoro-2-hydroxypropylsulfamoyl)phenylazo] 
benzoic acid} (4.58) 
 
N
HO
O
N
O2S N
H
Ph
CF3
OH
4.58
 
A solution of ester 4.55 (31 mg, 58 µmol, single diastereomer) in MeOH (2.5 mL) was 
hydrolysed with 0.25 M LiOH in MeOH/water (2:1, 350 µL, 87.5 µmol) at 70 °C until 
hydrolysis was complete by TLC. The solvent was removed in vacuo and the residue 
redissolved in water. The solution was acidified with 6 M aqueous HCl and the resulting 
precipitate taken up in ethyl acetate. The organic layer was washed with brine, dried over 
MgSO4 and concentrated in vacuo to afford an orange solid. Recrystallisation from 
aqueous acetone gave 4.58 as orange needles containing one water of crystallisation (30 
mg, 98 %, single diastereomer). 
mp 201-211 °C 
1H NMR (acetone-d6, 500 MHz); δ 8.40 (d, 2H, J = 8.5 Hz, ArH3’), 8.21 (d, 2H, J = 8.5 
Hz, ArH2’), 7.94 (d, 2H, J = 8.5 Hz, ArH2), 7.74 (d, 2H, J = 8.5 Hz, ArH3), 7.18 (m, 3H, 
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o-Ph, NH), 7.13 (m, 3H, m/p-Ph), 6.03 (br s, 1H), 4.57 (m, 1H, β-H), 3.94 (m, 1H, α-H), 
3.08 (dd, 1H, J = 2.9, 14.4 Hz, PhCHa), 2.95 (dd, 1H, J = 10.8, 14.4 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); δ 166.2 (COOH), 155.2 (ArC1’), 154.0 (ArC1), 143.4 
(ArC4), 137.5 (i-Ph), 133.4 (ArC4’), 131.1 (ArC3’), 129.4, 128.5, 127.8, 126.6 (p-Ph), 
125.4 (q, J = 288.5 Hz, CF3), 123.5, 123.1, 73.1 (q, J = 28.9 Hz, β-C), 56.2 (α-C), 34.2 
(PhCH2). 
19F NMR (acetone-d6, 282 MHz); δ -74.2 (d, 3F, J = 8.0 Hz). 
HRMS (ES) 508.1150 (MH+); C23H21F3N3O5S requires 508.1154. 
 
Ethylenediamine bridged dimer of 4.48 (4.59) 
 
N N
O2S N
H
CF3
Ph
OH
H
NN
H O
O
NN
S
O2
H
NF3C
Ph
OH
4.59
 
To a stirred solution of 4.48 (10.5 mg, 20 µmol) and ethylenediamine dihydrochloride (1.3 
mg, 10 µmol) in DMF (2 mL) was added HATU (8.4 mg, 22 µmol) and Hünigs base (7.6 
µL, 44 µmol). The solution was stirred overnight at rt under an inert atmosphere. The 
solution was diluted with ethyl acetate (20 mL) and washed with water, 10 % aqueous 
HCl, saturated aqueous NaHCO3 and brine, dried over MgSO4 and concentrated in vacuo 
to afford an orange solid (10 mg, 96 %). An analytical sample was recrystallised from 
MeOH. 
mp > 250 °C 
1H NMR (acetone-d6, 500 MHz); 8.48 (s, 2H, NHCO), 8.29 (d, 4H, J = 8.5 Hz, ArH3’), 
8.18 (d, 4H, J = 8.6 Hz, ArH2’), 7.92 (d, 4H, J = 8.6 Hz, ArH2), 7.81 (d, 2H, J = 7.96, 
NH), 7.73 (d, 4H, J = 8.6 Hz, ArH3), 7.18 (m, 4H, m-Ph), 7.13 (m, 6H, o/p-Ph), 6.52 (d, 
2H, J = 6.80 Hz, OH), 4.56 (m, 2H, β-H), 3.93 (m, 2H, α-H), 3.85 (m, 4H, NHCH2), 3.07 
(dd, 2H, J = 2.9, 14.5 Hz, PhCHa), 2.95 (dd, 2H, J = 10.9, 14.6 Hz, PhCHb). 
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13C NMR (acetone-d6, 75 MHz); δ 166.4 (CONH), 154.0, 153.8, 143.4 (ArC4), 137.8 (i-
Ph), 137.8 (ArC4’), 129.4, 128.8, 128.3, 127.7, 126.3 (p-Ph), 125.4 (q, J = 283.9 Hz, CF3), 
123.2, 123.0, 73.0 (q, J = 28.5 Hz, β-C), 56.2 (α-C), 40.12 (NHCH2), 34.1 (PhCH2). 
19F NMR (acetone-d6, 282 MHz); δ -74.2 (d, 6F, J = 7.9 Hz). 
LRMS (ES) 1039.4 (MH+); C48H45F6N8O8S2 requires 1039.3. 
 
E-{2S-[4-(4-Bromophenylazo)benzenesulfonylamino]-4-methylpentanoic acid 
(1S*,2R*)-(1-benzyl-3,3,3-trifluoro-2-hydroxypropyl)amide} (4.60) 
 
N N
Br
O2S N
H
H
N
O
CF3
Ph
OH
4.60
 
Sulfanilamide 4.42 (244 mg, 0.50 mmol, 2:3 mixture of diastereomers) and 4-bromo-
nitrosobenzene 4.25 (93 mg, 0.50 mmol) in glacial acetic acid (2.0 mL) were condensed 
following General Method K. Column chromatography of the crude azobenzene (1:9 ethyl 
acetate/dichloromethane) gave 4.60 as an orange solid (29 mg, 9 %) comprising a mixture 
of diastereomers (2:3 by 1H NMR). 
1H NMR (acetone-d6, 500 MHz);Mixture (2:3) δ 8.17-8.10 (m, 8H, ArH2, ArH3, major + 
minor), 8.04 (dd, 4H, J = 5.4, 8.3 Hz, ArH2’, major + minor), 7.95 (d, 4H, J = 8.5 Hz, 
ArH3’, major + minor), 7.65* (d, 1H, J = 8.1 Hz, TFMC NH), 7.60 (d, 1H, J = 8.8 Hz, 
TFMC NH), 7.38-7.28 (m, 10H, o/m/p-Ph, major + minor), 6.96* (d, 1H, J = 6.9 Hz, 
LeuNH), 6.82 (d, 1H, J = 8.7 Hz, LeuNH), 5.86* (d, 1H, J = 6.4 Hz, OH), 5.70 (d, 1H, J = 
6.4 Hz, OH), 4.44 (m, 1H, TFMC α-H), 4.34* (m, 1H, TFMC α-H), 4.12* (m, 1H, TFMC 
β-H), 3.97 (m, 2H, Leu α-H, major + minor), 3.93 (m, 1H, TFMC β-H), 3.13-2.91 (m, 4H, 
PhCH2, major + minor), 1.74* (m, 1H, LeuCH), 1.57 (m, 1H, LeuCH), 1.43* (m, 1H, 
LeuCH2), 1.14 (m, 1H, LeuCH2), 0.90* (d, 2H, J = 6.7 Hz, LeuCH3), 0.84 (d, 2H, J = 6.7 
Hz, LeuCH3), 0.80 (dd, 4H, J = 4.1, 6.3 Hz, LeuCH3, major + minor). 
13C NMR (acetone-d6, 75 MHz); Mixture δ 171.6* (CONH), 171.1 (CONH), 154.4, 154.3*, 
151.5, 151.5*, 143.7, 143.7*, 138.2, 138.0*, 132.9, 132.9*, 129.5, 129.5*, 128.5 (x 3), 
128.4, 126.6*, 126.5, 126.2 (ArC4’), 126.2* (ArC4’), 124.9, 124.9*, 123.3*, 123.2, 71.7 (q, 
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J = 29.3 Hz, β-C), 71.0* (q, J = 29.3 Hz, β-C), 55.5*, 55.2, 51.3*, 50.4, 42.3, 42.3*, 34.6*, 
34.2, 24.2*, 24.1, 22.6, 22.6*, 20.9, 20.8*. The quartets due to the CF3 could not be detected 
over the baseline noise. 
19F NMR (acetone-d6, 282 MHz); Mixture (2:3) δ -74.2* (d, 3F, J = 7.5 Hz), -74.4 (d, 3F, J 
= 8.0 Hz). 
HRMS (ES) 655.1207 (MH+); C28H31BrF3N4O4S requires 655.1201. 
 
E-{2S-[4-(4-Iodophenylazo)benzenesulfonylamino]-4-methylpentanoic acid (1S*,2R*)-
(1-benzyl-3,3,3-trifluoro-2-hydroxypropyl)amide} (4.61) 
 
N N
I
O2S N
H
H
N
O
CF3
Ph
OH
4.61
 
Sulfanilamide 4.42 (122 mg, 0.25 mmol, 2:3 mixture of diastereomers) and 4-iodo-
nitrosobenzene 4.26 (58 mg, 0.25 mmol) in glacial acetic acid (1.0 mL) were condensed 
following General Method K. Column chromatography of the crude azobenzene (1:9 ethyl 
acetate/dichloromethane) gave 4.61 as an orange solid (40 mg, 23 %) comprising a mixture 
of diastereomers (2:3 by 1H NMR). 
[α]D = -10.7, (c = 0.28, MeOH) 
1H NMR (acetone-d6, 500 MHz); δ 8.16-8.10 (m, 12H, ArH2, ArH3 ArH3’, major + 
minor), 7.88 (dd, 4H, J = 5.4, 8.4 Hz, ArH2’, major + minor), 7.65* (d, 1H, J = 8.3 Hz, 
TFMC NH), 7.60 (d, 1H, J = 8.9 Hz, TFMC NH), 7.38-7.28 (m, 10H, o/m/p-Ph, major + 
minor), 6.96* (d, 1H, J = 6.8 Hz, LeuNH), 6.82 (d, 1H, J = 8.8 Hz, LeuNH), 5.86* (d, 1H, J 
= 6.5 Hz, OH), 5.70 (d, 1H, J = 6.4 Hz, OH), 4.44 (m, 1H, TFMC α-H), 4.34* (m, 1H, 
TFMC α-H), 4.13* (m, 1H, TFMC β-H), 3.97 (m, 2H, Leu α-H, major + minor), 3.93 (m, 
1H, TFMC β-H), 3.13-2.92 (m, 4H, PhCH2, major + minor), 1.74* (m, 1H, LeuCH), 1.57 
(m, 1H, LeuCH), 1.43* (m, 1H, LeuCH2), 1.14 (m, 1H, LeuCH2), 0.90* (d, 2H, J = 6.7 Hz, 
LeuCH3), 0.83 (d, 2H, J = 6.7 Hz, LeuCH3), 0.80 (dd, 4H, J = 4.1, 6.5 Hz, LeuCH3, major 
+ minor). 
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13C NMR (acetone-d6, 75 MHz); Mixture δ 171.7* (CONH), 171.1 (CONH), 154.4, 154.4*, 
152.0, 152.0*, 143.7 (ArC4), 143.3* (ArC4), 139.0 (ArC3’), 139.0* (ArC3’), 138.2 (i-Ph), 
138.1* (i-Ph), 129.6, 126.9*, 128.6 (x 3), 128.5, 126.6* (p-Ph), 126.5 (p-Ph), 125.5* (q, J = 
283.3 Hz, CF3), 125.3 (q, J = 283.6 Hz, CF3), 124.9, 124.9*, 123.4* (ArC2), 123.2 (ArC2), 
98.9* (ArC4’), 98.8 (ArC4’), 71.7 (q, J = 29.1 Hz, β-C), 71.0* (q, J = 29.0 Hz, β-C), 55.6*, 
55.4, 51.4*, 50.4, 42.3, 42.3*, 34.6*, 34.2, 24.2*, 24.1, 22.6, 22.6*, 20.9, 20.8*. 
19F NMR (acetone-d6, 282 MHz); Mixture (2:3) δ -74.1* (d, 3F, J = 7.7 Hz), -74.4 (d, 3F, J 
= 7.7 Hz). 
HRMS (ES) 703.1076 (MH+); C28H31F3IN4O4S requires 703.1063. 
 
E-{2S-[4-(4-Iodophenylazo)benzenesulfonylamino]-4-methylpentanoic acid (1S*-
benzyl-3,3,3-trifluoro-2-oxopropyl)amide} (4.62) 
 
N N
I
O2S N
H
H
N
O
CF3
Ph
O
4.62
 
A solution of trifluoromethyl carbinol 4.61 (12 mg, 17 µmol) in dichloromethane (10 mL) 
was oxidised with Dess-Martin periodinane (ca. 60 %, 46 mg, 65 µmol) following General 
Method F. The crude product was purified down a silica plug (1:3 ethyl 
acetate/dichloromethane) and concentrated in vacuo to give 4.62 as an orange solid (9 mg, 
76 %) comprising a mixture of diastereomers (1:1 by 1H NMR). One drop of D2O was 
added to the NMR sample to give exclusively hydrate. 
1H NMR (acetone-d6, 500 MHz); Hydrate, mixture of diastereomers (2:3) δ 8.12 (br s, 4H, 
2 x ArH2), 8.07 (br s, 4H, 2 x ArH3), 8.01 (d, 4H, J = 8.7 Hz, 2 x ArH3’), 7.91 (dd, 4H, J 
= 1.2, 8.8, Hz, 2 x ArH2’), 7.35-7.33 (m, 8H, 2 x o/m-Ph), 7.29-7.22 (m, 2H, 2 x p-Ph), 
4.43 (m, 2H, 2 x TFMC α-H), 3.92 (m, 2H, 2 x Leu α-H), 3.34 (m, 2H, 2 x PhCHa), 2.85 
(m, 2H, 2 x PhCHb), 1.58-0.85 (m, 6H, 2 x LeuCH, 2 x LeuCH2), 0.80 (d, 3H, J = 6.7 Hz, 
LeuCH3), 0.77 (d, J = 6.7 Hz, LeuCH3), 0.70 (d, J = 6.5 Hz, LeuCH3), 0.67 (d, J = 6.5 Hz, 
LeuCH3). 
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13C NMR (acetone-d6, 75 MHz); Hydrate, mixture of diastereomers (2:3) δ 173.8 (CONH), 
173.6* (CONH), 154.9 (ArC1), 154.9* (ArC1), 152.6 (ArC1’), 152.6* (ArC1’), 144.1 
(ArC4), 143.7* (ArC4), 139.6 (ArC3’), 139.6* (ArC3’), 139.1 (i-Ph), 138.9* (i-Ph), 130.2, 
130.2*, 129.1, 129.0, 129.0, 129.0, 127.1 (p-Ph), 127.0* (p-Ph), 125.5* (ArC2’), 125.5 
(ArC2’), 124.1 (ArC2), 124.0* (ArC2), 99.5* (ArC4’), 99.4 (ArC4’), 94.6* (q, J = 29.0 Hz, 
β-C), 94.5 (q, J = 30.1 Hz, β-C), 56.2, 56.2*, 56.0*, 55.8, 42.7 (LeuCH2), 42.5* (LeuCH2), 
35.0 (PhCH2), 35.0* (PhCH2), 24.7* (LeuCH), 24.6 (LeuCH), 23.3 (LeuCH3), 23.1* 
(LeuCH3), 21.4 (LeuCH3), 21.4* (LeuCH3). 
19F NMR (acetone-d6, 282 MHz); Hydrate, mixture (53:47) δ -80.0 (s, 3F), -80.2* (s, 3F). 
 
E-{2S-[4-(4’-Methoxybiphenyl-4-ylazo)benzenesulfonylamino]-3-phenylpropionic 
acid methyl ester} (4.63) 
 
N N
O2S N
H
OMe
O
Ph
MeO 4.63
 
4-Methoxybenzene boronic acid (15 mg, 0.10 mmol), aryl bromide 4.47 (60 mg, 0.12 
mmol), tetrakis(triphenylphosphine)palladium0 (2.2 mg, 5.0 µmol), tetrabutyl ammonium 
bromide (33 mg, 0.10 mmol) and KOH (17 mg, 0.30 mmol) in dry THF (3 mL) were 
reacted together following General Method L to give the desired product as an orange 
brown solid. Flash chromatography of the crude product (1:9 ethyl 
acetate/dichloromethane) followed by recrystallisation from aqueous MeOH afforded 4.63 
as an orange solid (12 mg, 23 %). 
[α]D = +34.5, (c = 0.067, MeOH) 
mp 192-194 °C 
1H NMR (CDCl3, 500 MHz); δ 8.01 (d, 2H, J = 8.5 Hz), 7.95 (d, 2H, J = 8.6 Hz, ), 7.88 (d, 
2H, J = 8.6 Hz) 7.73 (d, 2H, J = 8.5 Hz), 7.63 (d, 2H, J = 8.7 Hz, MeOArH2), 7.25 (m, 3H, 
o/p-Ph), 7.08 (dd, 2H, J = 1.7, 7.2 Hz, m-Ph), 7.02 (d, 2H, J = 8.7 Hz, MeOArH3), 5.16 (d, 
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1H, J = 9.2 Hz, NH), 4.28 (m, 1H, α-H), 3.88 (s, 3H, ArOCH3), 3.52 (s, 3H, CO2CH3), 
3.07 (dq, 2H, J = 6.0, 13.8 Hz, PhCH2). 
13C NMR (CDCl3, 75 MHz); δ 171.1 (CO2Me), 159.9 (i-MeOAr), 154.8, 151.1, 144.5, 
140.7, 134.8, 132.5, 132.3, 129.4, 128.7, 128.3, 128.2, 127.3, 123.9, 123.2, 114.4 (o-
MeOAr), 56.7 (CH3OAr), 55.4 (α-C), 52.5 (CO2CH3), 39.4 (PhCH2). 
HRMS (ES) 530.1739 (MH+); C29H27N3O5S requires 530.1749. 
 
E-{2S-[4-[4-(Fluoropyridin-3-yl)phenylazo]benzenesulfonylamino]-3-phenyl 
propionic acid methyl ester} (4.64) 
 
N N
O2S N
H
OMe
O
Ph
NF 4.64
 
2-Fluoropyridine-5-boronic acidξ (14 mg, 100 µmol), aryl bromide 4.47 (60 mg, 120 
µmol), tetrakis(triphenylphosphine)palladium0 (2.2 mg, 5.0 µmol), tetrabutylammonium 
bromide (33 mg, 100 µmol) and KOH (17 mg, 300 µmol) in dry THF (3 mL) were reacted 
together following General Method L to give the desired product as an orange brown solid. 
Flash chromatography of the crude product (1:9 ethyl acetate/dichloromethane) followed 
by recrystallisation from aqueous MeOH afforded 4.64 as an orange solid (14 mg, 27 %). 
mp 177-179 °C 
1H NMR (CDCl3, 500 MHz); δ 8.52 (s, 1H, PyH2), 8.07 (m, 3H, PyH4, ArH2’), 7.96 (d, 
2H, J = 8.2 Hz, ArH2), 7.90 (d, 2H, J = 8.2 Hz, ArH3’), 7.73 (d, 2H, J = 8.1 Hz, ArH3’), 
7.25 (m, 3H, m/p-Ph), 7.07 (m, 3H, PyH5, o-Ph), 5.18 (d, 1H, J = 9.1 Hz, NH), 4.29 (m, 
1H, α-H), 3.53 (s, 3H, OCH3), 3.07 (m, 2H, PhCH2).  
13C NMR (CDCl3, 75 MHz); δ 171.1 (CO2Me), 165.3 (d, J = 240.6 Hz, PyH6), 154.6, 
151.9, 146.0 (d, J = 15.1 Hz, PyC2), 141.2 (ArC4), 140.1 (i-Ph), 139.8 (d, J = 7.9 Hz, 
                                                 
ξ Kindly gifted by A. McCarthy. 
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PyC4), 134.8 (ArC4’), 133.7 (d, J = 4.9 Hz, PyC3), 129.4, 128.7, 128.2, 127.9, 127.4 (p-
Ph), 124.1, 123.3, 109.8 (d, J = 37.5 Hz, PyC5), 56.7 (α-C), 52.5 (OCH3), 39.4 (PhCH2). 
HRMS (ES) 519.1483 (MH+); C27H24FN4O4S requires 519.1502. 
 
E-{N-((1S*,2R*)-1-Benzyl-3,3,3-trifluoro-2-hydroxypropyl)-4-(4’-methoxybiphenyl-4-
ylazo)benzenesulfonamide} (4.65)  
 
N N
O2S N
H
Ph
CF3
OH
MeO 4.65
 
To a deoxygenated solution of aryl iodide 4.51 (51 mg, 87 µmol, single diastereomer) and 
tetrakis(triphenylphosphine)palladium0 (9 mg, 8 µmol) in toluene under nitrogen was 
added deoxygenated aqueous Na2CO3 (2 M, 300 µL) and 4-methoxybenzene boronic acid 
(12 mg, 79 µmol) dissolved in deoxygenated EtOH.29 The solution was heated at reflux for 
16 h, cooled to rt and poured into a 1:1 mixture of ether/water. The aqueous layer was 
separated, back extracted with dichloromethane and the combined organics washed with 
water and brine, dried over MgSO4 and concentrated in vacuo. Column chromatography 
(1:9 ethyl acetate/dichloromethane) of the crude product gave 4.65 as an orange solid (30 
mg, 67 %, single diastereomer). 
mp 190-195 °C 
1H NMR (acetone-d6, 500 MHz); δ 8.19 (d, 2H, J = 8.6 Hz, ArH2’), 8.01 (d, 1H, J = 8.6 
Hz, ArH3’), 7.91 (d, 2H, J = 8.6 Hz, ArH3), 7.87 (d, 2H, J = 8.8 Hz, MeOArH2), 7.73 (d, 
2H, J = 8.6 Hz, ArH2), 7.21 (d, 2H, J = 8.8 Hz, MeOArH3), 7.20-7.16 (m, 3H, NH, m-
Ph), 7.16-7.13 (m, 3H, o/p-Ph), 6.02 (d, 1H, J = 6.5 Hz, OH), 4.57 (m, 1H, β-H), 4.00 (s, 
3H, ArOCH3), 3.94 (d, 1H, J = 10.6 Hz, α-H), 3.08 (dd, 1H, J = 3.0, 14.3 Hz, PhCHa), 
2.96 (dd, 1H, J = 10.6, 14.3 Hz, PhCHb). 
13C NMR (acetone-d6, 75 MHz); δ 160.5 (MeOArC4), 154.3, 151.4, 144.5, 142.6, 137.5, 
132.1, 129.4, 128.5, 127.8, 127.4, 126.6 (p-Ph), 125.9 (q, CF3), 124.0, 123.1, 114.7 
(MeOArC3), 73.0 (q, J = 28.7, Hz β-C), 56.1, 55.1, 34.2 (PhCH2). 
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19F NMR (acetone-d6, 282 MHz); δ -74.2 (d, 3F, J = 7.9 Hz). 
HRMS (ES) 570.1678 (MH+); C29H27F3N3O4S requires 570.1674. 
 
 
7.5 Experimental work outlined in chapter five  
 
Isomerisation studies of the target compounds. 
 
7.5.1 Experimental setup 
 
Eight potential inhibitors were chosen for the isomerisation studies. The samples were 
prepared as ca. 10 mM solutions in deuterated acetonitrile or DMSO and analysed by 1H 
NMR in a 5 mm quartz NMR tube. Samples were irradiated with a 500 W high pressure 
mercury arc lamp filtered to allow either UV or visible light transmission. A Schott UG11 
filter (230 < λ < 410 nm) or a Corning 7-37 filter (310 < λ < 390 nm) afforded Z-isomer 
enrichment while a Corning 0-51 filter (λ > 380 nm) afforded enrichment of the E-isomer. 
The filter was mounted at the end of a plastic tube 30 cm in length which contained a 17 
cm water cell with quartz glass windows to allow passage of UV and visible light but 
reduce sample heating from infrared radiation. Samples were placed an additional 5 cm 
from the filter. 
 
7.5.2 Isomerisation of the target molecule 
 
A typical experiment involved recording an NMR spectrum of the freshly prepared sample 
to ensure 100 % E-enrichment. If significant amounts of ketone were present, 10 µL of 
H2O was added to give hydrate exclusively. The use of H2O rather than D2O was 
important to prevent deuterium exchange of the NH and OH peaks which were necessary 
for integration. The sample was then irradiated with filtered UV light for 75-90 min in a 
darkened fumehood to enrich the sample with the Z-isomer. The sample was encased with 
foil to protect from ambient light and analysed by 1H NMR immediately after irradiation. 
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E/Z ratios were determined by measurement of the average E/Z integrals of appropriate 
non-overlapping proton resonances. Typically, the hydrate OH, α-H and NH signals were 
used depending on the degree of overlap. The sample was then irradiated with visible light 
for 75-90 min and analysed in an analogous manner. The photostationary state was 
determined by leaving the sample sitting on a window sill for one or two days then 
measuring the E/Z ratio by 1H NMR. All experiments were repeated on the same samples 
and agree within ± 2 %. The average value has been reported, rounded to the nearest 1 %. 
 
7.5.3 Selected data from 1H NMR studies 
 
Selected NMR data for the UV irradiated samples dissolved in deuterated acetonitrile have 
been listed below. Data for the initial ca. 100 % E-hydrate samples have also been 
included for comparison. Only the NH, OH and α-H protons has been assigned as they are 
the peaks of interest. Resonances for the Z-isomer are found upfield of the corresponding 
E-isomer peak. 
 
N-(1S*-Benzyl-3,3,3-trifluoro-2-oxopropyl)-4-phenylazobenzenesulfonamide (4.12) 
 
1H NMR (CD3CN, 500 MHz); E-4.12 δ 8.04 (dd, 2H, J = 1.7, 7.7 Hz), 7.74 (d, 2H, J = 8.5 
Hz), 7.68 (m, 3H), 7.59 (d, 2H, J = 8.5 Hz), 7.03 (m, 2H), 6.99 (m, 3H), 6.36 (d, 1H, J = 
9.1 Hz, NH), 5.40 (d, 2H, J = 4.2 Hz, OH), 3.89 (m, 1H, α-H), 3.20 (dd, 1H, J = 2.4, 14.4 
Hz), 2.62 (dd, 1H, J = 11.5, 14.3 Hz). 
1H NMR (CD3CN, 500 MHz); Z-4.12 from mixture δ 7.32 (m), 7.14 (m), 7.06 (d, J = 7.5 
Hz), 6.86 (d, J = 7.8 Hz), 6.71 (d, J = 8.3 Hz), 6.17 (d, J = 9.2 Hz, NH), 5.32 (d, J = 3.1 
Hz, OH), 3.84 (m, α-H), 3.18 (m), 2.58 (dd, J = 11.3, 14.1 Hz). 
1H NMR (DMSO-d6, 500 MHz); E-4.12 δ 8.10 (d, 1H, J = 9.2 Hz, NH), 8.05 (dd, 2H, J = 
1.4, 7.1 Hz), 7.81 (d, 2H, J = 8.3 Hz), 7.74 (m, 3H), 7.63 (d, 2H, J = 8.4 Hz), 7.21 (s, 1H, 
OH), 7.12 (s, 1H, OH), 7.09 (d, 2H, J = 7.2 Hz), 7.02 (m, 3H), 3.97 (m, 1H, α-H), 3.20 (d, 
1H, J = 12.5 Hz), 2.63 (d, 1H, J = 10.8 Hz). 
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1H NMR (DMSO-d6, 500 MHz); Z-4.12 from mixture δ 7.87 (d, J = 9.4 Hz, NH), 7.37 
(m), 7.14 (m), 7.09 (d, J = 7.8 Hz), 6.93 (d, J = 7.9 Hz), 6.82 (d, J = 8.4 Hz), 3.90 (m, α-
H), 3.17 (m), 2.53 (dd, J = 10.3, 14.1 Hz). 
 
4-Methyl-2S-(4-phenylazobenzenesulfonylamino)pentanoic acid (1S*-benzyl-3,3,3-
trifluoro-2-oxopropyl)amide (4.16) 
 
1H NMR (CD3CN, 500 MHz); E-4.16 (2:3 mixture of diastereomers) δ 8.01 (m), 7.66 (dd, 
J = 3.1, 6.9 Hz), 7.29 (m), 6.19* (d, J = 6.6 Hz, NH), 6.13 (d, J = 8.3 Hz, NH), 5.64* (s, 
OH), 5.57* (s, OH), 5.50 (s, OH), 5.45 (s, OH), 4.24 (m), 3.71 (m), 3.63* (m), 3.23 (m), 
2.87* (m), 2.77 (m). 
1H NMR (CD3CN, 500 MHz); Z-4.16 (2:3 mixture of diastereomers) δ 7.74 (d, J = 8.4 
Hz), 7.00 (d, J = 8.4 Hz), 6.92 (m), 6.11* (d, J = 6.6 Hz, NH), 6.03 (d, J = 8.1 Hz, NH), 
3.59 (m), 3.50* (m). 
 
N-(1S*-Benzyl-3,3,3-trifluoro-2-oxopropyl)-3-(4-bromophenylazo)benzene 
sulfonamide (4.44) 
 
1H NMR (CD3CN, 500 MHz); E-4.44 δ 8.01 (d, 1H, J = 7.9 Hz), 7.94 (d, 2H, J = 8.7 Hz), 
7.84 (m, 3H), 7.63 (d, 1H, J = 7.8 Hz), 7.53 (t, 1H, J = 7.9 Hz), 7.00 (d, 2H, J = 7.4 Hz), 
6.92 (t, 2H, J = 7.3 Hz), 6.87 (t, 1H, J = 7.2 Hz), 6.31 (d, 1H, J = 9.0 Hz, NH), 5.33 (d, 2H, 
J = 7.8 Hz, OH), 3.91 (t, 1H, J = 9.8 Hz, α-H), 3.18 (d, 1H, J = 14.1 Hz), 2.60 (dd, 1H, J = 
11.9, 13.9 Hz). 
1H NMR (CD3CN, 500 MHz); Z-4.44 from mixture δ 7.50 (d, J = 8.4 Hz), 7.19 (m), 7.11 
(m), 7.04 (d, J = 8.8 Hz), 6.89 (dd, J =1.5, 7.0 Hz), 6.79 (d, J = 8.3 Hz), 6.13 (d, J = 9.2 Hz, 
NH), 5.26 (s, OH), 5.22 (s, OH), 3.82 (t, J = 8.8 Hz, α-H), 3.16 (dd, J = 2.5, 14.2 Hz), 
2.58 (dd, J = 11.2, 14.2 Hz). 
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N-(1S*-Benzyl-3,3,3-trifluoro-2-oxopropyl)-3-(4-iodophenylazo)benzenesulfonamide 
(4.46) 
 
1H NMR (CD3CN, 500 MHz); E-4.46 δ 8.06 (d, 2H, J = 7.5 Hz), 8.01 (d, 1H, J = 7.9 Hz), 
7.82 (s, 1H), 7.78 (d, 2H, J = 8.4 Hz), 7.63 (d, 1H, J = 7.0 Hz), 7.53 (t, 1H, J = 7.9 Hz), 
7.00 (d, 2H, J = 7.6 Hz), 6.92 (t, 2H, J = 7.4 Hz), 6.87 (t, 1H, J = 7.3 Hz), 6.34 (d, 1H, J = 
8.9 Hz, NH), 5.37 (d, 2H, J = 4.7 Hz, OH), 3.91 (t, 1H, J = 9.7 Hz, α-H), 3.18 (dd, 1H, J = 
1.4, 14.6 Hz), 2.60 (dd, 1H, J = 11.7, 14.0 Hz). 
1H NMR (CD3CN, 500 MHz); Z-4.46 from mixture δ 7.70 (d, J = 8.5 Hz), 7.18 (d, J = 8.2 
Hz), 7.11 (d, J = 6.7 Hz), 7.03 (d, J = 7.2 Hz), 6.87 (dd, J = 1.5, 7.1 Hz), 6.65 (d, J = 8.6 
Hz), 6.15 (d, J = 9.2 Hz, NH), 5.30 (s, OH), 5.27 (s, OH), 3.82 (t, J = 8.9 Hz, α-H), 3.16 
(dd, J = 2.6, 14.2 Hz), 2.58 (dd, J = 11.1, 14.3 Hz). 
 
N-(1S*-Benzyl-3,3,3-trifluoro-2-oxopropyl)-4-(4-bromophenylazo)benzene 
sulfonamide (4.49) 
 
1H NMR (CD3CN, 500 MHz); E-4.49 δ 7.94 (d, 2H, J = 8.1 Hz), 7.85 (d, 2H, J = 8.2 Hz), 
7.74 (d, 2H, J = 8.1 Hz), 7.58 (d, 2H, J = 8.2 Hz), 7.03 (d, 2H, J = 4.9 Hz), 6.99 (m, 3H), 
6.33 (d, 1H, J = 9.0 Hz, NH), 5.35 (d, 2H, J = 2.74 Hz, OH), 3.89 (t, 1H, J = 9.3 Hz, α-H), 
3.19 (d, 1H, J = 14.4 Hz), 2.62 (dd, 1H, J = 11.9, 13.8 Hz). 
1H NMR (CD3CN, 500 MHz); Z-4.49 from mixture δ 7.47 (d, J = 7.8 Hz), 7.34 (d, J = 7.7 
Hz), 7.15 (m), 7.07 (d, J = 7.3 Hz), 6.79 (d, J = 7.7 Hz), 6.72 (d, J = 7.8 Hz), 6.29 (d, J = 
9.2 Hz, NH), 5.57 (d, J = 7.3 Hz, OH), 3.86 (t, J = 9.4 Hz, α-H), 3.17 (d, J = 13.8 Hz), 
2.58 (dd, J = 11.7, 13.5 Hz). 
 
N-(1S*-Benzyl-3,3,3-trifluoro-2-oxopropyl)-4-(4-iodophenylazo)benzenesulfonamide 
(4.52) 
 
1H NMR (CD3CN, 500 MHz); E-4.52 δ 8.06 (d, 2H, J = 8.4 Hz), 7.79 (d, 2H, J = 8.4 Hz), 
7.74 (d, 2H, J = 8.4 Hz), 7.58 (d, 2H, J = 8.4 Hz), 7.02 (d, 2H, J = 5.3 Hz), 6.97 (m, 3H), 
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6.35 (br s, 1H, NH), 5.37 (s, 2H, OH), 3.88 (d, 1H, J = 11.0 Hz, α-H), 3.19 (d, 1H, J = 
14.4 Hz), 2.62 (dd, 1H, J = 11.8, 13.9 Hz). 
1H NMR (CD3CN, 500 MHz); Z-4.52 from mixture δ 7.67 (d, J = 8.6 Hz), 7.34 (d, J = 8.6 
Hz), 7.16 (m), 6.72 (d, J = 8.5 Hz), 6.66 (d, J = 8.6 Hz), 6.15 (br s, NH), 5.27 (s, OH), 3.85 
(d, J = 10.6 Hz, α-H), 3.17 (dd, J = 2.7, 14.3 Hz), 2.59 (dd, J = 11.1, 14.1 Hz). 
 
2S-[4-(4-Iodophenylazo)benzenesulfonylamino]-4-methylpentanoic acid (1S*-benzyl-
3,3,3-trifluoro-2-oxopropyl)amide (4.62) 
 
1H NMR (CD3CN, 500 MHz); E-4.62 (2:3 mixture of diastereomers) δ 8.06-7.96 (m), 7.93 
(d, J = 7.5 Hz), 7.84 (d, J = 7.7 Hz), 7.32 (m), 7.26 (m, J = 8.1 Hz), 7.09* (d, 1H, J = 8.5 
Hz, NH), 6.95 (d, 1H, J = 8.3 Hz, NH), 6.15* (br s, NH), 6.08 (br s, NH), 5.60* (br s, OH), 
5.52* (br s, OH), 5.46 (br s, OH), 5.41 (br s, OH), 4.22 (m), 3.70 (d, J = 7.8 Hz), 3.63* (dd, 
J = 4.2, 9.5 Hz), 3.23 (d, J = 14.2 Hz), 2.86* (m), 2.76 (t, J = 13.1 Hz). 
1H NMR (CD3CN, 500 MHz); Z-4.62 (2:3 mixture of diastereomers) δ 7.76 (d, J = 8.4 
Hz), 7.69 (d, J = 8.4 Hz), 7.51 (d, J = 8.4 Hz), 7.34-7.21 (m), 7.01 (d, J = 8.4 Hz), 6.96 (d, 
J = 8.3 Hz), 6.84 (t, J = 8.0 Hz), 6.28* (d, J = 6.5 Hz, NH), 6.19 (d, J = 8.2 Hz, NH), 5.94* 
(s, OH), 5.89 (s, OH), 5.85* (s, OH), 5.78 (s, OH), 4.26 (m), 3.59 (m), 3.51* (m), 3.26 (m), 
3.23 (m), 2.84* (m), 2.76 (m). 
 
N-(1S*-Benzyl-3,3,3-trifluoro-2-oxopropyl)-3-phenylazobenzamide (4.7) 
 
1H NMR (CD3CN, 500 MHz); E-4.7 δ 8.10 (t, 2H), 8.00 (dd, 2H, J = 1.4, J = 8.0 Hz), 7.79 
(d, 1H, J = 7.9 Hz), 7.69-7.63 (m, 4H), 7.45 (d, 1H, J = 8.2 Hz, NH), 7.34 (m, 4H), 7.26 (t, 
1H, J = 6.7 Hz), 6.30 (s, OH), 5.85 (s, OH), 4.39 (dd, 1H, J =7.1, 10.2 Hz, α-H), 3.35 (m, 
1H), 3.18 (m, 1H). 
1H NMR (CD3CN, 500 MHz); Z-4.7 from mixture δ 7.40 (d, J = 7.8 Hz), 7.16 (d, J = 8.1 
Hz), 7.11 (s), 6.93 (d, J = 7.7 Hz), 6.86 (d, J = 8.2 Hz), 6.16 (s, OH), 5.75 (s, OH), 4.32 (t, 
J = 9.9 Hz, α-H), 3.32 (m), 3.08 (t, 1H, J = 13.0 Hz). 
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